{"meta":{"query_hash":"ea743a271976","filters":{"venue":"The Breast"},"cohort_total":210,"direct_labels_cover":0,"predictions_cover":210,"exported":210,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/ea743a271976","api":"https://metacan.xera.ac/api/v1/cohort?venue=The+Breast"},"results":[{"id":"W1486057347","doi":"10.1016/j.breast.2015.04.011","title":"Evaluation of effect of self-examination and physical examination on breast cancer","year":2015,"lang":"en","type":"article","venue":"The Breast","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Breast self-examination; Cancer; Physical examination; Incidence (geometry); Randomized controlled trial; Breast cancer screening; Internal medicine; Gynecology; Mammography","score_opus":0.06934641618294667,"score_gpt":0.36870682776970737,"score_spread":0.2993604115867607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1486057347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966837,0.00012959428,0.000011586196,0.00027264177,0.000042625754,0.0003137966,0.000018025241,0.000012909741,0.0025151165],"genre_scores_gemma":[0.9997683,0.000007019607,0.000010489611,0.000022623564,0.0001384422,0.000022376777,0.0000070788255,0.0000058565734,0.000017792414],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998568,0.00030510448,0.000109958426,0.000104283616,0.00083644036,0.0000762102],"domain_scores_gemma":[0.9990841,0.00008041326,0.000104449085,0.00013772798,0.00054730225,0.000046003745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024368493,0.00007410429,0.00016410176,0.000043114425,0.000021079006,0.0000040316017,0.000044618027,0.000030305193,0.000012680547],"category_scores_gemma":[0.0000895593,0.000045727313,0.000027674296,0.00014115773,0.00005503724,0.00007538399,0.000016180924,0.00006118632,0.0000029706453],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006419325,0.00016835667,0.038713653,0.00012387964,0.0001053006,0.0000010263983,0.002987204,0.00031768176,0.005945307,0.00031010053,0.0001767139,0.95050883],"study_design_scores_gemma":[0.0017504347,0.00059154304,0.9737828,0.00021645188,0.00055550685,0.00010911538,0.00021744063,0.01592755,0.006709103,0.00008922267,0.000005072307,0.00004576849],"about_ca_topic_score_codex":0.00025481798,"about_ca_topic_score_gemma":0.000012843054,"teacher_disagreement_score":0.95046306,"about_ca_system_score_codex":0.00014013959,"about_ca_system_score_gemma":0.00009111068,"threshold_uncertainty_score":0.18647057},"labels":[],"label_agreement":null},{"id":"W1818272034","doi":"10.1016/j.breast.2015.05.006","title":"Neurological complications of breast cancer: A prospective cohort study","year":2015,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Fundação para a Ciência e a Tecnologia; Fundação Grünenthal","keywords":"Medicine; Breast cancer; Prospective cohort study; Peripheral neuropathy; Cumulative incidence; Incidence (geometry); Cancer; Chemotherapy; Cohort; Internal medicine; Radiation therapy; Surgery; Diabetes mellitus","score_opus":0.03006641433419097,"score_gpt":0.31314583517516453,"score_spread":0.28307942084097354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1818272034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9739962,0.00012718707,0.000024903366,0.012986373,0.000105386396,0.0023803937,0.00017785795,0.00008603768,0.010115649],"genre_scores_gemma":[0.9987497,0.00001649468,0.000010004528,0.00035831486,0.0001425258,0.0004514988,0.000005380181,0.000013896474,0.00025219098],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99897254,0.00008179555,0.00020442974,0.00023649218,0.00032625167,0.00017847905],"domain_scores_gemma":[0.9988974,0.00006207925,0.00010305772,0.0003134689,0.000520753,0.00010329439],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024020296,0.00013012727,0.00029894637,0.00004234656,0.00009709052,0.000006252266,0.00011845643,0.000029922012,0.00007138525],"category_scores_gemma":[0.00004403165,0.00007870071,0.000057010897,0.00029578558,0.00029063024,0.000033312677,0.00011069809,0.00019912912,0.000042270247],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071749993,0.0009713279,0.993312,0.0000062993763,0.0003437131,0.000007079351,0.00076481554,0.000011231499,0.000036915688,0.000093098846,0.0018070174,0.0019290199],"study_design_scores_gemma":[0.0019759913,0.0005756889,0.99479187,0.000031431708,0.00041818037,0.0008863854,0.0009121316,0.00007704057,0.000008567388,0.0001424406,0.000107303604,0.00007294387],"about_ca_topic_score_codex":0.0006447963,"about_ca_topic_score_gemma":0.000083932755,"teacher_disagreement_score":0.024753481,"about_ca_system_score_codex":0.000104687744,"about_ca_system_score_gemma":0.00011928652,"threshold_uncertainty_score":0.32093218},"labels":[],"label_agreement":null},{"id":"W1970896527","doi":"10.1016/j.breast.2014.12.005","title":"A systematic review and quality appraisal of international guidelines for early breast cancer systemic therapy: Are recommendations sensitive to different global resources?","year":2015,"lang":"en","type":"review","venue":"The Breast","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Toronto; University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Guideline; Critical appraisal; Health care; Low and middle income countries; Quality (philosophy); Systematic review; Intensive care medicine; MEDLINE; Cancer; Family medicine; Alternative medicine; Developing country; Internal medicine; Pathology","score_opus":0.27971907084183784,"score_gpt":0.5029809274211725,"score_spread":0.22326185657933467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970896527","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019014653,0.98040134,0.00013452848,0.007395558,0.00027313762,0.0044266693,0.0070757978,0.00003063378,0.00007221049],"genre_scores_gemma":[0.00069972465,0.9963953,0.00008971194,0.001096334,0.0004770392,0.00092351716,0.0001490267,0.000030415104,0.0001389459],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99696153,0.0004658412,0.0014328427,0.0003815184,0.0005314686,0.00022676769],"domain_scores_gemma":[0.99573576,0.00029951692,0.0012929451,0.00051502057,0.0019677659,0.00018898708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015331893,0.0003949245,0.0029740029,0.00006214486,0.000070466,0.000040737974,0.00034533342,0.0001235196,0.00001752962],"category_scores_gemma":[0.000581447,0.00021240328,0.00041332483,0.00026794086,0.00006436304,0.000055619083,0.00013597342,0.00016967094,0.000006810869],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031663262,0.00007036114,0.0004798496,0.8121154,0.0022418795,0.000004004759,0.00034205525,8.9763915e-7,6.243164e-7,0.00015736933,0.011402259,0.17286871],"study_design_scores_gemma":[0.000552347,0.0000795745,0.0013776447,0.9529304,0.0055451714,0.0033779615,0.0005594514,0.000007670131,9.1828404e-8,0.0000067788496,0.035274,0.00028894778],"about_ca_topic_score_codex":0.0009240033,"about_ca_topic_score_gemma":0.00011128551,"teacher_disagreement_score":0.17257977,"about_ca_system_score_codex":0.0004185236,"about_ca_system_score_gemma":0.00023933714,"threshold_uncertainty_score":0.86615545},"labels":[],"label_agreement":null},{"id":"W1977983810","doi":"10.1016/s0960-9776(11)70295-8","title":"Reappraising antiangiogenic therapy for breast cancer","year":2011,"lang":"en","type":"review","venue":"The Breast","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; National Institutes of Health; National Health Research Institutes; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; National Institute for Health and Care Research; Canada Research Chairs; GlaxoSmithKline; Pfizer Canada; Cancer Research Institute","keywords":"Medicine; Bevacizumab; Sunitinib; Breast cancer; Oncology; Chemotherapy; Metastatic breast cancer; Internal medicine; Cancer; Angiogenesis; Trastuzumab; Clinical trial; Pharmacology","score_opus":0.055788762876342754,"score_gpt":0.3466847822153159,"score_spread":0.29089601933897313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977983810","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000316087,0.99609977,0.00018655266,0.00007883822,0.00040035692,0.0007843377,0.0020023687,0.000017222523,0.00039892062],"genre_scores_gemma":[0.00022130158,0.99512005,0.000058911897,0.00017012822,0.0023959582,0.00049037667,0.0002756927,0.00013363585,0.0011339354],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99856573,0.00009562186,0.0003298422,0.0005178089,0.00009237891,0.00039860897],"domain_scores_gemma":[0.9987758,0.000024176778,0.0002859505,0.0007315781,0.00010777686,0.0000747211],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025036093,0.00043683476,0.00065903115,0.000043534852,0.00018260501,0.000035707555,0.00062260876,0.0003570015,0.00018143092],"category_scores_gemma":[0.00000425543,0.00025998065,0.0011194987,0.00012957616,0.00012248126,0.0000027691422,0.00011482876,0.00009871154,0.000024182651],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000070582275,0.000032268526,0.000011455873,0.0005315622,0.0005670893,4.4528835e-7,0.000011664201,2.6356832e-7,0.00013624705,0.00007614939,0.0071839676,0.9913783],"study_design_scores_gemma":[0.00021138767,0.000042354277,0.00010016334,0.000948387,0.00043284215,0.00055930123,0.000005715029,5.9891227e-7,0.00006236698,0.000013838613,0.99725217,0.00037088245],"about_ca_topic_score_codex":0.00009080565,"about_ca_topic_score_gemma":0.000020379362,"teacher_disagreement_score":0.99100745,"about_ca_system_score_codex":0.00002464504,"about_ca_system_score_gemma":0.00033764413,"threshold_uncertainty_score":0.9999852},"labels":[],"label_agreement":null},{"id":"W1979370923","doi":"10.1016/j.breast.2007.12.004","title":"Fulvestrant: Expanding the endocrine treatment options for patients with hormone receptor-positive advanced breast cancer","year":2008,"lang":"en","type":"review","venue":"The Breast","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"AstraZeneca","keywords":"Fulvestrant; Exemestane; Medicine; Oncology; Breast cancer; Metastatic breast cancer; Internal medicine; Tolerability; Anastrozole; Clinical trial; Tamoxifen; Cancer; Aromatase inhibitor; Adverse effect","score_opus":0.00941036389523718,"score_gpt":0.27771896031029164,"score_spread":0.26830859641505445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979370923","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0035400395,0.9905394,0.000033531345,0.00014807687,0.00015190065,0.0025399672,0.002912632,0.00002060293,0.00011384796],"genre_scores_gemma":[0.0025770545,0.9929611,0.00007323349,0.000020775098,0.00044620084,0.001316549,0.0019869746,0.0000887487,0.0005293804],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99856067,0.0001455466,0.0002756891,0.00045343148,0.00014666344,0.00041802865],"domain_scores_gemma":[0.9989591,0.00007055714,0.0002567235,0.00050570717,0.00011138432,0.00009651439],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000048972113,0.00052377797,0.0005974752,0.00003654922,0.0004931681,0.000028981176,0.00031581623,0.00019541595,0.000008416181],"category_scores_gemma":[0.000004840716,0.00023162052,0.0004351924,0.00015281014,0.00020072823,0.000006077315,0.00006433397,0.00020376875,0.000012431092],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006316147,0.0003114466,0.000020289981,0.00021879475,0.0015646155,0.000004201334,0.000075169766,0.000024571998,0.00027761524,0.000030463241,0.0008425994,0.9959986],"study_design_scores_gemma":[0.004755191,0.0025503305,0.0007083242,0.0032803698,0.002715576,0.002800026,0.0000725746,0.000003888751,0.000392965,0.0000058156274,0.98155075,0.0011642136],"about_ca_topic_score_codex":0.00003839322,"about_ca_topic_score_gemma":0.000006658898,"teacher_disagreement_score":0.9948344,"about_ca_system_score_codex":0.00011662601,"about_ca_system_score_gemma":0.0002077909,"threshold_uncertainty_score":0.94452107},"labels":[],"label_agreement":null},{"id":"W1979489779","doi":"10.1016/j.breast.2005.07.002","title":"Breast screening in the emerging world: High prevalence of breast cancer in Cairo","year":2005,"lang":"en","type":"article","venue":"The Breast","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"European School of Oncology","keywords":"Medicine; Breast cancer; Breast cancer screening; Family medicine; Context (archaeology); Physical examination; Mammography; Primary care; Stage (stratigraphy); Cancer; Gynecology; Internal medicine","score_opus":0.03372545689701683,"score_gpt":0.3262338909180351,"score_spread":0.2925084340210183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979489779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9602006,0.0017756121,0.00009438139,0.034558453,0.000088406756,0.0005315333,0.00023603416,0.000037120106,0.0024778575],"genre_scores_gemma":[0.9976837,0.00012749921,0.00017261223,0.0010223372,0.00046318115,0.00004846114,0.0000045657275,0.000020068894,0.00045755168],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980157,0.0001424951,0.00045928216,0.00029409947,0.000602232,0.00048617108],"domain_scores_gemma":[0.99905473,0.00010554586,0.00015674834,0.0005074764,0.000098798984,0.00007668954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094154,0.0002091233,0.0003267609,0.0002025928,0.00009105818,0.000022375945,0.00050266477,0.00005477445,0.0005813467],"category_scores_gemma":[0.0000149221305,0.00012692812,0.00009422917,0.0010524113,0.00016648072,0.00023341009,0.000095918775,0.00045503437,0.000014889993],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011234672,0.0001767192,0.7408168,0.00019023666,0.00005117489,0.00006855057,0.0031084276,0.0036574395,0.0007170098,0.00096311787,0.0010004601,0.2481266],"study_design_scores_gemma":[0.0010259567,0.000021562357,0.99199706,0.0014356922,0.000072534174,0.0026161019,0.0010122996,0.001282955,0.000071921684,0.000052883013,0.0002682426,0.00014279928],"about_ca_topic_score_codex":0.012033499,"about_ca_topic_score_gemma":0.008212714,"teacher_disagreement_score":0.25118026,"about_ca_system_score_codex":0.00013834164,"about_ca_system_score_gemma":0.00012258762,"threshold_uncertainty_score":0.99454546},"labels":[],"label_agreement":null},{"id":"W1983381186","doi":"10.1016/j.breast.2012.01.006","title":"A comparison of systemic breast cancer therapy utilization in Canada (British Columbia), Scotland (Dundee), and Australia (Western Australia) with models of “optimal” therapy","year":2012,"lang":"en","type":"article","venue":"The Breast","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Chemotherapy; Radiation therapy; Population; Demography; Systemic therapy; Demographics; Cancer; Epidemiology; Cancer registry; Endocrine system; Internal medicine; Oncology; Gynecology; Environmental health; Hormone","score_opus":0.19002479147791676,"score_gpt":0.37062475941530476,"score_spread":0.180599967937388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983381186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99628675,0.002821199,0.000046122288,0.00011433807,0.000051500243,0.00047968028,0.00016592053,0.000007683104,0.000026787198],"genre_scores_gemma":[0.9991652,0.00043044836,0.000031836385,0.000059727496,0.00006055444,0.000026443895,0.00001218518,0.000016030526,0.0001976047],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987126,0.00006474609,0.00035568568,0.00016165031,0.00039516916,0.00031013743],"domain_scores_gemma":[0.9992871,0.000026352083,0.00021528114,0.00020880473,0.00014747406,0.00011494712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020002108,0.00012634502,0.000463709,0.000027048725,0.000043182194,0.000028497809,0.000116687275,0.000057203357,0.000101137375],"category_scores_gemma":[0.0000016682039,0.000111524336,0.000029195915,0.00021182455,0.00011418868,0.00019154034,0.000016943128,0.00013523336,2.9481652e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060102425,0.000075142925,0.9920907,0.00008528096,0.000072895135,0.000004586774,0.0007988247,0.0011253717,0.0005417979,0.000006612039,0.00029318308,0.0043045967],"study_design_scores_gemma":[0.0017931841,0.00012083463,0.9929979,0.0013498026,0.000044301567,0.0013194764,0.0015014063,0.0005405688,0.00019532387,0.0000067083006,0.000010672585,0.000119854325],"about_ca_topic_score_codex":0.9874509,"about_ca_topic_score_gemma":0.97649103,"teacher_disagreement_score":0.0109598115,"about_ca_system_score_codex":0.00019169197,"about_ca_system_score_gemma":0.00035134816,"threshold_uncertainty_score":0.45478302},"labels":[],"label_agreement":null},{"id":"W1984199328","doi":"10.1016/j.breast.2013.07.011","title":"Preclinical recapitulation of antiangiogenic drug clinical efficacies using models of early or late stage breast cancer metastatis","year":2013,"lang":"en","type":"review","venue":"The Breast","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Medicine; Sunitinib; Bevacizumab; Breast cancer; Metastatic breast cancer; Oncology; Cancer; Internal medicine; Context (archaeology); Clinical trial; Paclitaxel; Chemotherapy","score_opus":0.3010749332658669,"score_gpt":0.5013807287201687,"score_spread":0.20030579545430183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984199328","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.036794826,0.95761305,0.00004682616,0.00020334203,0.0004695211,0.0021201975,0.002631442,0.00003220296,0.000088579014],"genre_scores_gemma":[0.0079609165,0.9882538,0.00041875066,0.000030439362,0.00044851072,0.00008506575,0.0001318422,0.0000757386,0.0025949478],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966247,0.0006745594,0.0016546487,0.00041511533,0.00032861085,0.0003023703],"domain_scores_gemma":[0.9968813,0.0008284319,0.0013378459,0.0005636775,0.00024248709,0.00014628077],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00076556497,0.00041000466,0.0026860607,0.00015041705,0.000053849795,0.000011974764,0.00027094508,0.0002717045,0.0015663909],"category_scores_gemma":[0.000019359963,0.00022180722,0.0010924233,0.0003645639,0.00039797398,0.00011054965,0.00011883637,0.00042518857,0.000022802813],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014109447,0.0006566294,0.0007218031,0.007143279,0.0044552507,0.000015645897,0.00031604012,0.0001755754,0.0000189055,0.00005117934,0.00063202844,0.9844027],"study_design_scores_gemma":[0.040318858,0.0049101673,0.051415596,0.13895853,0.31009266,0.006287142,0.00033369902,0.022957874,0.00014293991,0.0006033555,0.4187688,0.005210386],"about_ca_topic_score_codex":0.0018422782,"about_ca_topic_score_gemma":0.00007271245,"teacher_disagreement_score":0.9791923,"about_ca_system_score_codex":0.000099188735,"about_ca_system_score_gemma":0.0009480436,"threshold_uncertainty_score":0.9993463},"labels":[],"label_agreement":null},{"id":"W1984366888","doi":"10.1016/s0960-9776(02)00284-9","title":"A case–control study of breast cancer and dietary intake of individual fatty acids and antioxidants in Montreal, Canada","year":2003,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Institute of Population and Public Health; University of Ottawa; Institut Universitaire de Gériatrie de Montréal; Université de Montréal","funders":"National Cancer Institute; Medical Research Council Canada","keywords":"Medicine; Breast cancer; Odds ratio; Polyunsaturated fatty acid; Quartile; Case-control study; Confidence interval; Arachidonic acid; Internal medicine; Physiology; Cancer; Vitamin E; Endocrinology; Population; Fatty acid; Antioxidant; Environmental health; Biochemistry","score_opus":0.008559678380930254,"score_gpt":0.22581398235553576,"score_spread":0.21725430397460552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984366888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99569625,0.0026313346,0.0000026824584,0.00006156009,0.00029241206,0.00023907797,0.0010108744,0.0000012571884,0.00006454861],"genre_scores_gemma":[0.99927735,0.0003029598,0.0000059252197,0.00006910497,0.00028870336,0.00001676832,0.0000041389867,0.000008964338,0.00002611098],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992345,0.000099816665,0.00019925227,0.00019100362,0.000116858006,0.00015854377],"domain_scores_gemma":[0.9995938,0.00001459043,0.00008710966,0.00020167034,0.00004705037,0.000055774024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019921034,0.00012081728,0.0002291886,0.00002757198,0.000040071194,0.000006390004,0.000086978805,0.000047260914,0.000009306914],"category_scores_gemma":[0.000010945302,0.00009018417,0.00002060781,0.00007806981,0.00009662519,0.00000394771,0.000048918057,0.000065530294,3.158827e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075590756,0.0004791232,0.8684285,0.00008441319,0.00056150573,0.000017120043,0.0019243865,0.00008444468,0.05759454,0.000021264668,0.0013733857,0.06867536],"study_design_scores_gemma":[0.0022022477,0.000083319836,0.99332595,0.000014498288,0.000101900376,0.0014601892,0.0017608844,0.000007014508,0.0006554427,0.0000077265695,0.00028028362,0.00010052695],"about_ca_topic_score_codex":0.40920195,"about_ca_topic_score_gemma":0.8340458,"teacher_disagreement_score":0.42484388,"about_ca_system_score_codex":0.000008657667,"about_ca_system_score_gemma":0.0001565683,"threshold_uncertainty_score":0.5947322},"labels":[],"label_agreement":null},{"id":"W1987049740","doi":"10.1016/j.breast.2014.01.003","title":"Lack of association between breast reconstructive surgery and the development of chronic pain after mastectomy: A propensity matched retrospective cohort analysis","year":2014,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Northwestern University","keywords":"Medicine; Mastectomy; Breast reconstruction; Breast cancer; Propensity score matching; Chronic pain; Retrospective cohort study; Incidence (geometry); Surgery; Reconstructive surgery; Cohort; Breast surgery; Cancer; Internal medicine; Physical therapy","score_opus":0.014795730296576865,"score_gpt":0.22600580914037652,"score_spread":0.21121007884379966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987049740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978323,0.00003702142,0.00057468977,0.00064837385,0.00006299732,0.00047277607,0.00007494628,0.000018137742,0.00027873093],"genre_scores_gemma":[0.9994645,0.00000505542,0.00015729445,0.000013313795,0.00016145804,0.000024914614,0.000031893607,0.000010818914,0.00013073209],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983826,0.00040798762,0.00049520703,0.00020919948,0.00031285465,0.00019211868],"domain_scores_gemma":[0.99832714,0.0005174329,0.0005565465,0.00024901674,0.00029666774,0.000053203377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037827126,0.0001504831,0.0008894931,0.00014568999,0.00009567573,0.0000118962935,0.00006737485,0.000107346495,0.000059165213],"category_scores_gemma":[0.00006290942,0.00008057521,0.00018260034,0.00046194217,0.00034484046,0.00006034293,0.000051747877,0.00018819747,0.000003666714],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006180603,0.000024230416,0.9273354,0.00006354915,0.0024625733,3.05804e-7,0.0004874919,6.2467404e-7,0.000062404026,0.000028185692,0.000009721825,0.068907455],"study_design_scores_gemma":[0.00091189553,0.000019893172,0.994887,0.000123019,0.0017652281,0.0011684855,0.00018434475,0.00018271491,0.00045510233,0.00020627947,0.0000043237424,0.00009173826],"about_ca_topic_score_codex":0.0001536335,"about_ca_topic_score_gemma":0.0002156507,"teacher_disagreement_score":0.068815716,"about_ca_system_score_codex":0.0002759338,"about_ca_system_score_gemma":0.00015825554,"threshold_uncertainty_score":0.32857618},"labels":[],"label_agreement":null},{"id":"W1988818641","doi":"10.1016/j.breast.2007.10.003","title":"Adjuvant and extended adjuvant use of aromatase inhibitors: Reducing the risk of recurrence and distant metastasis","year":2007,"lang":"en","type":"review","venue":"The Breast","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Exemestane; Letrozole; Tamoxifen; Anastrozole; Oncology; Aromatase inhibitor; Adjuvant therapy; Internal medicine; Aromatase; Breast cancer; Adjuvant; Adverse effect; Cancer","score_opus":0.027117066628117737,"score_gpt":0.29414762728639915,"score_spread":0.2670305606582814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988818641","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023220817,0.9751376,0.000022642696,0.000014360729,0.000091748,0.0005349362,0.0009545464,0.000004577391,0.000018752373],"genre_scores_gemma":[0.016577957,0.98297083,0.0001132617,0.0000051343545,0.00008818695,0.000016168326,0.00017552837,0.00002973122,0.000023191824],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99830747,0.00042591238,0.0005205541,0.00036606824,0.0001584647,0.00022155637],"domain_scores_gemma":[0.9983857,0.0001854938,0.0006253868,0.00066641584,0.00005499562,0.00008198625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007968727,0.00032517267,0.00076967716,0.000052900985,0.00010558006,0.000021817297,0.00022686212,0.00023532698,0.0000019679728],"category_scores_gemma":[0.00012484743,0.00015456174,0.00024968947,0.0001572143,0.0004982191,0.0000051663906,0.00026693195,0.000331167,8.9480875e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000081504746,0.000062606436,0.000013459392,0.0015581443,0.00049599604,0.000006680693,0.00006806469,0.0000012576074,0.0011008277,0.000032054726,0.00029426668,0.99628514],"study_design_scores_gemma":[0.001734289,0.00170596,0.0009932318,0.031483866,0.015321677,0.007236826,0.00044462245,0.00007954952,0.022192774,0.00018251012,0.91677034,0.0018543293],"about_ca_topic_score_codex":0.00011967713,"about_ca_topic_score_gemma":0.000005275856,"teacher_disagreement_score":0.9944308,"about_ca_system_score_codex":0.000008443339,"about_ca_system_score_gemma":0.00008973661,"threshold_uncertainty_score":0.6302845},"labels":[],"label_agreement":null},{"id":"W1995011952","doi":"10.1016/j.breast.2005.09.005","title":"A case of axillary web syndrome with subcutaneous nodules following axillary surgery","year":2005,"lang":"en","type":"article","venue":"The Breast","topic":"Lymphatic System and Diseases","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Axilla; Surgery; Breast cancer; Subcutaneous tissue; Axillary vein; Pain syndrome; Radiology; Cancer; Internal medicine","score_opus":0.011214561300843423,"score_gpt":0.2241166447661991,"score_spread":0.2129020834653557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995011952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949468,0.0022496004,0.000007822591,0.0007630965,0.000089801106,0.00026817142,0.00004416627,0.00007843291,0.0015521452],"genre_scores_gemma":[0.99906445,0.00002182518,0.0000856813,0.0002516837,0.00015077708,0.000012103652,0.000014745172,0.000033171054,0.00036554612],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.998896,0.00006620977,0.00030308389,0.00018435539,0.00029841345,0.00025196417],"domain_scores_gemma":[0.99889475,0.00028630535,0.0001084073,0.0004883709,0.00005943569,0.0001627077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024320431,0.00017101693,0.00044369872,0.000088092944,0.00009501025,0.0000147095,0.000080616395,0.000050220497,0.00011641979],"category_scores_gemma":[0.00004311829,0.00009648336,0.0002158772,0.00020782027,0.00009359165,0.00007588537,0.00003330753,0.000023365326,0.000059296017],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036118287,0.0016210323,0.3182001,0.0018078882,0.0022841892,0.60747886,0.002262437,0.00009706624,0.002799243,0.0002544012,0.004691463,0.0548915],"study_design_scores_gemma":[0.00095238525,0.0001254177,0.014761215,0.0005927648,0.00050937966,0.9815209,0.00083065394,0.000174824,0.00013565214,0.000010509697,0.00021972852,0.00016657848],"about_ca_topic_score_codex":0.00015938347,"about_ca_topic_score_gemma":0.000033907287,"teacher_disagreement_score":0.37404206,"about_ca_system_score_codex":0.00004943348,"about_ca_system_score_gemma":0.00026727133,"threshold_uncertainty_score":0.39344773},"labels":[],"label_agreement":null},{"id":"W1998162370","doi":"10.1016/j.breast.2012.07.003","title":"Does breast cancer tumor size really matter that much?","year":2012,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Hôpital du Saint-Sacrement; Université Laval","funders":"","keywords":"Breast cancer; Cancer; Breast tumor; Medicine; Medical physics; Oncology; Computer science; Internal medicine","score_opus":0.006909877168312911,"score_gpt":0.23864804288550356,"score_spread":0.23173816571719066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998162370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96818554,0.001594799,0.000021187667,0.023334268,0.0009617211,0.00031774453,0.000990841,0.00005057401,0.0045433296],"genre_scores_gemma":[0.99334395,0.00012801781,0.000059278053,0.0022799487,0.0017413511,0.00011087235,0.000028427386,0.000043994074,0.002264167],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988365,0.000066005305,0.00013446783,0.00028346176,0.00016768706,0.0005118332],"domain_scores_gemma":[0.9991778,0.00002973032,0.0000910379,0.000527873,0.00006142756,0.00011210339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012805994,0.00025712122,0.00017714726,0.000014462762,0.00019143427,0.000027686876,0.00027478093,0.000063946856,0.0007260185],"category_scores_gemma":[0.0000066220314,0.0001253295,0.00011350449,0.00006462689,0.00017765895,0.000010805173,0.00022147025,0.00008745195,0.0001915785],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039698946,0.00015706175,0.9462686,0.000027959133,0.00042219338,0.000003223653,0.00036271554,0.0000024261878,0.020666555,0.000063572275,0.026401183,0.0052274885],"study_design_scores_gemma":[0.00047610587,0.000011119712,0.97710615,0.000026060548,0.000098646,0.00063229573,0.000245412,5.33281e-7,0.0095105795,0.000047797268,0.0116082,0.00023711083],"about_ca_topic_score_codex":0.00071276247,"about_ca_topic_score_gemma":0.00018635362,"teacher_disagreement_score":0.030837506,"about_ca_system_score_codex":0.000045283337,"about_ca_system_score_gemma":0.000042697862,"threshold_uncertainty_score":0.7949394},"labels":[],"label_agreement":null},{"id":"W1998788444","doi":"10.1016/j.breast.2015.02.011","title":"Predictors of responses and sexual function for women in the St George breast boost randomized trial (StGBBT)","year":2015,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; George (robot); Sexual function; Randomized controlled trial; Internal medicine; Gynecology; Oncology; Artificial intelligence","score_opus":0.015465782158125232,"score_gpt":0.2556419737831769,"score_spread":0.24017619162505166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998788444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99614394,0.00049177377,0.000049144994,0.0012824492,0.00018914274,0.00103038,0.0004899104,0.0000073122487,0.0003159513],"genre_scores_gemma":[0.9983215,0.000025064743,0.000009616628,0.00010337822,0.00044414352,0.00048274224,0.000071521754,0.000013402555,0.0005286632],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9988555,0.00035808535,0.00021727159,0.0002007198,0.0001403902,0.0002280824],"domain_scores_gemma":[0.99929005,0.00021247024,0.00010807058,0.00026222726,0.00007878262,0.000048428097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015582533,0.00014298111,0.00028143902,0.00003093151,0.000074641,0.000015898355,0.0001426444,0.0000645758,0.000003937354],"category_scores_gemma":[0.00017586706,0.000076249176,0.000059317634,0.00007083888,0.00028539356,0.000005205608,0.00007550113,0.000049855953,8.049261e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98765975,0.00016305938,0.003900207,0.000014720239,0.00031844294,5.47199e-7,0.0016173231,0.00000489556,0.0011224557,0.00007067358,0.0030911074,0.002036842],"study_design_scores_gemma":[0.9169897,0.0014053715,0.06380693,0.000021177042,0.0003052067,0.00032628197,0.0078995945,0.00002580689,0.000471295,0.000600849,0.007889065,0.0002587113],"about_ca_topic_score_codex":0.00016454613,"about_ca_topic_score_gemma":0.000095099305,"teacher_disagreement_score":0.070670016,"about_ca_system_score_codex":0.000030213663,"about_ca_system_score_gemma":0.00009504473,"threshold_uncertainty_score":0.3109351},"labels":[],"label_agreement":null},{"id":"W2000462699","doi":"10.1016/s0960-9776(09)70002-5","title":"Clinical perspectives on the utility of aromatase inhibitors for the adjuvant treatment of breast cancer","year":2009,"lang":"en","type":"review","venue":"The Breast","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre Hospitalier de l’Université de Montréal; University of British Columbia","funders":"AstraZeneca","keywords":"Medicine; Aromatase; Adjuvant; Breast cancer; Oncology; Internal medicine; Gynecology; Aromatase inhibitor; Cancer","score_opus":0.0392571597724751,"score_gpt":0.36747072665262104,"score_spread":0.3282135668801459,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000462699","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028815551,0.99300694,0.000004065741,0.0004953299,0.00014496125,0.0014577395,0.0018678614,0.0000050138483,0.00013652939],"genre_scores_gemma":[0.038423188,0.96062696,0.0000052198734,0.000021347058,0.00053775427,0.00015438054,0.00010524209,0.000025515854,0.0001004],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998456,0.00038793287,0.0004886673,0.00034022034,0.0001298475,0.00019733151],"domain_scores_gemma":[0.9981997,0.00036204472,0.00044533782,0.00086646614,0.000078997706,0.000047457557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048916496,0.00031849663,0.0007669264,0.000018941315,0.00011872015,0.000008112539,0.00040209413,0.00029409045,0.000018332803],"category_scores_gemma":[0.000034787747,0.000113058464,0.0010582664,0.000093299146,0.00043515002,0.0000011729929,0.00005511741,0.00018274394,0.0000032155258],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030112773,0.00050906424,0.000016150263,0.0003063881,0.0010025391,9.743999e-7,0.00008305379,0.0000012019318,0.00005408912,0.00009038606,0.00240361,0.9952314],"study_design_scores_gemma":[0.0022324324,0.0038720851,0.003514961,0.005926488,0.007588819,0.00077340286,0.0010148395,0.000067336194,0.001769948,0.00008614758,0.97234815,0.0008054137],"about_ca_topic_score_codex":0.000073693314,"about_ca_topic_score_gemma":0.000006961467,"teacher_disagreement_score":0.994426,"about_ca_system_score_codex":0.000025917425,"about_ca_system_score_gemma":0.00023443949,"threshold_uncertainty_score":0.46103904},"labels":[],"label_agreement":null},{"id":"W2001293348","doi":"10.1016/j.breast.2013.04.002","title":"A pilot study of prospective memory functioning in early breast cancer survivors","year":2013,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Carleton University","funders":"Canadian Cancer Society","keywords":"Medicine; Depression (economics); Breast cancer; Cancer-related fatigue; Prospective cohort study; Cancer; Psychological intervention; Odds ratio; Center for Epidemiologic Studies Depression Scale; Physical therapy; Internal medicine; Clinical psychology; Oncology; Psychiatry; Cognition; Depressive symptoms","score_opus":0.0171175662123762,"score_gpt":0.25976573128747354,"score_spread":0.24264816507509734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001293348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927419,0.00014704387,0.0000046801774,0.0013941567,0.00023527635,0.002083044,0.000025195446,0.00005095679,0.003317753],"genre_scores_gemma":[0.9978609,0.000015732767,0.0000029659275,0.000094533854,0.00017794754,0.00059702114,0.000001251103,0.00002612913,0.0012235229],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988154,0.000092393326,0.00027158723,0.00024629943,0.0003104702,0.00026383405],"domain_scores_gemma":[0.9991624,0.000090711306,0.00011879469,0.00023674396,0.00033419512,0.000057200352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002105956,0.00016976356,0.00032454138,0.00012371222,0.000106386644,0.000013807481,0.00008707492,0.000019895087,0.00046486277],"category_scores_gemma":[0.000026185031,0.00011330551,0.000039521037,0.0004786799,0.00014928966,0.0001249767,0.000085469306,0.00028200683,0.00006574502],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012404977,0.0015118456,0.9844501,0.000030362788,0.00038036986,0.000006814171,0.0064189327,0.0000363537,0.0005975117,0.0000084094,0.00030359745,0.005015179],"study_design_scores_gemma":[0.0034669177,0.001564173,0.9845147,0.00023654623,0.00016181324,0.00014780572,0.009665791,0.000034259374,0.00005230387,0.000044566976,0.0000023364569,0.00010875745],"about_ca_topic_score_codex":0.106148295,"about_ca_topic_score_gemma":0.012901038,"teacher_disagreement_score":0.09324725,"about_ca_system_score_codex":0.00022148139,"about_ca_system_score_gemma":0.00007264561,"threshold_uncertainty_score":0.89980394},"labels":[],"label_agreement":null},{"id":"W2003862238","doi":"10.1016/j.breast.2010.06.004","title":"Factors associated with upgrading to malignancy at surgery of atypical ductal hyperplasia diagnosed on core biopsy","year":2010,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôpital du Saint-Sacrement","funders":"","keywords":"Medicine; Malignancy; Core biopsy; Biopsy; Hyperplasia; Core (optical fiber); General surgery; Radiology; Pathology; Internal medicine; Cancer; Breast cancer","score_opus":0.05039637274487417,"score_gpt":0.25628790448620653,"score_spread":0.20589153174133235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003862238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99792856,0.0000121245685,0.0000017368382,0.0010604989,0.00019086202,0.00023057783,0.000084968146,0.00004875112,0.00044191236],"genre_scores_gemma":[0.99930847,8.2351596e-7,0.000015816799,0.00012775094,0.0001202769,0.0000111876825,0.000049961604,0.000032280896,0.00033344192],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989668,0.000033410157,0.00019882944,0.00021593508,0.0003005887,0.00028439527],"domain_scores_gemma":[0.9988256,0.00039796997,0.000095148855,0.0003895704,0.00008678603,0.00020490192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018651418,0.0001822829,0.00036009,0.00009539635,0.0001173818,0.000008179116,0.0001105938,0.00010500127,0.0002758401],"category_scores_gemma":[0.00015165877,0.00009695794,0.0001271974,0.0003075816,0.00013354514,0.000024864317,0.000048501082,0.0002505251,0.000033502136],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063970045,0.00025564042,0.9489049,0.0000116435585,0.000072840005,0.00009084229,0.00025448276,6.472492e-7,0.047423873,0.00037933857,0.0010502125,0.0009158837],"study_design_scores_gemma":[0.0004977036,0.00012243984,0.99515307,0.0002343292,0.00008495588,0.0009080837,0.00013542108,0.000007629622,0.0026651102,0.000010065592,0.00006174669,0.00011946574],"about_ca_topic_score_codex":0.00006259024,"about_ca_topic_score_gemma":0.00007936186,"teacher_disagreement_score":0.046248153,"about_ca_system_score_codex":0.000051644125,"about_ca_system_score_gemma":0.00007585593,"threshold_uncertainty_score":0.395383},"labels":[],"label_agreement":null},{"id":"W2004864041","doi":"10.1054/brst.2001.0404","title":"Surveillance mammography after treatment of primary breast cancer: a systematic review","year":2002,"lang":"en","type":"review","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre; Ottawa Regional Cancer Foundation; University of Ottawa","funders":"National Cancer Institute","keywords":"Medicine; Mammography; Breast cancer; Systematic review; Observational study; Randomized controlled trial; Regimen; Stage (stratigraphy); Oncology; Cancer; Internal medicine; MEDLINE; Medical physics","score_opus":0.016771224713844304,"score_gpt":0.2724177705024511,"score_spread":0.2556465457886068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004864041","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000008626613,0.9927327,0.0000016358167,0.0002206015,0.00013876622,0.002444554,0.0041918107,0.000020489211,0.0002408347],"genre_scores_gemma":[0.00021810987,0.9947941,0.0000113709475,0.00013525577,0.00032134124,0.0036967848,0.00034295168,0.00009057427,0.00038951583],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9973878,0.0004483596,0.000875094,0.0006126405,0.00027936418,0.00039669476],"domain_scores_gemma":[0.99748856,0.00006659607,0.00078439334,0.0014369078,0.00013784935,0.000085689666],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017896936,0.0007962074,0.0034129322,0.00007325222,0.00008216793,0.000016618136,0.00043626985,0.00019976476,0.000080166916],"category_scores_gemma":[0.000007926122,0.00042791775,0.0013547069,0.00035694882,0.00022377672,0.000003223009,0.00014612329,0.00009148869,0.00003742041],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000550894,0.0003051718,0.00025977282,0.77666014,0.0035388798,0.000012374398,0.000027506374,1.1985247e-7,8.350148e-7,0.0000030635608,0.0008987918,0.21823822],"study_design_scores_gemma":[0.00080993376,0.00019754337,0.0018200845,0.66407275,0.015156383,0.0046773953,0.000014075735,1.874252e-7,0.000002144728,0.0000028880197,0.3121514,0.0010952275],"about_ca_topic_score_codex":0.000118161704,"about_ca_topic_score_gemma":0.000064059044,"teacher_disagreement_score":0.3112526,"about_ca_system_score_codex":0.00019356236,"about_ca_system_score_gemma":0.00016465447,"threshold_uncertainty_score":0.99981725},"labels":[],"label_agreement":null},{"id":"W2008333014","doi":"10.1016/j.breast.2005.08.026","title":"Anti-angiogenic treatment of breast cancer using metronomic low-dose chemotherapy","year":2005,"lang":"en","type":"review","venue":"The Breast","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":84,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute; Krebsliga Schweiz; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Canadian Institutes of Health Research; European Commission","keywords":"Medicine; Breast cancer; Chemotherapy; Oncology; Internal medicine; Cancer; Tamoxifen; Lung cancer; Pharmacology","score_opus":0.035890944529173616,"score_gpt":0.3396441336567344,"score_spread":0.3037531891275608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008333014","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008399752,0.98959845,0.000023471965,0.00005068387,0.00018855838,0.00049854594,0.0011766262,0.000008571476,0.000055336215],"genre_scores_gemma":[0.0056566726,0.99147516,0.00006705956,0.000048057627,0.0019538112,0.00008921835,0.0001576654,0.00011105746,0.00044132172],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99848235,0.000102751015,0.00046391625,0.00047318812,0.00012405239,0.00035372595],"domain_scores_gemma":[0.9986471,0.000013880508,0.0004344682,0.000765583,0.000062203966,0.00007677065],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001105514,0.0005088431,0.0011146609,0.00007175752,0.00008632618,0.00001866131,0.00041359838,0.0002880587,0.0002461157],"category_scores_gemma":[9.913592e-7,0.00031526302,0.0012767536,0.00016382907,0.00014505959,0.0000031287207,0.000073094525,0.000055815457,0.000017916427],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042788408,0.00016486285,0.00010945962,0.00038831934,0.0013030311,8.875107e-7,0.000014856707,0.00004396615,0.0013954478,0.00000446324,0.00023240474,0.9962995],"study_design_scores_gemma":[0.00062094786,0.000080316386,0.00060989975,0.0011095081,0.0016656065,0.0005918682,0.000009933658,0.00002099063,0.00066994445,0.0000011123692,0.994105,0.0005149138],"about_ca_topic_score_codex":0.00033693996,"about_ca_topic_score_gemma":0.000037771806,"teacher_disagreement_score":0.9957846,"about_ca_system_score_codex":0.00022231654,"about_ca_system_score_gemma":0.00050462957,"threshold_uncertainty_score":0.99992996},"labels":[],"label_agreement":null},{"id":"W2009740420","doi":"10.1016/j.breast.2007.09.001","title":"Benefit from adjuvant taxanes and endocrine responsiveness in breast cancer","year":2007,"lang":"en","type":"review","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Taxane; Medicine; Oncology; Internal medicine; Adjuvant; Breast cancer; Cancer; Chemotherapy; Clinical trial; Retrospective cohort study","score_opus":0.02650017942233748,"score_gpt":0.33056835277771524,"score_spread":0.3040681733553778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009740420","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003151562,0.9920234,0.0000023906873,0.0004799293,0.00019639735,0.00043240143,0.0035908998,0.000013527381,0.00010946939],"genre_scores_gemma":[0.0027061265,0.99534357,0.000020829606,0.00012153675,0.00076264085,0.00026043362,0.00044980936,0.00007069405,0.0002643712],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982499,0.00012806663,0.00038899764,0.00064922083,0.00016204974,0.00042175676],"domain_scores_gemma":[0.9989157,0.00010885421,0.00022495782,0.0005950972,0.00007306651,0.00008233887],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000156284,0.000537785,0.0010030913,0.0000944803,0.00010714432,0.00002749062,0.00034939378,0.0002127501,0.000055559183],"category_scores_gemma":[0.00001129735,0.0003455127,0.00019622155,0.0001941874,0.0002068463,0.0000038767726,0.00040098827,0.00021931114,0.000014092657],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027980027,0.000057119945,0.0013493671,0.000549682,0.00041265375,0.00004195741,0.00003859809,0.0000014460157,0.000025665404,0.000020648975,0.00022707864,0.996996],"study_design_scores_gemma":[0.00083236955,0.000025721092,0.054328315,0.004605824,0.00079387514,0.0021687644,0.00006930691,4.643264e-7,0.000033991153,0.00005040318,0.9364968,0.00059414876],"about_ca_topic_score_codex":0.0034300967,"about_ca_topic_score_gemma":0.0019077539,"teacher_disagreement_score":0.99640185,"about_ca_system_score_codex":0.00009572421,"about_ca_system_score_gemma":0.00016748357,"threshold_uncertainty_score":0.9998997},"labels":[],"label_agreement":null},{"id":"W2012535287","doi":"10.1016/j.breast.2011.04.009","title":"The low uptake of breast screening in cities is a major public health issue and may be due to organisational factors: A Census-based record linkage study","year":2011,"lang":"en","type":"article","venue":"The Breast","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Health and Social Care Research and Development Division; Queen's University; Economic and Social Research Council; Public Health Agency; Queen's University Belfast","keywords":"Census; Medicine; Linkage (software); Record linkage; Public health; Environmental health; Family medicine; Population; Nursing; Genetics; Gene","score_opus":0.13912669738673927,"score_gpt":0.3322318786566331,"score_spread":0.19310518126989384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012535287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9746939,0.0001454862,0.00017302444,0.023640528,0.000060764854,0.00072020915,0.00023097984,0.000030387966,0.00030472793],"genre_scores_gemma":[0.99649405,0.0000069421426,0.00065050676,0.0025004733,0.00012057081,0.00002553176,0.000017461505,0.000021152542,0.00016330442],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982757,0.00015145417,0.00043421888,0.0002995889,0.00044936445,0.00038966056],"domain_scores_gemma":[0.99885416,0.0001384539,0.00015921339,0.00046816672,0.00017434239,0.00020564752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013545591,0.00017962728,0.0003398209,0.000113565664,0.00024290547,0.000046533314,0.00024139168,0.000048125978,0.0002837743],"category_scores_gemma":[0.000106934385,0.00010748888,0.000052049523,0.0003931397,0.0001426125,0.00009882139,0.000095672025,0.00022147225,0.000006122907],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001402559,0.00041528474,0.8900365,0.00009610666,0.00016045288,0.0000427721,0.036055006,0.0000025653019,0.00011390533,0.0003086464,0.0024478852,0.06891828],"study_design_scores_gemma":[0.0010443663,0.0004603357,0.96833086,0.00021955634,0.000026117283,0.00021580684,0.028383732,0.00005928487,0.000071023525,0.000042887947,0.0010410459,0.00010500179],"about_ca_topic_score_codex":0.010033931,"about_ca_topic_score_gemma":0.0021998908,"teacher_disagreement_score":0.07829431,"about_ca_system_score_codex":0.00007888735,"about_ca_system_score_gemma":0.000308625,"threshold_uncertainty_score":0.99655837},"labels":[],"label_agreement":null},{"id":"W2014818610","doi":"10.1016/j.breast.2007.07.011","title":"Application of aromatase inhibitors in endocrine responsive breast cancers","year":2007,"lang":"en","type":"review","venue":"The Breast","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Fulvestrant; Aromatase; Tamoxifen; Breast cancer; Oncology; Adjuvant; Pharmacogenomics; Letrozole; Anastrozole; Internal medicine; PI3K/AKT/mTOR pathway; Bioinformatics; Cancer; Pharmacology; Signal transduction","score_opus":0.010421762561595962,"score_gpt":0.30452407708163126,"score_spread":0.2941023145200353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014818610","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001218415,0.9972517,0.000019295388,0.000026563952,0.00008241829,0.0007155578,0.00035943446,0.000007781318,0.0003188449],"genre_scores_gemma":[0.0062030302,0.99243784,0.000018834613,0.000017934051,0.0002649044,0.00009241006,0.00081935397,0.000042331936,0.000103342594],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987388,0.00017386233,0.00040570242,0.00031006976,0.00012576605,0.00024578374],"domain_scores_gemma":[0.9990185,0.00004599117,0.00028805868,0.00054211874,0.000043375218,0.00006197429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030814827,0.00026519175,0.00050913193,0.00011406567,0.000034567463,0.000005962093,0.00030245614,0.00024012077,0.0000034953541],"category_scores_gemma":[0.000016806265,0.00017444484,0.00023087389,0.00029840844,0.00013706618,0.0000017716541,0.000117146694,0.00027879974,0.000020990274],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016200317,0.000052733565,0.000017297747,0.001107537,0.00014166985,0.000019810972,0.000013725068,0.000009807994,0.0015244662,0.00006260139,0.00065173133,0.9962366],"study_design_scores_gemma":[0.00046576746,0.0001126288,0.000082006314,0.0025213659,0.00031349604,0.0042894054,0.000032496526,0.0000065912154,0.0018010656,0.000012718774,0.9899836,0.00037883647],"about_ca_topic_score_codex":0.0002442316,"about_ca_topic_score_gemma":0.00003166876,"teacher_disagreement_score":0.9958578,"about_ca_system_score_codex":0.00007067109,"about_ca_system_score_gemma":0.00026174827,"threshold_uncertainty_score":0.7113654},"labels":[],"label_agreement":null},{"id":"W2019134258","doi":"10.1016/j.breast.2007.07.023","title":"Adjuvant therapy of the very young woman","year":2007,"lang":"en","type":"review","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Oncology; Radiation therapy; Cancer; Hormonal therapy; Hormone therapy; Gynecology","score_opus":0.03405988825776794,"score_gpt":0.3165928460238964,"score_spread":0.28253295776612847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019134258","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002885,0.9971314,0.0000044593303,0.00009203708,0.00031861837,0.00041660288,0.00018454189,0.000007705344,0.0015561483],"genre_scores_gemma":[0.0027304585,0.9960706,0.0000079725305,0.000099587975,0.00047012884,0.0000620501,0.00006818727,0.000045622997,0.00044536614],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988976,0.0001284159,0.00028320283,0.0002762357,0.00017318234,0.00024136242],"domain_scores_gemma":[0.9987284,0.000030407855,0.00026984274,0.00088992243,0.000053293592,0.000028111308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001838557,0.00032966805,0.00059085526,0.000024365598,0.00012331734,0.000009224158,0.0006156904,0.00017262824,0.000015677244],"category_scores_gemma":[0.000008927505,0.00014716267,0.0005309191,0.00014838138,0.00025401215,0.000001072588,0.00026322756,0.00014900292,0.000013455254],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004450324,0.000065004766,0.00015462388,0.00035725266,0.0006790336,0.0000014711106,0.000050910905,2.1731408e-7,0.000030893592,0.000030374129,0.0015799506,0.99700576],"study_design_scores_gemma":[0.00024987242,0.00003224941,0.0026099605,0.001053992,0.00025516565,0.0004905248,0.000027460917,4.2930488e-8,0.00014093831,0.000011702508,0.99494225,0.00018586605],"about_ca_topic_score_codex":0.000087654225,"about_ca_topic_score_gemma":0.00004923663,"teacher_disagreement_score":0.9968199,"about_ca_system_score_codex":0.000035535355,"about_ca_system_score_gemma":0.00014671574,"threshold_uncertainty_score":0.60011196},"labels":[],"label_agreement":null},{"id":"W2025143483","doi":"10.1016/j.breast.2012.04.006","title":"Breast reconstruction following mastectomy for invasive breast cancer is strongly influenced by demographic factors in women in Victoria, Australia","year":2012,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Monash University; Victoria University; University of Victoria","keywords":"Medicine; Breast reconstruction; Mastectomy; Logistic regression; Breast cancer; Demography; Gynecology; Cancer; Internal medicine","score_opus":0.016659051475937166,"score_gpt":0.2667565143855638,"score_spread":0.25009746290962664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025143483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99583656,0.0001166925,0.000011450828,0.00066751544,0.0014738728,0.0009264195,0.0008568816,0.000057991172,0.000052644864],"genre_scores_gemma":[0.9987775,0.000018544928,0.00005799672,0.000044060078,0.0005598104,0.0002427142,0.000056419638,0.000043882646,0.00019905217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99755114,0.00010314702,0.00058640115,0.00037068527,0.000285624,0.0011030218],"domain_scores_gemma":[0.99894303,0.00012042887,0.00023062849,0.00028743982,0.00008817557,0.0003302915],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005539245,0.00037265368,0.0005572504,0.00039831153,0.00014269089,0.0000405987,0.0001782026,0.00027482395,0.00028829224],"category_scores_gemma":[0.000011208896,0.0002706874,0.00020720476,0.00072674267,0.00016540589,0.00061368174,0.00003946335,0.00045784356,0.000013864163],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008490538,0.00011871041,0.952938,0.00007944627,0.00017634056,0.0000024926992,0.0019641584,0.0000050509566,0.0047341217,0.000017208047,0.0001516701,0.038963735],"study_design_scores_gemma":[0.0035781008,0.00004284773,0.96661794,0.00051088893,0.00011895984,0.024840942,0.0030505962,0.000019522646,0.0007401952,0.000095998956,0.000055395052,0.0003286143],"about_ca_topic_score_codex":0.0024660546,"about_ca_topic_score_gemma":0.00054400245,"teacher_disagreement_score":0.03863512,"about_ca_system_score_codex":0.0005776573,"about_ca_system_score_gemma":0.000169787,"threshold_uncertainty_score":0.99997455},"labels":[],"label_agreement":null},{"id":"W2028619707","doi":"10.1016/j.breast.2015.01.005","title":"Pregnancy after breast cancer: Are young patients willing to participate in clinical studies?","year":2015,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Pregnancy; Infertility; Fertility; Cancer; Gynecology; Obstetrics; Fertility preservation; Population; Disease; Endocrine system; Prospective cohort study; Family medicine; Internal medicine; Hormone; Environmental health","score_opus":0.1148903504952607,"score_gpt":0.4107326383296403,"score_spread":0.2958422878343796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028619707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938255,0.0014431773,0.0000049091263,0.0031713517,0.0008042557,0.00048293362,0.00011256158,0.000031370048,0.0001239523],"genre_scores_gemma":[0.99818754,0.00025380557,0.000013725769,0.0006897321,0.00039201428,0.00017800843,0.0000040718915,0.000025367553,0.00025575247],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859864,0.00007395164,0.00041826058,0.00027121062,0.00028674357,0.0003511857],"domain_scores_gemma":[0.99900633,0.000037027257,0.00010537682,0.00034567044,0.000217178,0.00028843852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031151995,0.00015771894,0.00038688074,0.00004765123,0.00003781001,0.000014719548,0.000108293854,0.000055408178,0.00004275186],"category_scores_gemma":[0.000068356356,0.00009687264,0.00008306455,0.00022556321,0.00008467117,0.000070603455,0.000108956534,0.00022236335,0.00007022034],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007829908,0.00018706349,0.9679013,0.000026083664,0.00006350196,0.000026013973,0.0022710464,0.000026100972,0.000001112079,0.0000025113995,0.0012012959,0.027510993],"study_design_scores_gemma":[0.0018606494,0.00011407797,0.9952042,0.0012504007,0.000091355105,0.00003503733,0.00066189223,0.00004441134,0.0000039223237,0.000025507019,0.00059227645,0.00011626084],"about_ca_topic_score_codex":0.0012479406,"about_ca_topic_score_gemma":0.0021989818,"teacher_disagreement_score":0.027394732,"about_ca_system_score_codex":0.00020727271,"about_ca_system_score_gemma":0.00009144411,"threshold_uncertainty_score":0.39503515},"labels":[],"label_agreement":null},{"id":"W2028642805","doi":"10.1016/j.breast.2012.07.017","title":"Practice patterns and perceptions of margin status for breast conserving surgery for breast carcinoma: National Survey of Canadian General Surgeons","year":2012,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; Health Sciences Centre; Foothills Medical Centre; Sunnybrook Health Science Centre; Juravinski Cancer Centre; McMaster University; St. Joseph’s Healthcare Hamilton","funders":"Canadian Breast Cancer Research Alliance","keywords":"Medicine; Breast cancer; Breast-conserving surgery; Margin (machine learning); General surgery; Surgery; Cancer; Mastectomy; Internal medicine","score_opus":0.02967323559985989,"score_gpt":0.2808620864148288,"score_spread":0.2511888508149689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028642805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.949964,0.0004422173,0.00020967326,0.0017793012,0.00014339003,0.00037042194,0.04697031,0.0000044128938,0.00011626503],"genre_scores_gemma":[0.99793506,0.00009950649,0.0002736115,0.00013952501,0.00019072597,0.0001059124,0.0011751179,0.000027642483,0.000052902597],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988099,0.00014507142,0.00026007945,0.00020685965,0.000133236,0.00044485074],"domain_scores_gemma":[0.99819946,0.00051867147,0.00018113283,0.00021852159,0.0007164313,0.00016577805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007508704,0.00017250354,0.00024838853,0.00012578064,0.00018872113,0.000011991976,0.00009990786,0.00007885107,0.00002571917],"category_scores_gemma":[0.00017281386,0.00014361607,0.0001096415,0.00013675957,0.0001571499,0.000017688682,0.00006594606,0.000043566055,6.658495e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004011895,0.00012063469,0.99215734,0.000065507375,0.00025931402,2.0041377e-7,0.00018391862,0.0000051629736,0.0014394921,0.0001664132,0.0028996328,0.0023012096],"study_design_scores_gemma":[0.0005185236,0.000021118409,0.9972233,0.000018128741,0.00010678952,0.0006478245,0.00042603354,0.000021104992,0.00025244316,0.000010275049,0.0006114224,0.00014303853],"about_ca_topic_score_codex":0.25555766,"about_ca_topic_score_gemma":0.16967636,"teacher_disagreement_score":0.0858813,"about_ca_system_score_codex":0.000060421087,"about_ca_system_score_gemma":0.00047556008,"threshold_uncertainty_score":0.8454749},"labels":[],"label_agreement":null},{"id":"W2030822657","doi":"10.1016/j.breast.2010.03.002","title":"Hypofractionation should be the new ‘standard’ for radiation therapy after breast conserving surgery","year":2010,"lang":"en","type":"review","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Breast-conserving surgery; Randomized controlled trial; Standard of care; Medical prescription; Breast cancer; Radiation therapy; Surgery; Medical physics; Radiology; Mastectomy; Internal medicine; Cancer; Nursing","score_opus":0.04846224254649399,"score_gpt":0.3284188276487383,"score_spread":0.2799565851022443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030822657","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008086995,0.98868656,0.00023914722,0.007575167,0.0007021582,0.0011176154,0.0014636732,0.000025700316,0.000109087094],"genre_scores_gemma":[0.0009944501,0.9929462,0.000045270117,0.0007376285,0.0027553437,0.0008657391,0.0011326396,0.000087247114,0.00043545527],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99853694,0.0001625603,0.0003605061,0.00042202426,0.00022408464,0.00029387887],"domain_scores_gemma":[0.9983542,0.00039734232,0.00036820816,0.00066864426,0.00015043066,0.00006119812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044338373,0.00043062159,0.0006048342,0.00005391637,0.00032977204,0.000085180756,0.00031412765,0.00035834042,0.000063023246],"category_scores_gemma":[0.000058788617,0.00023115527,0.00060882664,0.00013384722,0.00013652063,0.000008894986,0.00009046443,0.0002667636,0.000010576267],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024713538,0.000026455093,0.000062811276,0.00018042268,0.0004114989,5.1759247e-7,0.000033307933,4.1139936e-7,0.000011159006,0.000026695849,0.01987903,0.97912055],"study_design_scores_gemma":[0.0003203246,0.000018766412,0.0013306199,0.0003095708,0.0004246575,0.0006615197,0.000015855907,7.666209e-7,0.000028108896,0.00006408034,0.9965656,0.00026012206],"about_ca_topic_score_codex":0.00012687763,"about_ca_topic_score_gemma":0.00015403856,"teacher_disagreement_score":0.97886044,"about_ca_system_score_codex":0.00007781055,"about_ca_system_score_gemma":0.0006064203,"threshold_uncertainty_score":0.9426238},"labels":[],"label_agreement":null},{"id":"W2031654328","doi":"10.1016/j.breast.2010.03.007","title":"What are the minimal standards of radiotherapy planning and dosimetry for “hypofractionated” radiotherapy in breast cancer?","year":2010,"lang":"en","type":"review","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Radiation therapy; Breast cancer; Radiation treatment planning; Medical physics; Dosimetry; Oncology; Cancer; Radiology; Internal medicine","score_opus":0.019894914244793012,"score_gpt":0.34891364133891273,"score_spread":0.3290187270941197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031654328","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012175551,0.9931652,0.000058687547,0.0013740393,0.0004673265,0.0008657468,0.002832034,0.000008822179,0.0000106213],"genre_scores_gemma":[0.0017273386,0.9964648,0.00006700356,0.00018814832,0.00086666783,0.0004456022,0.00009976607,0.0000797623,0.000060944363],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99849933,0.0001435196,0.0003870044,0.00044781997,0.00021611051,0.00030622972],"domain_scores_gemma":[0.9986959,0.00017380882,0.0004780245,0.0004930564,0.0001131575,0.00004605086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042240846,0.00044444768,0.0009275021,0.00007854574,0.00017274058,0.00006498485,0.00037595487,0.0003253353,0.000017616843],"category_scores_gemma":[0.000013165335,0.0002449199,0.0002811147,0.00017660159,0.00034347703,0.00001591037,0.000073426025,0.00030382865,1.9017077e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005548574,0.00007089695,0.0011044419,0.0010181573,0.0009488901,0.0000018453804,0.00016547635,0.000007822454,0.00018222752,0.000012785119,0.0011171706,0.9948154],"study_design_scores_gemma":[0.0014384149,0.000075426535,0.0054279,0.004113407,0.00044925412,0.000994809,0.00044629892,0.000008786884,0.00009403453,0.000010982934,0.9865485,0.00039217644],"about_ca_topic_score_codex":0.0001372963,"about_ca_topic_score_gemma":0.00007113285,"teacher_disagreement_score":0.9944233,"about_ca_system_score_codex":0.00013972321,"about_ca_system_score_gemma":0.0003278681,"threshold_uncertainty_score":0.99875444},"labels":[],"label_agreement":null},{"id":"W2036457189","doi":"10.1016/j.breast.2012.02.014","title":"A comparison of surgical and radiotherapy breast cancer therapy utilization in Canada (British Columbia), Scotland (Dundee), and Australia (Western Australia) with models of “optimal” therapy","year":2012,"lang":"en","type":"article","venue":"The Breast","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Radiation therapy; Breast cancer; Guideline; Demography; Mastectomy; Population; Cancer; Epidemiology; Surgery; Family medicine; Internal medicine; Environmental health","score_opus":0.0692755109281876,"score_gpt":0.3809497262237102,"score_spread":0.31167421529552264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036457189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861614,0.012483895,0.0001344829,0.00045690688,0.00008976994,0.00054121646,0.000105063074,0.000009109638,0.000018123832],"genre_scores_gemma":[0.9892805,0.009726514,0.00025915966,0.00008887035,0.0001375472,0.000027579112,0.000009606261,0.000026364398,0.00044380894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987279,0.000119629796,0.00035945707,0.00021183374,0.00025244657,0.00032868583],"domain_scores_gemma":[0.9992616,0.000115824645,0.00020757043,0.00020624102,0.000077938595,0.0001307821],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021709861,0.00016753512,0.0006357747,0.000036558624,0.000068554196,0.000018174851,0.000100921316,0.00011079176,0.00022881987],"category_scores_gemma":[0.0000011050956,0.00013788635,0.000031358133,0.00018303018,0.00048061725,0.0001804654,0.000011509931,0.00020588325,7.571912e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019137762,0.00030354687,0.9723233,0.000045328372,0.00016935161,0.000011372699,0.0009149935,0.00046695262,0.00024639242,0.000025719646,0.00022920767,0.023350032],"study_design_scores_gemma":[0.006179388,0.00032446228,0.9888409,0.00023061129,0.000032270826,0.0025582674,0.000302778,0.0006689693,0.000114629795,0.000024947953,0.00055647723,0.0001663086],"about_ca_topic_score_codex":0.7523309,"about_ca_topic_score_gemma":0.8215054,"teacher_disagreement_score":0.06917448,"about_ca_system_score_codex":0.00015078502,"about_ca_system_score_gemma":0.00025353272,"threshold_uncertainty_score":0.56228423},"labels":[],"label_agreement":null},{"id":"W2038762495","doi":"10.1016/s0960-9776(03)00100-0","title":"Socioeconomic status & returning for a second screen in the Ontario breast screening program","year":2003,"lang":"en","type":"article","venue":"The Breast","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre; Cancer Care Ontario","funders":"","keywords":"Medicine; Rurality; Socioeconomic status; Mammography; Attendance; Breast cancer screening; Demography; Breast cancer; Referral; Retrospective cohort study; Cohort; Rural area; Gerontology; Family medicine; Environmental health; Cancer; Population; Internal medicine","score_opus":0.06510922564897673,"score_gpt":0.33041081432893127,"score_spread":0.26530158867995457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038762495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857528,0.00029236195,0.000380867,0.002012541,0.00007746056,0.0014750609,0.000078234756,0.000062208324,0.009868417],"genre_scores_gemma":[0.9914209,0.0000038368476,0.005162362,0.0016918982,0.0001953628,0.00019782563,0.0000721879,0.000028944742,0.0012266492],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99829733,0.00012225201,0.00033794026,0.00031438374,0.00024578455,0.00068229146],"domain_scores_gemma":[0.99901366,0.00016785086,0.00013438684,0.00047028033,0.00009040387,0.00012341022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012958517,0.00021642388,0.00030682038,0.00006258413,0.00028170474,0.00010662956,0.00026836593,0.00009341899,0.0006748979],"category_scores_gemma":[0.000049373513,0.000133693,0.000174526,0.00015232408,0.00013185841,0.00016019071,0.000036440342,0.00051490346,0.000047236143],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025348607,0.00033431881,0.81759226,0.00011814297,0.00035033238,0.000050602004,0.03165829,0.00015239857,0.00046590043,0.0023728486,0.009835261,0.13453476],"study_design_scores_gemma":[0.0034604524,0.0003075646,0.77621645,0.00028440688,0.0001790221,0.0050596027,0.0058361497,0.00017794233,0.000039966366,0.0007262345,0.20735057,0.00036166015],"about_ca_topic_score_codex":0.014954949,"about_ca_topic_score_gemma":0.1104777,"teacher_disagreement_score":0.19751531,"about_ca_system_score_codex":0.00030473838,"about_ca_system_score_gemma":0.00031610954,"threshold_uncertainty_score":0.99160457},"labels":[],"label_agreement":null},{"id":"W2040018931","doi":"10.1016/j.breast.2013.07.052","title":"Supportive and palliative care for metastatic breast cancer: Resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement","year":2013,"lang":"en","type":"review","venue":"The Breast","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"National Cancer Institute; Fogarty International Center; Pan American Health Organization; American Society of Clinical Oncology; Fred Hutchinson Cancer Research Center; European School of Oncology; Sanofi; Livestrong Foundation; Amgen; Eunice Kennedy Shriver National Institute of Child Health and Human Development; Open Society Foundations","keywords":"Medicine; Palliative care; Psychosocial; Breast cancer; Psychological intervention; Nursing; Health care; Metastatic breast cancer; Family medicine; Intensive care medicine; Cancer; Internal medicine; Psychiatry; Economic growth","score_opus":0.15776208105951905,"score_gpt":0.4522439182843418,"score_spread":0.29448183722482274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040018931","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00074053236,0.94919497,0.000041618958,0.006172299,0.00007564537,0.0051699397,0.038460486,0.00003092425,0.00011358497],"genre_scores_gemma":[0.002596035,0.9940006,0.00050486607,0.00041728735,0.00012651073,0.0012296687,0.00096667476,0.00006633096,0.00009199716],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99643314,0.00050428824,0.0013463292,0.00065260584,0.0004139573,0.0006496844],"domain_scores_gemma":[0.996202,0.0009767744,0.001253118,0.00042756082,0.00078142824,0.0003591204],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005384453,0.00070054573,0.0026866503,0.0001897146,0.0001965863,0.000048669157,0.0002060109,0.00015722068,0.00006400278],"category_scores_gemma":[0.00007259042,0.0004686516,0.00022864345,0.00046025458,0.0007015543,0.00008297432,0.00014859338,0.00037278995,0.000010669735],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001559332,0.0006166098,0.017176459,0.2902361,0.0063730646,0.00010634457,0.048253108,0.000015244182,1.683718e-7,0.0016698436,0.006287514,0.6277062],"study_design_scores_gemma":[0.008510783,0.00091473304,0.02897986,0.39564145,0.005835247,0.0023418146,0.045619547,0.00013500886,0.0000014795327,0.00033536745,0.5100949,0.0015898232],"about_ca_topic_score_codex":0.0068460577,"about_ca_topic_score_gemma":0.002834416,"teacher_disagreement_score":0.6261164,"about_ca_system_score_codex":0.001132667,"about_ca_system_score_gemma":0.0020871204,"threshold_uncertainty_score":0.99977654},"labels":[],"label_agreement":null},{"id":"W2040696193","doi":"10.1016/j.breast.2014.02.002","title":"Evaluation of eligibility and recruitment in breast cancer clinical trials","year":2014,"lang":"en","type":"article","venue":"The Breast","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôpital du Saint-Sacrement; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Breast cancer; Oncology; Clinical trial; Cancer; Family medicine; Internal medicine; Medical physics","score_opus":0.8792104055012392,"score_gpt":0.7332901491485581,"score_spread":0.14592025635268113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040696193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96209323,0.00030292684,0.000020767622,0.033808604,0.00014380408,0.0013588921,0.00003532127,0.000008710816,0.0022277632],"genre_scores_gemma":[0.99830455,0.0007507649,0.00006020093,0.00037778742,0.00030126565,0.000101118385,0.0000024252083,0.000007927786,0.000093967414],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99018705,0.0062205316,0.0013182432,0.0003508108,0.0017202824,0.00020308144],"domain_scores_gemma":[0.9777445,0.020229746,0.00024223136,0.00065249356,0.000993578,0.00013745361],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.21976618,0.000075083866,0.0005192179,0.00004030775,0.000028036055,0.000007979358,0.00012920205,0.00019357735,0.00031671498],"category_scores_gemma":[0.04183747,0.00004254898,0.00009996593,0.0001340283,0.00042321216,0.000024090392,0.00010171812,0.0007802451,0.00001066247],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012358123,0.00040312874,0.31388906,0.00010377864,0.00008659304,4.692551e-7,0.00015431784,0.000010216096,0.0004122307,0.0021390372,0.00021191893,0.68135345],"study_design_scores_gemma":[0.0031545758,0.00011731409,0.95371515,0.0003180637,0.00022715802,0.000026469563,0.000052323056,0.0032066426,0.00008427637,0.038963307,0.00009205717,0.00004265993],"about_ca_topic_score_codex":0.00063344784,"about_ca_topic_score_gemma":0.00064182235,"teacher_disagreement_score":0.6813108,"about_ca_system_score_codex":0.00010661066,"about_ca_system_score_gemma":0.0006224282,"threshold_uncertainty_score":0.96623355},"labels":[],"label_agreement":null},{"id":"W2043733527","doi":"10.1016/s0960-9776(09)70113-4","title":"0068 Elevated bone resorption predicts shorter recurrence-free survival (RFS) for bone metastasis in breast cancer (BC)","year":2009,"lang":"en","type":"article","venue":"The Breast","topic":"Bone health and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Bone metastasis; Breast cancer; Resorption; Oncology; Bone resorption; Internal medicine; Cancer; Metastasis","score_opus":0.03314797552869088,"score_gpt":0.31194719606514093,"score_spread":0.27879922053645007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043733527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9366139,0.0012904016,0.00011184849,0.055955835,0.0005018192,0.0024237507,0.001925937,0.00017057877,0.0010059131],"genre_scores_gemma":[0.9968702,0.00033967546,0.00026491904,0.0009763649,0.00028033872,0.00021977522,0.00025562252,0.00003207546,0.00076099293],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99793655,0.00011414357,0.0004908885,0.00040151802,0.0004195422,0.00063735235],"domain_scores_gemma":[0.9986879,0.000080736034,0.00014427597,0.0006531778,0.00016744387,0.0002664156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060847076,0.00027292216,0.00051836885,0.00016203559,0.00013109943,0.000021123957,0.00015400835,0.00013044955,0.0001660889],"category_scores_gemma":[0.000048314705,0.00018423404,0.0001269499,0.00045322874,0.00007382729,0.00012718573,0.00003435216,0.0002737845,0.000035115747],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019545509,0.0032292763,0.19193856,0.00037243034,0.00047819933,0.00020051935,0.00092710095,0.000016716336,0.0025490322,0.00078003836,0.027954511,0.7520081],"study_design_scores_gemma":[0.007088456,0.0003477166,0.98809344,0.00036079474,0.00034279499,0.00077692344,0.000058905032,0.00032870917,0.0002543039,0.0008205979,0.0013336937,0.00019364963],"about_ca_topic_score_codex":0.0034166009,"about_ca_topic_score_gemma":0.0016421418,"teacher_disagreement_score":0.7961549,"about_ca_system_score_codex":0.00022681354,"about_ca_system_score_gemma":0.00021276316,"threshold_uncertainty_score":0.7512846},"labels":[],"label_agreement":null},{"id":"W2046319455","doi":"10.1016/j.breast.2011.12.013","title":"Local breast cancer recurrence after mastectomy and immediate breast reconstruction for invasive cancer: A meta-analysis","year":2012,"lang":"en","type":"review","venue":"The Breast","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Breast cancer; Mastectomy; Breast reconstruction; Cancer; Meta-analysis; Prophylactic Mastectomy; Oncology; Adjuvant therapy; Inclusion and exclusion criteria; Internal medicine; Surgery; Pathology; Alternative medicine","score_opus":0.074247150691652,"score_gpt":0.325369091730187,"score_spread":0.251121941038535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046319455","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032191223,0.9806637,0.0002239635,0.000998692,0.0010527583,0.0022268984,0.014394051,0.00007264195,0.000045366192],"genre_scores_gemma":[0.0066877967,0.98670065,0.00014337688,0.00006846337,0.0019236031,0.0034425657,0.00040430762,0.00011675055,0.00051249017],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99658436,0.0003119117,0.0010161543,0.00089028577,0.00040195163,0.0007953478],"domain_scores_gemma":[0.99721545,0.00031970273,0.0009490677,0.00069461536,0.00037903822,0.0004420973],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00059784343,0.0009501867,0.004321393,0.00057227956,0.0002467663,0.00008493517,0.00026998692,0.0005741859,0.0016595596],"category_scores_gemma":[0.0000056946246,0.00052738,0.0027271146,0.0010461897,0.00067006866,0.00028490028,0.00012907824,0.00078371796,0.000043436492],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036492865,0.000044885204,0.00043915233,0.005390489,0.06462837,0.0000064027445,0.00007003494,8.441455e-7,3.4949846e-7,0.000009597277,0.00007463579,0.92897034],"study_design_scores_gemma":[0.0006886715,0.000025871768,0.0024252045,0.0025268334,0.6158345,0.36065656,0.00009600929,0.000026223759,0.0000013016889,0.000027908156,0.017041525,0.00064944534],"about_ca_topic_score_codex":0.001216084,"about_ca_topic_score_gemma":0.0012635374,"teacher_disagreement_score":0.9283209,"about_ca_system_score_codex":0.00033366898,"about_ca_system_score_gemma":0.0007412185,"threshold_uncertainty_score":0.9997178},"labels":[],"label_agreement":null},{"id":"W2047708827","doi":"10.1016/j.breast.2005.10.011","title":"Intraductal papilloma in a reconstructed breast: Mammographic and sonographic appearance with pathologic correlation","year":2006,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Royal Victoria Hospital","funders":"","keywords":"Medicine; Radiology; Mastectomy; Intraductal papilloma; Breast reconstruction; Fat necrosis; Mammography; Occult; Carcinoma; Papilloma; Ductal carcinoma; Breast cancer; Surgery; Cancer; Pathology; Internal medicine","score_opus":0.0036492203756254174,"score_gpt":0.17711520828110636,"score_spread":0.17346598790548093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047708827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99748665,0.00041736785,0.0000931335,0.0008818185,0.000113655704,0.00036253492,0.000026535286,0.00008700737,0.00053129176],"genre_scores_gemma":[0.9994078,0.000034966244,0.00026631387,0.000026631491,0.000162292,0.000017375774,0.00003473586,0.000016177211,0.000033706678],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990175,0.00007199984,0.0002403757,0.00025902,0.00014323492,0.00026787078],"domain_scores_gemma":[0.9995742,0.00002363683,0.00010852937,0.00018635124,0.000047301306,0.000059973554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018254813,0.0001790988,0.00024144602,0.00023801366,0.00011322756,0.00002636593,0.00005637919,0.00011440451,0.000019165409],"category_scores_gemma":[0.0000016666017,0.00010706065,0.00004782308,0.0005962873,0.0004911918,0.00011667501,0.000015660658,0.0003046381,0.000006950333],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065746205,0.00006386302,0.8199809,0.000033944187,0.00002396075,0.000085902124,0.000070426664,0.000007652305,0.00057255453,0.00065605884,0.000013286669,0.17783399],"study_design_scores_gemma":[0.0011848734,0.000049877704,0.6272456,0.00016173464,0.000040048144,0.37014672,0.00009844238,0.00023111615,0.00001381431,0.0007292665,0.0000042261076,0.00009427729],"about_ca_topic_score_codex":0.00031813333,"about_ca_topic_score_gemma":0.0002945005,"teacher_disagreement_score":0.37006083,"about_ca_system_score_codex":0.00001777972,"about_ca_system_score_gemma":0.000035250858,"threshold_uncertainty_score":0.43658066},"labels":[],"label_agreement":null},{"id":"W2050437076","doi":"10.1016/s0960-9776(11)70291-0","title":"Obesity and insulin resistance in breast cancer – Chemoprevention strategies with a focus on metformin","year":2011,"lang":"en","type":"review","venue":"The Breast","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Metformin; Breast cancer; Insulin resistance; PI3K/AKT/mTOR pathway; Oncology; Insulin; Internal medicine; Cancer; Diabetes mellitus; Cancer research; Endocrinology; Signal transduction","score_opus":0.01618575017774309,"score_gpt":0.2700540664694002,"score_spread":0.2538683162916571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050437076","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020961778,0.99584264,0.000008534806,0.00001772943,0.00006482055,0.00044191437,0.00031043292,0.000008222074,0.0012095313],"genre_scores_gemma":[0.0025100654,0.9964796,0.00003384001,0.000037129146,0.0002754746,0.00023355681,0.00006455779,0.000042167172,0.00032361242],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99872833,0.0001513566,0.00027054103,0.00044964367,0.00012095008,0.00027917727],"domain_scores_gemma":[0.99916923,0.0000116586025,0.00023634623,0.00047156308,0.0000494866,0.00006173635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002852875,0.0003591654,0.00067205925,0.00005370788,0.00006411557,0.000040136125,0.0002831416,0.00023058665,0.000048068436],"category_scores_gemma":[0.000003870378,0.0002143492,0.00012683183,0.00015962489,0.00013489716,0.000008727867,0.0000770182,0.00023076347,0.0000065327],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015103989,0.00006385287,0.00001996224,0.0013687025,0.00011238351,0.0000022527165,0.00003932764,2.8063752e-7,0.000006463693,0.0006924848,0.00019463369,0.9973486],"study_design_scores_gemma":[0.0005621648,0.00005527693,0.0014524373,0.0046666483,0.00039344202,0.00013542204,0.000043878517,2.5805835e-7,0.0000815081,0.0007095743,0.9914237,0.00047566814],"about_ca_topic_score_codex":0.00025596947,"about_ca_topic_score_gemma":0.0018460193,"teacher_disagreement_score":0.99687296,"about_ca_system_score_codex":0.000036996382,"about_ca_system_score_gemma":0.00031946955,"threshold_uncertainty_score":0.8740907},"labels":[],"label_agreement":null},{"id":"W2058536228","doi":"10.1016/j.breast.2012.12.005","title":"Perceived risk and adherence to breast cancer screening guidelines among women with a familial history of breast cancer: A review of the literature","year":2013,"lang":"en","type":"review","venue":"The Breast","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; University of Toronto; York University; Public Health Ontario; Cancer Care Ontario","funders":"","keywords":"Medicine; Breast cancer; Mammography; Family history; Gynecology; Cancer; Family medicine; Breast cancer screening; Oncology; Internal medicine","score_opus":0.025928654574798086,"score_gpt":0.3060044109428364,"score_spread":0.28007575636803833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058536228","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003573492,0.99004066,0.000017330729,0.00033378825,0.00022452802,0.0012969682,0.004444023,0.000007616599,0.00006158092],"genre_scores_gemma":[0.0010340025,0.99536395,0.00022145997,0.00035651436,0.0004900026,0.0011371572,0.000049666458,0.00006956352,0.0012776578],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977957,0.00032575818,0.0006897389,0.0005577403,0.00030998315,0.0003210718],"domain_scores_gemma":[0.99704623,0.000027234462,0.00093317556,0.0009984894,0.0008745663,0.00012030712],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038438596,0.00048179767,0.0010437139,0.000059446178,0.000083728744,0.000019372532,0.0008060068,0.00023388985,0.0001591073],"category_scores_gemma":[0.000043172127,0.00025097397,0.00024477742,0.0003708896,0.00046594942,0.00001046317,0.00034377462,0.0003451672,0.0000015218104],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008924915,0.000020216283,0.0003803752,0.015919456,0.00044323923,5.899482e-7,0.00050576724,0.00001817461,0.00022656107,0.0000010104252,0.013602057,0.96879333],"study_design_scores_gemma":[0.00049501844,0.00014348459,0.014893181,0.21844684,0.001662426,0.0011237029,0.0001878567,0.00000954883,0.000011679394,0.0000034452637,0.76227397,0.0007488336],"about_ca_topic_score_codex":0.0025379278,"about_ca_topic_score_gemma":0.00034866433,"teacher_disagreement_score":0.96804446,"about_ca_system_score_codex":0.00036901343,"about_ca_system_score_gemma":0.0015521252,"threshold_uncertainty_score":0.9999943},"labels":[],"label_agreement":null},{"id":"W2059216229","doi":"10.1054/brst.1999.0118","title":"Open comparative trial of formestane versus megestrol acetate in postmenopausal patients with advanced breast cancer previously treated with tamoxifen","year":2000,"lang":"en","type":"article","venue":"The Breast","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"Kræftens Bekæmpelse","keywords":"Megestrol acetate; Medicine; Megestrol; Tamoxifen; Internal medicine; Ovarian cancer; Gynecology; Breast cancer; Cancer; Urology","score_opus":0.007305348898281031,"score_gpt":0.2593504333474157,"score_spread":0.25204508444913465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059216229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962482,0.00019046897,9.726066e-7,0.00011704419,0.000025824776,0.0015865631,0.00018293367,0.000007817092,0.0016402102],"genre_scores_gemma":[0.99915665,0.00011865158,0.000049891056,0.000023668616,0.000035045272,0.00013404479,0.00018400638,0.000024363038,0.0002736474],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99895245,0.00011810719,0.00019674737,0.0002844296,0.00015749667,0.00029080047],"domain_scores_gemma":[0.9993693,0.000017630857,0.00013295811,0.00031421168,0.00009047884,0.00007538232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009213766,0.0002209851,0.00029939835,0.000023653689,0.00006345892,0.000020917683,0.00034976777,0.00008558974,0.00004641727],"category_scores_gemma":[0.0000019391853,0.0001204591,0.000032167532,0.00017492672,0.00015236324,0.000017833861,0.00006212746,0.00012720072,0.0000051222805],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94056857,0.0012520489,0.01397867,0.000021680222,0.00080820365,0.000016096175,0.0005100773,0.0019482551,0.014787959,0.000018566181,0.00014882264,0.02594103],"study_design_scores_gemma":[0.57321995,0.042846944,0.3387226,0.00059980963,0.00082103483,0.00039938308,0.00040606566,0.00014477667,0.040540706,0.00001726861,0.00087977725,0.00140171],"about_ca_topic_score_codex":0.00033231277,"about_ca_topic_score_gemma":0.00019226101,"teacher_disagreement_score":0.36734867,"about_ca_system_score_codex":0.000031036103,"about_ca_system_score_gemma":0.00012590614,"threshold_uncertainty_score":0.49121794},"labels":[],"label_agreement":null},{"id":"W2065173866","doi":"10.1016/j.breast.2011.06.010","title":"Hypofractionated radiotherapy of the breast may be safer for the heart","year":2011,"lang":"en","type":"letter","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Radiation therapy; Breast cancer; Scopus; Randomized controlled trial; Oncology; Internal medicine; Cancer; MEDLINE","score_opus":0.017961385640546303,"score_gpt":0.25178587776229816,"score_spread":0.23382449212175185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065173866","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014918668,0.0035420286,0.0001422569,0.98943007,0.0009836624,0.0011362175,0.0025568372,0.000021409092,0.0006956573],"genre_scores_gemma":[0.19360074,0.0011678616,0.00025191743,0.7719166,0.013160031,0.001096953,0.0009925101,0.00033785787,0.017475508],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985981,0.00015344055,0.00025416576,0.00039064675,0.00024409704,0.00035953277],"domain_scores_gemma":[0.99821985,0.00014935735,0.00025244898,0.0011701318,0.00018534475,0.000022877546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018583515,0.00038037266,0.0003210426,0.000024143617,0.00035609878,0.000020396057,0.0007652146,0.00037891092,0.00011964495],"category_scores_gemma":[0.000014132725,0.00017284938,0.0004470749,0.00010033699,0.0005190938,0.0000041695503,0.00016417935,0.00041765213,0.0000074601257],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038249567,0.00006260637,0.0007322832,0.000032831365,0.0012863778,8.706878e-7,0.00008605448,0.0000056737736,0.0023899348,0.000035770914,0.99245983,0.0025252732],"study_design_scores_gemma":[0.0007233007,0.00005409664,0.031974185,0.000038712235,0.00031955616,0.0010882745,0.00004228084,0.0000034511388,0.0023022918,0.00007882588,0.96314234,0.00023267759],"about_ca_topic_score_codex":0.0005892746,"about_ca_topic_score_gemma":0.00005021994,"teacher_disagreement_score":0.21751344,"about_ca_system_score_codex":0.00005000501,"about_ca_system_score_gemma":0.00013506845,"threshold_uncertainty_score":0.7048593},"labels":[],"label_agreement":null},{"id":"W2068690776","doi":"10.1016/j.breast.2013.07.050","title":"Supportive care during treatment for breast cancer: Resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement","year":2013,"lang":"en","type":"review","venue":"The Breast","topic":"Cancer survivorship and care","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"Pan American Health Organization; Genentech; European School of Oncology; National Cancer Institute; Strong; American Society of Clinical Oncology; Livestrong Foundation; Fred Hutchinson Cancer Research Center; Eunice Kennedy Shriver National Institute of Child Health and Human Development; Sanofi; Roche; Novartis; Avon Foundation for Women; Amgen; Open Society Foundations; Susan G. Komen for the Cure","keywords":"Breast cancer; Psychosocial; Medicine; Health care; Family medicine; Nursing; Cancer; Psychiatry; Internal medicine; Political science","score_opus":0.046458089879992615,"score_gpt":0.35454955078040984,"score_spread":0.3080914609004172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068690776","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018267758,0.9337406,0.0000037667774,0.0077481396,0.00021636195,0.0065236012,0.049697377,0.00006608711,0.00017725595],"genre_scores_gemma":[0.011389221,0.98280936,0.000022054848,0.00029425704,0.00040979753,0.0034858272,0.0011115709,0.00009672228,0.00038121297],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99665207,0.00032401152,0.0010944502,0.0007378014,0.00038476923,0.0008069107],"domain_scores_gemma":[0.9975661,0.00020583939,0.0007489094,0.0006373562,0.00042428417,0.00041751334],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028281214,0.0007588493,0.0020442018,0.00016347293,0.00030966479,0.000077083496,0.00020927572,0.00021097943,0.00015221216],"category_scores_gemma":[0.000008036443,0.0005074463,0.0003513744,0.00041783837,0.00030223987,0.000062942265,0.000117295356,0.0003042078,0.000024257606],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015076348,0.00041907042,0.0033073763,0.11590457,0.00219164,0.000102100385,0.016755477,0.000012111391,7.7439395e-8,0.00020900914,0.0013025714,0.85828835],"study_design_scores_gemma":[0.011600389,0.0010336805,0.04278648,0.20300122,0.004602578,0.016095886,0.029486341,0.000030747855,0.0000012580633,0.000045352834,0.6893262,0.001989871],"about_ca_topic_score_codex":0.03230152,"about_ca_topic_score_gemma":0.032801643,"teacher_disagreement_score":0.8562985,"about_ca_system_score_codex":0.005302403,"about_ca_system_score_gemma":0.0030588477,"threshold_uncertainty_score":0.99973774},"labels":[],"label_agreement":null},{"id":"W2068699420","doi":"10.1016/j.breast.2015.12.010","title":"Second international consensus guidelines for breast cancer in young women (BCY2)","year":2016,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":230,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Consensus conference; Breast cancer; Family medicine; Gynecology; Cancer; Internal medicine","score_opus":0.01974951529995675,"score_gpt":0.30549981597038456,"score_spread":0.28575030067042784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068699420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9400393,0.00050615193,0.00013626236,0.05143656,0.0007134175,0.00032251078,0.0053793676,0.000019854102,0.0014465895],"genre_scores_gemma":[0.995719,0.00013422647,0.00009517636,0.00046743863,0.00075981684,0.00030555078,0.000017340153,0.000020360661,0.0024810717],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991896,0.000023145749,0.00018759645,0.00025163748,0.00008818414,0.0002597989],"domain_scores_gemma":[0.99939626,0.000030132436,0.00006851097,0.0002165126,0.00024916488,0.00003939534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014966371,0.00014200277,0.00012211906,0.000027338352,0.000059712085,0.000012319445,0.00020840288,0.000052322102,0.0003046708],"category_scores_gemma":[0.00003631917,0.00007933158,0.000055193646,0.000040963016,0.000114746115,0.0000031525512,0.00010440548,0.00002652391,0.000009381367],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005166311,0.00034252644,0.31201348,0.000054778033,0.0017381371,0.000010121349,0.00091392617,0.000074078926,0.2628466,0.0007802187,0.10218668,0.31387317],"study_design_scores_gemma":[0.005776349,0.0000643706,0.94490325,0.00013008909,0.000040004794,0.001013328,0.00062081625,0.000031300267,0.008197814,0.0007376978,0.038035933,0.0004490646],"about_ca_topic_score_codex":0.00015670947,"about_ca_topic_score_gemma":0.0017854621,"teacher_disagreement_score":0.63288975,"about_ca_system_score_codex":0.00010403277,"about_ca_system_score_gemma":0.00007169656,"threshold_uncertainty_score":0.33359316},"labels":[],"label_agreement":null},{"id":"W2071959976","doi":"10.1016/s0960-9776(14)70079-7","title":"PO69 Breast cancer in young women in Canada – a needs assessment","year":2014,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Oncology; Cancer; Family medicine; Gynecology; Internal medicine; Gerontology","score_opus":0.00606339186726763,"score_gpt":0.2536424989890219,"score_spread":0.2475791071217543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071959976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882474,0.000047199494,0.0000052256637,0.0059867487,0.0002180187,0.00018389478,0.00009172433,0.000010503542,0.0052092737],"genre_scores_gemma":[0.99865067,0.00003172804,0.0000034758236,0.0005524285,0.00018050146,0.00007051618,0.0000045166134,0.000016324077,0.0004898623],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99899733,0.000044700613,0.00018135432,0.00013085025,0.0002379814,0.00040775765],"domain_scores_gemma":[0.9995214,0.000029408717,0.000044453343,0.00024624183,0.00002469796,0.00013384403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028007056,0.00011650555,0.0002457999,0.000087214416,0.00002860288,0.000011662735,0.00011057644,0.00002846941,0.0005770415],"category_scores_gemma":[0.0000041316716,0.00007749135,0.000024383158,0.00032462153,0.000028658493,0.00003653677,0.000036117708,0.00022964584,0.0000040409477],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012337192,0.000038155722,0.9684266,0.000018993773,0.00001805666,0.000009820583,0.00092441443,0.000085085005,0.00015685965,0.00008590791,0.0005093961,0.029603345],"study_design_scores_gemma":[0.0010952667,0.000018499393,0.9949424,0.000096057614,0.000010877768,0.00020891722,0.0015596406,0.000812641,0.0000060918574,0.000034256755,0.0011214745,0.00009382957],"about_ca_topic_score_codex":0.9860655,"about_ca_topic_score_gemma":0.9852248,"teacher_disagreement_score":0.029509516,"about_ca_system_score_codex":0.0027223546,"about_ca_system_score_gemma":0.0013803549,"threshold_uncertainty_score":0.7118862},"labels":[],"label_agreement":null},{"id":"W2072860180","doi":"10.1016/j.breast.2014.04.001","title":"Does perceived risk predict breast cancer screening use? Findings from a prospective cohort study of female relatives from the Ontario site of the Breast Cancer Family Registry","year":2014,"lang":"en","type":"article","venue":"The Breast","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Cancer Care Ontario; York University; Public Health Ontario; University of Toronto","funders":"National Cancer Institute; Canadian Breast Cancer Research Alliance; Canadian Cancer Society","keywords":"Medicine; Breast cancer; Prospective cohort study; Cohort; Oncology; Cancer; Cancer registry; Gynecology; Cohort study; Internal medicine; Demography; Obstetrics","score_opus":0.026373491753905683,"score_gpt":0.27354454327350514,"score_spread":0.24717105151959945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072860180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99149424,0.0002133198,0.000051463212,0.0013274852,0.0002627409,0.0016729308,0.0045351624,0.00004711535,0.00039555295],"genre_scores_gemma":[0.99811995,0.00007565602,0.00008858943,0.000264404,0.0005038335,0.00016228345,0.000028888699,0.000045748693,0.00071062235],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966835,0.0004461954,0.0006303665,0.00068131625,0.0011257586,0.00043290583],"domain_scores_gemma":[0.9968133,0.00053109514,0.0007296599,0.0013150487,0.00047943258,0.0001314889],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068044825,0.00041514507,0.00078501995,0.0000415873,0.00052659254,0.000067110785,0.0007067684,0.00014712417,0.0003505206],"category_scores_gemma":[0.00010988558,0.0001766004,0.00026905685,0.000391156,0.00064193615,0.00030034018,0.00033061803,0.0009432406,0.000004605577],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020744386,0.00016882173,0.96898603,0.000011859095,0.0010298067,0.0000037178038,0.024477435,0.00028515115,0.0014525886,0.000008283509,0.00038809696,0.0011137553],"study_design_scores_gemma":[0.0021428363,0.00012895862,0.9828233,0.0014843795,0.0015699167,0.000063643645,0.011083205,0.00025346567,0.000078170575,0.00009990062,0.00005023819,0.00022199147],"about_ca_topic_score_codex":0.8332926,"about_ca_topic_score_gemma":0.30161732,"teacher_disagreement_score":0.5316752,"about_ca_system_score_codex":0.0004220782,"about_ca_system_score_gemma":0.00035829973,"threshold_uncertainty_score":0.72015554},"labels":[],"label_agreement":null},{"id":"W2080950316","doi":"10.1016/j.breast.2015.07.025","title":"Hypofractionated radiotherapy in early breast cancer: Clinical, dosimetric and radio-genomic issues","year":2015,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute for Health and Care Research; Cancer Research UK","keywords":"Hyperfractionation; Breast cancer; Medicine; Radiation therapy; Nuclear medicine; Cancer; Fractionation; Adverse effect; Dose fractionation; Oncology; Internal medicine; Chemistry","score_opus":0.024873775794235296,"score_gpt":0.3216234450921101,"score_spread":0.29674966929787483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080950316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97353125,0.019984033,0.000011476153,0.0057325684,0.00025555506,0.00020495345,0.00013190391,0.000020143589,0.00012810672],"genre_scores_gemma":[0.99224794,0.0061770123,0.00009239205,0.00038842205,0.0007072807,0.00004933608,0.000021175661,0.000029084087,0.0002873786],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890673,0.00014542807,0.00023869472,0.0003463918,0.00012300686,0.00023976713],"domain_scores_gemma":[0.9993717,0.000036287372,0.00009538388,0.00031146285,0.00007864998,0.00010648135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032445372,0.0001867964,0.00023715018,0.00006647632,0.00008088603,0.0000320389,0.00018534389,0.0001036826,0.000016904833],"category_scores_gemma":[0.00001880882,0.00013371684,0.00005980044,0.00023293063,0.00021579016,0.0000109302155,0.00008745737,0.00011923996,0.000012069935],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012003827,0.00025243172,0.9285874,0.0000068441173,0.0004312493,0.000006710751,0.0003046285,0.00004871116,0.0032661054,0.000033293854,0.0077030524,0.058159187],"study_design_scores_gemma":[0.0022001409,0.00009862593,0.986114,0.000013563095,0.000037648264,0.00035812525,0.00009153987,0.000025688862,0.00025570384,0.000048889935,0.010584032,0.00017202871],"about_ca_topic_score_codex":0.0033533063,"about_ca_topic_score_gemma":0.00018398419,"teacher_disagreement_score":0.057987157,"about_ca_system_score_codex":0.00008188153,"about_ca_system_score_gemma":0.00010151562,"threshold_uncertainty_score":0.5452814},"labels":[],"label_agreement":null},{"id":"W2083442629","doi":"10.1016/j.breast.2014.06.017","title":"A prognostic factor index for overall survival in patients receiving first-line chemotherapy for HER2-negative advanced breast cancer: An analysis of the ATHENA trial","year":2014,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Internal medicine; Oncology; Bevacizumab; Hazard ratio; Breast cancer; Anthracycline; Taxane; Chemotherapy; Cancer; Confidence interval","score_opus":0.010220535074357972,"score_gpt":0.2683287439906438,"score_spread":0.25810820891628583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083442629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994964,0.000030191084,0.00075779075,0.00096023054,0.0001804601,0.0015620871,0.0015215968,0.000008148628,0.000015481093],"genre_scores_gemma":[0.99875313,0.00003360089,0.00008210524,0.00011612803,0.00024186005,0.0005844319,0.00011932793,0.00003176979,0.00003767387],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988188,0.00010985966,0.0002766918,0.0003610193,0.00015917518,0.00027444988],"domain_scores_gemma":[0.9988856,0.00018205184,0.00025996493,0.00041748284,0.00021550227,0.000039416875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018960697,0.00022391071,0.00038252387,0.000047108755,0.00014052808,0.000013544981,0.00030380863,0.000081696206,0.000008891651],"category_scores_gemma":[0.00011417057,0.00013561711,0.00025569843,0.00021888636,0.00010555018,0.000009031961,0.00006922539,0.000056068522,1.3308753e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04223783,0.00086965825,0.9046612,0.000046392113,0.0017875014,3.1489463e-8,0.0008843326,0.0020653629,0.0006368999,0.000033353615,0.000036927337,0.046740558],"study_design_scores_gemma":[0.024200624,0.00042208363,0.9726815,0.000040074716,0.0003084033,6.1267224e-7,0.000055005745,0.0010655604,0.0008010783,0.00013901845,0.00011971765,0.00016628293],"about_ca_topic_score_codex":0.0006119211,"about_ca_topic_score_gemma":0.0052002687,"teacher_disagreement_score":0.06802038,"about_ca_system_score_codex":0.00007042976,"about_ca_system_score_gemma":0.00005485583,"threshold_uncertainty_score":0.55303055},"labels":[],"label_agreement":null},{"id":"W2083540373","doi":"10.1016/j.breast.2005.01.001","title":"Correlation between nutritional biomarkers and breast cancer: a case-control study","year":2005,"lang":"en","type":"article","venue":"The Breast","topic":"Antioxidant Activity and Oxidative Stress","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Population and Public Health; University of Ottawa; Hôtel-Dieu de Montréal; Hôpital Notre-Dame; Université de Montréal","funders":"","keywords":"Medicine; Breast cancer; Adipose tissue; Internal medicine; Odds ratio; Cancer; Case-control study; Population; Body mass index; Endocrinology; Gastroenterology; Physiology; Oncology","score_opus":0.015282486482466372,"score_gpt":0.2774175445126021,"score_spread":0.2621350580301357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083540373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888272,0.00020480463,0.00048761617,0.008583604,0.000032329386,0.0005794444,0.00088440813,0.000038262737,0.0003623105],"genre_scores_gemma":[0.9990127,0.000015098378,0.00003154112,0.00012895229,0.00061613816,0.00002620109,0.000013043762,0.000011112368,0.00014519131],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99925405,0.00010076167,0.00014061434,0.00017479107,0.00017574376,0.00015406356],"domain_scores_gemma":[0.9994822,0.00016445332,0.00006561865,0.00013480686,0.00006858051,0.00008435184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022061795,0.0001168957,0.00018962484,0.000056577624,0.00021023651,0.000019910043,0.00003680832,0.00004483237,0.00023298779],"category_scores_gemma":[0.000008642731,0.00007983878,0.00004363287,0.00012307646,0.00013490164,0.0001471164,0.000022021404,0.00015519377,0.000017613473],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065541465,0.00034394767,0.89902353,0.000017215109,0.00038580198,0.00013399971,0.00040378136,0.000009067858,0.00024225804,0.00006745572,0.0002652891,0.09845223],"study_design_scores_gemma":[0.0032127819,0.00007638651,0.98278373,0.00006187495,0.00037437808,0.0118395,0.00065991195,0.0007674321,0.000021063812,0.000022547352,0.000091725306,0.00008868311],"about_ca_topic_score_codex":0.00038129982,"about_ca_topic_score_gemma":0.00019308625,"teacher_disagreement_score":0.09836355,"about_ca_system_score_codex":0.000050163297,"about_ca_system_score_gemma":0.00003634493,"threshold_uncertainty_score":0.3255731},"labels":[],"label_agreement":null},{"id":"W2085214163","doi":"10.1016/s0960-9776(09)70271-1","title":"Issues regarding improving the impact of antiangiogenic drugs for the treatment of breast cancer","year":2009,"lang":"en","type":"review","venue":"The Breast","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Medicine; Bevacizumab; Sunitinib; Oncology; Sorafenib; Internal medicine; Breast cancer; Drug; Antiangiogenic therapy; Metastatic breast cancer; Cancer; Taxane; Chemotherapy; Pharmacology","score_opus":0.027058376072951803,"score_gpt":0.35307949426084895,"score_spread":0.32602111818789714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085214163","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00085086783,0.996318,0.00004428874,0.00018234692,0.00010898457,0.00096212985,0.0014784121,0.000004608243,0.000050352024],"genre_scores_gemma":[0.013730325,0.9841591,0.000015088714,0.000016542834,0.0011865663,0.0002048462,0.00007732914,0.000050277766,0.00055992504],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99877596,0.00010434594,0.00040256281,0.00029730488,0.00012994933,0.00028987182],"domain_scores_gemma":[0.99835473,0.00008916688,0.00053355255,0.00085678283,0.00013103521,0.00003471409],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027651576,0.00037265377,0.00076389645,0.00003021428,0.00016876787,0.00002172991,0.0005927515,0.00017537473,0.000028716877],"category_scores_gemma":[0.000006127822,0.00013751001,0.002134242,0.00014306977,0.00017430389,0.0000025826057,0.000062735555,0.00005319761,0.0000012388091],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008340435,0.000065799155,0.000028712437,0.00040774554,0.0015007975,1.7280794e-7,0.000088812674,0.000025339077,0.00072063063,0.000013524901,0.0014092467,0.99565583],"study_design_scores_gemma":[0.0007478201,0.0007507858,0.0010182186,0.0022012058,0.005154879,0.00037864817,0.0001896785,0.000053582033,0.0017780255,0.00001880879,0.98715764,0.00055071677],"about_ca_topic_score_codex":0.0014262601,"about_ca_topic_score_gemma":0.000032990563,"teacher_disagreement_score":0.9951051,"about_ca_system_score_codex":0.00008066197,"about_ca_system_score_gemma":0.00034144116,"threshold_uncertainty_score":0.56074953},"labels":[],"label_agreement":null},{"id":"W2090264949","doi":"10.1016/s0960-9776(13)70042-0","title":"PO29 METASTATIC BREAST CANCER IN CANADA: THE LIVED EXPERIENCE OF PATIENTS AND CAREGIVERS PRESENTED BY THE CANADIAN BREAST CANCER NETWORK","year":2013,"lang":"en","type":"article","venue":"The Breast","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Breast Cancer Network","funders":"","keywords":"Medicine; Breast cancer; Metastatic breast cancer; Cancer; Oncology; Internal medicine","score_opus":0.00799752239242615,"score_gpt":0.24683036387587753,"score_spread":0.23883284148345138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090264949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93692976,0.0012405532,0.000004033361,0.060321074,0.00021900807,0.00067620893,0.00037867588,0.0000072796456,0.00022338344],"genre_scores_gemma":[0.9967356,0.00017463107,0.000007042704,0.0026086713,0.00010475415,0.00012169044,0.000014108218,0.0000216393,0.00021190527],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99854654,0.00016044229,0.00024651986,0.00020882637,0.0003561921,0.00048148158],"domain_scores_gemma":[0.99899054,0.00014432678,0.00013161346,0.000306103,0.00015846388,0.000268945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021163841,0.00017361836,0.0002607734,0.00003309231,0.00028079984,0.000037852034,0.0003343149,0.000027897499,0.00043665155],"category_scores_gemma":[0.00003243969,0.00008354728,0.00003625131,0.00028156294,0.0004194944,0.00006826642,0.00007182241,0.00041583914,0.0000016557705],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007263905,0.000036882455,0.88863856,0.000042801672,0.00016955215,0.00000891957,0.0049403,0.0008236986,0.000058158123,0.000020055819,0.058739793,0.046448622],"study_design_scores_gemma":[0.0007466329,0.000009020796,0.98497933,0.0001709271,0.00008484881,0.00017888674,0.0024101315,0.009827053,0.00000335013,0.000013270275,0.0014726749,0.000103867686],"about_ca_topic_score_codex":0.9993088,"about_ca_topic_score_gemma":0.99132377,"teacher_disagreement_score":0.09634076,"about_ca_system_score_codex":0.00051233073,"about_ca_system_score_gemma":0.001319287,"threshold_uncertainty_score":0.47810283},"labels":[],"label_agreement":null},{"id":"W2099968866","doi":"10.1016/j.breast.2006.12.002","title":"Cost-utility of adjuvant hormone therapies with aromatase inhibitors in post-menopausal women with breast cancer: Upfront anastrozole, sequential tamoxifen-exemestane and extended tamoxifen-letrozole","year":2007,"lang":"en","type":"article","venue":"The Breast","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Cancer Centre; Cancer Care Nova Scotia; Dalhousie University","funders":"","keywords":"Exemestane; Medicine; Letrozole; Anastrozole; Tamoxifen; Breast cancer; Oncology; Hazard ratio; Gynecology; Aromatase inhibitor; Internal medicine; Cancer; Confidence interval","score_opus":0.004390067634372704,"score_gpt":0.22431233691575517,"score_spread":0.21992226928138248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099968866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950082,0.003182446,0.00013099397,0.0003624547,0.000045025474,0.0006407522,0.00049586274,0.000021970278,0.00011230598],"genre_scores_gemma":[0.9990303,0.00032431574,0.00013930043,0.00009458853,0.00011912702,0.00006101285,0.00014682295,0.00004324393,0.000041295967],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99815845,0.00012506913,0.00034736417,0.0004486277,0.00029222007,0.000628241],"domain_scores_gemma":[0.9989667,0.000021099255,0.00020876316,0.00045579797,0.00013557177,0.00021208503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056003727,0.00035348345,0.00036031543,0.00008562256,0.00011633536,0.000027056718,0.0002266565,0.00017047777,0.000021711186],"category_scores_gemma":[0.000005754687,0.000214155,0.000029814006,0.00023394937,0.00058874505,0.0000208659,0.00012191775,0.0002738609,0.0000014673606],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015951019,0.0005127426,0.0126521485,0.00004704207,0.00046976123,0.00012385375,0.00093660055,0.000049286267,0.9371727,0.000017559398,0.0002647563,0.031802546],"study_design_scores_gemma":[0.006272958,0.004170656,0.8724513,0.00015249163,0.00015157816,0.0027641272,0.0021588672,0.000084318395,0.11078064,0.000027678696,0.0003507389,0.0006346183],"about_ca_topic_score_codex":0.00072677596,"about_ca_topic_score_gemma":0.00050616986,"teacher_disagreement_score":0.85979915,"about_ca_system_score_codex":0.000058401867,"about_ca_system_score_gemma":0.00017686833,"threshold_uncertainty_score":0.87329876},"labels":[],"label_agreement":null},{"id":"W2112159509","doi":"10.1016/j.breast.2012.07.001","title":"An objective assessment of the perceived quality of life of living with bilateral mastectomy defect","year":2012,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Mastectomy; Population; Quality of life (healthcare); Breast cancer; Blindness; Surgery; Cancer; Internal medicine; Optometry; Environmental health","score_opus":0.013604501741776052,"score_gpt":0.2914210248700379,"score_spread":0.2778165231282618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112159509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99886763,0.00016876537,0.000073802556,0.0000675833,0.00003633532,0.00014987959,0.00008144853,0.0000032373591,0.0005513217],"genre_scores_gemma":[0.99969035,0.000007991796,0.00016396298,0.000025466381,0.00006739526,0.000015621405,0.000004225112,0.000010615983,0.000014347676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991814,0.0002443244,0.00016987596,0.000118290205,0.00014318725,0.00014290723],"domain_scores_gemma":[0.9991779,0.00005753605,0.00020986916,0.00041360036,0.00010811382,0.00003298985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002636875,0.000109797176,0.00019419214,0.000011843226,0.000052842577,0.0000024387662,0.00017326232,0.000036003275,0.000013746283],"category_scores_gemma":[0.000029817063,0.00005352049,0.00010199902,0.00007044507,0.00022703281,0.0000055395967,0.00010535448,0.000046849098,2.10601e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012614256,0.00021863899,0.8621869,0.00003244196,0.00031483828,2.0190797e-8,0.0009411955,0.000035487592,0.13584128,0.00005872603,0.000006106843,0.0002382118],"study_design_scores_gemma":[0.00026869262,0.00012504506,0.9821707,0.00005764914,0.00007417394,0.000012930452,0.00089325197,0.0000044516078,0.016322918,0.000004270125,0.0000026797366,0.00006321811],"about_ca_topic_score_codex":0.0004700768,"about_ca_topic_score_gemma":0.000113798415,"teacher_disagreement_score":0.11998381,"about_ca_system_score_codex":0.000016868597,"about_ca_system_score_gemma":0.00007936241,"threshold_uncertainty_score":0.21825022},"labels":[],"label_agreement":null},{"id":"W2114046627","doi":"10.1016/j.breast.2010.08.006","title":"Willingness of breast cancer survivors to participate in a randomized controlled trial of digital mammography with or without MRI as breast cancer surveillance: A feasibility study","year":2010,"lang":"en","type":"article","venue":"The Breast","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; St. Michael's Hospital; Juravinski Cancer Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Randomized controlled trial; Breast cancer; Mammography; Breast MRI; Population; Cancer; Radiology; Internal medicine; Environmental health","score_opus":0.03571251648455216,"score_gpt":0.35647985956461464,"score_spread":0.3207673430800625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114046627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98766476,0.0000789853,0.000024733363,0.0017833136,0.00032228962,0.00924219,0.0005967125,0.000040835715,0.00024617993],"genre_scores_gemma":[0.9978996,0.000029312818,0.000021128692,0.00009997825,0.00024868356,0.0015464821,0.0000059368626,0.000039771152,0.00010914437],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9961576,0.00047480466,0.0012266926,0.0005486356,0.0010271333,0.00056512567],"domain_scores_gemma":[0.9970126,0.0005243346,0.00061770936,0.00078302104,0.000774804,0.00028752658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032546453,0.00041853366,0.0031144933,0.00018195175,0.00007937229,0.00005065217,0.00037570306,0.000107941865,0.000294731],"category_scores_gemma":[0.00023714727,0.00020881034,0.00041135497,0.0011476909,0.00058134337,0.0001863039,0.00009090389,0.00040923536,0.0000027750375],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.53013045,0.00071379857,0.46685168,0.000038874634,0.00037418853,0.000012438257,0.0009194509,0.00010169679,0.00013689355,0.0000076833,0.0000058366154,0.0007070371],"study_design_scores_gemma":[0.5717628,0.0006749907,0.42485914,0.00031899996,0.00044237231,0.00025005435,0.0012275561,0.00020546964,0.000025213392,0.0000255234,0.0000025446016,0.00020534276],"about_ca_topic_score_codex":0.048711937,"about_ca_topic_score_gemma":0.09535796,"teacher_disagreement_score":0.046646025,"about_ca_system_score_codex":0.000078588746,"about_ca_system_score_gemma":0.0007529235,"threshold_uncertainty_score":0.95762277},"labels":[],"label_agreement":null},{"id":"W2117243202","doi":"10.1016/j.breast.2007.07.012","title":"Adjuvant therapy and thrombosis: How to avoid the problem?","year":2007,"lang":"en","type":"review","venue":"The Breast","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Thrombosis; Breast cancer; Antithrombotic; Venous thrombosis; Tamoxifen; Chemotherapy; Cancer; Warfarin; Surgery; Internal medicine; Oncology","score_opus":0.09946724046062966,"score_gpt":0.35462517295915286,"score_spread":0.2551579324985232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117243202","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000041291274,0.9777135,0.000020562702,0.012833921,0.00015540888,0.004281173,0.00003626106,0.00007181394,0.00484603],"genre_scores_gemma":[0.00018306846,0.9943377,0.00011948545,0.0028208743,0.0007004596,0.00048581936,0.000026157964,0.00009120562,0.0012352586],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981447,0.00016545606,0.000358297,0.00044697628,0.00040478923,0.00047978846],"domain_scores_gemma":[0.9984149,0.0001886841,0.00020137562,0.00095236645,0.00006603859,0.00017666668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010519978,0.00048681075,0.0017153358,0.00012178425,0.00026744555,0.000121512334,0.00045663564,0.00015333768,0.000120538774],"category_scores_gemma":[0.000013530402,0.0001990842,0.00034506546,0.00036470528,0.00015790387,0.00003757823,0.00025159214,0.0004653982,0.00016492688],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009797394,0.00016371258,0.0000040879963,0.0029764958,0.00056193536,0.0000084934445,0.00041967214,9.095406e-8,6.941011e-7,0.0011237038,0.028594946,0.9661364],"study_design_scores_gemma":[0.0002711444,0.000179507,0.0018128469,0.00872906,0.0014380567,0.00040904235,0.00017200493,3.860426e-7,6.5468384e-7,0.00007754435,0.9866707,0.00023909107],"about_ca_topic_score_codex":0.000114148585,"about_ca_topic_score_gemma":0.000029126,"teacher_disagreement_score":0.96589726,"about_ca_system_score_codex":0.00007639714,"about_ca_system_score_gemma":0.00010948404,"threshold_uncertainty_score":0.8118418},"labels":[],"label_agreement":null},{"id":"W2118788452","doi":"10.1016/j.breast.2010.05.009","title":"Alcohol consumption and the risk of breast cancer among BRCA1 and BRCA2 mutation carriers","year":2010,"lang":"en","type":"article","venue":"The Breast","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; McGill University; Women's College Hospital; BC Cancer Agency; University of Ottawa","funders":"National Cancer Institute; Canadian Breast Cancer Research Alliance","keywords":"Medicine; Breast cancer; Alcohol consumption; BRCA mutation; Oncology; Internal medicine; Cancer; Mutation; Consumption (sociology); Population; Gynecology; Environmental health; Demography; Alcohol; Gene; Genetics","score_opus":0.006114035816957914,"score_gpt":0.2504282676444363,"score_spread":0.2443142318274784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118788452","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99745214,0.00074027566,0.00009065926,0.00090715656,0.00015693146,0.00023258022,0.0002734764,0.0000057805196,0.00014099813],"genre_scores_gemma":[0.9989936,0.0005271007,0.00006645799,0.00008876475,0.00016190208,0.000051891948,0.000018704448,0.000013040232,0.00007857563],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993956,0.000091176706,0.00012986071,0.00018338024,0.000090275986,0.00010966993],"domain_scores_gemma":[0.99942493,0.000037655507,0.0001328002,0.00027635417,0.00008954357,0.000038731752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034009703,0.00009712756,0.000093129514,0.000018127597,0.00015541425,0.000024573008,0.00011440178,0.0000839088,0.000035200577],"category_scores_gemma":[0.000031516858,0.000059003847,0.000035750563,0.000049345064,0.0009848715,0.0000058804126,0.00006656189,0.00013493198,0.000001168929],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009402924,0.000039825252,0.56869346,0.00006563068,0.0006673854,0.0000012765204,0.003122658,0.00042351056,0.3295696,0.0008813222,0.0011665631,0.09442845],"study_design_scores_gemma":[0.0015483595,0.000015254843,0.98192847,0.000011936621,0.00016131168,0.00038993784,0.0002594886,0.00055817823,0.014315489,0.00027531848,0.0004218959,0.0001143801],"about_ca_topic_score_codex":0.000874486,"about_ca_topic_score_gemma":0.0011194593,"teacher_disagreement_score":0.41323495,"about_ca_system_score_codex":0.000010651803,"about_ca_system_score_gemma":0.000060914645,"threshold_uncertainty_score":0.36288002},"labels":[],"label_agreement":null},{"id":"W2119650475","doi":"10.1016/j.breast.2015.07.014","title":"Obesity, insulin resistance and breast cancer outcomes","year":2015,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Obesity; Psychological intervention; Intervention (counseling); Insulin resistance; Cancer; Oncology; Internal medicine; Clinical trial; Psychiatry","score_opus":0.027279773878883543,"score_gpt":0.29769429456136653,"score_spread":0.270414520682483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119650475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9648047,0.0019924315,0.000009898068,0.028810339,0.00019567064,0.00019457415,0.00018608647,0.000054294585,0.0037520009],"genre_scores_gemma":[0.9944129,0.00017521184,0.000027209157,0.0009687329,0.00022901244,0.000012235594,0.0000038058083,0.000014956914,0.0041559157],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993417,0.000020692705,0.00011489023,0.00014906983,0.00020641691,0.00016721639],"domain_scores_gemma":[0.99941987,0.000023004792,0.00004387387,0.0002589974,0.00007953314,0.0001747285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014685492,0.00010947867,0.00020275966,0.000026542137,0.00006172309,0.00002152812,0.000081266095,0.000038545386,0.00009219311],"category_scores_gemma":[0.00001141331,0.00006224853,0.00003926994,0.00010452076,0.00011422412,0.00005118508,0.00005938276,0.0001254643,0.000027002785],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047262863,0.000076651646,0.9684747,0.000032228723,0.00006610806,0.000013916089,0.00075776875,0.0000015249627,0.000060543698,0.00048856856,0.013053316,0.016502056],"study_design_scores_gemma":[0.0011370619,0.000015210997,0.98714536,0.000059784867,0.00006338935,0.00029177286,0.00018764487,0.000010990051,0.000019553017,0.0002733613,0.010711537,0.000084313375],"about_ca_topic_score_codex":0.0023786216,"about_ca_topic_score_gemma":0.0013615738,"teacher_disagreement_score":0.029608214,"about_ca_system_score_codex":0.000079853795,"about_ca_system_score_gemma":0.00011263547,"threshold_uncertainty_score":0.359578},"labels":[],"label_agreement":null},{"id":"W2128957662","doi":"10.1016/j.breast.2010.06.003","title":"Defining ovarian failure in amenorrheic young breast cancer patients","year":2010,"lang":"en","type":"review","venue":"The Breast","topic":"Reproductive Biology and Fertility","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Mount Sinai Hospital; Regional Municipality of Durham; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Gynecology; Oncology; Cancer; Breast cancer; Internal medicine; Obstetrics","score_opus":0.019701114226747377,"score_gpt":0.3043333642512791,"score_spread":0.28463225002453174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128957662","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021898441,0.99336296,0.0000012276187,0.00065854203,0.00072345475,0.0011800926,0.00055894273,0.000046487537,0.0012784459],"genre_scores_gemma":[0.01773499,0.98010904,0.00003827673,0.000106143736,0.00077267137,0.00027120474,0.00041392603,0.000069150025,0.00048460186],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99805456,0.00026419276,0.00049759354,0.0006226772,0.00017160038,0.00038936117],"domain_scores_gemma":[0.99856025,0.000073911804,0.00027287382,0.0008679928,0.00012664763,0.000098342076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000534229,0.0004008558,0.00126767,0.00011374671,0.00011269278,0.000015541871,0.00030878038,0.00052858173,0.00031731368],"category_scores_gemma":[0.00007676815,0.00022119019,0.00026425888,0.0003349467,0.0002452661,0.00005303362,0.000121037825,0.0015218391,0.00018806786],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029745503,0.00019155724,0.034156725,0.0015868191,0.00013652255,0.000009096544,0.00013734198,3.468219e-8,0.0000011340421,0.00008582003,0.00021810377,0.9631794],"study_design_scores_gemma":[0.0005832193,0.000039365947,0.5803917,0.0060630157,0.00079119083,0.001873904,0.000024713789,7.6338597e-7,2.964569e-7,0.000052741092,0.4098756,0.00030346215],"about_ca_topic_score_codex":0.0005406844,"about_ca_topic_score_gemma":0.00040645537,"teacher_disagreement_score":0.9628759,"about_ca_system_score_codex":0.00017473684,"about_ca_system_score_gemma":0.00036641152,"threshold_uncertainty_score":0.90198743},"labels":[],"label_agreement":null},{"id":"W2133119224","doi":"10.1016/j.breast.2005.09.002","title":"Adjuvant endocrine therapies for pre-/perimenopausal women","year":2005,"lang":"en","type":"review","venue":"The Breast","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thunder Bay Regional Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Endocrine system; Adjuvant; Hormone; Oncology; Breast cancer; Estrogen receptor; Internal medicine; Receptor; Estrogen; Hormone receptor; Cancer; Hormone therapy","score_opus":0.013815217998229518,"score_gpt":0.32167210841580673,"score_spread":0.30785689041757724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133119224","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00049464905,0.99765915,0.000020001487,0.000059221045,0.00015537455,0.0010121666,0.0001873377,0.000023413006,0.00038868084],"genre_scores_gemma":[0.0005642278,0.9935224,0.00006911918,0.00005548568,0.0012543508,0.0006462423,0.00038129196,0.000086260196,0.0034206305],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987365,0.00012242378,0.00026595086,0.00034978456,0.00009456602,0.00043079295],"domain_scores_gemma":[0.9991618,0.000037572714,0.00015497151,0.0005264597,0.00003420014,0.000085001644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020285336,0.00037858792,0.0006427257,0.00003181659,0.000122037425,0.000030192055,0.00043025793,0.00026042145,0.00003163301],"category_scores_gemma":[0.000011970243,0.00021002389,0.00029627423,0.000064109256,0.000098016964,0.0000017945122,0.0001312282,0.0002105852,0.00004252119],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008042436,0.00006080899,3.2344005e-7,0.00076016784,0.0005892315,0.0000021889693,0.00005390695,0.0000010838085,0.00093919167,0.00006528059,0.0014084295,0.996039],"study_design_scores_gemma":[0.00031753973,0.0003509515,0.0000025373818,0.00040341605,0.00027487322,0.0007505083,0.000013270286,0.0000014341381,0.0002048392,0.00001540224,0.9973922,0.00027307996],"about_ca_topic_score_codex":0.0000040371283,"about_ca_topic_score_gemma":8.124584e-7,"teacher_disagreement_score":0.9959837,"about_ca_system_score_codex":0.000036333266,"about_ca_system_score_gemma":0.0001446333,"threshold_uncertainty_score":0.8564526},"labels":[],"label_agreement":null},{"id":"W2136299543","doi":"10.1016/j.breast.2015.03.012","title":"Cost-effectiveness of breast cancer screening policies using simulation","year":2015,"lang":"en","type":"article","venue":"The Breast","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Metropolitan University; Public Health Ontario; University of Toronto","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Medicine; Breast cancer; Mammography; Breast cancer screening; Demography; Mammography screening; Cancer; Gerontology; Gynecology; Oncology; Internal medicine","score_opus":0.2921499684514256,"score_gpt":0.44409957702832936,"score_spread":0.15194960857690376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136299543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898107,0.00037102876,0.007834397,0.0005529374,0.00009971982,0.00042788172,0.00007661256,0.00003705691,0.0007896712],"genre_scores_gemma":[0.9992769,0.0000041537505,0.00024021263,0.00016388016,0.0002534314,0.000011499373,0.0000067270735,0.000014482269,0.000028747798],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99904424,0.00010449024,0.00016586919,0.00012798895,0.00035186997,0.0002055716],"domain_scores_gemma":[0.99910575,0.00010095291,0.00010080285,0.00021574866,0.0003643213,0.00011242339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058400334,0.00010967636,0.00022955616,0.00005404802,0.00007324613,0.000014276262,0.000101961945,0.000046623245,0.000030103278],"category_scores_gemma":[0.0000405516,0.00007436644,0.00006418004,0.0002845031,0.00011098085,0.0001386401,0.000053981767,0.00010563291,0.000004316313],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047465945,0.00008486842,0.5003735,0.00017044302,0.00020911155,0.000015801,0.0015432012,0.43147245,0.012128908,0.00044040752,0.00015445481,0.048660304],"study_design_scores_gemma":[0.0016212349,0.0000729823,0.93386126,0.001094546,0.00020951242,0.00094519614,0.0011693207,0.059223134,0.0013419547,0.0001408046,0.00017697291,0.00014307993],"about_ca_topic_score_codex":0.007912148,"about_ca_topic_score_gemma":0.00004322011,"teacher_disagreement_score":0.4334878,"about_ca_system_score_codex":0.00015765143,"about_ca_system_score_gemma":0.00017175055,"threshold_uncertainty_score":0.99869424},"labels":[],"label_agreement":null},{"id":"W2142010188","doi":"10.1016/j.breast.2013.01.007","title":"Should all postmenopausal patients with hormone receptor-positive breast cancer receive initial therapy with aromatase inhibitors?","year":2013,"lang":"en","type":"article","venue":"The Breast","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Tamoxifen; Breast cancer; Oncology; Adjuvant therapy; Internal medicine; Aromatase; Adjuvant; Hormone therapy; Hormonal therapy; Cancer; Gynecology","score_opus":0.005821622245608589,"score_gpt":0.22598039872120496,"score_spread":0.22015877647559637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142010188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99575365,0.0008703828,0.000009211616,0.0012012037,0.00008836303,0.00086667755,0.00075955223,0.000030492805,0.00042049252],"genre_scores_gemma":[0.9970404,0.00032028096,0.000067342655,0.0007390407,0.00038028028,0.00016776464,0.0011245385,0.00006480558,0.00009555044],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99863404,0.00013396578,0.0001662203,0.0003942842,0.00026411953,0.0004073641],"domain_scores_gemma":[0.99907607,0.000017673798,0.00013115736,0.0003821167,0.00022671111,0.00016628049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000079953585,0.00033178797,0.00019018752,0.000031553667,0.0001645857,0.000060777656,0.0002318902,0.00019506447,0.00008508042],"category_scores_gemma":[0.0000028607312,0.00017489043,0.000049720424,0.0001306514,0.0002459342,0.000021818872,0.00007552763,0.00025954656,0.00009330415],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020405015,0.0019348869,0.025457406,0.000019823874,0.0030122343,0.000036838763,0.0009941091,0.00010121725,0.82929236,0.000046138593,0.04909601,0.06960396],"study_design_scores_gemma":[0.01905165,0.014935341,0.70650524,0.00037919404,0.00045197917,0.001540429,0.00048087526,0.000036060566,0.24954095,0.0000489663,0.0045657204,0.0024635897],"about_ca_topic_score_codex":0.00058156037,"about_ca_topic_score_gemma":0.000018515986,"teacher_disagreement_score":0.68104786,"about_ca_system_score_codex":0.000032961638,"about_ca_system_score_gemma":0.0000883119,"threshold_uncertainty_score":0.7131825},"labels":[],"label_agreement":null},{"id":"W2142423329","doi":"10.1016/j.breast.2006.10.007","title":"Pilot study of the impact of letrozole vs. placebo on breast density in women completing 5 years of tamoxifen","year":2006,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Medicine; Letrozole; Tamoxifen; Breast cancer; Aromatase inhibitor; Placebo; Breast density; Oncology; Internal medicine; Gynecology; Aromatase; Estrogen; Cancer; Mammography","score_opus":0.009994283177436074,"score_gpt":0.2439072352647548,"score_spread":0.23391295208731872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142423329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99908936,0.000041410414,0.000001433808,0.00008406661,0.000026443684,0.00027814409,0.00013894077,0.000003203467,0.00033701942],"genre_scores_gemma":[0.99985874,0.0000029138644,0.0000055728187,0.00001532306,0.000054596087,0.000016324388,0.0000068173276,0.00001300666,0.000026689166],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990997,0.00013966115,0.00023853936,0.00016597797,0.00016400353,0.00019214368],"domain_scores_gemma":[0.9992484,0.000041833177,0.00020437753,0.00042503502,0.00006224177,0.000018144436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021054443,0.00013096973,0.00025011683,0.00003176786,0.00004233927,0.000003166256,0.00025054894,0.00002200106,0.000008437448],"category_scores_gemma":[0.0000147024175,0.00008116304,0.00007494147,0.00014237069,0.00016058833,0.0000019663923,0.0001872605,0.00006962771,0.0000011080846],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051180893,0.0028486415,0.8868348,0.00002187182,0.00033358415,0.0000019191625,0.0009537004,0.0018129757,0.1001976,0.0000256442,0.00044441072,0.0014067818],"study_design_scores_gemma":[0.001885094,0.0008288296,0.99166656,0.000036340276,0.000021301305,0.0000347843,0.00045909686,0.0000065901636,0.0049583786,0.000030089737,0.000003955482,0.00006900521],"about_ca_topic_score_codex":0.011278493,"about_ca_topic_score_gemma":0.0009935825,"teacher_disagreement_score":0.104831755,"about_ca_system_score_codex":0.00006342892,"about_ca_system_score_gemma":0.000045321976,"threshold_uncertainty_score":0.9953055},"labels":[],"label_agreement":null},{"id":"W2143006403","doi":"10.1016/j.breast.2012.05.010","title":"ABC 1 (1st International consensus guidelines for advanced breast cancer): A positive step","year":2012,"lang":"en","type":"editorial","venue":"The Breast","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Scopus; Metastatic breast cancer; Cancer; Disease; Oncology; Internal medicine; Family medicine; MEDLINE","score_opus":0.03580187537947058,"score_gpt":0.4063039905991022,"score_spread":0.3705021152196316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143006403","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005591713,0.0031449927,0.00003689418,0.043079942,0.9169479,0.0016740753,0.032121133,0.00010065283,0.0023352646],"genre_scores_gemma":[0.002698164,0.0007962764,0.00042030067,0.0008251515,0.97463125,0.00070822914,0.0032462478,0.00010216073,0.016572231],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981531,0.00005539799,0.0004403386,0.0003981126,0.0004999768,0.00045305456],"domain_scores_gemma":[0.9965132,0.0007520615,0.00033939365,0.0003082581,0.0019121163,0.00017495298],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025235707,0.00042053527,0.0006085875,0.00009692204,0.00015104911,0.0000263764,0.0002922812,0.00037173324,0.0008658326],"category_scores_gemma":[0.000118948905,0.00028185616,0.0002812863,0.000093923016,0.0001912682,0.000046202418,0.00009235982,0.00045971345,0.000053147436],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007129173,0.00021832039,0.0001139517,0.00008007078,0.0012489274,0.000020263398,0.00009926696,0.00000529924,0.00037287845,0.00003295188,0.95753527,0.03314366],"study_design_scores_gemma":[0.0073340638,0.00017732127,0.0009729005,0.00043389335,0.001745486,0.0009314577,0.00008256807,0.00006735334,0.000069057765,0.000030829815,0.9878568,0.00029823417],"about_ca_topic_score_codex":0.0012296541,"about_ca_topic_score_gemma":0.00028804323,"teacher_disagreement_score":0.057683364,"about_ca_system_score_codex":0.00056060136,"about_ca_system_score_gemma":0.00078612723,"threshold_uncertainty_score":0.99996334},"labels":[],"label_agreement":null},{"id":"W2143196768","doi":"10.1016/j.breast.2013.04.020","title":"Information for decision making by post-menopausal women with hormone receptor positive early-stage breast cancer considering adjuvant endocrine therapy","year":2013,"lang":"en","type":"article","venue":"The Breast","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Toronto; Ontario Institute for Cancer Research; Ottawa Hospital; Queen's University","funders":"Ontario Institute for Cancer Research; Cancer Care Ontario","keywords":"Medicine; Oncology; Adjuvant; Breast cancer; Stage (stratigraphy); Endocrine system; Gynecology; Internal medicine; Hormone receptor; Cancer; Hormone; Adjuvant therapy","score_opus":0.04419570259816437,"score_gpt":0.3500402727543723,"score_spread":0.3058445701562079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143196768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97630405,0.0010501782,0.0006552405,0.013137071,0.0002789436,0.005020358,0.003075866,0.00017358742,0.00030469624],"genre_scores_gemma":[0.9897895,0.00027754353,0.0012280628,0.003527331,0.00012589704,0.004670161,0.0001458083,0.000053172585,0.00018251328],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9975249,0.00040152043,0.00069953443,0.00020864645,0.00037117535,0.00079418713],"domain_scores_gemma":[0.9960499,0.0012893864,0.00059342926,0.00073684147,0.0011451741,0.0001852837],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0002809188,0.00027140416,0.00031454337,0.00010181791,0.0013347502,0.000064270236,0.0004613203,0.00010852484,0.00085193984],"category_scores_gemma":[0.00008239728,0.00017658668,0.000024712997,0.00021915478,0.000116946714,0.0010311411,0.00021879014,0.0005429971,0.0002479289],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019889053,0.00033762984,0.052801147,0.0005846248,0.0005416863,0.0000016888058,0.20096032,0.00013479238,0.026764993,0.0012518747,0.03537363,0.66135854],"study_design_scores_gemma":[0.0073897173,0.0017718402,0.8996013,0.0020859388,0.000039421466,0.00010460158,0.07077936,0.0007906056,0.00019897953,0.000607864,0.015722618,0.0009077799],"about_ca_topic_score_codex":0.0062943543,"about_ca_topic_score_gemma":0.00014565985,"teacher_disagreement_score":0.84680015,"about_ca_system_score_codex":0.0006263441,"about_ca_system_score_gemma":0.0003586123,"threshold_uncertainty_score":0.99996537},"labels":[],"label_agreement":null},{"id":"W2146935345","doi":"10.1016/s0960-9776(03)00107-3","title":"Management of recurrent locoregional breast cancer: oncologist survey","year":2003,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Axilla; Breast cancer; Axillary lymph nodes; Radiation oncologist; Radiation therapy; Systemic therapy; Disease; Cancer; Mastectomy; Lymph; Radiology; Oncology; General surgery; Surgery; Internal medicine; Pathology","score_opus":0.0211995155002044,"score_gpt":0.2853426657060423,"score_spread":0.2641431502058379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146935345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97149384,0.0071946355,0.00038628466,0.0037386962,0.00080664054,0.00088692445,0.0029050151,0.00003981573,0.012548134],"genre_scores_gemma":[0.99810314,0.0009832839,0.000097346194,0.000086283755,0.00008949597,0.000088615176,0.00009009311,0.000016150663,0.0004455939],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99901736,0.00014893946,0.00017477696,0.00026906602,0.00015987121,0.00022998678],"domain_scores_gemma":[0.99933726,0.00002046711,0.00011270361,0.00037003588,0.00011371291,0.0000458395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026045548,0.00016952047,0.00016269262,0.000016727181,0.000101831545,0.0000074924574,0.0002225514,0.000050683655,0.000072209055],"category_scores_gemma":[0.0000058048863,0.00011516892,0.000082870945,0.00012516238,0.00024608802,0.0000020380403,0.000113152055,0.000054761724,0.000010943651],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033770623,0.0018877676,0.7793437,0.00021291258,0.0035310998,0.0000304067,0.00022105355,0.00030412417,0.0023596317,0.009538492,0.051056165,0.14813757],"study_design_scores_gemma":[0.00081406924,0.0000564567,0.98952955,0.00004647408,0.000078302284,0.00024151591,0.00012307547,0.0000018685596,0.0012127468,0.000089156776,0.0076489896,0.00015779374],"about_ca_topic_score_codex":0.00050721585,"about_ca_topic_score_gemma":0.00044617534,"teacher_disagreement_score":0.21018584,"about_ca_system_score_codex":0.00005240938,"about_ca_system_score_gemma":0.00006758467,"threshold_uncertainty_score":0.46964523},"labels":[],"label_agreement":null},{"id":"W2149734383","doi":"10.1016/s0960-9776(03)00160-7","title":"The best use of adjuvant endocrine treatments","year":2003,"lang":"en","type":"review","venue":"The Breast","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Tamoxifen; Anastrozole; Oncology; Breast cancer; Internal medicine; Adjuvant; Adjuvant therapy; Aromatase inhibitor; Aromatase; Cyclophosphamide; Gynecology; Chemotherapy; Cancer","score_opus":0.030995274689780278,"score_gpt":0.30127654398046516,"score_spread":0.27028126929068486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149734383","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032409333,0.99829894,0.0000029410305,0.0000187492,0.00015800711,0.0004879115,0.00011455383,0.0000043274454,0.0005904843],"genre_scores_gemma":[0.00016036259,0.9939291,0.000014762823,0.000012770892,0.000109394896,0.000053775966,0.00017994184,0.0000404682,0.0054994468],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988928,0.00025689576,0.00027888312,0.00022127845,0.000107570806,0.00024255917],"domain_scores_gemma":[0.9989305,0.00006598116,0.00021804754,0.0006945739,0.000038215752,0.000052657164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010994932,0.00028424032,0.00046411811,0.000018218954,0.00013422171,0.00002351863,0.00031099486,0.00018389951,0.00000503428],"category_scores_gemma":[0.000021584816,0.00012111887,0.00040694725,0.00009083408,0.00015542399,0.0000013483861,0.00010389486,0.00017766975,0.00005327742],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026171985,0.00010452008,0.000008045518,0.00037403035,0.0009388466,0.000010718904,0.0000037878547,0.0000014981929,0.00016246208,0.00008530354,0.0014486718,0.99683595],"study_design_scores_gemma":[0.00016860373,0.0001413139,0.0000042962943,0.00061097863,0.0008881811,0.0011094703,0.0000046898695,6.579993e-7,0.00020653156,0.0000041960766,0.9967252,0.00013586927],"about_ca_topic_score_codex":0.000027268781,"about_ca_topic_score_gemma":0.0000022259098,"teacher_disagreement_score":0.99670005,"about_ca_system_score_codex":0.000014752587,"about_ca_system_score_gemma":0.0001109007,"threshold_uncertainty_score":0.4939084},"labels":[],"label_agreement":null},{"id":"W2151576006","doi":"10.1016/j.breast.2011.04.004","title":"Psychological impact of recall on women with BRCA mutations undergoing MRI surveillance","year":2011,"lang":"en","type":"article","venue":"The Breast","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Cancer Institute; Canadian Institutes of Health Research; Canadian Breast Cancer Research Alliance","keywords":"Medicine; Worry; Anxiety; Breast cancer; BRCA mutation; Hospital Anxiety and Depression Scale; Distress; Magnetic resonance imaging; Depression (economics); Oncology; Internal medicine; Cancer; Psychiatry; Clinical psychology; Radiology","score_opus":0.02094765838579599,"score_gpt":0.28882585191553756,"score_spread":0.26787819352974157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151576006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912671,0.000041576637,0.0007093319,0.00014045861,0.00003905082,0.0001012842,0.00004970983,0.000009502121,0.0076419883],"genre_scores_gemma":[0.9990726,0.000024569268,0.00053163624,0.00008691815,0.000060749833,0.00002810372,0.00001841632,0.00001369534,0.0001633149],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9994047,0.000065582695,0.00010645725,0.00018242092,0.000078808596,0.00016199383],"domain_scores_gemma":[0.9994287,0.000025148567,0.00007323851,0.00036896608,0.0000643658,0.000039584418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001444993,0.00009287465,0.000084047366,0.000015419051,0.000053985084,0.0000060433235,0.00018195945,0.000054105913,0.00012837155],"category_scores_gemma":[0.000018652721,0.000054630684,0.000041069172,0.00010375704,0.00015179839,0.0000018998377,0.000028551165,0.00006228553,0.000012664718],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020507354,0.0037147992,0.38868442,0.000117958036,0.0035240117,0.000041032792,0.014425662,0.022576192,0.4296375,0.003496383,0.022382662,0.09089202],"study_design_scores_gemma":[0.00082911155,0.0020312376,0.9878171,0.00001907017,0.000011920721,0.00027461746,0.00031813997,0.000025289826,0.007470749,0.0007700539,0.00023082625,0.00020186753],"about_ca_topic_score_codex":0.000035174195,"about_ca_topic_score_gemma":0.000061431776,"teacher_disagreement_score":0.5991327,"about_ca_system_score_codex":0.000052902793,"about_ca_system_score_gemma":0.000094481635,"threshold_uncertainty_score":0.22277746},"labels":[],"label_agreement":null},{"id":"W2154671238","doi":"10.1016/j.breast.2012.12.004","title":"Experts' opinion: Recommendations for retesting breast cancer metastases for HER2 and hormone receptor status","year":2013,"lang":"en","type":"article","venue":"The Breast","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Hormone receptor; Oncology; Breast cancer; Human Epidermal Growth Factor Receptor 2; Hormone; Metastatic breast cancer; Internal medicine; Cancer; Regimen; Hormone therapy; Receptor","score_opus":0.08686729125714283,"score_gpt":0.3959840605294179,"score_spread":0.3091167692722751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154671238","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14623092,0.020133793,0.00385035,0.7898715,0.0020328073,0.017712083,0.017392294,0.0005521785,0.0022240607],"genre_scores_gemma":[0.8749364,0.009734738,0.060711075,0.0069509083,0.008384081,0.027110634,0.0019534356,0.00051433285,0.0097043915],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986214,0.00006981299,0.0002490808,0.00030460127,0.00021349109,0.0005415856],"domain_scores_gemma":[0.9983326,0.0006027142,0.0000890156,0.00034931445,0.00036692055,0.0002594338],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004507156,0.00016940752,0.00026484072,0.00006342847,0.00031504585,0.00008011482,0.00013149402,0.00005681105,0.0010365284],"category_scores_gemma":[0.00019055243,0.00011450289,0.00007789129,0.00017312607,0.00014548325,0.00015534046,0.000074678625,0.00013991886,0.000018694167],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000504004,0.000097660166,0.001982533,0.00021495874,0.00018410389,3.7571814e-7,0.00070604426,0.0000017644339,0.006224049,0.00028615977,0.5953747,0.39442366],"study_design_scores_gemma":[0.0074939732,0.0010298407,0.042320147,0.0012086678,0.00025154473,0.0009957084,0.0056719473,0.0029778467,0.0017850907,0.00092438876,0.9346556,0.0006852336],"about_ca_topic_score_codex":0.0021067478,"about_ca_topic_score_gemma":0.00004737817,"teacher_disagreement_score":0.7829206,"about_ca_system_score_codex":0.00016295076,"about_ca_system_score_gemma":0.00023177422,"threshold_uncertainty_score":0.9998767},"labels":[],"label_agreement":null},{"id":"W2155477677","doi":"10.1016/j.breast.2015.04.006","title":"One step forward, two steps back: The story of everolimus in advanced breast cancer","year":2015,"lang":"en","type":"article","venue":"The Breast","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Manitoba; University of Toronto; CancerCare Manitoba","funders":"","keywords":"Medicine; Everolimus; Bevacizumab; Breast cancer; Drug; Anticancer drug; Cancer; Cancer drugs; Clinical trial; Intensive care medicine; Oncology; Internal medicine; Pharmacology; Chemotherapy","score_opus":0.025772968564792453,"score_gpt":0.2992484553007128,"score_spread":0.27347548673592037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155477677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9511024,0.008741053,0.00077276333,0.03120629,0.00075131666,0.0020697378,0.0005211357,0.00013351899,0.004701822],"genre_scores_gemma":[0.9965506,0.00008942587,0.00048920995,0.000991199,0.000436177,0.00012393511,0.000009436557,0.000067436,0.0012425712],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99793047,0.0002484674,0.00038598082,0.00032655324,0.0006106314,0.0004978706],"domain_scores_gemma":[0.9981452,0.00017557073,0.00024828993,0.00091882906,0.0003206211,0.0001914729],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077586016,0.00027438664,0.0005394118,0.00009897187,0.00009396816,0.000010585248,0.00043675664,0.00006899049,0.0002657269],"category_scores_gemma":[0.000035686335,0.00016860153,0.000121235076,0.00046218283,0.00043565643,0.00020146664,0.0001323105,0.0005643997,0.000079908285],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013698952,0.00074672006,0.036215927,0.00021699458,0.0005869627,0.000023681043,0.0065408098,0.0037125037,0.008076578,0.0009417019,0.0013621515,0.927877],"study_design_scores_gemma":[0.026976887,0.00044452646,0.9292787,0.0014985618,0.00044310908,0.002456787,0.010044995,0.0007310857,0.0015958125,0.0017264528,0.024045223,0.0007579004],"about_ca_topic_score_codex":0.0010731723,"about_ca_topic_score_gemma":0.00088707305,"teacher_disagreement_score":0.92711914,"about_ca_system_score_codex":0.00043870558,"about_ca_system_score_gemma":0.00042729563,"threshold_uncertainty_score":0.6875371},"labels":[],"label_agreement":null},{"id":"W2157138888","doi":"10.1016/j.breast.2009.06.003","title":"Survivin and COX-2 expression in male breast carcinoma","year":2009,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer and Skin Lesions","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Cancer Care Nova Scotia; Queen Elizabeth II Health Sciences Centre","funders":"Dalhousie University","keywords":"Survivin; Immunohistochemistry; Tissue microarray; Medicine; Aromatase; Proportional hazards model; Oncology; Breast cancer; Breast carcinoma; Cancer research; Cancer; Pathology; Internal medicine","score_opus":0.011041185287837905,"score_gpt":0.252636334876926,"score_spread":0.2415951495890881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157138888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849487,0.0003867942,0.00001849997,0.0058484073,0.000043202846,0.00015547275,0.000025512038,0.000019164983,0.008554238],"genre_scores_gemma":[0.99822223,0.000028390348,0.00003635258,0.00040299507,0.00014964317,0.0000044248877,0.0000073611113,0.000006835202,0.0011417794],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994438,0.000037040198,0.000104837694,0.00013353834,0.00012083546,0.00015989842],"domain_scores_gemma":[0.9996169,0.000033629083,0.000019340108,0.00023051444,0.000019956218,0.000079650126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014018921,0.00008077338,0.00014033396,0.000044642038,0.000058350615,0.000010725176,0.000059336257,0.000038260037,0.00022790005],"category_scores_gemma":[0.0000067866135,0.000050391547,0.000028082986,0.00011076089,0.000049543705,0.00003632977,0.000027594973,0.00012855121,0.000017464758],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011732415,0.00043829897,0.8216055,0.00005166528,0.000009964562,0.00023224462,0.0021608232,0.0000055936985,0.069853954,0.0005085523,0.0118460525,0.09211409],"study_design_scores_gemma":[0.0009014842,0.000044122426,0.9904572,0.000105788706,0.000013607445,0.007269773,0.00014990076,0.0000710956,0.00042264373,0.00012649281,0.00037769994,0.000060241848],"about_ca_topic_score_codex":0.00030479277,"about_ca_topic_score_gemma":0.0000982742,"teacher_disagreement_score":0.16885163,"about_ca_system_score_codex":0.000028315515,"about_ca_system_score_gemma":0.000036430727,"threshold_uncertainty_score":0.24953458},"labels":[],"label_agreement":null},{"id":"W2166283583","doi":"10.1016/j.breast.2006.01.002","title":"The extended adjuvant NCIC CTG MA.17 trials: Initial and rerandomization studies","year":2006,"lang":"en","type":"review","venue":"The Breast","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Sunnybrook Health Science Centre","funders":"","keywords":"Letrozole; Medicine; Tamoxifen; Breast cancer; Aromatase inhibitor; Internal medicine; Adverse effect; Placebo; Oncology; Zoledronic acid; Adjuvant; Randomized controlled trial; Cancer; Gynecology; Alternative medicine","score_opus":0.05042748622701733,"score_gpt":0.3845853797491913,"score_spread":0.334157893522174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166283583","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013333834,0.9978253,0.000024237495,0.00010952732,0.00033255233,0.00094629807,0.000053628388,0.000014335636,0.000560747],"genre_scores_gemma":[0.0004090734,0.99680656,0.000009838174,0.000028161132,0.0009801706,0.00013431991,0.0002860012,0.00003935482,0.0013065273],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975885,0.001188347,0.0005461617,0.00031005108,0.0001306243,0.00023632229],"domain_scores_gemma":[0.9986959,0.00037760395,0.0003985145,0.0004168687,0.00006925388,0.00004187512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016332091,0.0003377095,0.0010285283,0.00002919157,0.0003672369,0.000078048615,0.00024480224,0.00032735086,0.0000022908273],"category_scores_gemma":[0.0002799851,0.00014452757,0.00039142143,0.0000901084,0.00026001988,0.000002708724,0.00016114536,0.00025482674,0.000010432525],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003291534,0.000024049896,2.0362316e-7,0.0005286256,0.0008745927,0.000007021429,0.000020751244,0.0000018643015,0.00006699114,0.00006838806,0.0077407914,0.99033755],"study_design_scores_gemma":[0.0017692102,0.00012402421,0.0000065830604,0.0012739906,0.0019482038,0.0009439,0.000048355836,0.0000058075943,0.00008922756,0.0001279002,0.9933576,0.00030522107],"about_ca_topic_score_codex":0.000007314092,"about_ca_topic_score_gemma":0.0000071701556,"teacher_disagreement_score":0.9900324,"about_ca_system_score_codex":0.000017287313,"about_ca_system_score_gemma":0.00011745119,"threshold_uncertainty_score":0.5893663},"labels":[],"label_agreement":null},{"id":"W2166444077","doi":"10.1016/j.breast.2013.07.008","title":"Obesity and endocrine therapy: Host factors and breast cancer outcome","year":2013,"lang":"en","type":"review","venue":"The Breast","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; University of Toronto","funders":"","keywords":"Anastrozole; Medicine; Tamoxifen; Letrozole; Breast cancer; Body mass index; Internal medicine; Hazard ratio; Oncology; Overweight; Aromatase inhibitor; Obesity; Cancer; Gynecology; Confidence interval","score_opus":0.0751165627732092,"score_gpt":0.3647562106218635,"score_spread":0.28963964784865426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166444077","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022369135,0.9743059,6.6851516e-7,0.00061851693,0.00023799056,0.0012301842,0.0010087562,0.000055572087,0.0001732246],"genre_scores_gemma":[0.010553446,0.9875146,0.0000037214024,0.0001405327,0.00048237926,0.00009570134,0.00004737592,0.00007560021,0.0010866397],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985059,0.00007395596,0.0004033331,0.00042197196,0.00023117675,0.00036368537],"domain_scores_gemma":[0.99881536,0.00013189542,0.00023429158,0.00050198473,0.000059557584,0.0002568862],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011179941,0.00056514324,0.0017020641,0.00009546866,0.00014552285,0.00007188554,0.00016603178,0.00015674873,0.0007650233],"category_scores_gemma":[0.000008089132,0.000262165,0.0002719272,0.00015729692,0.00023922739,0.000072643794,0.00014098037,0.0005298582,0.000028184562],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002459561,0.000049805112,0.0711649,0.0026533655,0.00031841776,0.000008490646,0.00011826449,5.2074642e-9,0.0000015676925,0.000023520757,0.00052103365,0.92511606],"study_design_scores_gemma":[0.0005638946,0.000040989125,0.2929203,0.0023891774,0.00091048505,0.0025913087,0.000051426927,6.7569437e-7,6.587008e-7,0.0000055681385,0.70020276,0.00032277775],"about_ca_topic_score_codex":0.007538245,"about_ca_topic_score_gemma":0.0001370433,"teacher_disagreement_score":0.92479324,"about_ca_system_score_codex":0.00011768251,"about_ca_system_score_gemma":0.0001454389,"threshold_uncertainty_score":0.9999831},"labels":[],"label_agreement":null},{"id":"W2167694626","doi":"10.1016/j.breast.2011.01.006","title":"Reasons for risk-reducing mastectomy versus MRI-screening in a cohort of women at high hereditary risk of breast cancer","year":2011,"lang":"en","type":"article","venue":"The Breast","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"","keywords":"Medicine; Breast cancer; Prophylactic Mastectomy; BRCA mutation; Cohort; Cancer; Breast MRI; Risk perception; Family medicine; Family history; Mammography; Mastectomy; Obstetrics; Gynecology; Oncology; Demography; Internal medicine; Perception","score_opus":0.01448447418864692,"score_gpt":0.24977716208057904,"score_spread":0.2352926878919321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167694626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960599,0.00045837235,0.0006520693,0.00008813876,0.00024123216,0.0003623207,0.0018542293,0.0000074698146,0.00027627157],"genre_scores_gemma":[0.9970489,0.00021077097,0.0020783576,0.000011679871,0.00021327371,0.00025650923,0.00004794326,0.00003243792,0.0001001194],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988959,0.00010428454,0.00027140896,0.0002918321,0.00012587963,0.00031071863],"domain_scores_gemma":[0.9989672,0.00005543852,0.00030079152,0.00048264043,0.00013617077,0.000057795518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051594654,0.00014835208,0.00021754322,0.00005090686,0.00008056267,0.000003245371,0.00027971645,0.0001045895,0.00013419254],"category_scores_gemma":[0.000049081424,0.00012185483,0.00008303753,0.0001490526,0.00016730525,0.0000056404174,0.00015129831,0.00010289359,0.0000012838567],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016062813,0.0003826706,0.8437976,0.00017541467,0.0025785798,0.000004595394,0.005380293,0.007931245,0.06820511,0.000090432135,0.0030776013,0.052313626],"study_design_scores_gemma":[0.0029033946,0.00024163666,0.94717896,0.00008170289,0.00022105066,0.00008132612,0.0010153522,0.00028864125,0.04718035,0.00010008413,0.0004614369,0.00024606247],"about_ca_topic_score_codex":0.0074205725,"about_ca_topic_score_gemma":0.0012737679,"teacher_disagreement_score":0.10338134,"about_ca_system_score_codex":0.00015917637,"about_ca_system_score_gemma":0.0001619554,"threshold_uncertainty_score":0.9991891},"labels":[],"label_agreement":null},{"id":"W2170856158","doi":"10.1016/j.breast.2013.10.004","title":"The impact of a breast cancer diagnosis in young women on their relationship with their mothers","year":2013,"lang":"en","type":"article","venue":"The Breast","topic":"Family Support in Illness","field":"Social Sciences","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; York University; University of Toronto; Health Sciences Centre","funders":"","keywords":"Medicine; Daughter; Breast cancer; Cancer; Young adult; Gynecology; Gerontology; Internal medicine","score_opus":0.01862182082207191,"score_gpt":0.2783743497667665,"score_spread":0.2597525289446946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170856158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98135704,0.000051100542,0.0000016811055,0.0055125896,0.000081157916,0.00050922483,0.00014646446,0.000029937357,0.012310817],"genre_scores_gemma":[0.99850017,0.0000725856,0.0000021851667,0.000070033995,0.000093057155,0.0007739547,0.0000012889861,0.000021716047,0.00046500392],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985565,0.0003579423,0.00018438704,0.0001584766,0.0002822135,0.0004605142],"domain_scores_gemma":[0.9983141,0.0009761047,0.00014466402,0.00038083654,0.000096035525,0.00008828081],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009091073,0.00015119216,0.00016376287,0.000052823274,0.00050971966,0.000090810805,0.0005500729,0.00006418005,0.00061359],"category_scores_gemma":[0.00005240723,0.00006303221,0.0000716414,0.000542326,0.00062198576,0.00020843685,0.000035306093,0.00020279262,0.00002940364],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000087984714,0.00007054439,0.9316037,0.000002329339,0.00005116843,3.497679e-7,0.055165768,0.0003109863,0.00001027731,0.0013946358,0.001048429,0.010253788],"study_design_scores_gemma":[0.00019485396,0.000031055002,0.9591251,0.00005827985,0.000003841598,0.0000080688615,0.037466876,0.000059348462,0.0000069256716,0.0028584928,0.00008687908,0.000100270896],"about_ca_topic_score_codex":0.10749471,"about_ca_topic_score_gemma":0.016703503,"teacher_disagreement_score":0.0907912,"about_ca_system_score_codex":0.00044552897,"about_ca_system_score_gemma":0.00026761933,"threshold_uncertainty_score":0.9320947},"labels":[],"label_agreement":null},{"id":"W2171244965","doi":"10.1016/j.breast.2012.03.003","title":"1st International consensus guidelines for advanced breast cancer (ABC 1)","year":2012,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":299,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Consensus conference; Breast cancer; Medical physics; Family medicine; Cancer; Internal medicine","score_opus":0.08269649930811482,"score_gpt":0.4304189945483469,"score_spread":0.34772249524023213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171244965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5991054,0.004465705,0.00011970423,0.37683305,0.0057401867,0.0014423723,0.0020785083,0.00016219777,0.010052883],"genre_scores_gemma":[0.9841561,0.00016970957,0.00054014684,0.003969753,0.00358429,0.00021630528,0.00007106369,0.000023103164,0.007269576],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993361,0.00001523581,0.00016986372,0.000114547576,0.00011621438,0.00024802692],"domain_scores_gemma":[0.9993056,0.00008072566,0.000066807486,0.00013597381,0.00030947145,0.00010139755],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013085199,0.000114929375,0.00015417972,0.000031795535,0.000078781064,0.0000066158436,0.00008965376,0.00003600747,0.0012524526],"category_scores_gemma":[0.000018702935,0.000071166374,0.00008593183,0.000057651414,0.00007847498,0.000041376414,0.000028653223,0.000066561006,0.000046568155],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007981548,0.0008525573,0.10425535,0.00007657473,0.0011996514,0.000009844345,0.0006497621,0.00007487491,0.03304082,0.0017511599,0.5662568,0.28385103],"study_design_scores_gemma":[0.014949105,0.0001755558,0.28377613,0.00017814954,0.0010698801,0.0063900417,0.0004999405,0.000709417,0.0036815233,0.00026603317,0.68791056,0.00039365215],"about_ca_topic_score_codex":0.0001969991,"about_ca_topic_score_gemma":0.000043133157,"teacher_disagreement_score":0.38505065,"about_ca_system_score_codex":0.0001045519,"about_ca_system_score_gemma":0.0000775477,"threshold_uncertainty_score":0.99966055},"labels":[],"label_agreement":null},{"id":"W2180442422","doi":"10.1016/j.breast.2015.10.010","title":"Nipple sparing mastectomy: Surgical and oncological outcomes from a national multicentric registry with 913 patients (1006 cases) over a six year period","year":2015,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"123 Certification (Canada)","funders":"Università degli Studi di Firenze","keywords":"Medicine; Mastectomy; General surgery; Surgery; Total Mastectomy; Breast cancer; Cancer; Internal medicine","score_opus":0.029760906611227395,"score_gpt":0.2621248849149978,"score_spread":0.2323639783037704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2180442422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975398,0.00004429341,0.0000054387483,0.00048560833,0.00013374545,0.00022709297,0.00010946567,0.000038713893,0.0014158143],"genre_scores_gemma":[0.99901015,0.0000015472393,0.00026200013,0.000037098005,0.00025833718,0.000008925625,0.000072773226,0.000011002247,0.000338183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990936,0.000047463924,0.00014429781,0.00018943599,0.00035324477,0.00017194197],"domain_scores_gemma":[0.9994284,0.00010138949,0.00007727659,0.00012012533,0.00011069633,0.00016209923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011841593,0.00012626621,0.00022276028,0.000041098698,0.000074476455,0.000030733103,0.000054939737,0.00008822828,0.00013728856],"category_scores_gemma":[0.000037953778,0.00006571666,0.000038131788,0.000092053,0.00013835474,0.00006517108,0.00005425293,0.00018540847,0.000032540178],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013982024,0.00015279673,0.9908213,0.0000086385435,0.00007025455,0.00013637751,0.00014214944,0.000002995065,0.0000047657572,0.00009813614,0.00030935148,0.006855009],"study_design_scores_gemma":[0.0069883643,0.00012802138,0.94281054,0.00005170115,0.000095759344,0.048500568,0.00036370737,0.00025385933,0.000004747377,0.000039299186,0.00064947666,0.00011397566],"about_ca_topic_score_codex":0.00037290677,"about_ca_topic_score_gemma":0.000056929137,"teacher_disagreement_score":0.048364192,"about_ca_system_score_codex":0.00009959669,"about_ca_system_score_gemma":0.000113942915,"threshold_uncertainty_score":0.26798478},"labels":[],"label_agreement":null},{"id":"W2215157211","doi":"10.1016/j.breast.2015.11.007","title":"The use of granulocyte colony stimulating factor (G-CSF) and management of chemotherapy delivery during adjuvant treatment for early-stage breast cancer—Further observations from the IMPACT solid study","year":2015,"lang":"en","type":"article","venue":"The Breast","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"Amgen","keywords":"Medicine; Regimen; Febrile neutropenia; Neutropenia; Internal medicine; Granulocyte colony-stimulating factor; Breast cancer; Chemotherapy; Chemotherapy regimen; Oncology; Surgery; Cancer","score_opus":0.11562767487227553,"score_gpt":0.34888635538337764,"score_spread":0.2332586805111021,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2215157211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99511653,0.00024902157,0.000034449007,0.0013694892,0.0000680615,0.002082917,0.0010440552,0.00002012646,0.000015343838],"genre_scores_gemma":[0.99878365,0.00036426986,0.000047881374,0.00004862461,0.00010010051,0.0002417569,0.000008902712,0.00002794294,0.00037686637],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908626,0.000071218055,0.00027099752,0.00017333982,0.00020097161,0.00019719946],"domain_scores_gemma":[0.998891,0.00021872272,0.00018574555,0.00044669205,0.00018453767,0.000073324634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012507667,0.00017249485,0.0002852866,0.000021008667,0.00026911387,0.000042207605,0.00012225717,0.00002509757,0.000027811517],"category_scores_gemma":[0.0000051467396,0.000077340956,0.00011587128,0.0001315351,0.00011423463,0.000097178236,0.0000495142,0.00006903993,7.500058e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033567336,0.00053381704,0.9696917,0.000032072217,0.0018279345,0.0000035251496,0.0077248854,0.0018768938,0.003532547,0.000019831985,0.00010550498,0.011294532],"study_design_scores_gemma":[0.004648682,0.00045126924,0.99112505,0.000102329665,0.0003910432,0.000016543094,0.0018436693,0.0006737378,0.0004779496,0.000013738336,0.00017819206,0.00007779378],"about_ca_topic_score_codex":0.015850702,"about_ca_topic_score_gemma":0.001205694,"teacher_disagreement_score":0.02143333,"about_ca_system_score_codex":0.000174777,"about_ca_system_score_gemma":0.00008228002,"threshold_uncertainty_score":0.9907028},"labels":[],"label_agreement":null},{"id":"W2226119970","doi":"10.1016/j.breast.2015.12.004","title":"Does breast composition influence late adverse effects in breast radiotherapy?","year":2016,"lang":"en","type":"article","venue":"The Breast","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Niilo Helanderin Säätiö; Institute of Cancer Research; Cancer Research UK; National Institute for Health and Care Research; Australian Government","keywords":"Medicine; Seroma; Breast cancer; Logistic regression; Radiation therapy; Univariate analysis; Odds ratio; Confounding; Adverse effect; Risk factor; Internal medicine; Oncology; Multivariate analysis; Cancer; Complication","score_opus":0.002745082565074225,"score_gpt":0.21535753989007378,"score_spread":0.21261245732499956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2226119970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98062634,0.00009041709,0.0002596168,0.016771171,0.00017770458,0.00049957144,0.0001544077,0.00016247196,0.0012582939],"genre_scores_gemma":[0.99831516,0.000040855855,0.00010622271,0.0008541543,0.0002530708,0.000026367094,0.000011934058,0.000037956233,0.00035430604],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998459,0.000104281324,0.00028793808,0.00034943438,0.00031899835,0.00048037717],"domain_scores_gemma":[0.99895567,0.00018205176,0.00010012332,0.0004896671,0.00008385279,0.00018865471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026538866,0.00027728223,0.00033768022,0.00022620124,0.00009748153,0.00004139738,0.00023473178,0.00007348659,0.00007752424],"category_scores_gemma":[0.000007978009,0.000117038486,0.00018996489,0.00049387245,0.00035257402,0.0005540681,0.000049851824,0.00018552467,0.00009723223],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021403285,0.00045396492,0.49692538,0.00017078558,0.00021721527,0.0002758986,0.00040460037,0.00002959803,0.12569942,0.00084355107,0.00018487086,0.37265438],"study_design_scores_gemma":[0.0030860715,0.00006556086,0.9826191,0.0014014106,0.0000654219,0.01093122,0.00003248475,0.00008332399,0.00071555574,0.00056563213,0.00019864141,0.00023558897],"about_ca_topic_score_codex":0.00015381885,"about_ca_topic_score_gemma":0.00000998889,"teacher_disagreement_score":0.4856937,"about_ca_system_score_codex":0.000119540106,"about_ca_system_score_gemma":0.00005124063,"threshold_uncertainty_score":0.47726908},"labels":[],"label_agreement":null},{"id":"W2305942576","doi":"10.1016/j.breast.2016.02.012","title":"Does a dedicated program for young breast cancer patients affect the likelihood of fertility preservation discussion and referral?","year":2016,"lang":"en","type":"article","venue":"The Breast","topic":"Reproductive Biology and Fertility","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research; BC Cancer Agency","funders":"","keywords":"Medicine; Fertility; Breast cancer; Referral; Cancer; Fertility preservation; Documentation; Prospective cohort study; Gynecology; Family medicine; Internal medicine; Population","score_opus":0.017600189257271356,"score_gpt":0.29869298235254177,"score_spread":0.2810927930952704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2305942576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97300315,0.000070483744,0.000050208437,0.024711551,0.00013688588,0.0017455871,0.00020909046,0.000037758946,0.000035265188],"genre_scores_gemma":[0.9991845,0.00001887464,0.000020363643,0.000048437563,0.000112815746,0.00032967085,0.000023840901,0.00000866715,0.00025281444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990877,0.00014513217,0.00018805938,0.00027090585,0.00012945173,0.00017878934],"domain_scores_gemma":[0.99909675,0.00007999616,0.00011464248,0.0004144989,0.000243831,0.00005030403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005445927,0.00010851384,0.00017514377,0.000015228391,0.00013049158,0.000005258932,0.000109991866,0.000073131436,0.000026968299],"category_scores_gemma":[0.00016868119,0.000024862497,0.000058123067,0.000085235166,0.00037094826,0.00009931409,0.00006512365,0.000076399956,9.843178e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008147748,0.00036098968,0.7970328,0.0000753887,0.00006970051,5.974723e-8,0.00024516883,1.5248151e-8,0.008316994,0.000009174523,0.00020351002,0.18553846],"study_design_scores_gemma":[0.0011033562,0.0002199305,0.99548507,0.00012855015,0.00010237907,0.0000093595145,0.00003826592,0.000021979715,0.0018834986,0.0007479611,0.00020937443,0.000050290833],"about_ca_topic_score_codex":0.00019997134,"about_ca_topic_score_gemma":0.00011276231,"teacher_disagreement_score":0.19845226,"about_ca_system_score_codex":0.000033372984,"about_ca_system_score_gemma":0.000040598836,"threshold_uncertainty_score":0.13667743},"labels":[],"label_agreement":null},{"id":"W2319623115","doi":"10.1016/j.breast.2016.02.010","title":"New onset vasomotor symptoms but not musculoskeletal symptoms associate with clinical outcomes on extended adjuvant letrozole – Analyses from NCIC CTG MA.17","year":2016,"lang":"en","type":"article","venue":"The Breast","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Queen's University","funders":"","keywords":"Medicine; Letrozole; Vasomotor; Adjuvant; Internal medicine; Oncology; Physical therapy; Cancer; Breast cancer; Tamoxifen","score_opus":0.01360929907153333,"score_gpt":0.3073635627656535,"score_spread":0.29375426369412017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319623115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968027,0.0003353044,0.0003515634,0.0012110576,0.00027116213,0.00027156112,0.00033020237,0.000057214103,0.0003692209],"genre_scores_gemma":[0.9928429,0.00009787113,0.000117027026,0.0005376012,0.00050809974,0.000018912653,0.00013969818,0.000055992896,0.0056818887],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9978382,0.00032901551,0.0003838012,0.0006038715,0.00035448524,0.00049060053],"domain_scores_gemma":[0.99834573,0.00022873818,0.00023754178,0.00085488934,0.00006548668,0.00026761348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003192965,0.0003858668,0.00046335655,0.00004412485,0.00016415888,0.000041156938,0.00047883042,0.0003479561,0.000088980225],"category_scores_gemma":[0.0000896899,0.00018077696,0.0004819401,0.00009511228,0.00022771966,0.000009086246,0.00015725626,0.00027264562,0.0002453076],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058195684,0.0011643091,0.26965955,0.000019868787,0.0090884995,0.00013749924,0.000095329735,0.00003775339,0.52352077,0.00014657526,0.016926302,0.173384],"study_design_scores_gemma":[0.004904554,0.0018080045,0.9291261,0.00013618518,0.00069479673,0.0001286706,0.000034124725,0.000019856116,0.061030712,0.000081405946,0.0013850785,0.0006505166],"about_ca_topic_score_codex":0.00022217318,"about_ca_topic_score_gemma":0.000041201027,"teacher_disagreement_score":0.65946656,"about_ca_system_score_codex":0.000039758987,"about_ca_system_score_gemma":0.00015970126,"threshold_uncertainty_score":0.737187},"labels":[],"label_agreement":null},{"id":"W2400028560","doi":"10.1016/j.breast.2016.04.013","title":"Overdiagnosis and overtreatment associated with breast cancer mammography screening: A simulation study with calibration to population-based data","year":2016,"lang":"en","type":"article","venue":"The Breast","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer; Agence Nationale de la Recherche","keywords":"Overdiagnosis; Medicine; Breast cancer; Mammography; Population; Incidence (geometry); Internal medicine; Gynecology; Cancer; Oncology; Confidence interval","score_opus":0.06502274715821088,"score_gpt":0.3351735388951199,"score_spread":0.27015079173690904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2400028560","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98800147,0.000041934632,0.003882556,0.0063729486,0.000015102429,0.0010106422,0.00058269285,0.00006642069,0.000026262074],"genre_scores_gemma":[0.9988101,0.0000030731971,0.00018349923,0.0006568556,0.00007849022,0.000082611696,0.00012679289,0.000022357639,0.000036227233],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869174,0.00007370119,0.00015959378,0.00037013905,0.0004962958,0.00020852652],"domain_scores_gemma":[0.9989188,0.00018309098,0.00010755598,0.0005148205,0.00013637931,0.00013941075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020552297,0.00017506744,0.00021258614,0.00007776663,0.0001679203,0.00004904871,0.000115745126,0.000035906873,0.000058489826],"category_scores_gemma":[0.000030135268,0.00008057215,0.000021901373,0.000403982,0.000039893905,0.00029060553,0.000052485433,0.00005514979,0.0000013024163],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002161231,0.00017835775,0.9802936,0.0000042420215,0.00021999946,0.0000126814375,0.00009740675,0.0032301184,0.00002198288,0.000006228651,0.00014295682,0.013631198],"study_design_scores_gemma":[0.0028153649,0.00066302216,0.9886334,0.00059564353,0.00042067512,0.000042398202,0.00017227426,0.006482206,0.000010185538,0.0000048762818,0.000021756592,0.0001382139],"about_ca_topic_score_codex":0.006376407,"about_ca_topic_score_gemma":0.0047268695,"teacher_disagreement_score":0.013492984,"about_ca_system_score_codex":0.00012377909,"about_ca_system_score_gemma":0.000082089355,"threshold_uncertainty_score":0.9639263},"labels":[],"label_agreement":null},{"id":"W2468316166","doi":"10.1016/j.breast.2016.06.013","title":"A prospective study on the neurological complications of breast cancer and its treatment: Updated analysis three years after cancer diagnosis","year":2016,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"European Regional Development Fund; Fundação para a Ciência e a Tecnologia; Universidade do Porto","keywords":"Medicine; Breast cancer; Prospective cohort study; Taxane; Internal medicine; Peripheral neuropathy; Cancer; Chemotherapy; Odds ratio; Confidence interval; Surgery","score_opus":0.033388218821180156,"score_gpt":0.3313250317947832,"score_spread":0.297936812973603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2468316166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96673167,0.0004061176,0.0000010840201,0.030480111,0.000029753199,0.0010406104,0.0011679311,0.000021003783,0.000121721816],"genre_scores_gemma":[0.9944336,0.00031711214,7.679192e-7,0.0004482792,0.000082786006,0.0044684825,0.000004766753,0.000010715848,0.00023349245],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992594,0.0000775567,0.00013409741,0.00025243332,0.00012313,0.00015336522],"domain_scores_gemma":[0.99934095,0.00017948615,0.00007521732,0.00026578177,0.00007949124,0.000059063597],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000060164042,0.00013941324,0.00027145364,0.00006344045,0.0000758536,0.0000068425547,0.000087068096,0.000031136373,0.0018590828],"category_scores_gemma":[0.0000031093025,0.000053737505,0.00009521358,0.00036504766,0.0001401182,0.00002433989,0.00003758525,0.00006345693,0.000014984336],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014105862,0.0011327452,0.9856599,0.0000016939131,0.0022182735,0.000010241782,0.00048562707,0.0000029268156,0.00022740233,0.00008539603,0.0002615591,0.00850366],"study_design_scores_gemma":[0.0021041695,0.0005338622,0.9936036,0.000015713396,0.003269653,0.000028260809,0.000035395806,0.000036245136,0.00011361805,0.000040679868,0.00016002767,0.00005880526],"about_ca_topic_score_codex":0.0010857636,"about_ca_topic_score_gemma":0.0019760476,"teacher_disagreement_score":0.030031832,"about_ca_system_score_codex":0.00009300759,"about_ca_system_score_gemma":0.000041146683,"threshold_uncertainty_score":0.99905336},"labels":[],"label_agreement":null},{"id":"W2474715597","doi":"10.1016/j.breast.2016.06.015","title":"Paget's disease of the male breast in the 21st century: A systematic review","year":2016,"lang":"en","type":"review","venue":"The Breast","topic":"Cancer and Skin Lesions","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal University Hospital; University of Saskatchewan","funders":"","keywords":"Medicine; Breast cancer; Context (archaeology); Disease; Dermatology; Pathology; Breast carcinoma; Cancer; Internal medicine","score_opus":0.0248988679470238,"score_gpt":0.31303946272035754,"score_spread":0.28814059477333376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2474715597","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000011388088,0.98558956,6.849514e-7,0.0045802966,0.00017600684,0.005252122,0.00079297967,0.000013505652,0.0035936818],"genre_scores_gemma":[0.00052816723,0.996494,8.474909e-7,0.0007984875,0.00029877803,0.0006183684,0.000032268257,0.000043901808,0.0011852013],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9968422,0.0011070699,0.00089467946,0.00027214125,0.00058841275,0.00029548875],"domain_scores_gemma":[0.99656546,0.0004609667,0.0005545938,0.0022291027,0.00007309227,0.00011677787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011487845,0.0003765425,0.0021298134,0.00006232456,0.00010442465,0.00001833366,0.0010431511,0.00008797424,0.00037406426],"category_scores_gemma":[0.00019461557,0.00011045754,0.0010832397,0.00056878885,0.00021125657,0.000029330617,0.00017517158,0.00043550448,0.00016776437],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016123138,0.000109812776,0.000013235968,0.91920817,0.00011522783,0.00003299664,0.00007961704,8.715868e-9,8.152274e-8,0.00082022307,0.002578289,0.07702624],"study_design_scores_gemma":[0.0001828857,0.000007704592,0.0003355571,0.7878382,0.005194932,0.0076328395,0.00007260018,1.8110747e-7,6.9901045e-9,0.000020183626,0.19859408,0.00012079664],"about_ca_topic_score_codex":0.00004952438,"about_ca_topic_score_gemma":0.000013776137,"teacher_disagreement_score":0.19601579,"about_ca_system_score_codex":0.00013451398,"about_ca_system_score_gemma":0.00054347893,"threshold_uncertainty_score":0.45043278},"labels":[],"label_agreement":null},{"id":"W2484915095","doi":"10.1016/j.breast.2016.07.006","title":"Radiotherapy for breast cancer: The predictable consequences of an unmet need","year":2016,"lang":"en","type":"article","venue":"The Breast","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Radiation therapy; Breast cancer; Commission; Cancer; Disease; Family medicine; Intensive care medicine; Surgery; Internal medicine; Finance","score_opus":0.013491777831525836,"score_gpt":0.34455280168654484,"score_spread":0.331061023855019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2484915095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6302752,0.009827812,0.01836462,0.33222985,0.0017972235,0.0031620266,0.002395904,0.00021465932,0.0017327414],"genre_scores_gemma":[0.98944265,0.002195957,0.0017636426,0.0024704253,0.001396805,0.00016219191,0.00000445307,0.0000340337,0.0025298393],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99913734,0.00009832893,0.0002030763,0.00017157008,0.00014603976,0.00024367073],"domain_scores_gemma":[0.99878025,0.00048183615,0.00013952194,0.00043136592,0.00010116227,0.00006587668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041822347,0.00012872064,0.00028009,0.000029805107,0.00017721584,0.000005487482,0.00029559035,0.00007971158,0.0005700212],"category_scores_gemma":[0.000019411918,0.000047167483,0.000086242704,0.00012083182,0.0012796661,0.00010512584,0.0000109335215,0.00008601714,0.0000021028873],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008857483,0.0004046197,0.030958042,0.000074851334,0.0008855763,0.000008227313,0.0013372136,0.00006866352,0.16600397,0.009101171,0.0065252497,0.77577496],"study_design_scores_gemma":[0.05200473,0.007339106,0.51780534,0.0019204614,0.0016557024,0.03456956,0.0044806753,0.0024902252,0.07650583,0.043867264,0.25576934,0.0015917759],"about_ca_topic_score_codex":0.00010636253,"about_ca_topic_score_gemma":0.000028267408,"teacher_disagreement_score":0.77418315,"about_ca_system_score_codex":0.00008402713,"about_ca_system_score_gemma":0.00022573171,"threshold_uncertainty_score":0.6241333},"labels":[],"label_agreement":null},{"id":"W2503815376","doi":"10.1016/j.breast.2016.07.012","title":"Effects of a regional guideline for completion axillary lymph node dissection in women with breast cancer to reduce variation in surgical practice: A qualitative study of physicians' views","year":2016,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; Hamilton Health Sciences; Juravinski Hospital; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Guideline; Multidisciplinary approach; Breast cancer; Sentinel lymph node; Family medicine; Axillary Lymph Node Dissection; Cancer; Internal medicine; Pathology","score_opus":0.016037310819170862,"score_gpt":0.3455489956408191,"score_spread":0.3295116848216482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2503815376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938655,0.00012779605,0.00078379747,0.004258331,0.00003089295,0.00079505617,0.000120210534,0.000003348256,0.000015106096],"genre_scores_gemma":[0.9987574,0.000050794457,0.00016168908,0.00012416723,0.00010061549,0.0007662281,0.00001385199,0.0000135110895,0.000011717662],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99886376,0.00029266186,0.00029138784,0.00024665755,0.00015127612,0.00015424436],"domain_scores_gemma":[0.99918026,0.00017200159,0.00022794642,0.00016369057,0.00023659716,0.000019511657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040670705,0.00012638293,0.00024105268,0.00004900647,0.000031467433,0.0000028484803,0.00008138322,0.000036116642,0.0000020427947],"category_scores_gemma":[0.000042524585,0.0000736723,0.000027276585,0.00019530406,0.00005569641,0.000011955249,0.000038998427,0.000024515426,3.355771e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10636818,0.009440633,0.016030509,0.00035521554,0.001499845,0.000014039888,0.12506211,0.001050625,0.65148586,0.00024095294,0.0008630131,0.08758903],"study_design_scores_gemma":[0.010214045,0.00085695495,0.96885306,0.00047137344,0.0001001684,0.00011980584,0.014449209,0.000018712477,0.004214237,0.00006716207,0.00042356178,0.00021170876],"about_ca_topic_score_codex":0.0014818984,"about_ca_topic_score_gemma":0.00050767546,"teacher_disagreement_score":0.95282257,"about_ca_system_score_codex":0.00014722717,"about_ca_system_score_gemma":0.000060662987,"threshold_uncertainty_score":0.30042693},"labels":[],"label_agreement":null},{"id":"W2508687991","doi":"10.1016/j.breast.2016.08.012","title":"PATI: Patient accessed tailored information: A pilot study to evaluate the effect on preoperative breast cancer patients of information delivered via a mobile application","year":2016,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer survivorship and care","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Anxiety; Breast cancer; Depression (economics); Demographics; Cancer; Randomized controlled trial; Physical therapy; Medical physics; Family medicine; Internal medicine; Psychiatry; Demography","score_opus":0.007619440578436137,"score_gpt":0.26222785249079067,"score_spread":0.2546084119123545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2508687991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99194443,0.00001053781,0.0004751263,0.0008113748,0.00021941718,0.005744847,0.00043019705,0.00003896922,0.0003251227],"genre_scores_gemma":[0.996348,0.0000040762816,0.0000020125226,0.00065653975,0.000057488705,0.0028321692,0.000073253825,0.000011374256,0.000015090403],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99829286,0.00023181549,0.00045216156,0.00014081693,0.00069152506,0.00019080183],"domain_scores_gemma":[0.9982563,0.00013363134,0.0002302329,0.0005214478,0.0007683926,0.00008994406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036514897,0.00020255729,0.0002448624,0.00009169201,0.00015134847,0.0000377895,0.00023016639,0.000026502117,0.00013413755],"category_scores_gemma":[0.000035276895,0.00008758479,0.000055624445,0.00038145256,0.000055479377,0.0005308304,0.000099110905,0.000098780576,0.00014565985],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017357219,0.0011524432,0.13878901,0.00014577027,0.0003042273,2.6589007e-7,0.050850622,0.00040413236,0.0010767073,0.000027379996,0.00096403627,0.7889282],"study_design_scores_gemma":[0.0057278164,0.015700107,0.97120225,0.00027962806,0.0002521771,0.000013310616,0.0029844148,0.0003721575,0.0028839838,0.000013157619,0.000350981,0.00021998581],"about_ca_topic_score_codex":0.0027202817,"about_ca_topic_score_gemma":0.00058193965,"teacher_disagreement_score":0.83241326,"about_ca_system_score_codex":0.00023192319,"about_ca_system_score_gemma":0.00008474723,"threshold_uncertainty_score":0.41122702},"labels":[],"label_agreement":null},{"id":"W2528814032","doi":"10.1016/j.breast.2016.08.002","title":"Overview of guidelines on breast screening: Why recommendations differ and what to do about it","year":2016,"lang":"en","type":"review","venue":"The Breast","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto","funders":"","keywords":"Observational study; Overdiagnosis; Medicine; Breast cancer; Guideline; Psychological intervention; Breast cancer screening; Harm; Clinical study design; Observational methods in psychology; Randomized controlled trial; Clinical trial; Intensive care medicine; Family medicine; Medical physics; Mammography; Cancer; Pathology; Internal medicine; Psychiatry; Psychology","score_opus":0.3111421300673582,"score_gpt":0.46674116058760096,"score_spread":0.15559903052024276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2528814032","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000010320575,0.9616615,0.00015250673,0.035845704,0.00020356254,0.00079587736,0.00052090426,0.000024615989,0.0007850121],"genre_scores_gemma":[0.000025816084,0.9923103,0.00038130244,0.0056250393,0.0006518516,0.0000641949,0.000090532754,0.00004979942,0.0008011885],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978343,0.00014388768,0.0008163014,0.00043079973,0.0004513762,0.00032330424],"domain_scores_gemma":[0.99801964,0.0002330974,0.00036173334,0.00081048015,0.00033798307,0.00023704345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063282286,0.00042230764,0.0014226054,0.00016024172,0.00011798682,0.000112181864,0.0003623357,0.00016811374,0.0005969314],"category_scores_gemma":[0.0001143337,0.00021485373,0.00036405452,0.0003412531,0.00009815309,0.00021375735,0.00021205883,0.00026900892,0.0001201914],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000063773005,0.000020846019,0.000016342545,0.001509241,0.00014125303,0.00000457823,0.000043382137,1.1562993e-7,4.031854e-7,0.00030067086,0.046939135,0.9509603],"study_design_scores_gemma":[0.00024417738,0.00008467497,0.0003688011,0.18990904,0.0005493293,0.0016809693,0.00010705001,0.0000010089166,3.8442803e-7,0.000036808775,0.8068286,0.0001891306],"about_ca_topic_score_codex":0.00014100227,"about_ca_topic_score_gemma":0.000023562241,"teacher_disagreement_score":0.95077115,"about_ca_system_score_codex":0.00008282931,"about_ca_system_score_gemma":0.00013850273,"threshold_uncertainty_score":0.8761481},"labels":[],"label_agreement":null},{"id":"W2533474121","doi":"10.1016/j.breast.2016.09.014","title":"Evaluation of human epidermal growth factor receptor 2 (HER2) single nucleotide polymorphisms (SNPs) in normal and breast tumor tissues and their link with breast cancer prognostic factors","year":2016,"lang":"en","type":"article","venue":"The Breast","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement; Université Laval","funders":"Fonds de Recherche du Québec - Santé; Fondation Cancer; Fondation du cancer du sein du Québec; Université Laval","keywords":"Breast cancer; Medicine; Oncology; Internal medicine; Single-nucleotide polymorphism; Lymphovascular invasion; Carcinogenesis; Genotype; Cancer; CA15-3; Pathology; Metastasis; Gene; Biology; Genetics","score_opus":0.044005681133845204,"score_gpt":0.31511709530617416,"score_spread":0.271111414172329,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2533474121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99030334,0.0005861428,0.000010471938,0.0068768077,0.000068524445,0.0011025448,0.00072328455,0.000046273984,0.00028260399],"genre_scores_gemma":[0.9991926,0.00006414038,0.000023577728,0.00005839763,0.00036242252,0.000091640315,0.000015554851,0.00007066342,0.000120999604],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973361,0.00039490248,0.0003746936,0.0004514634,0.0008980002,0.0005448462],"domain_scores_gemma":[0.9983825,0.0002771143,0.0001940184,0.0003720859,0.00051136105,0.00026293338],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010076138,0.00033269287,0.00049514417,0.00019112403,0.00013369079,0.00004152051,0.00019615269,0.0000891777,0.0011834864],"category_scores_gemma":[0.00010061246,0.00016514212,0.00004858354,0.000292283,0.0006873462,0.00026653215,0.000120744146,0.00026721458,0.00000924089],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005700326,0.0002125065,0.79221827,0.0001487664,0.00013373076,0.0000093616745,0.0018343357,0.00000129009,0.07246528,0.000029370005,0.000094782416,0.1322823],"study_design_scores_gemma":[0.0025642938,0.0004480013,0.98026127,0.0011659327,0.00013350135,0.0010083604,0.00044220153,0.00009909652,0.013539438,0.00006332538,0.000038667804,0.00023592693],"about_ca_topic_score_codex":0.0035597202,"about_ca_topic_score_gemma":0.0010237837,"teacher_disagreement_score":0.18804301,"about_ca_system_score_codex":0.00032173927,"about_ca_system_score_gemma":0.00037511787,"threshold_uncertainty_score":0.9997296},"labels":[],"label_agreement":null},{"id":"W2554000772","doi":"10.1016/j.breast.2016.11.004","title":"Moving forward with obesity research in breast cancer","year":2016,"lang":"en","type":"editorial","venue":"The Breast","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute","funders":"Breast Cancer Research Foundation","keywords":"Medicine; Breast cancer; Overweight; Hazard ratio; Internal medicine; Obesity; Body mass index; Gynecology; Confidence interval; Oncology; Relative risk; Meta-analysis; Incidence (geometry); Cancer","score_opus":0.02351137024318164,"score_gpt":0.3569164618711637,"score_spread":0.3334050916279821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554000772","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.052967206,0.0019760723,0.00002516249,0.02293972,0.9045535,0.0024070013,0.0061213784,0.0001828048,0.008827181],"genre_scores_gemma":[0.12788461,0.001072912,0.0000065959644,0.00004978549,0.86547047,0.00014983068,0.00006502544,0.00010513734,0.0051956186],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99697065,0.00013582794,0.0002531942,0.00049126835,0.001466664,0.00068236643],"domain_scores_gemma":[0.9980166,0.00047625165,0.00011260199,0.0007401225,0.00046948425,0.0001849277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009918272,0.00029574567,0.0005620931,0.00023338215,0.0001594486,0.000049391936,0.00038259392,0.00043183225,0.0004324809],"category_scores_gemma":[0.00003895876,0.00014334578,0.0001021221,0.00040059528,0.00032945137,0.000077641875,0.00017556248,0.0017647521,0.0000799035],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020480002,0.000091919595,0.021681976,0.00020027124,0.00010768824,0.00007366121,0.00022874105,0.0000010816372,0.000033876942,0.000016049944,0.9574087,0.018108018],"study_design_scores_gemma":[0.0031654572,0.0001600775,0.1466694,0.005202985,0.00016914759,0.00029420707,0.00018501865,0.000008300648,0.000015837688,0.00012612228,0.8435976,0.00040585117],"about_ca_topic_score_codex":0.027961498,"about_ca_topic_score_gemma":0.0046844166,"teacher_disagreement_score":0.12498743,"about_ca_system_score_codex":0.00096620707,"about_ca_system_score_gemma":0.0016389627,"threshold_uncertainty_score":0.9785114},"labels":[],"label_agreement":null},{"id":"W2555676011","doi":"10.1016/j.breast.2016.11.009","title":"A sensitivity and specificity comparison of fine needle aspiration cytology and core needle biopsy in evaluation of suspicious breast lesions: A systematic review and meta-analysis","year":2016,"lang":"en","type":"review","venue":"The Breast","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":150,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; St. Joseph’s Healthcare Hamilton; Population Health Research Institute; McMaster University","funders":"","keywords":"Medicine; Meta-analysis; Biopsy; Fine needle aspiration cytology; Radiology; Subgroup analysis; Cytology; Breast cancer; Diagnostic accuracy; Core biopsy; Pathology; Cancer; Internal medicine","score_opus":0.2049381745224407,"score_gpt":0.39754350005296213,"score_spread":0.19260532553052143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555676011","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031460712,0.9928101,0.00006201741,0.00048199485,0.000011227271,0.0030208277,0.00041545808,0.000010867282,0.00004143752],"genre_scores_gemma":[0.31045073,0.6891443,0.000046477817,0.000026602218,0.00002097092,0.00015252028,0.00009593596,0.000025170306,0.000037258575],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99595577,0.0015720003,0.0014061751,0.0004227092,0.00045607876,0.0001872944],"domain_scores_gemma":[0.9969743,0.00055184634,0.0012434437,0.00071794755,0.00042846642,0.00008402721],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037585015,0.00039575552,0.0071154283,0.00042461287,0.0000619292,0.000011618779,0.00008468844,0.00021640783,0.00007042524],"category_scores_gemma":[0.00018680329,0.00019938362,0.0005915411,0.0007947127,0.00029367598,0.000053288095,0.00011640261,0.00023723752,0.0000025558963],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000097231605,0.00046070304,0.0011423965,0.7785678,0.029544681,0.000017073766,0.00034479267,0.0000018802639,0.000044384768,0.00030248598,0.00003251151,0.18944404],"study_design_scores_gemma":[0.0006604627,0.00013620025,0.013715925,0.05637903,0.91973126,0.00816595,0.00025616385,0.0005822129,0.0000013038295,0.000036769066,0.00006652512,0.00026817844],"about_ca_topic_score_codex":0.00029349598,"about_ca_topic_score_gemma":0.00024440826,"teacher_disagreement_score":0.8901866,"about_ca_system_score_codex":0.00006768719,"about_ca_system_score_gemma":0.00015493685,"threshold_uncertainty_score":0.8130628},"labels":[],"label_agreement":null},{"id":"W2562466185","doi":"10.1016/j.breast.2016.12.012","title":"Barriers, beliefs and practice patterns for breast cancer reconstruction: A provincial survey","year":2016,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Cambridge Memorial Hospital; McMaster University","funders":"McMaster University","keywords":"Medicine; Guideline; Breast reconstruction; Breast cancer; Radiation therapy; Family medicine; Cancer; Clinical Practice; Adjuvant therapy; Health care; Adjuvant radiotherapy; Surgery; Internal medicine; Pathology","score_opus":0.019414836384721502,"score_gpt":0.27927086565220127,"score_spread":0.25985602926747975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562466185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96145636,0.00015623003,0.00077178667,0.030047335,0.001188116,0.0008587061,0.0051338207,0.00008439084,0.00030326933],"genre_scores_gemma":[0.996947,0.000099274,0.00017085293,0.00021539742,0.00169529,0.00007332924,0.000014126951,0.000025525833,0.0007592358],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990098,0.00014089333,0.00020156139,0.00025190326,0.0001428004,0.0002530762],"domain_scores_gemma":[0.998827,0.00041265297,0.00013676824,0.0001988109,0.00024666928,0.00017814618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006149293,0.00015121157,0.00020917343,0.000048848455,0.0002233069,0.000026584486,0.00006801886,0.00009773609,0.00026460417],"category_scores_gemma":[0.00009764695,0.00007664231,0.000056913916,0.000083397215,0.00021557926,0.00022816837,0.00003314457,0.00010458191,0.00001090568],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021045317,0.000016220025,0.21459077,0.00003873167,0.00011522737,0.0000028462252,0.000084368716,3.800226e-8,0.00050507503,0.00009511452,0.0006405781,0.7818065],"study_design_scores_gemma":[0.0017688135,0.000052431715,0.6715341,0.00022298266,0.00014946432,0.32533506,0.00018823108,0.00000847051,0.00010115861,0.00006706508,0.00044692997,0.0001252632],"about_ca_topic_score_codex":0.0014929058,"about_ca_topic_score_gemma":0.0009580178,"teacher_disagreement_score":0.78168124,"about_ca_system_score_codex":0.000072554336,"about_ca_system_score_gemma":0.0002411675,"threshold_uncertainty_score":0.3125383},"labels":[],"label_agreement":null},{"id":"W2576787462","doi":"10.1016/j.breast.2017.01.001","title":"Corrigendum to “3rd ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 3)” [Breast 31 (February 2017) 244–259]","year":2017,"lang":"en","type":"erratum","venue":"The Breast","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Medicine; Breast cancer; Regret; Oncology; Internal medicine; Cancer","score_opus":0.08359641699928291,"score_gpt":0.37835754730210835,"score_spread":0.29476113030282547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2576787462","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001958971,0.021910263,0.0035774342,0.51783067,0.2889641,0.013245911,0.10420978,0.0016819315,0.046620976],"genre_scores_gemma":[0.009758273,0.0019855532,0.0059733195,0.014588641,0.050323937,0.0031609724,0.0049740197,0.001020322,0.908215],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99352026,0.00010326257,0.0014867451,0.0017985003,0.0014831948,0.0016080342],"domain_scores_gemma":[0.9901458,0.00016141476,0.0015355848,0.0030604126,0.0042878506,0.00080895185],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0006753935,0.0016263364,0.0020240461,0.00048926426,0.0009793392,0.0002330295,0.002478316,0.0008548757,0.00094997336],"category_scores_gemma":[0.00030571944,0.0012233574,0.0008615423,0.00030729696,0.00088900793,0.00029911002,0.00066393137,0.0016807662,0.0003460679],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00632065,0.00019023003,0.00041431183,0.00027789065,0.0012719365,0.00010302751,0.00019505755,0.00010127838,0.000616601,0.00011922882,0.83157134,0.15881847],"study_design_scores_gemma":[0.0057468377,0.0001986957,0.037184615,0.004044004,0.0009375226,0.016965747,0.0004912684,0.0004910149,0.00007233116,0.00061652175,0.9317133,0.0015381488],"about_ca_topic_score_codex":0.0037588319,"about_ca_topic_score_gemma":0.0014834583,"teacher_disagreement_score":0.86159396,"about_ca_system_score_codex":0.0012485272,"about_ca_system_score_gemma":0.002680759,"threshold_uncertainty_score":0.9999633},"labels":[],"label_agreement":null},{"id":"W2584609353","doi":"10.1016/j.breast.2017.01.004","title":"Extended adjuvant endocrine therapy – A standard to all or some?","year":2017,"lang":"en","type":"review","venue":"The Breast","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Letrozole; Tamoxifen; Oncology; Clinical trial; Breast cancer; Endocrine system; Internal medicine; Adjuvant; Randomized controlled trial; Adjuvant therapy; Intensive care medicine; Cancer; Hormone","score_opus":0.06236989224435918,"score_gpt":0.38326811129608124,"score_spread":0.32089821905172206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584609353","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010362737,0.99734557,0.000011988031,0.00024591066,0.00029689827,0.0010579434,0.00025975044,0.000024009907,0.00065431074],"genre_scores_gemma":[0.00011136826,0.99339294,0.000039384307,0.00024990397,0.0008281837,0.00016164087,0.000256244,0.0000878974,0.0048724106],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984217,0.00019058354,0.00029429488,0.0004764202,0.00018577841,0.00043119487],"domain_scores_gemma":[0.99823666,0.00002508123,0.00022703414,0.0012866103,0.000050255883,0.00017436412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002554059,0.0004650308,0.0008897084,0.00004969634,0.00018061949,0.000076479504,0.00089905155,0.00029638884,0.00004392204],"category_scores_gemma":[0.000039061077,0.00022352728,0.00047283233,0.000056326397,0.00009458834,0.0000029304967,0.00028859978,0.00031431706,0.00016487672],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033961982,0.000042990378,2.448286e-7,0.000335217,0.00054829847,0.000057639092,0.000012445321,2.7945637e-7,0.0002852579,0.000035823865,0.007247625,0.9910945],"study_design_scores_gemma":[0.00045095885,0.0005091493,0.0000037813074,0.0010255813,0.00025055945,0.0017562802,0.000003016039,2.8587246e-7,0.00034486607,0.000018756946,0.995302,0.0003347447],"about_ca_topic_score_codex":0.000015552343,"about_ca_topic_score_gemma":0.000004341037,"teacher_disagreement_score":0.9907598,"about_ca_system_score_codex":0.000027774187,"about_ca_system_score_gemma":0.0003421146,"threshold_uncertainty_score":0.9115178},"labels":[],"label_agreement":null},{"id":"W2588190826","doi":"10.1016/j.breast.2017.01.018","title":"Cognitive impairment in the first year after breast cancer diagnosis: A prospective cohort study","year":2017,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Universidade do Porto; Fundação para a Ciência e a Tecnologia; Federación Española de Enfermedades Raras","keywords":"Medicine; Anxiety; Prospective cohort study; Montreal Cognitive Assessment; Breast cancer; Cohort; Internal medicine; Percentile; Incidence (geometry); Relative risk; Confidence interval; Depression (economics); Cohort study; Hospital Anxiety and Depression Scale; Cancer; Cognitive impairment; Psychiatry; Disease","score_opus":0.012136021005510611,"score_gpt":0.29872949919917,"score_spread":0.28659347819365943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588190826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9691296,0.00027641407,0.0000013915442,0.020406516,0.00021446477,0.006195861,0.00043077042,0.00004598547,0.0032989788],"genre_scores_gemma":[0.98342854,0.00020028322,0.0000013169612,0.0009706612,0.00049949996,0.014545528,0.000004428555,0.000036075042,0.00031364258],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981485,0.000113809656,0.00026522402,0.0004555096,0.00057101896,0.00044592287],"domain_scores_gemma":[0.998647,0.0001600088,0.00018066281,0.0006753429,0.00026469526,0.00007228691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006135882,0.00030312495,0.0004019688,0.000072195835,0.00067903625,0.00011633846,0.00033883943,0.000056986315,0.0005182573],"category_scores_gemma":[0.00007296874,0.00016401942,0.0001248622,0.00017521445,0.00047335643,0.0001515784,0.00025742798,0.00045289524,0.00015521648],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002225153,0.0016396361,0.98396295,0.000020805415,0.00082983746,0.00014348437,0.0075647645,5.158895e-7,3.4711545e-7,0.000007725603,0.002068631,0.0015361635],"study_design_scores_gemma":[0.005288667,0.00044711097,0.98202884,0.0007190895,0.0010367691,0.00032911386,0.009782051,0.0000060220937,0.000007656131,0.000052413205,0.00010305526,0.00019923838],"about_ca_topic_score_codex":0.0028950374,"about_ca_topic_score_gemma":0.0050691105,"teacher_disagreement_score":0.019435856,"about_ca_system_score_codex":0.00036956125,"about_ca_system_score_gemma":0.00010384952,"threshold_uncertainty_score":0.6688518},"labels":[],"label_agreement":null},{"id":"W2591609812","doi":"10.1016/j.breast.2017.02.016","title":"Trial sponsorship and self-reported conflicts of interest in breast cancer radiation therapy: An analysis of prospective clinical trials","year":2017,"lang":"en","type":"article","venue":"The Breast","topic":"Pharmaceutical industry and healthcare","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Memorial Sloan-Kettering Cancer Center","keywords":"Medicine; Clinical trial; Breast cancer; Internal medicine; Radiation therapy; Cancer","score_opus":0.8019048102967077,"score_gpt":0.6570336509654486,"score_spread":0.14487115933125905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591609812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993865,0.00029310057,0.000001428567,0.0034614515,0.00050716975,0.0010683148,0.0006175858,0.000020933989,0.00016502613],"genre_scores_gemma":[0.99765736,0.0013594084,0.000003587606,0.0003941525,0.00045482808,0.00006550386,0.000017799011,0.000011324466,0.00003602984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9922694,0.005779369,0.00125504,0.0003147164,0.00011159966,0.00026988232],"domain_scores_gemma":[0.9957573,0.0020695354,0.00126953,0.0004437622,0.00019842612,0.00026146809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0155725265,0.00017828483,0.00095801905,0.00015698464,0.00022531745,0.000025751522,0.00038620364,0.00050514063,0.00062823825],"category_scores_gemma":[0.0007833074,0.00012361426,0.0002080852,0.00024412526,0.0005986413,0.00017283147,0.00006893325,0.0010441619,0.0000017098434],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09354324,0.0014827206,0.8606748,0.000030540763,0.0034796544,0.000010882044,0.0012968554,0.00003869716,0.0014304759,0.0012369516,0.00003174338,0.036743466],"study_design_scores_gemma":[0.022721455,0.00021521788,0.96870947,0.000022495737,0.002005354,0.000024170455,0.00010342088,0.0036412836,0.0017283785,0.00022236728,0.00047992694,0.00012645523],"about_ca_topic_score_codex":0.0008077484,"about_ca_topic_score_gemma":0.0004705508,"teacher_disagreement_score":0.1080347,"about_ca_system_score_codex":0.000052214786,"about_ca_system_score_gemma":0.00019827971,"threshold_uncertainty_score":0.6878768},"labels":[],"label_agreement":null},{"id":"W2593967339","doi":"10.1016/j.breast.2017.02.015","title":"Validation of the electronic version of the BREAST-Q in the army of women study","year":2017,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Cancer Institute","keywords":"Breast cancer; Cronbach's alpha; Breast reconstruction; Breast-conserving surgery; Mastectomy; Medicine; Quality of life (healthcare); Convergent validity; Checklist; Medical physics; Gynecology; Physical therapy; Psychology; Psychometrics; Clinical psychology; Cancer; Internal medicine; Internal consistency; Nursing","score_opus":0.009745345068018265,"score_gpt":0.2474612930656186,"score_spread":0.23771594799760032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593967339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965914,0.000019294575,0.0000014119486,0.0018569543,0.0001775197,0.00058290234,0.000024191584,0.00000385381,0.00074246567],"genre_scores_gemma":[0.9997522,0.000004909163,0.0000011048401,0.000015615988,0.00007901469,0.000009584622,0.0000020268744,0.000006618051,0.00012887611],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998944,0.00021820552,0.00023404704,0.000095601,0.00031841575,0.00018974555],"domain_scores_gemma":[0.99866277,0.00006151008,0.00037999186,0.00080734876,0.00007106667,0.000017294806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009518496,0.000087776,0.00019693915,0.000034515684,0.0001805487,0.000008878482,0.00054055406,0.000043845965,0.000038767295],"category_scores_gemma":[0.000021521166,0.0000328095,0.000089865134,0.00013694601,0.00027215554,0.000059254013,0.00010355565,0.00021339883,0.0000029587784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017437586,0.0010629598,0.88588125,0.00012086684,0.00027816172,0.0000012343871,0.013163318,0.000025183435,0.017794082,0.0010063272,0.00019799787,0.07872486],"study_design_scores_gemma":[0.0013682266,0.00011040934,0.9841276,0.00011801235,0.000118262404,0.004368715,0.0043447334,0.000024802432,0.0049555334,0.0004030199,0.00002207032,0.000038656075],"about_ca_topic_score_codex":0.0005460598,"about_ca_topic_score_gemma":0.000068119014,"teacher_disagreement_score":0.098246306,"about_ca_system_score_codex":0.00007153191,"about_ca_system_score_gemma":0.00012037519,"threshold_uncertainty_score":0.13886529},"labels":[],"label_agreement":null},{"id":"W2594709205","doi":"10.1016/j.breast.2017.02.012","title":"Secondary gastric cancer malignancies following a breast cancer diagnosis: A population-based analysis","year":2017,"lang":"en","type":"article","venue":"The Breast","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Hospital; Health Sciences Centre; Queen's University; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Cancer; Oncology; Internal medicine; Population; Environmental health","score_opus":0.019062989860445953,"score_gpt":0.29621751348345543,"score_spread":0.27715452362300946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594709205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9801165,0.0022399132,0.00006261976,0.013943366,0.00044573724,0.00043898646,0.001427324,0.00008502549,0.00124053],"genre_scores_gemma":[0.99518764,0.0001962382,0.00008030889,0.0024581174,0.00047175688,0.00066846894,0.00011844842,0.000037430687,0.0007815691],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983452,0.000060331833,0.00032897375,0.000412065,0.0004064804,0.00044693574],"domain_scores_gemma":[0.99824494,0.000088655695,0.00029392663,0.0010662645,0.00011077858,0.0001954441],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025471736,0.00027459284,0.00057858304,0.00021572872,0.0008464703,0.00015107638,0.00041841695,0.00008816184,0.004295151],"category_scores_gemma":[0.000030246167,0.00019127961,0.0005837521,0.0003846327,0.00010948421,0.0002756472,0.00007755413,0.00027432805,0.000019082798],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023751214,0.0000588374,0.9411222,0.000060478338,0.0013950315,0.000039363036,0.0001401559,0.00039485813,0.00018538126,0.000009193426,0.0015548657,0.05480212],"study_design_scores_gemma":[0.001749633,0.000021714286,0.9918722,0.00021354742,0.0026792386,0.000070522496,0.00007806503,0.0017996379,0.000082696264,0.0000145855565,0.0011934316,0.00022475245],"about_ca_topic_score_codex":0.024106814,"about_ca_topic_score_gemma":0.005151284,"teacher_disagreement_score":0.05457737,"about_ca_system_score_codex":0.00036510165,"about_ca_system_score_gemma":0.0006537677,"threshold_uncertainty_score":0.99661505},"labels":[],"label_agreement":null},{"id":"W2594730512","doi":"10.1016/j.breast.2017.02.018","title":"Evaluation of percutaneous vacuum assisted intact specimen breast biopsy device for ultrasound visualized breast lesions: Upstage rates and long term follow-up for high risk lesions and DCIS","year":2017,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University Health Network","keywords":"Medicine; Biopsy; Malignancy; Radiology; Percutaneous; Breast cancer; Ultrasound; Lesion; Cancer; Surgery; Pathology; Internal medicine","score_opus":0.051880870889845936,"score_gpt":0.3505464066924878,"score_spread":0.2986655358026419,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594730512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99187124,0.00059541484,0.0004656564,0.0016768561,0.00019636359,0.0024230443,0.002591541,0.00004994462,0.00012993604],"genre_scores_gemma":[0.9978517,0.00014871094,0.0007194325,0.000051903542,0.00030120628,0.00017133309,0.00022869253,0.00007763286,0.00044933162],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99754506,0.0002761503,0.00054239243,0.0005876308,0.0005910147,0.00045774455],"domain_scores_gemma":[0.9963899,0.0008024035,0.00058275374,0.0010360432,0.0009195732,0.00026932033],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0020984362,0.00040992815,0.0006983155,0.00015265535,0.0014264799,0.00019607141,0.0003229896,0.00020094967,0.00015506048],"category_scores_gemma":[0.00037151267,0.00027731323,0.00022753389,0.0001212796,0.00045829607,0.00022731967,0.00015293439,0.0002102625,0.000005378391],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009073804,0.0011338316,0.17025846,0.00076154387,0.001691296,0.000046632256,0.0017397786,0.0000023514938,0.22407433,0.0013792629,0.0005194916,0.5893192],"study_design_scores_gemma":[0.0074451705,0.0002693469,0.9578779,0.0004787329,0.0033737593,0.027093552,0.0009037161,0.0006695452,0.00078991003,0.00076133525,0.000025256682,0.00031178893],"about_ca_topic_score_codex":0.00086891075,"about_ca_topic_score_gemma":0.0002775208,"teacher_disagreement_score":0.7876194,"about_ca_system_score_codex":0.00012496841,"about_ca_system_score_gemma":0.00026059852,"threshold_uncertainty_score":0.99996793},"labels":[],"label_agreement":null},{"id":"W2604933613","doi":"10.1016/j.breast.2017.03.008","title":"Reirradiation for locally recurrent breast cancer","year":2017,"lang":"en","type":"review","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Breast cancer; Recurrent breast cancer; Oncology; Disease; Radiation therapy; Internal medicine; Cancer; Surgery","score_opus":0.07165201901023002,"score_gpt":0.38542364335674784,"score_spread":0.31377162434651784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604933613","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000028276932,0.9929907,0.00006943379,0.00077310397,0.0006712629,0.0010080817,0.0041482397,0.000017171942,0.00031921195],"genre_scores_gemma":[0.0001517185,0.9941805,0.00003331196,0.00006501378,0.002321629,0.0014592813,0.0009142688,0.00007876537,0.0007954921],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99859,0.00008388953,0.00031465347,0.00052941724,0.00013682978,0.00034523208],"domain_scores_gemma":[0.99832714,0.000034338103,0.00048565253,0.00093886146,0.00014462855,0.000069380745],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018673188,0.00045320566,0.00075893465,0.000034955694,0.00038996295,0.00006205556,0.00061779877,0.00024980961,0.000021551175],"category_scores_gemma":[0.000023758861,0.00028085543,0.00052044285,0.000049129052,0.00015338861,0.0000038260837,0.00019596083,0.00013697088,0.000029819594],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000087942666,0.000040854826,0.0000152796,0.0012312989,0.000590087,6.3208176e-7,0.000014193835,7.8942514e-7,0.0000012459304,0.000041469146,0.008297176,0.98967904],"study_design_scores_gemma":[0.0003619114,0.000037863643,0.0006266813,0.002482872,0.001033128,0.00041339808,0.000006265421,0.0000017500521,0.000001934397,0.00002588473,0.9946825,0.000325847],"about_ca_topic_score_codex":0.00012303914,"about_ca_topic_score_gemma":0.00017061217,"teacher_disagreement_score":0.9893532,"about_ca_system_score_codex":0.00012586627,"about_ca_system_score_gemma":0.00043946516,"threshold_uncertainty_score":0.99996436},"labels":[],"label_agreement":null},{"id":"W2605169409","doi":"10.1016/j.breast.2017.03.015","title":"Effect of acupuncture on aromatase inhibitor-induced arthralgia in patients with breast cancer: A meta-analysis of randomized controlled trials","year":2017,"lang":"en","type":"review","venue":"The Breast","topic":"Acupuncture Treatment Research Studies","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Discontinuation; Acupuncture; WOMAC; Randomized controlled trial; Breast cancer; Meta-analysis; Physical therapy; Osteoarthritis; Quality of life (healthcare); Joint pain; Aromatase inhibitor; Brief Pain Inventory; Cochrane Library; Internal medicine; Cancer; Chronic pain; Alternative medicine; Tamoxifen","score_opus":0.09676823259904971,"score_gpt":0.42608297398171635,"score_spread":0.32931474138266664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605169409","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0034607672,0.9629204,5.962393e-7,0.00041226074,0.00007600039,0.02780537,0.005138906,0.000023161296,0.00016253412],"genre_scores_gemma":[0.09603148,0.89448464,0.000008878766,0.000027991518,0.00018285778,0.007593167,0.0012439144,0.00010612775,0.00032092046],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98515844,0.009009796,0.0029447756,0.0006807039,0.0017218527,0.0004844089],"domain_scores_gemma":[0.9761439,0.015973477,0.0053221807,0.0019280572,0.00047113374,0.00016127994],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow","metaepi_broad"],"category_scores_codex":[0.012168968,0.0018059483,0.08457998,0.0012452716,0.00011562534,0.000036073016,0.0005183679,0.00035255682,0.00034709548],"category_scores_gemma":[0.004258555,0.00038376873,0.020290602,0.00084451574,0.00050221477,0.00006356112,0.00015157762,0.0006876767,0.000007749447],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.30193666,0.0004122025,0.00015808517,0.005235447,0.6108966,0.000023875975,0.000049244067,0.0000028114353,6.2062696e-7,0.0000048807215,0.00014315639,0.08113646],"study_design_scores_gemma":[0.23117745,0.0007057977,0.0006644505,0.004797563,0.76203054,0.00002088841,0.0000031082168,0.000002263349,0.0000074293334,0.0000016832038,0.0003749697,0.00021387148],"about_ca_topic_score_codex":0.00053976127,"about_ca_topic_score_gemma":0.000103439175,"teacher_disagreement_score":0.15113397,"about_ca_system_score_codex":0.0002523827,"about_ca_system_score_gemma":0.00043151563,"threshold_uncertainty_score":0.9998614},"labels":[],"label_agreement":null},{"id":"W2607026570","doi":"10.1016/j.breast.2017.03.014","title":"The reality of economics for oncologists","year":2017,"lang":"en","type":"review","venue":"The Breast","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Value for money; Investment (military); Value (mathematics); Breast cancer; Health economics; Economic growth; Public economics; Cancer; Nursing; Internal medicine; Public health; Economics","score_opus":0.8252259482517306,"score_gpt":0.5715313032750519,"score_spread":0.2536946449766787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607026570","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000058174546,0.96616304,0.00016130014,0.019256158,0.0012157946,0.0025173055,0.004884363,0.000020828504,0.0057754023],"genre_scores_gemma":[0.0000426191,0.9950785,0.0001473671,0.000574602,0.0009941884,0.0006669264,0.00011455924,0.000062803505,0.002318433],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9926654,0.0005415454,0.00573285,0.0005498991,0.00004066295,0.00046960442],"domain_scores_gemma":[0.98032993,0.005737272,0.011455923,0.0022883238,0.00008320343,0.00010533684],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.034531504,0.0003505088,0.0033514139,0.00010718434,0.0008666455,0.00017311731,0.0019327309,0.00035319952,0.000042922835],"category_scores_gemma":[0.0034492174,0.00024893982,0.0008650705,0.000059449336,0.0004491222,0.00015615113,0.0001829521,0.00029023748,0.0006196756],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018804592,0.000056108725,0.00003438415,0.009822447,0.00045154296,1.5201587e-7,0.00017527743,0.000009541648,9.1212987e-10,0.44347426,0.045736067,0.50022143],"study_design_scores_gemma":[0.00019353244,0.00002932397,0.0001298795,0.00089462136,0.000081605474,0.0000333301,0.00005236925,0.00011344646,1.1245538e-8,0.027377976,0.9708508,0.0002431014],"about_ca_topic_score_codex":0.0008256973,"about_ca_topic_score_gemma":0.0006380996,"teacher_disagreement_score":0.92511475,"about_ca_system_score_codex":0.00070036453,"about_ca_system_score_gemma":0.0007327806,"threshold_uncertainty_score":0.9999963},"labels":[],"label_agreement":null},{"id":"W2608878607","doi":"10.1016/j.breast.2017.04.007","title":"New agents for endocrine resistance in breast cancer","year":2017,"lang":"en","type":"review","venue":"The Breast","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Charles-Le Moyne; Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Université de Sherbrooke","funders":"","keywords":"Endocrine system; Breast cancer; Medicine; Disease; Acquired resistance; Estrogen receptor; Oncology; Metastatic breast cancer; Internal medicine; Blockade; Estrogen; Cancer; Bioinformatics; Cancer research; Receptor; Hormone; Biology","score_opus":0.11168353010337549,"score_gpt":0.43499997076240043,"score_spread":0.32331644065902493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2608878607","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000012112455,0.99003863,0.00012863008,0.0041824584,0.0004998502,0.0024037021,0.0014024485,0.00006891845,0.0012741628],"genre_scores_gemma":[0.000018284836,0.9592597,0.00066655595,0.00022951722,0.0020742705,0.0009138942,0.00010829066,0.00017882511,0.03655066],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976088,0.00007774052,0.0006449205,0.0006323348,0.00034536666,0.00069083937],"domain_scores_gemma":[0.9973205,0.00014859166,0.00064470817,0.0015443267,0.000119232405,0.00022269676],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024020424,0.0006373418,0.0021619855,0.0001696281,0.0001876916,0.00005325686,0.0008360185,0.00017568815,0.00042801056],"category_scores_gemma":[0.00003322209,0.000401954,0.00057383435,0.00023125601,0.00016216765,0.00012875754,0.00013672671,0.0005485251,0.00006860969],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004923716,0.00004417746,0.000039623625,0.0076238257,0.00029706382,0.00004069607,0.00006422161,4.3857494e-7,5.4301523e-7,0.00031015885,0.004619459,0.9864674],"study_design_scores_gemma":[0.0017985927,0.000014915161,0.0013841976,0.03184737,0.0008828851,0.0020561244,0.00001036398,7.9918834e-7,4.4125832e-7,0.00040653205,0.96123797,0.00035980463],"about_ca_topic_score_codex":0.0005159534,"about_ca_topic_score_gemma":0.0006150549,"teacher_disagreement_score":0.9861076,"about_ca_system_score_codex":0.0006374191,"about_ca_system_score_gemma":0.0012282158,"threshold_uncertainty_score":0.99984324},"labels":[],"label_agreement":null},{"id":"W2614270208","doi":"10.1016/j.breast.2017.04.005","title":"MRI surveillance for women with dense breasts and a previous breast cancer and/or high risk lesion","year":2017,"lang":"en","type":"article","venue":"The Breast","topic":"MRI in cancer diagnosis","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Alberta; Alberta Health Services; Sunnybrook Hospital; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"University of Toronto","keywords":"Medicine; Breast cancer; Radiology; Lesion; Breast MRI; Cancer; Oncology; Mammography; Internal medicine; Pathology","score_opus":0.017272763009664033,"score_gpt":0.2891932709924163,"score_spread":0.2719205079827523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2614270208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9752038,0.0006503878,0.000053517295,0.021855412,0.00010652603,0.0010163811,0.0008981005,0.00005246823,0.00016341028],"genre_scores_gemma":[0.99253327,0.004810155,0.000248491,0.00029448658,0.0004451818,0.0005253064,0.000005074225,0.00004990105,0.0010881252],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876773,0.000050994036,0.00016564042,0.00040058332,0.00021940602,0.0003956373],"domain_scores_gemma":[0.99838054,0.00021383625,0.00024806222,0.00078427116,0.00015047367,0.00022283041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043850622,0.0002299208,0.0003967947,0.000035182493,0.0005036783,0.00010492485,0.0001980829,0.00007271993,0.000108358814],"category_scores_gemma":[0.000035350407,0.00012488877,0.000029180404,0.000054612232,0.00035671383,0.000115859715,0.00012028639,0.00015647506,0.000004560636],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008947576,0.0001080896,0.77137554,0.00036393685,0.00024502483,0.000028565657,0.00066757516,0.000006125847,0.000087836976,0.000046790457,0.0053512314,0.2127717],"study_design_scores_gemma":[0.00389682,0.00033279633,0.98920333,0.00045049557,0.00014442434,0.0031099764,0.00010048948,0.00013050718,0.000051885036,0.00014412984,0.0022430883,0.00019203106],"about_ca_topic_score_codex":0.0039108032,"about_ca_topic_score_gemma":0.0027627144,"teacher_disagreement_score":0.21782781,"about_ca_system_score_codex":0.00012469619,"about_ca_system_score_gemma":0.0001404274,"threshold_uncertainty_score":0.59119904},"labels":[],"label_agreement":null},{"id":"W2617889858","doi":"10.1016/j.breast.2017.05.004","title":"Switching between intravenous and subcutaneous trastuzumab: Safety results from the PrefHer trial","year":2017,"lang":"en","type":"article","venue":"The Breast","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"F. Hoffmann-La Roche; Roche","keywords":"Medicine; Trastuzumab; Tolerability; Discontinuation; Adverse effect; Cohort; Internal medicine; Adjuvant; Syringe; Oncology; Breast cancer; Cancer","score_opus":0.05830078814096429,"score_gpt":0.3442258103662161,"score_spread":0.2859250222252518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2617889858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95979005,0.00017926333,0.000041024457,0.026990868,0.00025355926,0.0010929015,0.0004412349,0.000049155453,0.011161919],"genre_scores_gemma":[0.9958018,0.000088730216,0.00004563097,0.0001670175,0.002871848,0.000015685131,0.000027008819,0.00003517716,0.00094711356],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983098,0.00018998979,0.00029051318,0.00032803474,0.00050405227,0.00037762715],"domain_scores_gemma":[0.9973753,0.0008765547,0.00015199326,0.0013871122,0.000052931246,0.00015608197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012840605,0.00016413147,0.00031258943,0.000019326244,0.0008759196,0.00019631184,0.00063138123,0.000100640485,0.000091797716],"category_scores_gemma":[0.00048822505,0.00008420003,0.000069199166,0.000044481752,0.0002999861,0.000059760765,0.00023780277,0.0006491692,0.00005952265],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10340393,0.00012746228,0.008812403,0.000031889795,0.000412679,0.00025277352,0.0063198754,0.0000024780484,0.0010859728,0.00010404324,0.0040487153,0.8753978],"study_design_scores_gemma":[0.054351803,0.0013956005,0.9169766,0.00049734063,0.00042715797,0.0015765501,0.0006180007,0.00016166561,0.00034219076,0.0016369034,0.021668902,0.00034729196],"about_ca_topic_score_codex":0.0048634186,"about_ca_topic_score_gemma":0.00032740162,"teacher_disagreement_score":0.9081642,"about_ca_system_score_codex":0.000112645386,"about_ca_system_score_gemma":0.00020487925,"threshold_uncertainty_score":0.73520666},"labels":[],"label_agreement":null},{"id":"W2719469262","doi":"10.1016/j.breast.2017.06.014","title":"Vacuum-assisted complete excision of solid intraductal/intracystic masses and complex cysts: Is follow-up necessary?","year":2017,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôpital du Saint-Sacrement","funders":"","keywords":"Medicine; Biopsy; Malignancy; Atypia; Cyst; Radiology; Lesion; Surgery; Pathology","score_opus":0.05712154340864791,"score_gpt":0.30880845586718636,"score_spread":0.25168691245853847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2719469262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98478806,0.00036070056,0.0002244556,0.011147365,0.000219922,0.00035625166,0.00025110628,0.000045129047,0.0026070306],"genre_scores_gemma":[0.9983261,0.000062231244,0.00037488242,0.0003208691,0.00020224764,0.00000872879,0.000032743836,0.000031324016,0.0006408561],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986305,0.000064048676,0.00036116343,0.00030342615,0.00033890447,0.0003019624],"domain_scores_gemma":[0.99811476,0.00011015316,0.00028149493,0.0011471314,0.00016616532,0.00018028631],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026527137,0.00022735028,0.00051953027,0.000071068636,0.0005204669,0.00006824468,0.00039090778,0.00008447142,0.00035205073],"category_scores_gemma":[0.000052739168,0.00014549047,0.00013119527,0.00008527486,0.0004968943,0.00013082642,0.0002357781,0.00020293499,0.00003654829],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058651497,0.0013179154,0.08088587,0.0014001321,0.0011521712,0.000460007,0.0029253222,0.0000018700324,0.5686379,0.006847849,0.037293505,0.2932123],"study_design_scores_gemma":[0.0025714906,0.00015439905,0.98764205,0.00031153523,0.00027711768,0.0044203796,0.00039449622,0.000709193,0.000529667,0.00071935845,0.0021028414,0.00016747636],"about_ca_topic_score_codex":0.0003859363,"about_ca_topic_score_gemma":0.00002765402,"teacher_disagreement_score":0.90675616,"about_ca_system_score_codex":0.000030459936,"about_ca_system_score_gemma":0.00007058777,"threshold_uncertainty_score":0.5932929},"labels":[],"label_agreement":null},{"id":"W2729590981","doi":"10.1016/j.breast.2017.06.042","title":"Completeness of breast cancer operative reports in a community care setting","year":2017,"lang":"en","type":"article","venue":"The Breast","topic":"Digital Imaging in Medicine","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Ontario Stroke Network; University of British Columbia; Dalhousie University","funders":"BC Cancer Agency; Canadian Cancer Society","keywords":"Medicine; Breast cancer; Completeness (order theory); Narrative; Narrative review; Health care; General surgery; Family medicine; Cancer; Medical physics; Surgery; Intensive care medicine; Internal medicine","score_opus":0.027476967231121818,"score_gpt":0.3578288017967606,"score_spread":0.33035183456563877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2729590981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97328925,0.00016946867,0.000006909503,0.0072541614,0.00014958286,0.00031589018,0.00010732943,0.000023745813,0.018683665],"genre_scores_gemma":[0.9991848,0.00000575005,0.00006670109,0.0003625411,0.00011175289,0.000020552718,0.000025713469,0.000018732451,0.00020346486],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990358,0.00010164247,0.00030512657,0.00012771612,0.00023857843,0.00019114744],"domain_scores_gemma":[0.9981664,0.00007351582,0.0002593955,0.0011454568,0.0002900836,0.00006517157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005504643,0.00012525884,0.0003432571,0.000045378518,0.00029004074,0.00003934541,0.0002939843,0.000030585703,0.000043176893],"category_scores_gemma":[0.00017999428,0.00007939261,0.000045899866,0.00006692353,0.0005269293,0.00015103724,0.00022580444,0.0003972487,0.0000029872888],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017925235,0.00017657949,0.9411004,0.0003123561,0.00006624096,0.00024392478,0.00999912,0.000025431214,0.0035857204,0.000056587876,0.00042117786,0.043833163],"study_design_scores_gemma":[0.0008157752,0.00003423792,0.9876646,0.0016097466,0.000051573083,0.0036197284,0.005395626,0.0001000744,0.00046736898,0.000065232605,0.000096212745,0.00007982006],"about_ca_topic_score_codex":0.011322641,"about_ca_topic_score_gemma":0.0007428644,"teacher_disagreement_score":0.046564158,"about_ca_system_score_codex":0.00008958888,"about_ca_system_score_gemma":0.00013447483,"threshold_uncertainty_score":0.9952611},"labels":[],"label_agreement":null},{"id":"W2732206834","doi":"10.1016/j.breast.2017.06.001","title":"Impact of physical activity in group versus individual physical activity on fatigue in patients with breast cancer: A pilot study","year":2017,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer survivorship and care","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hôpital du Saint-Sacrement","funders":"","keywords":"Medicine; Breast cancer; Physical activity; Physical therapy; Quality of life (healthcare); Randomized controlled trial; Cancer; Aerobic exercise; Internal medicine; Nursing","score_opus":0.04999265612660535,"score_gpt":0.348315206130503,"score_spread":0.2983225500038976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2732206834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99814945,0.0000017489357,7.850983e-7,0.00020244466,0.00009961865,0.00079204165,0.00045575728,0.000015679272,0.00028245713],"genre_scores_gemma":[0.9996721,7.5024434e-7,3.2305357e-7,0.000006445031,0.00020674393,0.00007286305,0.000008277097,0.000025637797,0.0000068430554],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985171,0.00015299549,0.00008959145,0.00032777258,0.0005991545,0.00031339886],"domain_scores_gemma":[0.99877864,0.00011957252,0.00018466299,0.00075056305,0.000065456516,0.00010108562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015692877,0.0002499039,0.00052112626,0.00008246994,0.000101195095,0.000031692267,0.00030101888,0.000031362928,0.00001263469],"category_scores_gemma":[0.000018062405,0.0001481205,0.00009830611,0.00019019021,0.00018653292,0.00020969281,0.0001273726,0.0004661271,0.0000028584054],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03894486,0.01692005,0.8768211,0.000023205408,0.00018918654,0.000008775816,0.002673999,0.000029844881,0.00017478192,0.000011018177,0.000007825717,0.064195365],"study_design_scores_gemma":[0.011180859,0.0081117125,0.9799071,0.00016662052,0.00011350774,0.000003010315,0.00019528327,0.0000968163,0.00006849005,0.0000047851026,3.109094e-7,0.00015153678],"about_ca_topic_score_codex":0.052487142,"about_ca_topic_score_gemma":0.020158872,"teacher_disagreement_score":0.10308598,"about_ca_system_score_codex":0.0003243165,"about_ca_system_score_gemma":0.00014655877,"threshold_uncertainty_score":0.99772066},"labels":[],"label_agreement":null},{"id":"W2741986458","doi":"10.1016/j.breast.2017.07.011","title":"Re: Secondary gastric cancer following a breast cancer diagnosis; beware of metastatic breast cancer","year":2017,"lang":"en","type":"letter","venue":"The Breast","topic":"Metastasis and carcinoma case studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Cancer; Oncology; Metastatic breast cancer; Internal medicine; CA15-3","score_opus":0.03860122394789683,"score_gpt":0.31136561504176563,"score_spread":0.2727643910938688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741986458","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.035552353,0.054638956,0.0000072721655,0.83985734,0.00289255,0.0020384232,0.0627651,0.00012739215,0.0021205978],"genre_scores_gemma":[0.67097646,0.016276944,0.00013637215,0.26633573,0.02149841,0.009804191,0.0010852602,0.0007936275,0.013092988],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99451345,0.00036013368,0.0011030904,0.0011581632,0.0015523339,0.0013128287],"domain_scores_gemma":[0.9952704,0.00032775023,0.0013523751,0.0021176357,0.0006551096,0.00027674634],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00066679355,0.0012069149,0.0027479336,0.00036660742,0.00071817945,0.0001278103,0.0010107259,0.00042830812,0.008386164],"category_scores_gemma":[0.000050962215,0.0007875358,0.0014287035,0.00048847846,0.0006060933,0.00024067902,0.00048653426,0.0025253436,0.00004407962],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003098255,0.00014796936,0.03858725,0.0020346697,0.005051651,0.0017451326,0.00044801758,0.0000046739688,0.000054419306,0.0000034981,0.88123083,0.07038208],"study_design_scores_gemma":[0.0064350576,0.00019713963,0.58436984,0.012171533,0.023565562,0.012207119,0.001128574,0.000030804964,0.00016236061,0.00007214642,0.35759532,0.0020645345],"about_ca_topic_score_codex":0.020763205,"about_ca_topic_score_gemma":0.0021537913,"teacher_disagreement_score":0.63542414,"about_ca_system_score_codex":0.0005686503,"about_ca_system_score_gemma":0.0016932156,"threshold_uncertainty_score":0.9997759},"labels":[],"label_agreement":null},{"id":"W2745262430","doi":"10.1016/j.breast.2017.07.002","title":"Omitting radiation therapy after lumpectomy for pure DCIS does not reduce the risk of salvage mastectomy","year":2017,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sudbury Regional Hospital; Mount Sinai Hospital; Thunder Bay Regional Health Sciences Centre; Kingston General Hospital; Juravinski Hospital; London Health Sciences Centre; Systems, Applications & Products in Data Processing (Canada); Health Sciences Centre; University Health Network; University of Toronto; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"Canadian Cancer Society Research Institute; Ontario Institute for Cancer Research; Ontario Ministry of Health and Long-Term Care","keywords":"Medicine; Lumpectomy; Mastectomy; Breast-conserving surgery; Radiation therapy; Ductal carcinoma; Breast cancer; Population; Cohort; Oncology; Proportional hazards model; Internal medicine; Hazard ratio; Surgery; Gynecology; Cancer; Confidence interval","score_opus":0.009709941076713701,"score_gpt":0.26045766151521865,"score_spread":0.25074772043850496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2745262430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932566,0.0011019473,0.0001048913,0.004317524,0.00019058911,0.00045299172,0.00032409676,0.000009357132,0.00024198438],"genre_scores_gemma":[0.9980695,0.00048232192,0.00008828188,0.0001370277,0.0007202103,0.00024755078,0.00001760359,0.000023145643,0.00021432021],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9992774,0.00007042142,0.00014254318,0.00022378526,0.00009950037,0.00018631827],"domain_scores_gemma":[0.9988047,0.000055472534,0.00027671305,0.0007769715,0.00006475512,0.00002139838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002633279,0.000151476,0.00014145402,0.000011615392,0.00049829454,0.000046876958,0.00037731355,0.00006275811,0.000009825638],"category_scores_gemma":[0.00007108433,0.000069409485,0.0001480019,0.000021048734,0.00021309558,0.000006906233,0.00011091993,0.00006551173,0.0000026932264],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00605167,0.0002652994,0.2556599,0.00006392474,0.0024360935,0.0000025914997,0.0026151014,0.00002054774,0.30916813,0.00017626447,0.002257513,0.42128298],"study_design_scores_gemma":[0.0016390331,0.0000654607,0.7927689,0.00001834441,0.00011210034,0.000019918249,0.00019020465,0.000016635115,0.20105903,0.0002169347,0.0037585986,0.00013482955],"about_ca_topic_score_codex":0.00015679591,"about_ca_topic_score_gemma":0.00008778374,"teacher_disagreement_score":0.537109,"about_ca_system_score_codex":0.000012764083,"about_ca_system_score_gemma":0.000028010512,"threshold_uncertainty_score":0.3832529},"labels":[],"label_agreement":null},{"id":"W2745905123","doi":"10.1016/j.breast.2017.07.017","title":"ESO-ESMO 3rd international consensus guidelines for breast cancer in young women (BCY3)","year":2017,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":247,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Consensus conference; Breast cancer; Family medicine; MEDLINE; Gynecology; Cancer; Oncology; Internal medicine","score_opus":0.030736206921722766,"score_gpt":0.3427459615247155,"score_spread":0.31200975460299274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2745905123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9205421,0.00058893947,0.00006956901,0.07151294,0.0012204834,0.00043703496,0.0032027208,0.000021638838,0.0024045664],"genre_scores_gemma":[0.9966171,0.00017689416,0.00015245889,0.00038176618,0.0010090894,0.0003068101,0.00003636982,0.00002359193,0.0012959625],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908,0.000021077703,0.00019943721,0.00029088726,0.00011511826,0.0002934533],"domain_scores_gemma":[0.99900603,0.000016526132,0.000145341,0.0004884489,0.00029747232,0.0000461824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019150213,0.00017222189,0.00015747304,0.000025096406,0.0002689462,0.000058815895,0.0004763482,0.00006786641,0.00005779735],"category_scores_gemma":[0.000079998834,0.0001232737,0.00007184044,0.000021713218,0.0002015326,0.000005119417,0.00023166499,0.000053215947,0.000006745375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041959756,0.00037809176,0.7615073,0.00005443424,0.0017005274,0.000017790462,0.000942502,0.0003825693,0.022133732,0.00066486315,0.054491173,0.15353109],"study_design_scores_gemma":[0.0023179685,0.000029097191,0.9859531,0.000054268265,0.000035481276,0.0004193705,0.0003985076,0.0001330034,0.0011894713,0.0003013024,0.008928708,0.00023975229],"about_ca_topic_score_codex":0.0017675152,"about_ca_topic_score_gemma":0.0030768663,"teacher_disagreement_score":0.22444582,"about_ca_system_score_codex":0.00009102663,"about_ca_system_score_gemma":0.00008400902,"threshold_uncertainty_score":0.50269556},"labels":[],"label_agreement":null},{"id":"W2757511999","doi":"10.1016/j.breast.2016.10.001","title":"3rd ESO–ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3)","year":2016,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":232,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; Metastatic breast cancer; Overall survival; Cancer","score_opus":0.06115132011510013,"score_gpt":0.41052325189541666,"score_spread":0.34937193178031656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2757511999","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29875684,0.00096943637,0.00029256646,0.68920153,0.0027152267,0.0010612662,0.0023854538,0.00014663216,0.0044710375],"genre_scores_gemma":[0.9685898,0.0003143483,0.0004662992,0.004248355,0.0022364473,0.00028027678,0.000035101937,0.000031592688,0.02379781],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99923265,0.000018047598,0.0002058635,0.00019360901,0.00013455377,0.0002152633],"domain_scores_gemma":[0.9990577,0.00015525828,0.00008188152,0.0001784327,0.00044545176,0.00008128181],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001078327,0.00013492306,0.00018189916,0.00003949988,0.0000752797,0.0000069958514,0.00012639342,0.000043078173,0.0015790482],"category_scores_gemma":[0.000032371292,0.00006656247,0.000102300975,0.000055393284,0.00012678251,0.00003304771,0.00003469087,0.000048738228,0.00005708786],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008039902,0.00028931038,0.020111643,0.000033372155,0.0008071596,0.000024343923,0.00012175934,0.000021275164,0.053775165,0.0008907267,0.4190407,0.49684465],"study_design_scores_gemma":[0.035947215,0.00043538222,0.15867129,0.000632483,0.001100365,0.005780329,0.00021556376,0.0005015818,0.010599392,0.0017334156,0.78381383,0.0005691349],"about_ca_topic_score_codex":0.00019354424,"about_ca_topic_score_gemma":0.00012558323,"teacher_disagreement_score":0.68495315,"about_ca_system_score_codex":0.00013898454,"about_ca_system_score_gemma":0.00013386835,"threshold_uncertainty_score":0.9993336},"labels":[],"label_agreement":null},{"id":"W2765099943","doi":"10.1016/s0960-9776(17)30667-7","title":"Creating a Novel Drug Navigation Tool for Metastatic Breast Cancer Drugs in Canada","year":2017,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Drug; Metastatic breast cancer; Breast cancer; Oncology; Cancer drugs; Cancer; Internal medicine; Medical physics; Intensive care medicine; Pharmacology","score_opus":0.022026568746454204,"score_gpt":0.329341557099641,"score_spread":0.3073149883531868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765099943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832951,0.00011655751,0.00001578841,0.014203537,0.0002656357,0.00068563607,0.0007026812,0.000011035306,0.0007040276],"genre_scores_gemma":[0.99728554,0.0000136662175,0.00011886063,0.00046401317,0.00027073894,0.00028856995,0.00004567711,0.00001726142,0.0014956417],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992814,0.000018534662,0.00016800199,0.00015840388,0.00013910013,0.00023455359],"domain_scores_gemma":[0.999359,0.000118321186,0.00014023864,0.00025903515,0.0000665344,0.00005687397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001715978,0.00011869562,0.0002170186,0.0000219652,0.00025850857,0.000027030577,0.00013676075,0.000014305371,0.00016418633],"category_scores_gemma":[0.000011842451,0.00008065162,0.000048457183,0.0000448373,0.000049855862,0.000084147105,0.00003096329,0.000102386424,0.0000030171952],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005551584,0.0009875842,0.7054583,0.00079785485,0.0012413397,0.00009127846,0.008236945,0.00032676663,0.016963853,0.0010261623,0.019304043,0.2400143],"study_design_scores_gemma":[0.0083317375,0.00003414774,0.98371124,0.00036181972,0.00054750615,0.00057513133,0.00069583056,0.003203454,0.00091713027,0.00011878491,0.0013091583,0.00019407514],"about_ca_topic_score_codex":0.9226085,"about_ca_topic_score_gemma":0.77391034,"teacher_disagreement_score":0.27825293,"about_ca_system_score_codex":0.00064550363,"about_ca_system_score_gemma":0.0010373556,"threshold_uncertainty_score":0.32888776},"labels":[],"label_agreement":null},{"id":"W2766236538","doi":"10.1016/j.breast.2017.10.015","title":"Editorial: Approaches of the treatment of DCIS","year":2017,"lang":"en","type":"editorial","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Incidence (geometry); Breast cancer; Colorectal cancer; Mammography; Cancer; Internal medicine; Population; Stage (stratigraphy); Oncology; Colonoscopy; Concomitant; Adenomatous polyps","score_opus":0.016662939474928626,"score_gpt":0.254539978383062,"score_spread":0.2378770389081334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766236538","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011603767,0.0021353154,0.0000018850627,0.00023269258,0.9930683,0.00033178704,0.001815296,0.0000053945064,0.0012490025],"genre_scores_gemma":[0.019402357,0.0010260739,0.000015445974,0.000002121768,0.97792697,0.000090763264,0.00024683253,0.000040127812,0.001249335],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987173,0.000088124136,0.00024370165,0.00032468064,0.0004304049,0.00019577496],"domain_scores_gemma":[0.99759287,0.00008636275,0.0005530822,0.0015459768,0.00019461775,0.000027100497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001267249,0.00031783312,0.00043900916,0.000016154308,0.00018013209,0.000014333231,0.0007962773,0.00045220944,0.0000044922404],"category_scores_gemma":[0.00008950768,0.00015641136,0.00036733027,0.000034493634,0.0005312937,0.0000017023074,0.00021401777,0.000111101785,0.0000027300298],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002973242,0.00026249498,0.00034044974,0.00004070002,0.000757151,1.730431e-7,0.00017007829,0.0000025549905,0.00029031094,0.000008125207,0.9928434,0.0049872356],"study_design_scores_gemma":[0.0009089436,0.00023381448,0.001147344,0.000062109444,0.00042064107,0.0000047529725,0.00005089532,3.9458368e-7,0.0048142993,0.000040202627,0.99216735,0.0001492623],"about_ca_topic_score_codex":0.00044296792,"about_ca_topic_score_gemma":0.00018391428,"teacher_disagreement_score":0.018241981,"about_ca_system_score_codex":0.000042539683,"about_ca_system_score_gemma":0.00031286458,"threshold_uncertainty_score":0.63782704},"labels":[],"label_agreement":null},{"id":"W2769509722","doi":"10.1016/j.breast.2017.11.004","title":"Impact of body mass index on the clinical outcomes of patients with HER2-positive metastatic breast cancer","year":2017,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Hôpital Charles-Le Moyne; Université de Sherbrooke","funders":"European Society for Medical Oncology","keywords":"Medicine; Metastatic breast cancer; Oncology; Breast cancer; Body mass index; Internal medicine; Cancer; Index (typography)","score_opus":0.031749542178073034,"score_gpt":0.3798423642163952,"score_spread":0.3480928220383222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769509722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99596226,0.000011416093,0.0000110512765,0.0017532345,0.000086727996,0.00042781187,0.0012127912,0.0000058980577,0.00052880356],"genre_scores_gemma":[0.99963367,0.000017907165,0.000006131531,0.00012502102,0.000059983893,0.000012103899,0.000008991484,0.000019023688,0.000117163036],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99897844,0.000077614764,0.00028162668,0.00014667059,0.00034501767,0.00017062572],"domain_scores_gemma":[0.99834603,0.0002080278,0.0004506975,0.0007256318,0.0001890962,0.00008052079],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024973747,0.00015318053,0.00045732304,0.00002721835,0.000110921785,0.00001530049,0.00025119144,0.00003441109,0.00026427794],"category_scores_gemma":[0.000042334756,0.000057162906,0.00023323749,0.0000497994,0.00043816032,0.000051878204,0.00004613787,0.00021093851,0.0000051476395],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021009296,0.00038711872,0.98984987,0.000011547393,0.0008712921,0.0000020329892,0.00013278783,0.000008482975,0.0000123785085,0.000044225886,0.00021336037,0.006365972],"study_design_scores_gemma":[0.0019179593,0.00054167706,0.9968394,0.000142574,0.00031929562,0.000009803276,0.00006654136,0.000028649616,0.000024112867,0.000032138018,0.000009484941,0.000068374335],"about_ca_topic_score_codex":0.008926629,"about_ca_topic_score_gemma":0.00019624043,"teacher_disagreement_score":0.008730389,"about_ca_system_score_codex":0.000060628918,"about_ca_system_score_gemma":0.00016389694,"threshold_uncertainty_score":0.99767303},"labels":[],"label_agreement":null},{"id":"W2774001440","doi":"10.1016/j.breast.2017.12.008","title":"A retrospective review of phyllodes tumours of the breast: A single institution experience","year":2017,"lang":"en","type":"review","venue":"The Breast","topic":"Breast Lesions and Carcinomas","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre","funders":"Ofelia Cancer Research Fund; Michael and Karyn Goldstein Cancer Research Fund; Joseph and Silvana Melara Cancer Research Fund","keywords":"Medicine; Institution; Retrospective cohort study; Phyllodes tumor; Oncology; Internal medicine","score_opus":0.08382066367347908,"score_gpt":0.35421380441322986,"score_spread":0.2703931407397508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2774001440","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022754857,0.99225205,0.000006044805,0.00046594357,0.00019814553,0.0012706292,0.0002634794,0.00001710803,0.0052990494],"genre_scores_gemma":[0.054786056,0.94436216,0.00001794859,0.000071788345,0.0002134131,0.000088216126,0.000017537479,0.0000320778,0.00041082894],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9980225,0.00021820964,0.00067733636,0.00032829834,0.0005170255,0.00023663262],"domain_scores_gemma":[0.99649245,0.000039111088,0.0012480365,0.0018248863,0.00031379296,0.00008170428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005050974,0.00035417572,0.0019056813,0.00006819146,0.00020186536,0.000013647215,0.0007944479,0.00014878124,0.000100232195],"category_scores_gemma":[0.00016170955,0.00016258963,0.00094767695,0.0003741878,0.0009196209,0.00007331658,0.00025740292,0.00042698192,0.000014852484],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004018859,0.00030523603,0.0004997861,0.072773844,0.00013064273,0.000010966792,0.00026713515,2.9516919e-8,0.000029509998,0.0013295675,0.0004211322,0.92419195],"study_design_scores_gemma":[0.00041649913,0.0001224262,0.059479445,0.6670538,0.0035387073,0.021794405,0.00010367995,0.000001247499,0.00002044136,0.000058653404,0.24707682,0.00033388048],"about_ca_topic_score_codex":0.00016338233,"about_ca_topic_score_gemma":0.0000066457314,"teacher_disagreement_score":0.9238581,"about_ca_system_score_codex":0.00018542373,"about_ca_system_score_gemma":0.00066345034,"threshold_uncertainty_score":0.66302127},"labels":[],"label_agreement":null},{"id":"W2790201825","doi":"10.1016/j.breast.2018.03.003","title":"Reply to the letter “Body mass index and clinical outcomes in trastuzumab-treated metastatic breast cancer patients: An alternative explanation for the lack of association”","year":2018,"lang":"en","type":"letter","venue":"The Breast","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; Hôpital Charles-Le Moyne; Centre intégré de santé et de services sociaux de Chaudière-Appalaches","funders":"","keywords":"Medicine; Breast cancer; Body mass index; Underweight; Metastatic breast cancer; Oncology; Trastuzumab; Internal medicine; Overweight; Cancer; Gynecology","score_opus":0.049871077709294255,"score_gpt":0.36922296582124153,"score_spread":0.31935188811194726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790201825","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1813996,0.00003688859,0.00014278379,0.81129,0.0006698716,0.00241788,0.0039863586,0.000019028896,0.000037552923],"genre_scores_gemma":[0.4945613,0.000081571336,0.000021863734,0.500151,0.0031798922,0.0003905148,0.0004014307,0.00007104451,0.0011414024],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976942,0.00031299013,0.000692737,0.00039629557,0.00058359094,0.00032021463],"domain_scores_gemma":[0.9971464,0.0012160459,0.00063900213,0.00052288425,0.00041780496,0.000057846533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008929121,0.000296107,0.00066234655,0.000113716975,0.00011463846,0.000050149465,0.00032879494,0.00018067317,0.00009074312],"category_scores_gemma":[0.0001625544,0.00013309518,0.00019611767,0.00018800693,0.00015791118,0.00009274502,0.00005294638,0.00073556945,0.0000063239604],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049655925,0.00011996728,0.56848866,0.000037038164,0.0008882862,0.000003294808,0.00071395555,0.000007503118,0.0000016307548,0.0000028389109,0.4259642,0.0032760324],"study_design_scores_gemma":[0.002267696,0.00027369012,0.9251383,0.00012821358,0.000759018,0.000011941962,0.00014177168,0.0003372011,0.0000046178848,0.000050852494,0.070720725,0.00016597033],"about_ca_topic_score_codex":0.011287192,"about_ca_topic_score_gemma":0.0016760606,"teacher_disagreement_score":0.3566496,"about_ca_system_score_codex":0.00040715796,"about_ca_system_score_gemma":0.00010518101,"threshold_uncertainty_score":0.9952967},"labels":[],"label_agreement":null},{"id":"W2790590882","doi":"10.1016/j.breast.2018.02.030","title":"Body mass index and clinical outcomes in trastuzumab-treated metastatic breast cancer patients: An alternative explanation for the lack of association","year":2018,"lang":"en","type":"letter","venue":"The Breast","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement; Université Laval","funders":"","keywords":"Medicine; Breast cancer; Body mass index; Metastatic breast cancer; Underweight; Oncology; Trastuzumab; Internal medicine; Overweight; Cancer","score_opus":0.05443320802663595,"score_gpt":0.37996930203087353,"score_spread":0.3255360940042376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790590882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7738653,0.00008899131,0.00014804916,0.21447171,0.0008757649,0.0028084859,0.0076440754,0.00003158535,0.00006604448],"genre_scores_gemma":[0.966678,0.00020304395,0.00001524543,0.030028142,0.001532547,0.00018079125,0.00074215786,0.00005610724,0.00056392036],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99816084,0.00021587206,0.00059693004,0.00030755534,0.00046303225,0.00025578003],"domain_scores_gemma":[0.9977265,0.00086437695,0.0007032122,0.00028611024,0.00037413804,0.000045687324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000571495,0.00025132537,0.0006583973,0.000112487396,0.00006715407,0.000029132912,0.00017883215,0.00024390368,0.00007960724],"category_scores_gemma":[0.00009762822,0.0001322382,0.0001653431,0.00012802005,0.00014567544,0.00010226705,0.000027178723,0.0006028189,0.0000022662248],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054458244,0.00018974373,0.9495112,0.0000694356,0.0009513163,0.0000029454748,0.00038806326,0.00000292621,0.000002403191,0.0000033560461,0.043184247,0.005149794],"study_design_scores_gemma":[0.0032691185,0.00028714168,0.99098724,0.00013699412,0.00086182903,0.000009301372,0.00013088199,0.0008366794,0.0000048326046,0.00009557355,0.0032371245,0.00014328978],"about_ca_topic_score_codex":0.008115745,"about_ca_topic_score_gemma":0.0015684627,"teacher_disagreement_score":0.19281276,"about_ca_system_score_codex":0.00043295757,"about_ca_system_score_gemma":0.00011263507,"threshold_uncertainty_score":0.9984893},"labels":[],"label_agreement":null},{"id":"W2793113650","doi":"10.1016/j.breast.2018.02.027","title":"Endocrine therapy and palbociclib within a compassionate use program in heavily pretreated hormone receptor-positive, HER2-negative metastatic breast cancer","year":2018,"lang":"en","type":"article","venue":"The Breast","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Hôpital Charles-Le Moyne; Université de Sherbrooke","funders":"European Society for Medical Oncology; Pfizer","keywords":"Medicine; Palbociclib; Metastatic breast cancer; Oncology; Internal medicine; Breast cancer; Hormone receptor; Endocrine system; Hazard ratio; Population; Cancer; Gynecology; Hormone; Confidence interval","score_opus":0.02977192552836007,"score_gpt":0.32005924517608986,"score_spread":0.2902873196477298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793113650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881784,0.0012760721,0.00004628848,0.007372625,0.00012061888,0.0021253054,0.0005081773,0.0002204363,0.00015212057],"genre_scores_gemma":[0.9940368,0.00047333864,0.0031149464,0.0008754068,0.00023432645,0.00056905067,0.00004544403,0.00009100414,0.00055970263],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99771935,0.00029089398,0.00044707002,0.00055186136,0.00040861467,0.0005822276],"domain_scores_gemma":[0.99847144,0.0002200084,0.00023477124,0.00046741412,0.00037506875,0.00023129837],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002381084,0.00044811674,0.0006418603,0.000148575,0.00020975443,0.000073155905,0.00018331467,0.00006166001,0.0002805695],"category_scores_gemma":[0.000029398456,0.00027744897,0.00008165856,0.00073636963,0.0010539086,0.0003732956,0.00008985537,0.00042115175,0.000026228758],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.045639273,0.002866199,0.122770116,0.00012774717,0.0019412616,0.00018830544,0.0153914085,0.000047492602,0.04088756,0.00066753215,0.0008714989,0.7686016],"study_design_scores_gemma":[0.009939946,0.0010637274,0.9770486,0.00070796633,0.0001254041,0.002213112,0.0008566384,0.00067213847,0.0052960464,0.0004905947,0.0011657579,0.00042010026],"about_ca_topic_score_codex":0.004076275,"about_ca_topic_score_gemma":0.00063407375,"teacher_disagreement_score":0.85427845,"about_ca_system_score_codex":0.0002333187,"about_ca_system_score_gemma":0.00015567514,"threshold_uncertainty_score":0.99996775},"labels":[],"label_agreement":null},{"id":"W2800546213","doi":"10.1016/j.breast.2018.05.002","title":"The oncologic impact of hormone replacement therapy in premenopausal breast cancer survivors: A systematic review","year":2018,"lang":"en","type":"review","venue":"The Breast","topic":"Menopause: Health Impacts and Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital; Western University","funders":"","keywords":"Medicine; Breast cancer; Relative risk; Hormone replacement therapy (female-to-male); Internal medicine; Meta-analysis; Confidence interval; Observational study; Oncology; Randomized controlled trial; Gynecology; Hormone therapy; Rate ratio; Incidence (geometry); Cancer","score_opus":0.08021355174970679,"score_gpt":0.4220523243763472,"score_spread":0.3418387726266404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800546213","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029795207,0.98446894,3.8798723e-7,0.0007184079,0.00015804397,0.013543599,0.000485919,0.000032484768,0.00029429467],"genre_scores_gemma":[0.0009530944,0.9957267,0.0000049757064,0.00024197334,0.00024260391,0.002083568,0.00007014309,0.00008729253,0.0005896255],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99446845,0.0014724111,0.002093327,0.0004845732,0.0007046706,0.0007765945],"domain_scores_gemma":[0.99502516,0.00062099786,0.0019437629,0.0018680013,0.00026269033,0.00027939107],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0036858595,0.00076901517,0.004349251,0.00012739938,0.00020005608,0.000036885715,0.00060165254,0.00021586526,0.00019969202],"category_scores_gemma":[0.00013978183,0.0002692631,0.00024271148,0.00071400526,0.00021284014,0.000056460627,0.00011362341,0.00049524434,0.000092237],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013263023,0.00082422583,0.00008394602,0.8964323,0.0038120984,0.00003987023,0.0001566145,1.4598177e-7,0.0000023473822,0.000018231674,0.005068815,0.092235096],"study_design_scores_gemma":[0.0033692098,0.00819506,0.001676201,0.9448551,0.00817593,0.004356077,0.000020039126,0.0000034535228,1.4742818e-7,0.0000169901,0.028923528,0.00040829735],"about_ca_topic_score_codex":0.005257314,"about_ca_topic_score_gemma":0.00042213834,"teacher_disagreement_score":0.0918268,"about_ca_system_score_codex":0.0015061774,"about_ca_system_score_gemma":0.0018474563,"threshold_uncertainty_score":0.999976},"labels":[],"label_agreement":null},{"id":"W2800769618","doi":"10.1016/j.breast.2018.04.008","title":"Valid assessment of women's satisfaction with breast cancer screening programs","year":2018,"lang":"en","type":"letter","venue":"The Breast","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Université Laval; Institut National de Santé Publique du Québec","funders":"","keywords":"Medicine; Mammography; Checklist; Breast cancer; Scopus; Breast cancer screening; Family medicine; Medical physics; Patient satisfaction; Cancer; Gynecology; MEDLINE; Nursing; Internal medicine; Psychology","score_opus":0.054226211015562915,"score_gpt":0.34299956436716217,"score_spread":0.28877335335159926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800769618","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.302372,0.0002710415,0.0014387242,0.6882059,0.0006260028,0.0022807217,0.0005976838,0.00026691737,0.003940988],"genre_scores_gemma":[0.831705,0.0000529831,0.0019344968,0.15604167,0.008140785,0.0004536213,0.00024618005,0.00013099833,0.0012942755],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972192,0.000104518964,0.00036324144,0.00043264314,0.0011632672,0.0007171274],"domain_scores_gemma":[0.9982534,0.0000421049,0.0004468399,0.0006583671,0.00047064078,0.00012864293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047139206,0.00038293708,0.0006647377,0.00010006713,0.0001473853,0.000056779834,0.00025518876,0.0003140202,0.00072417123],"category_scores_gemma":[0.000005103873,0.00022373906,0.00014358747,0.0003403205,0.00035186528,0.00012970822,0.0000791114,0.001165065,0.000012086524],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012545134,0.00007590779,0.49945602,0.0008248558,0.0015829155,0.00031069134,0.000697902,0.000032921955,0.00014900313,0.000029628776,0.31351322,0.18207243],"study_design_scores_gemma":[0.0016568005,0.0009809722,0.90018636,0.0046843663,0.00096066843,0.007549231,0.00072459166,0.0001493123,0.00002464017,0.000040059636,0.08248187,0.0005611533],"about_ca_topic_score_codex":0.0075638043,"about_ca_topic_score_gemma":0.00027767415,"teacher_disagreement_score":0.5321642,"about_ca_system_score_codex":0.0007263417,"about_ca_system_score_gemma":0.0005234792,"threshold_uncertainty_score":0.9990449},"labels":[],"label_agreement":null},{"id":"W2809625159","doi":"10.1016/j.breast.2018.06.007","title":"The impact of organized breast assessment on survival by stage for screened women diagnosed with invasive breast cancer","year":2018,"lang":"en","type":"article","venue":"The Breast","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Lakeridge Health; Hamilton Regional Laboratory Medicine Program; Regional Municipality of Waterloo; Champlain Regional College; North York General Hospital; Cancer Care South East; Sunnybrook Health Science Centre; St. Michael's Hospital; Health Sciences Centre; University of Toronto; Barrie Urology Group; St. Clair College; Cancer Care Ontario","funders":"Canadian Institutes of Health Research; Cancer Care Ontario","keywords":"Medicine; Breast cancer; Oncology; Stage (stratigraphy); Internal medicine; Cancer; Gynecology","score_opus":0.03320413301882735,"score_gpt":0.3583362316166302,"score_spread":0.32513209859780284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809625159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99124396,0.00007260882,0.00017964009,0.0033777147,0.00009158165,0.0010386901,0.0026222027,0.000043717777,0.0013298789],"genre_scores_gemma":[0.9981106,0.000060015514,0.000060826274,0.00039254353,0.00045477072,0.00018814416,0.000043957596,0.000049221784,0.00063990336],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980324,0.0001157754,0.00029950507,0.00031907542,0.000609848,0.0006233997],"domain_scores_gemma":[0.9977612,0.00045389263,0.00027147925,0.00062072126,0.00066219637,0.0002304937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072011945,0.00029189087,0.00046083023,0.000041029107,0.0003826054,0.00006112425,0.00038932703,0.00006873635,0.00053662335],"category_scores_gemma":[0.00004832421,0.00013425302,0.00013457278,0.00036925942,0.00044318018,0.00011103373,0.00007313008,0.00020113483,0.000011577932],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09135574,0.0014117952,0.7163947,0.00024041861,0.0048446273,0.000075204385,0.005218362,0.00020571417,0.051931746,0.0015971218,0.054908134,0.07181643],"study_design_scores_gemma":[0.0066478136,0.002707493,0.9830362,0.00044796604,0.00016972888,0.00047896686,0.004311803,0.00015767568,0.0013740186,0.00006268251,0.0003262276,0.00027939034],"about_ca_topic_score_codex":0.008406489,"about_ca_topic_score_gemma":0.0014540136,"teacher_disagreement_score":0.26664153,"about_ca_system_score_codex":0.000599486,"about_ca_system_score_gemma":0.00092272466,"threshold_uncertainty_score":0.9981966},"labels":[],"label_agreement":null},{"id":"W2869455612","doi":"10.1016/j.breast.2018.07.002","title":"Local control in young women with early-stage breast cancer treated with hypofractionated whole breast irradiation","year":2018,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Univariate analysis; Oncology; Cohort; Multivariate analysis; Logistic regression; Gynecology; Gastroenterology; Cancer","score_opus":0.003990784049060356,"score_gpt":0.21362464043381427,"score_spread":0.2096338563847539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2869455612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99502534,0.000095266085,0.0004440643,0.0021953047,0.000057555433,0.00038829513,0.0011569961,0.000044541666,0.000592621],"genre_scores_gemma":[0.99820185,0.00002313936,0.000016878084,0.0003143089,0.00034729092,0.0003297692,0.00009929728,0.000054000917,0.00061349035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984839,0.00009869737,0.00019273662,0.00047352075,0.0002380445,0.00051309535],"domain_scores_gemma":[0.9990829,0.000016592083,0.00014435082,0.0004068073,0.00024119427,0.00010813889],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012573376,0.00032650755,0.00025889394,0.000065562854,0.00022487786,0.000043852484,0.0001946642,0.00010945439,0.00011006344],"category_scores_gemma":[0.000002300967,0.00020178565,0.00003451883,0.00030112654,0.00049241696,0.00002975371,0.000046482583,0.00013609852,0.000036738966],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018418187,0.0004764478,0.9464545,0.000020460599,0.0011956269,0.00002772674,0.0008771519,0.0007561519,0.0160065,0.000039661227,0.0005082717,0.015219265],"study_design_scores_gemma":[0.004498296,0.00030885206,0.9915742,0.000050234565,0.00007778444,0.0011828138,0.00057350285,0.00017544196,0.00069515285,0.000005817784,0.00056608865,0.00029180423],"about_ca_topic_score_codex":0.007965089,"about_ca_topic_score_gemma":0.0069512296,"teacher_disagreement_score":0.04511966,"about_ca_system_score_codex":0.00027410933,"about_ca_system_score_gemma":0.00014779838,"threshold_uncertainty_score":0.99864095},"labels":[],"label_agreement":null},{"id":"W2890786262","doi":"10.1016/j.breast.2018.08.105","title":"Prevalence of pain in patients with breast cancer post-treatment: A systematic review","year":2018,"lang":"en","type":"review","venue":"The Breast","topic":"Anesthesia and Pain Management","field":"Medicine","cited_by":177,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre","funders":"Ofelia Cancer Research Fund; Joey and Mary Furfari Cancer Research Fund; Michael and Karyn Goldstein Cancer Research Fund; Joseph and Silvana Melara Cancer Research Fund","keywords":"Medicine; Breast cancer; Oncology; Cancer; Internal medicine; Physical therapy","score_opus":0.0156313098014423,"score_gpt":0.2765933767966427,"score_spread":0.2609620669952004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890786262","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000036078938,0.9918642,0.0000018675076,0.0002946069,0.000013146207,0.007564497,0.00011205242,0.00001787446,0.000095695825],"genre_scores_gemma":[0.00012270134,0.9970575,0.000012158787,0.00056624337,0.000056354856,0.0008712886,0.00006653014,0.000049105576,0.0011981336],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9974304,0.0008846603,0.00073977065,0.000311334,0.00038814062,0.00024571738],"domain_scores_gemma":[0.9979481,0.00017035735,0.00068393606,0.0009393132,0.00018737893,0.00007092657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011413052,0.00041825342,0.0023664339,0.00010118157,0.00003264588,0.0000073738333,0.0003052355,0.000082403356,0.00019574855],"category_scores_gemma":[0.000035598623,0.00017746094,0.00029724487,0.00034996323,0.0001113234,0.00003233322,0.00003275618,0.00012274414,0.00007135266],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004635171,0.00022336225,0.0038376637,0.92205423,0.0003955056,0.000010306244,0.000052537478,2.9076496e-8,1.080272e-9,0.000009616482,0.00015289181,0.07321748],"study_design_scores_gemma":[0.00038654066,0.00041656266,0.009422059,0.96034884,0.010792064,0.00024014433,0.00001011025,0.0000012445097,3.4402958e-9,7.8330925e-7,0.018203435,0.00017823702],"about_ca_topic_score_codex":0.00017150115,"about_ca_topic_score_gemma":0.00001781635,"teacher_disagreement_score":0.07303925,"about_ca_system_score_codex":0.00023102318,"about_ca_system_score_gemma":0.00021800309,"threshold_uncertainty_score":0.7236647},"labels":[],"label_agreement":null},{"id":"W2895782917","doi":"10.1016/j.breast.2018.10.001","title":"Targeting CDK4/6 pathways and beyond in breast cancer","year":2018,"lang":"en","type":"review","venue":"The Breast","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Palbociclib; Oncology; Metastatic breast cancer; Internal medicine; Fulvestrant; Breast cancer; Neutropenia; Cancer; Clinical trial; Disease; Adjuvant; Adjuvant therapy; Toxicity; Tamoxifen","score_opus":0.031651075078762796,"score_gpt":0.3233811829162637,"score_spread":0.2917301078375009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2895782917","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007256066,0.9961859,0.0000142971085,0.0009697903,0.0002851361,0.00096702034,0.000671094,0.00008324252,0.00075098407],"genre_scores_gemma":[0.0002568453,0.99657786,0.00016903809,0.0003986687,0.0017351819,0.00028440898,0.00007643046,0.00014970274,0.0003518387],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99773127,0.00015692778,0.0006077922,0.00060750556,0.00031399698,0.0005825327],"domain_scores_gemma":[0.99860674,0.00013807557,0.0003584613,0.00061556575,0.00011085618,0.00017032544],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044158194,0.0005958364,0.0016663289,0.00018343871,0.00013638524,0.000036080295,0.00030939438,0.0002538797,0.0003703432],"category_scores_gemma":[0.000017902528,0.00035753896,0.00022366062,0.00046643362,0.0004249668,0.00011030886,0.0002044778,0.00070011924,0.00008757163],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010183547,0.000048390037,0.00013727562,0.004925418,0.00018156585,0.00003667861,0.00030931924,4.9235246e-7,0.0000069419775,0.00009897383,0.0004012427,0.9937519],"study_design_scores_gemma":[0.00096429355,0.000041022147,0.0010979339,0.02270943,0.000815168,0.009810731,0.0001933394,0.000014018559,8.500832e-7,0.00026704962,0.96354014,0.00054601015],"about_ca_topic_score_codex":0.00018986542,"about_ca_topic_score_gemma":0.00003129401,"teacher_disagreement_score":0.99320585,"about_ca_system_score_codex":0.00035283747,"about_ca_system_score_gemma":0.0004536115,"threshold_uncertainty_score":0.99988765},"labels":[],"label_agreement":null},{"id":"W2902876869","doi":"10.1016/j.breast.2018.11.012","title":"Estimation of the benefit and harms of including clinical breast examination in an organized breast screening program","year":2018,"lang":"en","type":"article","venue":"The Breast","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; Cancer Care Ontario; McMaster University; University of Toronto; Public Health Ontario","funders":"","keywords":"Medicine; Mammography; Breast cancer; Family history; Logistic regression; Hormone therapy; Breast density; Cohort; Breast cancer screening; Gynecology; Oncology; Mammography screening; Internal medicine; Hormone replacement therapy (female-to-male); Cancer","score_opus":0.11091578725150852,"score_gpt":0.4085162621348857,"score_spread":0.29760047488337715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902876869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99775916,0.00004121793,0.00040339094,0.0009686305,0.0000566189,0.00045554445,0.000025052404,0.000028175005,0.0002621784],"genre_scores_gemma":[0.997799,0.000005775576,0.0018717721,0.000090812726,0.00017936304,0.000008876917,0.000012378463,0.000014020542,0.000018047744],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986687,0.0001336164,0.0004755553,0.00020147505,0.0003414124,0.00017929825],"domain_scores_gemma":[0.99896556,0.00008387005,0.00026672168,0.00033174967,0.000281192,0.00007089217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013333586,0.00011620511,0.00028168288,0.00006410871,0.000109190856,0.0000198221,0.00019642313,0.00008264005,0.000036304507],"category_scores_gemma":[0.00009967724,0.000069790876,0.00005371285,0.0004614481,0.00040828317,0.00021222395,0.00014172409,0.00018254394,0.0000019262682],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004336535,0.00013186896,0.34057418,0.00003395479,0.00002203127,0.0000012048391,0.000720094,0.000029322271,0.001450101,0.00019745786,0.000011678497,0.6563944],"study_design_scores_gemma":[0.0012140947,0.00027914264,0.9777786,0.0005832256,0.00008102451,0.000983747,0.0006125468,0.017536376,0.00071451906,0.00014211609,0.0000051528127,0.0000694698],"about_ca_topic_score_codex":0.00057253824,"about_ca_topic_score_gemma":0.00022460354,"teacher_disagreement_score":0.656325,"about_ca_system_score_codex":0.000035576155,"about_ca_system_score_gemma":0.00006021525,"threshold_uncertainty_score":0.28459892},"labels":[],"label_agreement":null},{"id":"W2903411408","doi":"10.1016/j.breast.2018.11.008","title":"Why upfront use of CDK inhibitors for the treatment of advanced breast cancer may be wasteful, and how we can increase their value","year":2018,"lang":"en","type":"article","venue":"The Breast","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Medicine; Breast cancer; Value (mathematics); Cyclin-dependent kinase; Cancer; Oncology; Internal medicine","score_opus":0.02622463847702784,"score_gpt":0.2785753223596665,"score_spread":0.25235068388263865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903411408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8718514,0.0054755816,0.00044838028,0.11588358,0.0003826993,0.002293016,0.003569771,0.00006321545,0.00003237909],"genre_scores_gemma":[0.9956494,0.0011676073,0.00060627534,0.00086582836,0.00071894174,0.0003072888,0.000020655947,0.00007365879,0.000590359],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99856985,0.00009243961,0.0002959436,0.00035395077,0.00028426797,0.000403526],"domain_scores_gemma":[0.9979254,0.00043077065,0.00031995415,0.00079120556,0.0003725188,0.00016016279],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016458484,0.0003709584,0.00058828504,0.00007911834,0.00019855196,0.000021678321,0.00019263502,0.00007798807,0.00006314633],"category_scores_gemma":[0.00002510962,0.00018299607,0.00018500672,0.0002192963,0.0010660535,0.00016006173,0.00006075264,0.000095236355,5.5677066e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01799609,0.0011257185,0.014765237,0.00039806098,0.0021491034,0.0000070643086,0.013907859,0.00027978103,0.053607658,0.00085227913,0.0038398176,0.8910713],"study_design_scores_gemma":[0.028565172,0.006617014,0.24141525,0.0027213085,0.0032855063,0.0032059818,0.016274173,0.0023492747,0.19054402,0.0011837315,0.502433,0.0014055632],"about_ca_topic_score_codex":0.0034150195,"about_ca_topic_score_gemma":0.0012827812,"teacher_disagreement_score":0.8896658,"about_ca_system_score_codex":0.00021883218,"about_ca_system_score_gemma":0.0001854679,"threshold_uncertainty_score":0.7462363},"labels":[],"label_agreement":null},{"id":"W2913547072","doi":"10.1016/j.breast.2019.01.007","title":"Taking the pulse of multidisciplinary cancer conferences for breast cancer care in Canada: A stocktake of current practice","year":2019,"lang":"en","type":"article","venue":"The Breast","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Foothills Medical Centre; University of Toronto; Sunnybrook Hospital; St. Michael's Hospital","funders":"Canadian Institutes of Health Research; Canadian Cancer Society","keywords":"Medicine; Cancer; Multidisciplinary approach; Breast cancer; Family medicine; Oncology; Gynecology; Internal medicine","score_opus":0.07425731377741926,"score_gpt":0.3832132460460257,"score_spread":0.3089559322686064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913547072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98144245,0.009477212,0.000013670716,0.005506243,0.00038619988,0.0010709708,0.001056138,0.00000542986,0.0010417138],"genre_scores_gemma":[0.99930865,0.00019623581,0.000029539413,0.00016100379,0.00012618073,0.00012849027,0.000008876101,0.00001109435,0.000029918567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987848,0.000064475185,0.00031308836,0.00018626574,0.00039368382,0.0002577168],"domain_scores_gemma":[0.99852645,0.00024141894,0.00039099017,0.000297196,0.0004931949,0.000050716808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027807453,0.00013171264,0.00032126706,0.000033197666,0.00006185656,0.0000061971973,0.00025474667,0.000031627373,0.00029936247],"category_scores_gemma":[0.000048110007,0.00007289445,0.000067742505,0.00020650061,0.0000892607,0.00009298758,0.00007484852,0.00020857142,8.026407e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031621195,0.000066616056,0.7292696,0.00062176056,0.00013323026,0.00000571857,0.005283246,0.0013264748,0.00086120545,0.0005366345,0.0002782135,0.2584552],"study_design_scores_gemma":[0.0011698735,0.00008859537,0.97016275,0.0015302345,0.000188487,0.00013706769,0.024745388,0.0009750664,0.00031872728,0.000015471405,0.0005624189,0.0001058952],"about_ca_topic_score_codex":0.9384794,"about_ca_topic_score_gemma":0.9179223,"teacher_disagreement_score":0.25834927,"about_ca_system_score_codex":0.00043261598,"about_ca_system_score_gemma":0.0041278843,"threshold_uncertainty_score":0.7322689},"labels":[],"label_agreement":null},{"id":"W2946676747","doi":"10.1016/j.breast.2019.05.012","title":"Mepitel Film and Mepilex Lite for the prophylaxis and treatment of skin toxicities from breast radiation","year":2019,"lang":"en","type":"article","venue":"The Breast","topic":"Effects of Radiation Exposure","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Dermatology; Breast cancer; Cancer; Internal medicine","score_opus":0.0058469806162081295,"score_gpt":0.22640957488285682,"score_spread":0.22056259426664868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946676747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914315,0.0028142394,0.00004450882,0.0036135553,0.000074966534,0.0013228909,0.0005090823,0.000019806967,0.00016947831],"genre_scores_gemma":[0.99835116,0.00025699337,0.00012854519,0.00011614742,0.0002466835,0.00006178457,0.000058091755,0.00001678812,0.00076380797],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9993886,0.00005251968,0.00014901345,0.00015658939,0.0001364597,0.00011685269],"domain_scores_gemma":[0.99883354,0.0006699575,0.000098371354,0.0002937696,0.000056669007,0.00004766849],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015687,0.00012164486,0.00022265005,0.000037112357,0.00007058549,0.000021599759,0.000054049087,0.00005526964,0.00005634591],"category_scores_gemma":[0.0000252038,0.00006124179,0.000056885805,0.000060771992,0.0001038612,0.00006746381,0.0000152092425,0.000045374283,0.0000074136574],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018957648,0.000274804,0.121262476,0.0002049737,0.0006517652,0.0000019650054,0.010095963,0.00006688355,0.015483191,0.001108926,0.000800433,0.8481529],"study_design_scores_gemma":[0.0032425914,0.0012342427,0.9862917,0.000061004,0.00021775301,0.00018433754,0.00066755735,0.0031930185,0.0025396573,0.00025004207,0.0020198303,0.000098231554],"about_ca_topic_score_codex":0.00041087845,"about_ca_topic_score_gemma":0.000025605139,"teacher_disagreement_score":0.8650293,"about_ca_system_score_codex":0.000035199315,"about_ca_system_score_gemma":0.000030926865,"threshold_uncertainty_score":0.24973679},"labels":[],"label_agreement":null},{"id":"W2950576577","doi":"10.1016/j.breast.2019.06.004","title":"Patient-reported fatigue in breast cancer patients receiving radiation therapy","year":2019,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer survivorship and care","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Multivariate analysis; Univariate analysis; Radiation therapy; Cancer; Cancer-related fatigue; Anxiety; Disease; Oncology","score_opus":0.014374575204214134,"score_gpt":0.2626253431247604,"score_spread":0.24825076792054623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950576577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99396384,0.0003150065,0.0000019926126,0.002030842,0.000686986,0.0005747855,0.000045513818,0.00003922369,0.0023418372],"genre_scores_gemma":[0.99848866,0.00018322197,0.0000017275763,0.0008124014,0.00013292792,0.000054844375,0.000052619816,0.000024924024,0.00024866223],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989599,0.00006526751,0.00024249214,0.00021214967,0.00029990906,0.00022029762],"domain_scores_gemma":[0.99933136,0.000034182365,0.00012669411,0.0003260791,0.00011858278,0.00006311518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013194028,0.00013156382,0.00019244781,0.00007232719,0.000039257076,0.000017343935,0.00007698862,0.00006066804,0.0005973811],"category_scores_gemma":[0.000007254439,0.00008816358,0.00006463047,0.00030083617,0.000024574869,0.000095314535,0.00002267583,0.00016780481,0.000035678357],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003440412,0.00009980024,0.7757593,0.000013942294,0.00003121784,0.0000020090274,0.0019368129,0.000013583227,0.00031224918,0.000007512564,0.00030952695,0.22117002],"study_design_scores_gemma":[0.0018280192,0.00006400727,0.99604774,0.00015112096,0.00001642248,0.000050785195,0.00027653654,0.00008032486,0.00017571359,0.000016069394,0.0011821208,0.000111151974],"about_ca_topic_score_codex":0.0049991063,"about_ca_topic_score_gemma":0.00073384156,"teacher_disagreement_score":0.22105888,"about_ca_system_score_codex":0.00017023267,"about_ca_system_score_gemma":0.00009191876,"threshold_uncertainty_score":0.75571865},"labels":[],"label_agreement":null},{"id":"W2969944916","doi":"10.1016/j.breast.2019.08.003","title":"A phase II randomized clinical trial of the effect of metformin versus placebo on progression-free survival in women with metastatic breast cancer receiving standard chemotherapy","year":2019,"lang":"en","type":"article","venue":"The Breast","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":101,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Western University; Princess Margaret Cancer Centre; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; Statistics Canada; University Health Network; University of Toronto","funders":"Breast Cancer Research Foundation","keywords":"Medicine; Metformin; Placebo; Internal medicine; Hazard ratio; Breast cancer; Chemotherapy; Metastatic breast cancer; Population; Progression-free survival; Cancer; Gastroenterology; Confidence interval; Pathology","score_opus":0.01188174010589312,"score_gpt":0.3308717787892518,"score_spread":0.3189900386833587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969944916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941776,0.0028662875,0.000010306791,0.00012654484,0.0005543292,0.0018829359,0.00021065492,0.000004441934,0.00016693349],"genre_scores_gemma":[0.99758387,0.0017137954,0.00003394907,0.00005623417,0.00020009612,0.00031125077,0.0000066145985,0.00002748503,0.00006673413],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9973676,0.0012259592,0.00047444412,0.00027067284,0.00039263623,0.00026864407],"domain_scores_gemma":[0.9982697,0.00050440815,0.00040144767,0.00069956743,0.00007020781,0.000054676497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044342875,0.00020790144,0.000862911,0.00003096741,0.00004516711,0.000009046619,0.00044410382,0.000079956204,0.00011012773],"category_scores_gemma":[0.00024081864,0.00009358583,0.00021041039,0.00015577044,0.00028768633,0.0000057480856,0.000108721266,0.00016324005,7.050156e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7832843,0.0002524099,0.00024734216,0.000039355884,0.00037413862,2.4059588e-7,0.0001370522,0.00002226198,0.0016542391,0.000008519354,0.00006456731,0.21391556],"study_design_scores_gemma":[0.95957106,0.006246856,0.00036828857,0.0002088279,0.00017277843,0.0000050149847,0.00008385073,0.00003957768,0.032005575,0.000026531392,0.0011130603,0.00015858942],"about_ca_topic_score_codex":0.00004262646,"about_ca_topic_score_gemma":0.000047718633,"teacher_disagreement_score":0.21375698,"about_ca_system_score_codex":0.000032326825,"about_ca_system_score_gemma":0.00021372338,"threshold_uncertainty_score":0.38163197},"labels":[],"label_agreement":null},{"id":"W2972178862","doi":"10.1016/j.breast.2019.09.001","title":"Does timing of alloplastic breast reconstruction in older women impact immediate postoperative complications? An analysis of the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) database","year":2019,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Women's College Hospital; Public Health Ontario; University of Toronto","funders":"","keywords":"Medicine; National database; General surgery; Breast reconstruction; Database; Surgery; Breast cancer; Internal medicine; Cancer","score_opus":0.01693794918358189,"score_gpt":0.3171130099093767,"score_spread":0.3001750607257948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972178862","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99466825,0.000004514484,0.000011208343,0.00059137034,0.00011174128,0.00078250916,0.0037586389,0.000013014076,0.000058776703],"genre_scores_gemma":[0.99950695,0.000004783392,0.00013222071,0.000014343893,0.000023812841,0.00004151918,0.00024210851,0.000009344091,0.000024908986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998225,0.00025770135,0.0006604309,0.00023822678,0.00040457046,0.00021407662],"domain_scores_gemma":[0.9982067,0.00026772823,0.00065011,0.00038870392,0.00040088777,0.00008589461],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007728926,0.00015469712,0.0006088601,0.00029280328,0.00005800149,0.0000059148883,0.00015370594,0.00004476955,0.00014442338],"category_scores_gemma":[0.00002025836,0.000073722425,0.0001774953,0.0011449434,0.000504088,0.00013391615,0.000058517002,0.00016522985,0.0000012111955],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012708186,0.0008468189,0.918101,0.00006842907,0.0008854342,9.656577e-7,0.0006717833,0.00020009572,0.013297514,0.00032709344,0.00000520474,0.064324856],"study_design_scores_gemma":[0.0011498575,0.00015242546,0.99052525,0.00009824843,0.00023059166,0.0024387941,0.0022823948,0.0023156975,0.00067561446,0.000035386925,0.0000018829578,0.00009384834],"about_ca_topic_score_codex":0.0016323639,"about_ca_topic_score_gemma":0.00043293546,"teacher_disagreement_score":0.07242427,"about_ca_system_score_codex":0.00018347744,"about_ca_system_score_gemma":0.00028584056,"threshold_uncertainty_score":0.3006313},"labels":[],"label_agreement":null},{"id":"W2973847581","doi":"10.1016/j.breast.2019.09.009","title":"A systematic review and meta-analysis of clinician-reported versus patient-reported outcomes of radiation dermatitis","year":2019,"lang":"en","type":"review","venue":"The Breast","topic":"Effects of Radiation Exposure","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre","funders":"Ofelia Cancer Research Fund; Michael and Karyn Goldstein Cancer Research Fund; Joseph and Silvana Melara Cancer Research Fund","keywords":"Medicine; Breast cancer; Dermatology; Meta-analysis; Adverse effect; Telangiectasia; Edema; Internal medicine; Cancer","score_opus":0.0900676372164974,"score_gpt":0.3830994691184503,"score_spread":0.29303183190195287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973847581","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000038853443,0.99355775,0.000006027909,0.000368514,0.00009825808,0.0054193838,0.00034088062,0.000025290514,0.00014505941],"genre_scores_gemma":[0.0010603829,0.9976231,0.00003143323,0.000294156,0.0000120552895,0.00024228284,0.0004786092,0.000042586602,0.00021539726],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99451584,0.000883304,0.0034513255,0.00033738432,0.00064939534,0.00016275205],"domain_scores_gemma":[0.9890531,0.0019487839,0.006929299,0.0016348509,0.00034666777,0.00008730476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012526948,0.00043440348,0.013139303,0.0004550186,0.000028808769,0.0000101197475,0.0001965055,0.00020974221,0.00017272512],"category_scores_gemma":[0.0018444929,0.0002252512,0.003568152,0.0011435413,0.00008189544,0.00006877903,0.000053197586,0.000234012,0.000018741724],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006580494,0.000053735475,0.00006838143,0.5965229,0.39365947,0.000007257925,0.00004676379,0.000001023455,4.706487e-8,0.000013976192,0.00015674799,0.009463114],"study_design_scores_gemma":[0.0004041757,0.00010162202,0.0008531306,0.023850078,0.9725797,0.00028490426,0.000013328119,0.000013119315,3.159245e-7,9.541992e-7,0.0017385533,0.00016011951],"about_ca_topic_score_codex":0.000073895906,"about_ca_topic_score_gemma":0.000009228822,"teacher_disagreement_score":0.57892025,"about_ca_system_score_codex":0.00006452385,"about_ca_system_score_gemma":0.00022826732,"threshold_uncertainty_score":0.91854775},"labels":[],"label_agreement":null},{"id":"W2979495041","doi":"10.1016/j.breast.2019.10.001","title":"The ethical, legal and social implications of using artificial intelligence systems in breast cancer care","year":2019,"lang":"en","type":"article","venue":"The Breast","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":301,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Health and Medical Research Council; UK Research and Innovation; University of Wollongong; Canadian Institute for Advanced Research; Centre National de la Recherche Scientifique; National Breast Cancer Foundation","keywords":"Deliberation; Confidentiality; Medicine; Health care; Government (linguistics); Informed consent; Engineering ethics; Public relations; Political science; Alternative medicine; Law","score_opus":0.1318606227581367,"score_gpt":0.4332914254438005,"score_spread":0.3014308026856638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979495041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9563333,0.0008157726,0.00013768657,0.041605104,0.00037302397,0.0005168182,0.00004194407,0.00001130936,0.0001650546],"genre_scores_gemma":[0.9992089,0.000085192965,0.000014713514,0.00025364582,0.00036863858,0.00003240875,0.0000041574667,0.000010300904,0.000021992026],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990335,0.000093366274,0.0003679267,0.00014984014,0.0001548631,0.00020052133],"domain_scores_gemma":[0.99915326,0.00020068606,0.00011022243,0.00022116659,0.0002740195,0.000040620023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037671495,0.000081692975,0.00016023777,0.00004207592,0.00029249224,0.00003855167,0.00011437746,0.00012348422,0.000024306646],"category_scores_gemma":[0.000018295805,0.000050051312,0.000036312016,0.00022472623,0.00025463104,0.000045067634,0.00003205681,0.00036267025,0.000012639854],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080658693,0.00018232715,0.17053747,0.0007522711,0.000060995662,0.0000018167891,0.030184938,0.00084888743,0.01667037,0.2321678,0.00018870378,0.5475978],"study_design_scores_gemma":[0.00014514738,0.00019837351,0.64522547,0.0015771447,0.0003007972,0.0017306429,0.3076725,0.02000303,0.0052789347,0.015400872,0.0018460816,0.00062099757],"about_ca_topic_score_codex":0.013965802,"about_ca_topic_score_gemma":0.00092356873,"teacher_disagreement_score":0.54697686,"about_ca_system_score_codex":0.00012661457,"about_ca_system_score_gemma":0.00036570386,"threshold_uncertainty_score":0.99260026},"labels":[],"label_agreement":null},{"id":"W2996716426","doi":"10.1016/s0960-9776(19)31116-6","title":"Identifying research priorities in the treatment of patients with early breast cancer: from the patient perspective","year":2019,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Perspective (graphical); Oncology; Cancer; Intensive care medicine; Internal medicine; Family medicine; Medical physics; Artificial intelligence","score_opus":0.01811634053481083,"score_gpt":0.29368160491009143,"score_spread":0.2755652643752806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996716426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941551,0.0019369278,0.0000010294283,0.0019748867,0.0000810361,0.00074097625,0.0007605082,0.0000041661183,0.00034537967],"genre_scores_gemma":[0.9991387,0.00033779084,0.000009206221,0.00006699557,0.00014590993,0.00018916295,0.00003497219,0.000017902865,0.000059365928],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986166,0.00026438656,0.00014539425,0.00029947245,0.00039558078,0.00027861926],"domain_scores_gemma":[0.9989163,0.00012779157,0.00008378221,0.0005845375,0.00026662493,0.000020907386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013876703,0.0001702903,0.00016324416,0.000026409607,0.00019402878,0.000037405123,0.00033791442,0.000042570653,0.00002699944],"category_scores_gemma":[0.000005423221,0.00007121781,0.000068530404,0.0001832842,0.0002944143,0.000007649906,0.000094044335,0.00010196007,0.000010223731],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012340507,0.00048641095,0.96895343,0.0000056200442,0.00035636083,0.000001552574,0.021666162,0.000012137255,0.00040680388,0.00017469321,0.00016362722,0.0065391334],"study_design_scores_gemma":[0.0012445647,0.00041595782,0.98386276,0.00005016109,0.00004697763,0.000007541205,0.013221051,9.896722e-7,0.0005345158,0.00012863563,0.00039730818,0.00008953783],"about_ca_topic_score_codex":0.020132063,"about_ca_topic_score_gemma":0.0027465604,"teacher_disagreement_score":0.017385503,"about_ca_system_score_codex":0.0001612854,"about_ca_system_score_gemma":0.00009093656,"threshold_uncertainty_score":0.986393},"labels":[],"label_agreement":null},{"id":"W3015700607","doi":"10.1016/j.breast.2020.04.002","title":"Changes in weight, physical and psychosocial patient-reported outcomes among obese women receiving treatment for early-stage breast cancer: A nationwide clinical study","year":2020,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; Institut Gustave-Roussy; European Society for Medical Oncology; Memorial Sloan-Kettering Cancer Center; Susan G. Komen; Agence Nationale de la Recherche","keywords":"Medicine; Weight loss; Weight change; Breast cancer; Quality of life (healthcare); Weight gain; Prospective cohort study; Internal medicine; Anthropometry; Psychosocial; Cancer; Exacerbation; Obesity; Physical therapy; Body weight","score_opus":0.04908684853192525,"score_gpt":0.36597876378364225,"score_spread":0.316891915251717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015700607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99063456,0.000028959432,0.000002646683,0.007356983,0.00015480426,0.0015083362,0.00022887907,0.000045752746,0.00003910377],"genre_scores_gemma":[0.9982343,0.00009877502,0.0000064791325,0.0003370886,0.00063242903,0.0005299435,0.00000776427,0.000028369324,0.00012485987],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987308,0.000079248886,0.00033065915,0.00035695158,0.00022318646,0.00027915815],"domain_scores_gemma":[0.9992194,0.00015662181,0.00017161455,0.00018763234,0.000060271508,0.00020443258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001762192,0.0001931434,0.00051973,0.000043416592,0.00009828734,0.000029227489,0.00007030438,0.000051827665,0.000039011895],"category_scores_gemma":[0.00004185496,0.00011841114,0.00009574784,0.00019580298,0.00009477074,0.00006151297,0.000041132895,0.00015645807,0.0000016532141],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011617139,0.00069354405,0.91735023,0.000016130438,0.00026492152,0.000014214322,0.020633297,0.0000011304201,0.000014921225,0.0000037775965,0.00006524892,0.05978085],"study_design_scores_gemma":[0.0054834546,0.001062737,0.9898329,0.00003952122,0.00013789906,0.0000093857025,0.0026981384,0.00017775716,0.000007645772,0.0000152333205,0.00041349343,0.000121859164],"about_ca_topic_score_codex":0.0037132553,"about_ca_topic_score_gemma":0.004950497,"teacher_disagreement_score":0.07248262,"about_ca_system_score_codex":0.00017494359,"about_ca_system_score_gemma":0.00008644883,"threshold_uncertainty_score":0.5613356},"labels":[],"label_agreement":null},{"id":"W3021990204","doi":"10.1016/j.breast.2020.04.011","title":"A multi-stakeholder approach in optimising patients’ needs in the benefit assessment process of new metastatic breast cancer treatments","year":2020,"lang":"en","type":"review","venue":"The Breast","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Breast Cancer Network","funders":"Eli Lilly and Company","keywords":"Metastatic breast cancer; Medicine; Quality of life (healthcare); Stakeholder; Disease; Breast cancer; Intensive care medicine; Cancer; Oncology; Internal medicine; Nursing; Political science","score_opus":0.15362467482816022,"score_gpt":0.3314302479767575,"score_spread":0.1778055731485973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021990204","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025147735,0.9885521,0.00025534665,0.0004479749,0.0001998196,0.002342943,0.0030560943,0.000014607971,0.0026163172],"genre_scores_gemma":[0.025762469,0.97202814,0.0006330794,0.00022849,0.00018899923,0.0005665142,0.00016492858,0.00011451823,0.0003128846],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9972793,0.00006411673,0.0015280847,0.00054196815,0.0000944676,0.0004920579],"domain_scores_gemma":[0.9978984,0.000082672545,0.001332296,0.00054571294,0.00003699676,0.00010393307],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005819924,0.0005415883,0.0022094967,0.00039570668,0.00007141337,0.00010734822,0.0009507754,0.00016033983,0.00011189543],"category_scores_gemma":[0.00001812984,0.0003657048,0.0003609776,0.0009946687,0.00008862666,0.00029084473,0.00009363127,0.0005267085,0.000029639958],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050941166,0.0012533875,0.016298568,0.0036552295,0.0005645173,0.000005541778,0.0050096787,0.0014059762,1.8836412e-8,0.0036702158,0.00015718077,0.96792877],"study_design_scores_gemma":[0.018453049,0.0005027079,0.5645841,0.019262832,0.002801368,0.0004735303,0.0037254887,0.008981726,3.7755137e-7,0.0059168804,0.37021393,0.0050840145],"about_ca_topic_score_codex":0.0028377369,"about_ca_topic_score_gemma":0.00013176008,"teacher_disagreement_score":0.9628447,"about_ca_system_score_codex":0.0006472367,"about_ca_system_score_gemma":0.0004260001,"threshold_uncertainty_score":0.9998795},"labels":[],"label_agreement":null},{"id":"W3033981055","doi":"10.1016/j.breast.2020.05.012","title":"Estimation of historical control rate for a single arm de-escalation study – Application to the POSITIVE trial","year":2020,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Canadian Cancer Society Research Institute; National Institutes of Health; Ipsen; Kræftfonden; National Institute for Health and Care Research; National Health and Medical Research Council; Cancer Research UK; University of South Alabama; AstraZeneca; National Cancer Research Institute; Universiteit Stellenbosch; American College of Radiology Imaging Network; ASCRS Research Foundation; Royal Marsden NHS Foundation Trust; Breast Cancer Research Foundation; Pfizer; Gateway for Cancer Research","keywords":"De-escalation; Estimation; Statistics; Mathematics; Economics; Medicine; Internal medicine; Management","score_opus":0.02506510687249958,"score_gpt":0.2931817826740381,"score_spread":0.26811667580153853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033981055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.68033814,0.000023129121,0.27920517,0.035413664,0.00009436194,0.0047326544,0.000051073665,0.000025786323,0.00011603721],"genre_scores_gemma":[0.99887276,2.7472532e-7,0.000052262356,0.00049270404,0.00035499464,0.00018577393,0.000011045935,0.0000071071954,0.000023107057],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99956,0.000048725447,0.0001394122,0.000090400004,0.00009608161,0.00006539617],"domain_scores_gemma":[0.99959344,0.00012106669,0.00007554804,0.00010664076,0.00005827592,0.00004503759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023267463,0.000049162467,0.0001252805,0.000012184288,0.000051794777,0.0000065588083,0.000048626574,0.00001789951,0.0000046204873],"category_scores_gemma":[0.000082708095,0.000027658487,0.000045860557,0.000100605874,0.000011013624,0.000017756496,0.000007375769,0.000045063385,0.000003962002],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2826158,0.004540926,0.0035812624,0.00007789749,0.00038826631,0.0000017707591,0.029831933,0.010680675,0.05125204,0.0008353968,0.0068416023,0.6093524],"study_design_scores_gemma":[0.14973679,0.030557208,0.3855327,0.000088608154,0.0025939264,0.000067450914,0.0025827133,0.41629782,0.0055522416,0.00079446175,0.00576224,0.0004338241],"about_ca_topic_score_codex":0.00023461663,"about_ca_topic_score_gemma":0.0000144670885,"teacher_disagreement_score":0.6089186,"about_ca_system_score_codex":0.00017458705,"about_ca_system_score_gemma":0.000034448887,"threshold_uncertainty_score":0.11278804},"labels":[],"label_agreement":null},{"id":"W3049246635","doi":"10.1016/j.breast.2020.08.002","title":"Four cycles of docetaxel and cyclophosphamide as adjuvant chemotherapy in node negative breast cancer: A real-world study","year":2020,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Breast cancer; Hazard ratio; Docetaxel; Oncology; Internal medicine; Cyclophosphamide; Proportional hazards model; Cancer; Population; Chemotherapy; Confidence interval; Gynecology","score_opus":0.013330600194873513,"score_gpt":0.273761792519244,"score_spread":0.26043119232437045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049246635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98866343,0.00087362825,0.000004436226,0.009024252,0.000036004665,0.00046085418,0.00026306396,0.000015394704,0.000658944],"genre_scores_gemma":[0.997576,0.0012359956,0.000051631232,0.0007501132,0.0001738426,0.00009895243,0.000008841408,0.000031438773,0.0000732153],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886256,0.000086440996,0.00024707703,0.0004020804,0.00015841691,0.00024342295],"domain_scores_gemma":[0.9994012,0.00003186738,0.00013953657,0.00027616203,0.00006898982,0.00008220514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000099730045,0.00024559803,0.00034607764,0.000031782656,0.00007754628,0.000013468114,0.00021692309,0.000044223372,0.000030247264],"category_scores_gemma":[0.000013144241,0.00017522252,0.00006361652,0.00023262377,0.00019206981,0.000006463144,0.0001757597,0.000098933575,0.0000037420923],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002855097,0.00048003034,0.9579196,0.00004325887,0.0006265235,0.000021026022,0.0046257223,0.000097499586,0.010200778,0.000053974058,0.00045778402,0.02261869],"study_design_scores_gemma":[0.0030730695,0.00013637882,0.98954153,0.00004376121,0.00006890477,0.00006699334,0.0014946093,0.00002278982,0.005173775,0.00008972337,0.000105115796,0.00018334693],"about_ca_topic_score_codex":0.011042543,"about_ca_topic_score_gemma":0.004569865,"teacher_disagreement_score":0.031621918,"about_ca_system_score_codex":0.00003446718,"about_ca_system_score_gemma":0.000081522405,"threshold_uncertainty_score":0.995543},"labels":[],"label_agreement":null},{"id":"W3081095386","doi":"10.1016/j.breast.2020.07.007","title":"A case-control study of the joint effect of reproductive factors and radiation treatment for first breast cancer and risk of contralateral breast cancer in the WECARE study","year":2020,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Lunenfeld-Tanenbaum Research Institute; Public Health Ontario; University of Toronto","funders":"National Institute of Environmental Health Sciences; National Cancer Institute","keywords":"Breast cancer; Medicine; Oncology; Case-control study; Cancer; Internal medicine; Gynecology; Radiation therapy; Obstetrics","score_opus":0.01776318632635906,"score_gpt":0.2798722651584156,"score_spread":0.2621090788320566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081095386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98724115,0.0005703945,0.0000011922571,0.0023026934,0.00007174551,0.005147655,0.0046567,0.000006281763,0.000002216195],"genre_scores_gemma":[0.99936354,0.00013757891,3.0114688e-7,0.000023093944,0.00014841935,0.00030270137,0.000002313298,0.00001761276,0.000004443172],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986537,0.0003033518,0.0003586906,0.00031231623,0.00020986567,0.00016208451],"domain_scores_gemma":[0.99887145,0.00027573796,0.00033862036,0.00035925562,0.00009985896,0.00005510587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037039418,0.00022254254,0.00064982247,0.000038915303,0.00011441555,0.000010623229,0.00008730463,0.000036853708,0.000019986428],"category_scores_gemma":[0.000033502278,0.00008993385,0.00011466527,0.00019061446,0.00014111478,0.0000489717,0.000031818818,0.0001317785,4.3120664e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00389111,0.00043451015,0.926222,0.00009762334,0.0008065015,0.000007706854,0.05158953,0.00014279342,0.00020119757,0.0000010423988,0.000014248949,0.016591687],"study_design_scores_gemma":[0.011487799,0.0023001013,0.97029734,0.00008055119,0.0018774205,0.00028695862,0.013024237,0.00026367512,0.00029891296,0.0000018545386,0.0000030532344,0.0000780932],"about_ca_topic_score_codex":0.06471996,"about_ca_topic_score_gemma":0.011499701,"teacher_disagreement_score":0.053220257,"about_ca_system_score_codex":0.00010570459,"about_ca_system_score_gemma":0.000060441413,"threshold_uncertainty_score":0.9415082},"labels":[],"label_agreement":null},{"id":"W3082907133","doi":"10.1016/j.breast.2020.08.013","title":"The impact on clinical outcomes of post-operative radiation therapy delay after neoadjuvant chemotherapy in patients with breast cancer: A multicentric international study","year":2020,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Breast cancer; Radiation therapy; Chemotherapy; Stage (stratigraphy); Internal medicine; Surgery; Neoadjuvant therapy; Cancer; Oncology","score_opus":0.008989130148440565,"score_gpt":0.314509113048479,"score_spread":0.30551998290003846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082907133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929147,0.00021155005,0.0000036388226,0.0057161725,0.00008436574,0.00067470624,0.0003728441,0.0000056427166,0.00001638797],"genre_scores_gemma":[0.99842185,0.0003294215,0.000005752109,0.00092602294,0.00014359575,0.000106753636,0.000037712245,0.00002017539,0.000008699429],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989223,0.00016043619,0.00026543,0.00026546128,0.00021707865,0.00016929867],"domain_scores_gemma":[0.99931955,0.00006725836,0.00015100863,0.00023276765,0.0001812295,0.00004815493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013128611,0.00020060489,0.00021848697,0.000020724985,0.00007184124,0.000021544754,0.00024073783,0.000041176063,0.000027775495],"category_scores_gemma":[0.000018109058,0.00008628351,0.00010385021,0.00010685156,0.000106091684,0.000008033044,0.000054829397,0.00010361072,0.0000033345434],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013878388,0.0009297475,0.9368819,6.584757e-7,0.0009046354,0.0000013263199,0.0010309169,0.00013256987,0.00003262857,0.0000011029107,0.00005932874,0.046146806],"study_design_scores_gemma":[0.0072517027,0.0010709917,0.99108505,0.000007586947,0.000024083605,0.000002915364,0.0002861834,0.00003945104,0.00007650882,8.8775715e-7,0.0000527577,0.000101854144],"about_ca_topic_score_codex":0.00048794903,"about_ca_topic_score_gemma":0.00015631417,"teacher_disagreement_score":0.054203182,"about_ca_system_score_codex":0.000052609495,"about_ca_system_score_gemma":0.00007131448,"threshold_uncertainty_score":0.35185394},"labels":[],"label_agreement":null},{"id":"W3093752709","doi":"10.1016/j.breast.2020.10.003","title":"Do all patients with HER2 positive breast cancer require one year of adjuvant trastuzumab? A systematic review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"The Breast","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; University of Toronto; Mount Sinai Hospital; Western University","funders":"Janssen Canada; Novartis; Bayer","keywords":"Trastuzumab; Medicine; Breast cancer; Meta-analysis; Internal medicine; Adjuvant; Oncology; Adjuvant therapy; Randomized controlled trial; Subgroup analysis; Cancer; Surgery","score_opus":0.10818742444388223,"score_gpt":0.39569247456465007,"score_spread":0.2875050501207678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093752709","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000026211733,0.98462677,0.0000065875215,0.0022129584,0.00001225161,0.0066937874,0.0061543817,0.00002480583,0.00026585461],"genre_scores_gemma":[0.00047206573,0.99705666,0.000037665563,0.00045453876,0.000063598,0.0010846881,0.0002333526,0.000116249284,0.00048120055],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99524957,0.0010432113,0.001157336,0.00072071195,0.0013984119,0.00043075136],"domain_scores_gemma":[0.9965836,0.0002552372,0.0010116047,0.0012702863,0.0005378336,0.00034145656],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00096005236,0.00065174414,0.011201581,0.00021675233,0.000060164763,0.000039729537,0.00052144384,0.00015939037,0.0013093026],"category_scores_gemma":[0.00006844008,0.00030678965,0.0016557885,0.0015572887,0.00026464995,0.00007869028,0.00019880965,0.00067550485,0.000053010008],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000067858186,0.00015503452,0.00002449297,0.7654708,0.21859147,0.00002236534,0.00017604318,1.3842838e-7,4.9529206e-8,0.000017376351,0.00022912057,0.015245241],"study_design_scores_gemma":[0.00031947342,0.00018703249,0.00022622007,0.16463861,0.8278189,0.00029838475,0.00002889583,9.4629354e-7,9.89171e-8,0.0000015546419,0.0062096063,0.00027029266],"about_ca_topic_score_codex":0.00045568298,"about_ca_topic_score_gemma":0.00006285952,"teacher_disagreement_score":0.6092274,"about_ca_system_score_codex":0.00040833463,"about_ca_system_score_gemma":0.0006765826,"threshold_uncertainty_score":0.9999384},"labels":[],"label_agreement":null},{"id":"W3093770202","doi":"10.1016/j.breast.2020.10.005","title":"Eligibility of real-world patients with metastatic breast cancer for clinical trials","year":2020,"lang":"en","type":"article","venue":"The Breast","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Metastatic breast cancer; Medicine; Oncology; Breast cancer; Clinical trial; Internal medicine; Cancer","score_opus":0.1608991240040951,"score_gpt":0.4737175903520319,"score_spread":0.31281846634793686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093770202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95235246,0.0005228962,0.0032722685,0.033426717,0.00031024136,0.004820675,0.004702808,0.00015947525,0.0004324372],"genre_scores_gemma":[0.995958,0.00006604001,0.0015011713,0.001587766,0.0005184594,0.00016345862,0.00004840152,0.00005102179,0.000105698986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99763566,0.00035950224,0.00096350285,0.00038583737,0.00037482646,0.00028068846],"domain_scores_gemma":[0.9972525,0.0009839858,0.00058477494,0.00049019494,0.00045677138,0.00023175516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014998545,0.0002249035,0.0011411437,0.000037577316,0.000063291336,0.000009155899,0.00020167851,0.000037649374,0.00025939223],"category_scores_gemma":[0.00030366605,0.000119573655,0.00028836486,0.0003322924,0.00033523043,0.00008985563,0.000046595087,0.00019922423,0.0000075751113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049559716,0.0009113979,0.6518237,0.0005597077,0.0016182458,0.0000032417718,0.0006738239,0.00006354742,0.0003401686,0.00046195628,0.001513782,0.29247072],"study_design_scores_gemma":[0.01177122,0.00054105074,0.9829289,0.0002197769,0.0010613695,0.00002854624,0.00014019683,0.00013681673,0.00025654255,0.00039194667,0.0023360394,0.0001876001],"about_ca_topic_score_codex":0.00028435566,"about_ca_topic_score_gemma":0.00010324022,"teacher_disagreement_score":0.3311052,"about_ca_system_score_codex":0.00007507264,"about_ca_system_score_gemma":0.00027398468,"threshold_uncertainty_score":0.4876072},"labels":[],"label_agreement":null},{"id":"W3101785640","doi":"10.1016/j.breast.2020.11.002","title":"A randomized trial of individualized versus standard of care antiemetic therapy for breast cancer patients at high risk for chemotherapy-induced nausea and vomiting","year":2020,"lang":"en","type":"article","venue":"The Breast","topic":"Nausea and vomiting management","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Regional Municipality of Durham; Kingston General Hospital; University of Ottawa; Markham Stouffville Hospital; Ottawa Hospital","funders":"Canadian Cancer Society","keywords":"Medicine; Antiemetic; Nausea; Vomiting; Chemotherapy-induced nausea and vomiting; Chemotherapy; Breast cancer; Randomized controlled trial; Oncology; Cancer; Internal medicine","score_opus":0.02788678472772144,"score_gpt":0.3059523390972795,"score_spread":0.27806555436955804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3101785640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889114,0.00022066176,0.00010155267,0.0022089027,0.00019814592,0.006223687,0.0020553092,0.00002785321,0.00005251135],"genre_scores_gemma":[0.99842024,0.00028975384,0.00038518585,0.00019379155,0.0002945588,0.0003040836,0.00006046653,0.00003825862,0.000013648785],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9985441,0.00014891132,0.00048659247,0.00025724916,0.00033435572,0.00022876589],"domain_scores_gemma":[0.9981697,0.0006812771,0.00052420585,0.00020176568,0.00033723176,0.00008580747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006183177,0.00019745925,0.0009753762,0.000056177665,0.00012006671,0.000013677499,0.00012560721,0.00006616943,0.00003907941],"category_scores_gemma":[0.00021474436,0.00012602788,0.00027837235,0.00013274803,0.00012060395,0.000032423668,0.000055162825,0.00008066504,2.3885394e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9495885,0.00010690549,0.0023149028,0.0003806049,0.0009299799,1.8481377e-7,0.0021443935,0.0000013949673,0.0005083785,0.00007667343,0.0001537383,0.04379436],"study_design_scores_gemma":[0.9829945,0.003215252,0.005789803,0.0001450028,0.0009373206,0.0000012542869,0.00036516617,0.00010170026,0.0060243807,0.000051298706,0.00024317851,0.00013115072],"about_ca_topic_score_codex":0.00015265976,"about_ca_topic_score_gemma":0.000013365024,"teacher_disagreement_score":0.04366321,"about_ca_system_score_codex":0.00005722282,"about_ca_system_score_gemma":0.00007518184,"threshold_uncertainty_score":0.51392674},"labels":[],"label_agreement":null},{"id":"W3102261601","doi":"10.1016/j.breast.2020.11.009","title":"Older women’s experience with breast cancer treatment: A systematic review of qualitative literature","year":2020,"lang":"en","type":"review","venue":"The Breast","topic":"Cancer survivorship and care","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Ottawa; University of Toronto","funders":"","keywords":"CINAHL; PsycINFO; Medicine; Breast cancer; MEDLINE; Systematic review; Qualitative research; Health care; Cochrane Library; Family medicine; Coping (psychology); Alternative medicine; Clinical psychology; Nursing; Cancer; Psychological intervention; Internal medicine; Pathology","score_opus":0.0411928876502815,"score_gpt":0.3847233339232084,"score_spread":0.3435304462729269,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3102261601","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000008824974,0.99326795,0.0000031484458,0.000807453,0.000104636914,0.0035146778,0.0019834212,0.000040738716,0.0002691558],"genre_scores_gemma":[0.0002612377,0.99199575,0.0000040018017,0.0006058885,0.00022247146,0.0055535375,0.00012356888,0.00007489438,0.0011586294],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9971881,0.00074445526,0.00078674796,0.00045274,0.00051183446,0.0003161598],"domain_scores_gemma":[0.9976617,0.00020486173,0.00073799054,0.0008876235,0.0002958273,0.00021201665],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031903767,0.0006178155,0.004324117,0.00007203661,0.000055988843,0.000030213674,0.0003121331,0.00013382339,0.00039441325],"category_scores_gemma":[0.000028466304,0.00026111392,0.00057228503,0.00096543954,0.00017828954,0.00006377521,0.00004621876,0.00032199486,0.000026863394],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006488057,0.000058395926,9.430024e-7,0.85611486,0.00086400367,0.000049447113,0.08898744,4.677824e-9,4.232964e-8,0.000043595057,0.00010204894,0.053714313],"study_design_scores_gemma":[0.00031071724,0.00015418249,0.0000032856217,0.92862433,0.0051782164,0.004096714,0.008067416,2.1545772e-7,1.5805408e-7,0.0000015328762,0.053308506,0.00025470307],"about_ca_topic_score_codex":0.0003037008,"about_ca_topic_score_gemma":0.000053316682,"teacher_disagreement_score":0.080920026,"about_ca_system_score_codex":0.0007209587,"about_ca_system_score_gemma":0.0007116743,"threshold_uncertainty_score":0.9999841},"labels":[],"label_agreement":null},{"id":"W3111250988","doi":"10.1016/j.breast.2020.11.023","title":"A systematic review and meta-analysis on the effect of neoadjuvant chemotherapy on complications following immediate breast reconstruction","year":2020,"lang":"en","type":"review","venue":"The Breast","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Queen Mary University of London","keywords":"Medicine; Chemotherapy; Oncology; Meta-analysis; Breast reconstruction; Neoadjuvant therapy; Breast cancer; Internal medicine; General surgery; Cancer","score_opus":0.0379412719852355,"score_gpt":0.3109041916159927,"score_spread":0.2729629196307572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111250988","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004520462,0.98871714,0.000012450343,0.0052784244,0.000099839184,0.005129074,0.00044254,0.0000469685,0.00022836514],"genre_scores_gemma":[0.0010343983,0.9974117,0.000016601145,0.00038868806,0.00011596709,0.00072134513,0.00014064263,0.000059215137,0.00011141131],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9967629,0.00110332,0.0011046901,0.0004491225,0.00037014368,0.00020984346],"domain_scores_gemma":[0.99653065,0.0011620068,0.0011484756,0.0009807746,0.000058887657,0.000119184755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011639979,0.00057690195,0.0070954966,0.00022309119,0.00018225863,0.00003157,0.00028019352,0.00016515472,0.00011155877],"category_scores_gemma":[0.00004775503,0.00021897214,0.003787949,0.0009713559,0.0001633384,0.00003517566,0.000036378795,0.0005523247,0.00007069686],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005909153,0.000033387758,0.0000038677395,0.37145892,0.20074257,0.0000056755503,0.000035069672,2.4576366e-7,6.603855e-7,0.000114890136,0.00008358674,0.42746204],"study_design_scores_gemma":[0.00027970894,0.00012931737,0.000030582163,0.067131996,0.8668547,0.06480945,0.000015610272,0.000012237153,0.0000014148546,0.00000869447,0.0005287618,0.00019753196],"about_ca_topic_score_codex":0.00002377474,"about_ca_topic_score_gemma":0.0000021113287,"teacher_disagreement_score":0.6661121,"about_ca_system_score_codex":0.000071161936,"about_ca_system_score_gemma":0.00006852657,"threshold_uncertainty_score":0.8929425},"labels":[],"label_agreement":null},{"id":"W3130416374","doi":"10.1016/j.breast.2021.02.009","title":"Risk of recurrence among patients with HR-positive, HER2-negative, early breast cancer receiving adjuvant endocrine therapy: A systematic review and meta-analysis","year":2021,"lang":"en","type":"review","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"Pfizer","keywords":"Medicine; Meta-analysis; Breast cancer; Internal medicine; Oncology; Subgroup analysis; Adjuvant therapy; Population; Randomized controlled trial; MEDLINE; Cancer","score_opus":0.019520902889589277,"score_gpt":0.2870374293321055,"score_spread":0.2675165264425162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130416374","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00049859326,0.99026054,0.000011594697,0.000092220434,0.00002385932,0.0022664585,0.0068059317,0.000009267576,0.00003156211],"genre_scores_gemma":[0.0063447542,0.9915749,0.000046947483,0.000061239305,0.00003577757,0.0014043453,0.00033332364,0.00006360655,0.0001351021],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99631906,0.0013244775,0.00082790916,0.00082101335,0.0003709978,0.00033654695],"domain_scores_gemma":[0.99643594,0.00019394263,0.0016231503,0.0010693684,0.00058459694,0.000092978844],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035359565,0.00078204094,0.0055604675,0.00008962409,0.00016619707,0.000040595056,0.00042132914,0.000113307215,0.000085517604],"category_scores_gemma":[0.000064746615,0.0003835436,0.0014550489,0.0007776348,0.000325272,0.000012192237,0.0002745398,0.0002529563,0.0000019133126],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009699307,0.00037068594,0.0120928185,0.21933945,0.7262739,0.000009101415,0.00021019092,0.0000031844688,3.1685394e-7,0.0000041222506,0.00011077133,0.04148849],"study_design_scores_gemma":[0.00043183178,0.0000970301,0.050082583,0.048457455,0.89977294,0.00013600041,0.000020868569,2.786901e-7,0.0000053011,0.000002031596,0.00042194745,0.000571724],"about_ca_topic_score_codex":0.0018379432,"about_ca_topic_score_gemma":0.0005142744,"teacher_disagreement_score":0.17349906,"about_ca_system_score_codex":0.000057941947,"about_ca_system_score_gemma":0.00014042576,"threshold_uncertainty_score":0.99986166},"labels":[],"label_agreement":null},{"id":"W3135009976","doi":"10.1016/j.breast.2021.02.013","title":"Should oncoplastic breast conserving surgery be used for the treatment of early stage breast cancer? Using the GRADE approach for development of clinical recommendations","year":2021,"lang":"en","type":"review","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"National Cancer Institute","keywords":"Stage (stratigraphy); Medicine; Oncoplastic Surgery; Breast cancer; Breast-conserving surgery; Cancer; General surgery; Oncology; Breast surgery; Internal medicine; Mastectomy; Biology","score_opus":0.3377252705418814,"score_gpt":0.45660589737202406,"score_spread":0.11888062683014267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135009976","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002644352,0.9666904,0.0059605944,0.0019315094,0.00079606625,0.0040562088,0.017889692,0.000018417508,0.000012719179],"genre_scores_gemma":[0.0063250265,0.9841504,0.0028271894,0.00008259558,0.0010080166,0.0031933903,0.0020712737,0.00015523055,0.00018686113],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968044,0.00042536037,0.001421016,0.0006400531,0.0002554595,0.00045371387],"domain_scores_gemma":[0.99491036,0.0024647778,0.0012643165,0.0009469887,0.00033563434,0.00007789925],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00091716147,0.00061280164,0.0018706894,0.00005835748,0.0005823199,0.00004087708,0.0005533667,0.00027858515,0.000017524373],"category_scores_gemma":[0.000053984717,0.00030366905,0.0013809673,0.00025915285,0.00042090582,0.000006769539,0.00020391749,0.00015748458,2.8384434e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042502355,0.0013385846,0.0017982653,0.0032964952,0.009445902,9.59081e-7,0.0006557911,0.00007638236,0.00002799881,0.000066472836,0.0010463911,0.9818217],"study_design_scores_gemma":[0.0029405474,0.00026050053,0.0046260417,0.005407323,0.011633451,0.0009409067,0.0017329762,0.00026168246,0.00024003409,0.000006538885,0.9708297,0.0011202496],"about_ca_topic_score_codex":0.00056479225,"about_ca_topic_score_gemma":0.0004342664,"teacher_disagreement_score":0.9807015,"about_ca_system_score_codex":0.00018909336,"about_ca_system_score_gemma":0.00216005,"threshold_uncertainty_score":0.9999415},"labels":[],"label_agreement":null},{"id":"W3138361250","doi":"10.1016/s0960-9776(21)00144-2","title":"Efficacy of fulvestrant in hormone refractory metastatic breast cancer (mBC): a Canadian province experience","year":2021,"lang":"en","type":"article","venue":"The Breast","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Fulvestrant; Metastatic breast cancer; Oncology; Refractory (planetary science); Cancer; Internal medicine; Breast cancer; Gynecology; Tamoxifen","score_opus":0.0176664327392084,"score_gpt":0.2939968056899863,"score_spread":0.2763303729507779,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3138361250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98643327,0.0054211295,0.000070059694,0.0065250937,0.00011017128,0.000515768,0.00034213345,0.00003532127,0.00054704107],"genre_scores_gemma":[0.9982232,0.00018789244,0.00038180395,0.0005337117,0.00011169816,0.00008611904,0.000016537253,0.00003864852,0.0004204027],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99834424,0.00009446828,0.0003752439,0.00035148655,0.00033939848,0.0004951887],"domain_scores_gemma":[0.9987017,0.0000914914,0.00013102741,0.00062844175,0.00017609587,0.0002712486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015899095,0.00022376893,0.00042724752,0.000122979,0.00007500495,0.000014133841,0.0002260408,0.000049401715,0.0003815976],"category_scores_gemma":[0.000037995054,0.00016387603,0.0000909529,0.00054190756,0.00032180749,0.00015485109,0.000043217657,0.00030045625,0.000013334801],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067092776,0.0021297422,0.033244006,0.00052713254,0.0007399711,0.0026317767,0.021942923,0.00065888715,0.32717088,0.001322841,0.00031334095,0.6026092],"study_design_scores_gemma":[0.0039809337,0.000095815,0.97899956,0.0005601799,0.0001282493,0.00535712,0.0027642772,0.00008986685,0.0040344656,0.00011134636,0.0035816515,0.00029655948],"about_ca_topic_score_codex":0.077710874,"about_ca_topic_score_gemma":0.08190364,"teacher_disagreement_score":0.94575554,"about_ca_system_score_codex":0.00048624675,"about_ca_system_score_gemma":0.002208141,"threshold_uncertainty_score":0.9348492},"labels":[],"label_agreement":null},{"id":"W3138903897","doi":"10.1016/s0960-9776(21)00240-x","title":"Reproductive outcomes in young breast cancer survivors treated (15–39) in Ontario, Canada: a population-based study","year":2021,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Demography; Gynecology; Oncology; Population; Cancer; Gerontology; Obstetrics; Internal medicine; Environmental health","score_opus":0.017200923387374643,"score_gpt":0.2696917564832178,"score_spread":0.25249083309584314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3138903897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99240434,0.000054003584,4.292356e-7,0.0063081793,0.00027177433,0.00057224184,0.00015454719,0.000020092975,0.00021440886],"genre_scores_gemma":[0.99820197,0.0000017489191,0.000002985065,0.00026660654,0.00006721343,0.00007760947,0.000074360374,0.00002320974,0.0012843286],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853206,0.0001126756,0.00032541706,0.00041874786,0.00033204866,0.0002790281],"domain_scores_gemma":[0.99913275,0.00005565859,0.00007968471,0.0005187795,0.0001355018,0.00007762762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020143049,0.0001908306,0.00044310573,0.000092161434,0.00006038312,0.000015966772,0.00008815478,0.000042506766,0.0006794279],"category_scores_gemma":[0.00003156045,0.00013260337,0.000051952033,0.0005823996,0.000018530081,0.000047969042,0.00003078184,0.00031174798,0.0000020256293],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035414225,0.00041588244,0.99618644,0.000008077224,0.00007480036,0.00013821296,0.0016056781,0.00033273705,0.00003285547,0.0000031458364,0.00006076961,0.0007872384],"study_design_scores_gemma":[0.0019363886,0.00002381042,0.99582946,0.00007085997,0.00007415086,0.00008708657,0.0017235044,0.000051743966,0.000023584867,0.00000540896,0.00003125668,0.00014275053],"about_ca_topic_score_codex":0.9998954,"about_ca_topic_score_gemma":0.9999929,"teacher_disagreement_score":0.006041573,"about_ca_system_score_codex":0.0022228311,"about_ca_system_score_gemma":0.0021489128,"threshold_uncertainty_score":0.74392587},"labels":[],"label_agreement":null},{"id":"W3149251690","doi":"10.1016/j.breast.2021.03.011","title":"Anticancer effects of radiation therapy combined with Polo-Like Kinase 4 (PLK4) inhibitor CFI-400945 in triple negative breast cancer","year":2021,"lang":"en","type":"article","venue":"The Breast","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; St Joseph's Health Care; University of Toronto; London Health Sciences Centre; Western University","funders":"Terry Fox Research Institute; Ontario Institute for Cancer Research; Stand Up To Cancer Canada","keywords":"Medicine; Triple-negative breast cancer; Radiation therapy; In vivo; Breast cancer; Cancer; Cancer research; Oncology; Kinase; Ex vivo; Clinical endpoint; Internal medicine; Clinical trial","score_opus":0.003520738151201363,"score_gpt":0.2200889338834454,"score_spread":0.21656819573224403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3149251690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969767,0.001494596,0.00007528181,0.0006832735,0.00017042866,0.00035626595,0.00015874085,0.0000065665217,0.00007820219],"genre_scores_gemma":[0.9974913,0.00143328,0.000038326878,0.00044757436,0.00016426765,0.000061497616,0.000097688324,0.000023643795,0.00024239413],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99912995,0.00012537788,0.00016653936,0.0002550942,0.0001148839,0.00020816071],"domain_scores_gemma":[0.9993877,0.000028514318,0.000105933614,0.0003142018,0.00011886464,0.000044815344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008741708,0.00015864837,0.00019890006,0.00003092697,0.00004945543,0.00001463103,0.00013354901,0.000093376955,0.000026564909],"category_scores_gemma":[0.000012638563,0.000110050765,0.00005689854,0.00023451525,0.00011381522,0.0000063926727,0.00005084787,0.000099295474,0.000001618728],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016075028,0.00031730955,0.013770396,0.000052747953,0.00015302382,0.000011860099,0.0003244577,0.000056063196,0.958324,0.00006425202,0.0007902205,0.024528138],"study_design_scores_gemma":[0.0043375464,0.00028219068,0.1496191,0.00010499311,0.000035059536,0.000076151,0.00012916625,0.00007340738,0.84462357,0.000031795415,0.00048495288,0.0002020558],"about_ca_topic_score_codex":0.0004827891,"about_ca_topic_score_gemma":0.00074281375,"teacher_disagreement_score":0.13584872,"about_ca_system_score_codex":0.000030802305,"about_ca_system_score_gemma":0.00021228754,"threshold_uncertainty_score":0.44877398},"labels":[],"label_agreement":null},{"id":"W3149636610","doi":"10.1016/j.breast.2021.03.012","title":"A multi-centre study comparing granulocyte-colony stimulating factors to antibiotics for primary prophylaxis of docetaxel-cyclophosphamide induced febrile neutropenia","year":2021,"lang":"en","type":"article","venue":"The Breast","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; University of Alberta; Ottawa Hospital; Northeast Cancer Centre; University of Ottawa","funders":"Canadian Institutes of Health Research; Ottawa Hospital; Cancer Care Ontario","keywords":"Medicine; Febrile neutropenia; Internal medicine; Docetaxel; Clinical endpoint; Neutropenia; Ciprofloxacin; Chemotherapy; Granulocyte colony-stimulating factor; Cyclophosphamide; Antibiotics; Randomized controlled trial","score_opus":0.0433929551540049,"score_gpt":0.3064668189717604,"score_spread":0.26307386381775555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3149636610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99647963,0.00005597906,0.00014488924,0.00034748027,0.00028703082,0.002323569,0.00005511233,0.000062617284,0.00024371046],"genre_scores_gemma":[0.9983708,0.0000029551622,0.0008550752,0.00014225736,0.00011935628,0.00001517498,0.00003037759,0.000044526456,0.00041945954],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985306,0.00008646545,0.0004114391,0.00036564854,0.00026962484,0.00033616746],"domain_scores_gemma":[0.99870104,0.0001332684,0.00014370543,0.0005181652,0.0003504622,0.00015337077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018149102,0.00022390424,0.0005904434,0.00006711516,0.0002471315,0.00004007603,0.00016349355,0.00005680974,0.00004355953],"category_scores_gemma":[0.00007952478,0.00016161428,0.00015785347,0.0004572842,0.00004509566,0.00006583636,0.00016854364,0.00024169624,0.000012819144],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005352784,0.0013568861,0.84366024,0.0001828866,0.00020257971,0.000020904481,0.0021148617,0.00043591004,0.14959635,0.000016535843,0.000078753,0.0017988433],"study_design_scores_gemma":[0.0040060375,0.0005431958,0.96625686,0.00015703114,0.00028801113,0.0000822442,0.0013959148,0.0001517009,0.026777126,0.000002594687,0.00016104591,0.00017821524],"about_ca_topic_score_codex":0.0005964822,"about_ca_topic_score_gemma":0.00031838912,"teacher_disagreement_score":0.12281922,"about_ca_system_score_codex":0.0001372875,"about_ca_system_score_gemma":0.00022239896,"threshold_uncertainty_score":0.65904397},"labels":[],"label_agreement":null},{"id":"W3154821758","doi":"10.1016/j.breast.2021.04.005","title":"Neurocognitive outcomes following fetal exposure to chemotherapy for gestational breast cancer: A Canadian multi-center cohort study","year":2021,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"North York General Hospital; Mount Sinai Hospital; Princess Margaret Cancer Centre; Queen's University; Hospital for Sick Children; Juravinski Cancer Centre; Sunnybrook Health Science Centre; Sinai Health System; Hamilton Health Sciences; SickKids Foundation; University of Toronto; Health Sciences Centre","funders":"Canadian Cancer Society","keywords":"Medicine; Pediatrics; Neurocognitive; Cohort; Context (archaeology); Pregnancy; Prospective cohort study; Pediatric cancer; Gestational age; Cohort study; Cancer; Cognition; Internal medicine; Psychiatry","score_opus":0.02033280582521499,"score_gpt":0.3154858419035457,"score_spread":0.29515303607833077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3154821758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98067266,0.000043340566,0.00011039059,0.015345255,0.00035907343,0.0017115201,0.0016045413,0.000027899845,0.00012529743],"genre_scores_gemma":[0.9934635,0.0000066849234,0.00009711973,0.004711527,0.00018116165,0.0003650958,0.00009016317,0.000040699448,0.0010440253],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989173,0.00003447796,0.00017980342,0.00030706445,0.00024235196,0.00031899416],"domain_scores_gemma":[0.99919975,0.00005707821,0.00003773642,0.0002222563,0.0002075777,0.0002756309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012351335,0.00017373597,0.00029565077,0.00006348855,0.00018053538,0.00004056928,0.00009001749,0.00003568041,0.00021624658],"category_scores_gemma":[0.000021460595,0.0001227335,0.00018243429,0.00016397036,0.000022269156,0.000050253428,0.000022091808,0.00012387829,0.000013375797],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017606503,0.0003778249,0.98151416,0.000007727559,0.00045043416,0.000055318927,0.0014708426,0.000006453949,0.0000981846,0.00000405678,0.00048905495,0.0153498845],"study_design_scores_gemma":[0.0054050293,0.00009672703,0.9913309,0.000040896524,0.0001804375,0.00019436507,0.001447917,0.000039588973,0.000024083429,0.0000027698793,0.0011017262,0.00013555563],"about_ca_topic_score_codex":0.061426118,"about_ca_topic_score_gemma":0.18225655,"teacher_disagreement_score":0.120830424,"about_ca_system_score_codex":0.00020580413,"about_ca_system_score_gemma":0.0005357462,"threshold_uncertainty_score":0.9448239},"labels":[],"label_agreement":null},{"id":"W3160352463","doi":"10.1016/j.breast.2021.04.011","title":"Towards population-based genetic screenings for breast and ovarian cancer: A comprehensive review from economic evaluations to patient perspectives","year":2021,"lang":"en","type":"review","venue":"The Breast","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Optech (Canada)","funders":"","keywords":"Ovarian cancer; Breast cancer; Medicine; Population; Genetic testing; Oncology; Gynecology; Cancer; Internal medicine; Environmental health","score_opus":0.03194031188855451,"score_gpt":0.35859860630793416,"score_spread":0.32665829441937966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160352463","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002992374,0.98471266,0.0007301372,0.0015989736,0.00017905956,0.002070948,0.010374363,0.000010633368,0.000024016632],"genre_scores_gemma":[0.0005748946,0.9891927,0.0038245388,0.0006480285,0.0005605803,0.0018467944,0.0032441297,0.000073928524,0.000034365978],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99827063,0.00022183343,0.0004533418,0.00070289645,0.00013610764,0.00021518386],"domain_scores_gemma":[0.99855196,0.000072402334,0.0003114126,0.00065822294,0.0003042976,0.00010169671],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011618014,0.0003578482,0.0007629268,0.00005712952,0.00018706587,0.00005988734,0.00027943455,0.00015197588,0.00016236246],"category_scores_gemma":[0.00004252694,0.0002896413,0.000332104,0.0001313167,0.00006348668,0.0000033033573,0.00015029313,0.000109031556,0.000008260331],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015620953,0.000017708433,0.000016435888,0.0014655321,0.00037322886,3.8975148e-7,0.00008246679,0.00028155305,0.000007528277,0.000025355848,0.0026270705,0.9950871],"study_design_scores_gemma":[0.00041040004,0.00009048059,0.0025791733,0.012602078,0.0022533883,0.00020132105,0.0001745686,0.000120227116,0.0000106704,0.000043745415,0.9808924,0.0006215419],"about_ca_topic_score_codex":0.0011975903,"about_ca_topic_score_gemma":0.0002448184,"teacher_disagreement_score":0.9944656,"about_ca_system_score_codex":0.00035024452,"about_ca_system_score_gemma":0.0014696221,"threshold_uncertainty_score":0.9999556},"labels":[],"label_agreement":null},{"id":"W3163713040","doi":"10.1016/j.breast.2021.05.006","title":"Trajectories of cognitive performance over five years in a prospective cohort of patients with breast cancer (NEON-BC)","year":2021,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Fundação para a Ciência e a Tecnologia; Universidade do Porto","keywords":"Medicine; Montreal Cognitive Assessment; Conventional PCI; Cohort; Receiver operating characteristic; Baseline (sea); Cognition; Quartile; Cognitive test; Breast cancer; Physical therapy; Demography; Internal medicine; Cognitive impairment; Cancer; Psychiatry","score_opus":0.004548131539697643,"score_gpt":0.23424186398158298,"score_spread":0.22969373244188535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3163713040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99649245,0.0001904447,0.0000029502974,0.00016741116,0.00006544177,0.0008345861,0.00092256966,0.000013012171,0.0013111307],"genre_scores_gemma":[0.9991237,0.00014490266,0.000008172216,0.00006024468,0.00005408888,0.000121034296,0.000036634778,0.000021573027,0.00042965583],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888253,0.000043213615,0.00024013495,0.00023355556,0.000386665,0.00021389831],"domain_scores_gemma":[0.9987028,0.00010958969,0.00016464869,0.0001505507,0.00083197746,0.00004038867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008693504,0.00016056989,0.00040780325,0.00006918594,0.000040144503,0.000003944294,0.000055692777,0.000044673277,0.00025041253],"category_scores_gemma":[0.000033751017,0.00010985749,0.000057726687,0.00052087684,0.00039037137,0.00009312588,0.000059909064,0.00020224333,0.000003544275],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034958133,0.00045205196,0.9873714,0.00011318142,0.0005696828,0.000012549775,0.00420455,0.000008177807,0.000039162802,0.000013375486,0.00007622209,0.0036438552],"study_design_scores_gemma":[0.004486977,0.0003172063,0.98974454,0.0018006022,0.00036558943,0.00006238128,0.001983644,0.000014240698,0.0010884093,0.000010024247,0.0000069804696,0.000119423916],"about_ca_topic_score_codex":0.00091176276,"about_ca_topic_score_gemma":0.00047917597,"teacher_disagreement_score":0.0035244313,"about_ca_system_score_codex":0.00017221787,"about_ca_system_score_gemma":0.00028300402,"threshold_uncertainty_score":0.44798586},"labels":[],"label_agreement":null},{"id":"W3174949713","doi":"10.1016/j.breast.2021.05.003","title":"Locoregional therapy in de novo metastatic breast cancer: Systemic review and meta-analysis","year":2021,"lang":"en","type":"review","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Oncology; Breast cancer; Confidence interval; Metastatic breast cancer; Population; Meta-analysis; Cancer; Randomized controlled trial; Adjuvant therapy","score_opus":0.07876204760154336,"score_gpt":0.3646114644662783,"score_spread":0.2858494168647349,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174949713","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000149452035,0.995549,0.000017434497,0.0015529805,0.0000248925,0.0008390235,0.0019641588,0.000008536885,0.00002900936],"genre_scores_gemma":[0.00036294165,0.9964299,0.000036217454,0.00077011733,0.000107822816,0.0015503507,0.00044590258,0.00005435105,0.00024237006],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99745333,0.00071432476,0.00057025714,0.0006957018,0.00019990852,0.00036646568],"domain_scores_gemma":[0.9985578,0.00007674359,0.00037767668,0.00078400306,0.00012056371,0.00008318402],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046759564,0.0006138343,0.0037462062,0.0001037608,0.000090204594,0.000034212277,0.0003886288,0.00013176403,0.00020275486],"category_scores_gemma":[0.000010574206,0.0003411209,0.0017611091,0.0006966168,0.00015575149,0.0000037673503,0.0002012654,0.00020505034,0.0000061508194],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004116113,0.00024388662,0.00027571208,0.020079387,0.59540266,0.00008071404,0.00006915543,0.000016613578,0.0000036672952,0.00006947492,0.0017166805,0.3820009],"study_design_scores_gemma":[0.000394309,0.000020671288,0.0003133787,0.0024228208,0.78432757,0.011694132,0.000033162352,6.1696585e-7,0.0000011773379,0.000008304685,0.20021854,0.0005653298],"about_ca_topic_score_codex":0.00042029237,"about_ca_topic_score_gemma":0.0003744265,"teacher_disagreement_score":0.38143557,"about_ca_system_score_codex":0.00011651902,"about_ca_system_score_gemma":0.00043868626,"threshold_uncertainty_score":0.9999041},"labels":[],"label_agreement":null},{"id":"W3177968379","doi":"10.1016/j.breast.2021.07.005","title":"Higher-risk breast cancer in women aged 80 and older: Exploring the effect of treatment on survival","year":2021,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; Alberta Health; University of Calgary","funders":"","keywords":"Medicine; Breast cancer; Hazard ratio; Internal medicine; Trastuzumab; Proportional hazards model; Oncology; Radiation therapy; Systemic therapy; Cancer; Hormonal therapy; Population; Chemotherapy; Cancer registry; Confidence interval; Gynecology","score_opus":0.011340067968934126,"score_gpt":0.24514122542037875,"score_spread":0.2338011574514446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3177968379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99621123,0.0015968643,0.0000010986954,0.0013464143,0.000185902,0.00018285919,0.00029212132,0.000007307338,0.00017617698],"genre_scores_gemma":[0.9974157,0.0017086889,0.0000022382126,0.000049473558,0.0002050443,0.00037027142,0.000012027343,0.000019563351,0.0002169568],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895614,0.0002835197,0.0001303894,0.00028183984,0.00010161866,0.00024651663],"domain_scores_gemma":[0.9993849,0.00010597439,0.000065723,0.00037800174,0.000025762765,0.000039671748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017928274,0.0002015322,0.00023726402,0.000017393077,0.00012271869,0.000013836001,0.00010832228,0.000038187427,0.00003225082],"category_scores_gemma":[0.00000843598,0.000104897954,0.00006595446,0.00010829119,0.00011690271,0.0000034877532,0.00011039496,0.00007464647,0.0000021379026],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034366883,0.00031193634,0.6142945,0.000071324284,0.0014659155,0.000027469809,0.002811856,0.00034125615,0.03152334,0.00005043031,0.00019062521,0.34547463],"study_design_scores_gemma":[0.002075421,0.00027320758,0.9706312,0.00005790427,0.00007977172,0.000060042832,0.00033852886,0.0000020972122,0.02597372,0.000011491473,0.0003835601,0.000113044625],"about_ca_topic_score_codex":0.0010618613,"about_ca_topic_score_gemma":0.0006596734,"teacher_disagreement_score":0.35633668,"about_ca_system_score_codex":0.00011955178,"about_ca_system_score_gemma":0.000043482683,"threshold_uncertainty_score":0.42776144},"labels":[],"label_agreement":null},{"id":"W3186455232","doi":"10.1016/j.breast.2021.07.017","title":"Efficacy and safety of palbociclib in patients with estrogen receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer with preexisting conditions: A post hoc analysis of PALOMA-2","year":2021,"lang":"en","type":"article","venue":"The Breast","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Pfizer","keywords":"Palbociclib; Letrozole; Medicine; Post-hoc analysis; Internal medicine; Oncology; Adverse effect; Placebo; Breast cancer; Fulvestrant; Cancer; Common Terminology Criteria for Adverse Events; Estrogen receptor; Metastatic breast cancer; Aromatase; Pathology","score_opus":0.007593714205128284,"score_gpt":0.26553065339647824,"score_spread":0.25793693919134997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186455232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99308795,0.00031783018,0.00006936382,0.0006800983,0.000019684243,0.00077029236,0.0049469676,0.000029766663,0.00007807148],"genre_scores_gemma":[0.9978982,0.00004167126,0.0011917204,0.00009770059,0.000040210598,0.00006990723,0.00057711836,0.000050170045,0.000033286713],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979592,0.00021033926,0.00054046937,0.00048298284,0.0004505729,0.00035642885],"domain_scores_gemma":[0.9975009,0.00034913182,0.00055892655,0.0004051561,0.0010463743,0.00013953718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000115792594,0.00033426422,0.0009069293,0.00021575292,0.0001435247,0.000012093243,0.00013427551,0.00006895677,0.00042550548],"category_scores_gemma":[0.00005799414,0.00022320607,0.000109183726,0.0013258503,0.00063010654,0.00024029631,0.00007271755,0.00025546085,0.000001042385],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026712637,0.00083037297,0.9249026,0.00018795399,0.0041414523,0.000012671671,0.0038713787,0.00034643855,0.013137984,0.0003304095,0.0000027500942,0.025523318],"study_design_scores_gemma":[0.010667154,0.00064934324,0.9810894,0.0010444198,0.0009406217,0.000062181396,0.001155966,0.000016501739,0.0041008303,0.000024407866,0.0000045129136,0.00024466586],"about_ca_topic_score_codex":0.0004263951,"about_ca_topic_score_gemma":0.0003557553,"teacher_disagreement_score":0.056186765,"about_ca_system_score_codex":0.00019921355,"about_ca_system_score_gemma":0.00021892977,"threshold_uncertainty_score":0.9102079},"labels":[],"label_agreement":null},{"id":"W3187853271","doi":"10.1016/j.breast.2021.07.021","title":"Who are the women who enrolled in the POSITIVE trial: A global study to support young hormone receptor positive breast cancer survivors desiring pregnancy","year":2021,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Cancer Institute; NRG Oncology; ECOG-ACRIN Cancer Research Group; Emory University; American College of Radiology Imaging Network","keywords":"Medicine; Tamoxifen; Breast cancer; Pregnancy; Fertility preservation; Obstetrics; Fertility; Gynecology; Mastectomy; Cancer; Breastfeeding; Internal medicine; Population; Pediatrics","score_opus":0.02011653005674881,"score_gpt":0.3023161623035004,"score_spread":0.2821996322467516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3187853271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98095196,0.0007640858,0.000012835886,0.011927447,0.00034552586,0.0034516621,0.0011571206,0.000039688362,0.0013496558],"genre_scores_gemma":[0.9964303,0.0002025613,0.0000038129647,0.0011086995,0.0004920878,0.0006601431,0.000023752616,0.000040983,0.0010376745],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969875,0.0006801738,0.00045030046,0.0005211712,0.0006925597,0.00066826044],"domain_scores_gemma":[0.9983997,0.00020158016,0.00018638966,0.00074826076,0.0002767924,0.00018729872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009070111,0.00035878384,0.0006943489,0.000055725483,0.00033282046,0.00014149926,0.00044721772,0.00007225384,0.00022131053],"category_scores_gemma":[0.000058670666,0.0001828812,0.00017729781,0.0010808323,0.00012714825,0.00011478446,0.00021871389,0.00043212567,0.00002722163],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09353436,0.004097008,0.61347175,0.000066096945,0.0019559588,0.00094777555,0.22962499,0.00006261522,0.00058893947,0.00019838354,0.0047178366,0.050734323],"study_design_scores_gemma":[0.014130837,0.0007133269,0.9202082,0.0005609797,0.00021190578,0.0005923156,0.063182585,0.000009155428,0.00004346319,0.00002465523,0.00008786204,0.00023472043],"about_ca_topic_score_codex":0.014669482,"about_ca_topic_score_gemma":0.017833995,"teacher_disagreement_score":0.30673647,"about_ca_system_score_codex":0.00082413625,"about_ca_system_score_gemma":0.00042413833,"threshold_uncertainty_score":0.99517876},"labels":[],"label_agreement":null},{"id":"W3203775877","doi":"10.1016/j.breast.2021.09.009","title":"Machine learning to predict individual patient-reported outcomes at 2-year follow-up for women undergoing cancer-related mastectomy and breast reconstruction (INSPiRED-001)","year":2021,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; University of British Columbia; Memorial Sloan-Kettering Cancer Center","keywords":"Medicine; Mastectomy; Breast cancer; Breast reconstruction; Oncology; General surgery; Cancer; Medical physics; Internal medicine","score_opus":0.01374698479601957,"score_gpt":0.23565210267009035,"score_spread":0.22190511787407077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203775877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951025,0.00016951324,0.000017675664,0.001918179,0.0010679297,0.00069610856,0.00037557847,0.00021513295,0.0004373758],"genre_scores_gemma":[0.9952357,0.000039629034,0.00028326025,0.000087250926,0.00017724841,0.000117311974,0.00024086046,0.0000501826,0.0037686012],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982406,0.00009854198,0.000473304,0.00042911616,0.00029720174,0.00046125348],"domain_scores_gemma":[0.9989172,0.00013714786,0.00024610347,0.0002479214,0.00018730684,0.0002643102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027732467,0.00026673533,0.0004406107,0.00014459249,0.00043801314,0.00005720217,0.00007396257,0.00015742618,0.00032950923],"category_scores_gemma":[0.000050342605,0.00019185565,0.00011420346,0.00030536414,0.00009219181,0.0001331599,0.00013471456,0.0003028928,0.000015623962],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012768793,0.000082153274,0.45092312,0.00014428503,0.0011507573,0.00002790647,0.0021621305,0.000028429089,0.0014629951,0.00003720859,0.00012401918,0.5425801],"study_design_scores_gemma":[0.016951805,0.00046630725,0.6008043,0.0006381754,0.0009983036,0.37145168,0.0047162934,0.0008541641,0.00085704494,0.0002549187,0.0014256164,0.0005813993],"about_ca_topic_score_codex":0.00016797666,"about_ca_topic_score_gemma":0.00030689125,"teacher_disagreement_score":0.54199874,"about_ca_system_score_codex":0.00028032015,"about_ca_system_score_gemma":0.00021070888,"threshold_uncertainty_score":0.78236467},"labels":[],"label_agreement":null},{"id":"W3209188040","doi":"10.1016/j.breast.2021.09.010","title":"The association between endocrine therapy use and osteoporotic fracture among post-menopausal women treated for early-stage breast cancer in Ontario, Canada","year":2021,"lang":"en","type":"article","venue":"The Breast","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Canadian Centre for Applied Research in Cancer Control; CancerCare Manitoba; University of Toronto; London Health Sciences Centre; Sunnybrook Health Science Centre; Western University","funders":"","keywords":"Tamoxifen; Medicine; Aromatase inhibitor; Breast cancer; Hazard ratio; Internal medicine; Osteoporosis; Oncology; Anastrozole; Proportional hazards model; Aromatase; Cancer; Gynecology; Confidence interval","score_opus":0.004528635657235276,"score_gpt":0.20555662643288372,"score_spread":0.20102799077564845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209188040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99739176,0.00047142242,0.0000011672211,0.0013507046,0.00005993859,0.00034093246,0.0003446791,0.000005395665,0.0000340261],"genre_scores_gemma":[0.9957318,0.0002021839,0.0000025460656,0.00022047946,0.000101955986,0.00007774248,0.00017780293,0.000020485748,0.0034650106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990783,0.0001105996,0.00014094051,0.00020917326,0.00011978015,0.00034122003],"domain_scores_gemma":[0.9994057,0.00010450688,0.00009372109,0.00020185501,0.00012063285,0.0000735852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015332617,0.00014884889,0.00014210763,0.000010971133,0.00018260909,0.000073424184,0.00010744845,0.00011360553,0.000027229253],"category_scores_gemma":[0.000023049706,0.00008938565,0.000025479949,0.00006629795,0.000033060976,0.000008644946,0.000044506538,0.00020344077,3.7561978e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034493965,0.000026864187,0.9535892,0.0000054616,0.00042768335,0.000015974727,0.00029412142,0.000051082843,0.042713534,0.000004254007,0.00035588196,0.0021709707],"study_design_scores_gemma":[0.0009831006,0.00012236556,0.98328096,0.000010610146,0.00003353256,0.000036441772,0.0001133098,0.0000068103254,0.011579514,0.000006534635,0.0037043937,0.00012242937],"about_ca_topic_score_codex":0.76964074,"about_ca_topic_score_gemma":0.9185574,"teacher_disagreement_score":0.14891668,"about_ca_system_score_codex":0.00027929194,"about_ca_system_score_gemma":0.0004525486,"threshold_uncertainty_score":0.3645041},"labels":[],"label_agreement":null},{"id":"W3209816014","doi":"10.1016/j.breast.2021.10.007","title":"Response to Soran et al.","year":2021,"lang":"en","type":"letter","venue":"The Breast","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine","score_opus":0.025517602676456187,"score_gpt":0.29945844350591333,"score_spread":0.27394084082945713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209816014","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001139311,0.00037453166,0.000016723407,0.9902971,0.0003455611,0.00044112073,0.00031840388,0.000059652917,0.007007592],"genre_scores_gemma":[0.0027846075,0.0000281152,0.00006753612,0.95153385,0.0012230583,0.00007509091,0.00021938844,0.00007262269,0.043995745],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99857086,0.0002821733,0.00014716556,0.00032559736,0.00038737056,0.00028680422],"domain_scores_gemma":[0.9988914,0.00012604397,0.00003934513,0.0007771836,0.00007806462,0.00008792266],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002534481,0.00024082075,0.00034467306,0.00006783697,0.0000624326,0.000037058053,0.00016796724,0.0001730282,0.0009763116],"category_scores_gemma":[0.000031271717,0.0001483913,0.00016224869,0.00015528296,0.000042632848,0.000017433882,0.00007379608,0.00083434675,0.00070224283],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012940665,0.00003497556,0.000049673563,0.000019806976,0.00018548289,0.0011431056,0.0002492232,2.1690187e-7,0.00034807686,0.000002277457,0.99409926,0.002573834],"study_design_scores_gemma":[0.00085164665,0.00014790475,0.004134845,0.00023327225,0.00020639041,0.002102998,0.00002877199,3.6475998e-7,0.000115197385,0.000022046821,0.99201316,0.0001434258],"about_ca_topic_score_codex":0.00020361583,"about_ca_topic_score_gemma":0.00001027838,"teacher_disagreement_score":0.03876327,"about_ca_system_score_codex":0.00010101662,"about_ca_system_score_gemma":0.00037539031,"threshold_uncertainty_score":0.99993694},"labels":[],"label_agreement":null},{"id":"W3211935866","doi":"10.1016/j.breast.2021.11.007","title":"Development of novel agents for the treatment of early estrogen receptor positive breast cancer","year":2021,"lang":"en","type":"review","venue":"The Breast","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Breast cancer; Estrogen receptor; Oncology; Adjuvant; Disease; PI3K/AKT/mTOR pathway; Cancer; Internal medicine; Biomarker; Estrogen; Targeted therapy; Adjuvant therapy; Bioinformatics; Signal transduction","score_opus":0.08722767617663327,"score_gpt":0.38408548017142,"score_spread":0.2968578039947868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211935866","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003963775,0.9907098,0.0005272355,0.00037317802,0.00026896587,0.0028035839,0.004866866,0.000019180958,0.00003480341],"genre_scores_gemma":[0.00012161256,0.9926245,0.0037446353,0.000042586147,0.00050747703,0.0015221942,0.00030371273,0.00012468635,0.0010085944],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99801797,0.00006401984,0.0007761075,0.00039560534,0.00038482208,0.00036145296],"domain_scores_gemma":[0.9977466,0.0003111968,0.0007517708,0.00070259697,0.00039010574,0.00009775037],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016579927,0.0005248725,0.0018832046,0.00007496106,0.00014028446,0.000011306828,0.00034349455,0.00014839813,0.0002020957],"category_scores_gemma":[0.0000073805422,0.00025743173,0.0007690399,0.00032753887,0.00023432888,0.00003752548,0.00006577991,0.00014610373,0.000007030657],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039284074,0.00060772273,0.000021941145,0.0020542608,0.0040581487,0.0000015917915,0.001624895,0.0000024239755,0.00005954026,0.00012315046,0.000032276992,0.9910212],"study_design_scores_gemma":[0.002167902,0.00021571074,0.0011111631,0.017457703,0.004291148,0.0007991873,0.0003387973,0.0000031107224,0.00025989328,0.0000027598235,0.97304803,0.00030456766],"about_ca_topic_score_codex":0.00020595764,"about_ca_topic_score_gemma":0.000018745564,"teacher_disagreement_score":0.99071664,"about_ca_system_score_codex":0.0006953579,"about_ca_system_score_gemma":0.0015492371,"threshold_uncertainty_score":0.9999878},"labels":[],"label_agreement":null},{"id":"W4212945590","doi":"10.1016/j.breast.2022.02.012","title":"Exploring breast surgeons’ reasons for women not undergoing immediate breast reconstruction","year":2022,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of Alberta","funders":"","keywords":"Medicine; Mastectomy; Breast cancer; Breast reconstruction; Referral; General surgery; Breast surgery; Retrospective cohort study; Cancer; Surgery; Family medicine; Internal medicine","score_opus":0.051835408763934124,"score_gpt":0.24129692482208995,"score_spread":0.1894615160581558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212945590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98719996,0.0000401199,0.00011367395,0.006829144,0.0025827175,0.0007939297,0.0012849492,0.00026407265,0.0008914468],"genre_scores_gemma":[0.99604994,0.00004069629,0.00015272938,0.00013336394,0.0010213742,0.00082416995,0.00015166291,0.00007698876,0.0015490665],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9976504,0.00017016655,0.00046985116,0.0004800731,0.00044132688,0.00078816863],"domain_scores_gemma":[0.9985097,0.0003229136,0.00025787597,0.0004925404,0.00013353737,0.00028343152],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009777879,0.0003146982,0.0004599812,0.00026620014,0.0011521209,0.0000569495,0.0002265844,0.00007277993,0.0006087791],"category_scores_gemma":[0.00001883995,0.00024857844,0.0002538236,0.00047689085,0.000194998,0.00035304355,0.0001659817,0.00052548974,0.000043727076],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045422306,0.00021651384,0.021285035,0.00018533193,0.00041526876,0.000030201369,0.0013228469,0.000060948918,0.0021258332,0.0010383629,0.000699761,0.96807766],"study_design_scores_gemma":[0.0030500523,0.0001447634,0.16841388,0.00014990663,0.00018673297,0.8178782,0.0077123386,0.00036147732,0.00015304968,0.00053000957,0.0010201519,0.0003994807],"about_ca_topic_score_codex":0.0002228919,"about_ca_topic_score_gemma":0.000050123715,"teacher_disagreement_score":0.9676782,"about_ca_system_score_codex":0.00055193447,"about_ca_system_score_gemma":0.0003551399,"threshold_uncertainty_score":0.99999666},"labels":[],"label_agreement":null},{"id":"W4230263812","doi":"10.1016/j.breast.2014.08.009","title":"ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)","year":2014,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":335,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Disease; Oncology; Quality of life (healthcare); Family medicine; Cancer; Internal medicine; Intensive care medicine; Medical physics; Nursing","score_opus":0.022116237763396898,"score_gpt":0.3237934648715714,"score_spread":0.3016772271081745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230263812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.69480515,0.0041357763,0.0052252216,0.27535215,0.0043412466,0.0015773897,0.006310662,0.00018031154,0.008072104],"genre_scores_gemma":[0.9931739,0.00016242919,0.0011449836,0.0019717626,0.001780257,0.0002436131,0.00015037313,0.000036262907,0.0013364307],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99906147,0.000033296514,0.00020640578,0.000320675,0.0001304385,0.00024771647],"domain_scores_gemma":[0.9989729,0.00004177605,0.0001062309,0.00033476495,0.0004920964,0.00005224955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001505745,0.00019596303,0.00015711789,0.00002063427,0.00016106297,0.000020999396,0.0002824522,0.00006429487,0.000053737953],"category_scores_gemma":[0.000076626886,0.00013486712,0.00011066842,0.000045286528,0.00014853089,0.0000029694793,0.0001247323,0.000046266745,0.00001076985],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050812117,0.00042493342,0.041081212,0.00007960797,0.002390172,0.000003864986,0.00027266328,0.0023698676,0.09723665,0.0028696535,0.3108483,0.5373419],"study_design_scores_gemma":[0.01042488,0.00023524705,0.26602322,0.00019868318,0.00040810753,0.001798488,0.00062752765,0.0013412337,0.026231056,0.0015961307,0.6899065,0.0012089318],"about_ca_topic_score_codex":0.000265109,"about_ca_topic_score_gemma":0.00031745675,"teacher_disagreement_score":0.53613293,"about_ca_system_score_codex":0.00003353381,"about_ca_system_score_gemma":0.000053124862,"threshold_uncertainty_score":0.5499722},"labels":[],"label_agreement":null},{"id":"W4237328149","doi":"10.1016/s0960-9776(13)70002-x","title":"Speakers' Abstracts","year":2013,"lang":"en","type":"article","venue":"The Breast","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Dermatology","score_opus":0.007845878108867157,"score_gpt":0.23814446719075277,"score_spread":0.2302985890818856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237328149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9178851,0.00047994798,0.00020115796,0.029041283,0.00020918646,0.00061008206,0.000009441717,0.00019712438,0.051366657],"genre_scores_gemma":[0.9937924,0.000005455927,0.00046285157,0.0014857014,0.00036448453,0.000028426548,0.0000039344286,0.00002019782,0.003836543],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9994022,0.000011503101,0.000116954936,0.00011376323,0.0001501058,0.00020544155],"domain_scores_gemma":[0.9994315,0.0000311714,0.000042697287,0.00033842068,0.00006590303,0.000090301466],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000065767825,0.000093885064,0.000116305695,0.000021327183,0.00005580217,0.000016630802,0.00009891365,0.000027570366,0.0017114251],"category_scores_gemma":[0.000010233767,0.000054109994,0.00004694827,0.00008336837,0.00010707055,0.00009897335,0.000024258297,0.00013054624,0.0024853451],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000443588,0.00025346864,0.009879481,0.00006677659,0.00025601065,0.000041303276,0.0015551174,0.00007929525,0.04386742,0.0014794272,0.009723544,0.93235457],"study_design_scores_gemma":[0.0009497686,0.000042514028,0.96083057,0.000058765225,0.00003655036,0.0026733354,0.00041994994,0.000032738142,0.0016350514,0.0020946886,0.031109573,0.000116482835],"about_ca_topic_score_codex":0.0002285136,"about_ca_topic_score_gemma":0.000004883638,"teacher_disagreement_score":0.9509511,"about_ca_system_score_codex":0.000038409784,"about_ca_system_score_gemma":0.00003183274,"threshold_uncertainty_score":0.9992011},"labels":[],"label_agreement":null},{"id":"W4245399092","doi":"10.1016/j.breast.2010.06.008","title":"Following the case of fat grafting in glandular tissue, a comment on “lipomodelling of the breast: A review” in the breast volume 19, issue 3, 2010","year":2010,"lang":"en","type":"letter","venue":"The Breast","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Hôpital Notre-Dame","funders":"","keywords":"Medicine; Volume (thermodynamics); Breast tissue; Breast cancer; Internal medicine; Cancer","score_opus":0.030197682746736627,"score_gpt":0.31145301576754514,"score_spread":0.2812553330208085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245399092","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04350588,0.006290142,0.000020848533,0.94252807,0.00055086106,0.0049586715,0.0003244059,0.000022013128,0.0017991236],"genre_scores_gemma":[0.7080756,0.0012988324,0.00007895071,0.28161702,0.003983934,0.0004618164,0.00021376231,0.00025696072,0.00401315],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9930142,0.0021425628,0.0013306094,0.0006530328,0.0018573949,0.0010021554],"domain_scores_gemma":[0.9945658,0.001428718,0.00068092503,0.0029804746,0.00022502281,0.000119051896],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0064414176,0.00066176,0.0014389653,0.00025909735,0.00032280694,0.000060712086,0.0020399669,0.0007396175,0.00040707953],"category_scores_gemma":[0.0002950385,0.00028490328,0.0005904008,0.0010932579,0.0004641587,0.000069019254,0.00053594576,0.007954666,0.00006763548],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007015392,0.0008889344,0.008587686,0.00892671,0.0006253213,0.011667453,0.007205114,0.00015438585,0.0016848294,0.00008049488,0.9133147,0.046162836],"study_design_scores_gemma":[0.0062986827,0.0005533875,0.0074249925,0.054666672,0.0020593219,0.16816358,0.0027448284,0.006177488,0.0005001311,0.00038743837,0.7495004,0.0015230494],"about_ca_topic_score_codex":0.025791278,"about_ca_topic_score_gemma":0.0012447211,"teacher_disagreement_score":0.6645697,"about_ca_system_score_codex":0.00020040634,"about_ca_system_score_gemma":0.00023510876,"threshold_uncertainty_score":0.9999603},"labels":[],"label_agreement":null},{"id":"W4290997184","doi":"10.1016/j.breast.2022.08.004","title":"Response to comment on: “Global guidelines for breast cancer screening: A systematic review”","year":2022,"lang":"en","type":"review","venue":"The Breast","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Centre International de Recherche sur le Cancer","keywords":"Scopus; Guideline; Medicine; Breast cancer; Task force; Systematic review; Family medicine; Health care; Citation; Breast cancer screening; Alternative medicine; Cancer; Library science; MEDLINE; Gynecology; Mammography; Internal medicine; Pathology; Political science; Computer science","score_opus":0.5626471825821608,"score_gpt":0.5992041882873362,"score_spread":0.036557005705175394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4290997184","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[1.3734184e-7,0.67996824,0.00035701256,0.30289677,0.00033134426,0.011532104,0.0048131365,0.00006139954,0.00003984838],"genre_scores_gemma":[4.7121316e-7,0.8400533,0.0010515893,0.15043491,0.0006846219,0.0066490965,0.00041805836,0.00009156517,0.00061638135],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9923557,0.0018945127,0.0036200108,0.00064529554,0.0010325777,0.0004518755],"domain_scores_gemma":[0.98985374,0.005892534,0.0016076014,0.0016154512,0.00072746444,0.00030322763],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.009937795,0.0006127737,0.0033816937,0.000113089205,0.00025832074,0.000049033013,0.0007051384,0.00011964825,0.0015640394],"category_scores_gemma":[0.013385274,0.00035580553,0.001111172,0.0006155396,0.00004403934,0.000055486296,0.00036712523,0.00048607937,0.0001609762],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001117502,0.00008593357,5.6840963e-7,0.28812099,0.00046416686,0.000010178201,0.000011402789,0.0000016520689,2.8425909e-8,0.000031282154,0.35083157,0.35932472],"study_design_scores_gemma":[0.00054309965,0.00019613218,0.0000052724195,0.33335453,0.009201293,0.0025819729,0.00008255058,0.000013310786,7.697577e-9,0.000008941914,0.6537962,0.00021671194],"about_ca_topic_score_codex":0.00030991924,"about_ca_topic_score_gemma":0.000026550686,"teacher_disagreement_score":0.359108,"about_ca_system_score_codex":0.0010372186,"about_ca_system_score_gemma":0.0009666541,"threshold_uncertainty_score":0.9998894},"labels":[],"label_agreement":null},{"id":"W4293311778","doi":"10.1016/j.breast.2022.08.003","title":"The Canadian Task Force on Preventive Health Care should not receive high ranking based on AGREEII or GRADE","year":2022,"lang":"en","type":"letter","venue":"The Breast","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Guideline; Task force; Disappointment; Breast cancer; Rigour; Family medicine; Health care; Alternative medicine; Scopus; MEDLINE; Cancer; Pathology; Psychology; Social psychology; Law; Internal medicine","score_opus":0.06363400810665079,"score_gpt":0.32344902214630994,"score_spread":0.2598150140396591,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293311778","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00056589546,0.0004139048,0.00000810868,0.9897808,0.00081821077,0.0015876164,0.00120137,0.000059567883,0.005564525],"genre_scores_gemma":[0.22065958,0.000035725785,0.000024820425,0.7701912,0.0024016153,0.0001725673,0.0009028102,0.00007628135,0.005535414],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99619526,0.0005217908,0.00035740423,0.0005608781,0.0014327341,0.0009319591],"domain_scores_gemma":[0.997771,0.0005482274,0.00030489493,0.0010178221,0.00012958529,0.00022845791],"candidate_categories":["sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.000708752,0.00043301232,0.00054080633,0.00016647366,0.0017774191,0.00009348997,0.00072894205,0.00029487596,0.00047745722],"category_scores_gemma":[0.00009447264,0.00023551549,0.00025489784,0.000350199,0.00014706029,0.00003411531,0.00006956893,0.0032684957,0.00004146058],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019127291,0.000010743722,0.00007455051,0.00012333137,0.00013596476,0.00071832817,0.00132531,0.00019611482,0.0000013190261,0.00010807573,0.9824306,0.012962947],"study_design_scores_gemma":[0.0014230075,0.0016979589,0.004162116,0.0017668618,0.00026405297,0.00042469424,0.0014612821,0.000102158825,0.000021835504,0.00008991581,0.9881583,0.00042785],"about_ca_topic_score_codex":0.31829858,"about_ca_topic_score_gemma":0.320397,"teacher_disagreement_score":0.22009368,"about_ca_system_score_codex":0.0031907686,"about_ca_system_score_gemma":0.0029511775,"threshold_uncertainty_score":0.99952215},"labels":[],"label_agreement":null},{"id":"W4306739715","doi":"10.1016/j.breast.2022.10.007","title":"Antibody-drug conjugates targeting TROP-2: Clinical development in metastatic breast cancer","year":2022,"lang":"en","type":"article","venue":"The Breast","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"EMD Serono; Genentech; PharmaMar; G1 Therapeutics; MacroGenics; Pfizer; Incyte; NuCana; Seagen; Relay Therapeutics; Plexxikon; Ontario Brain Institute; Syndax Pharmaceuticals; Regeneron Pharmaceuticals; Amgen; Radius Health; Gilead Sciences; Merck; Mersana Therapeutics; Novartis; GlaxoSmithKline; AstraZeneca; Eli Lilly and Company; Roche; Astellas Pharma US","keywords":"Medicine; Metastatic breast cancer; Antibody-drug conjugate; Drug; Cancer; Antibody; Breast cancer; Oncology; Conjugate; Drug development; Cancer research; Internal medicine; Pharmacology; Immunology; Monoclonal antibody","score_opus":0.05927251587468007,"score_gpt":0.42484980232567876,"score_spread":0.3655772864509987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306739715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97334516,0.0016365697,0.000028888564,0.022177473,0.0004260775,0.0008752143,0.00019230183,0.00007500453,0.0012433205],"genre_scores_gemma":[0.996557,0.00018009721,0.00044661202,0.0009842545,0.00028186108,0.00029982504,0.00008478352,0.000050827537,0.0011147626],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969601,0.0006160837,0.00060384563,0.00039754616,0.0008261753,0.00059621833],"domain_scores_gemma":[0.9989088,0.00030955623,0.00012192153,0.00037086985,0.00009817028,0.00019064483],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00319642,0.00018758197,0.00044969493,0.00012477927,0.0003057956,0.00002929089,0.0003933816,0.000025870671,0.0039921794],"category_scores_gemma":[0.0000819266,0.00013231218,0.000101671016,0.0005288474,0.0001984994,0.00005285258,0.000405596,0.0009591613,0.00010140995],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001885627,0.0011164142,0.83146536,0.00033028354,0.0004281122,0.0005576372,0.0037500968,0.0003409297,0.004863751,0.00025108166,0.016241373,0.13876936],"study_design_scores_gemma":[0.0052015577,0.00020271173,0.8857522,0.0004175714,0.00013651373,0.0024664847,0.0042239623,0.0017510366,0.0006309401,0.00012611465,0.09859248,0.0004984242],"about_ca_topic_score_codex":0.001266238,"about_ca_topic_score_gemma":0.00019424957,"teacher_disagreement_score":0.13827093,"about_ca_system_score_codex":0.00049295556,"about_ca_system_score_gemma":0.0012121855,"threshold_uncertainty_score":0.9969183},"labels":[],"label_agreement":null},{"id":"W4309348334","doi":"10.1016/j.breast.2022.11.005","title":"Effect of palbociclib plus endocrine therapy on time to chemotherapy across subgroups of patients with hormone receptor‒positive/human epidermal growth factor receptor 2‒negative advanced breast cancer: Post hoc analyses from PALOMA-2 and PALOMA-3","year":2022,"lang":"en","type":"article","venue":"The Breast","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Pfizer","keywords":"Medicine; Palbociclib; Oncology; Human Epidermal Growth Factor Receptor 2; Hormone receptor; Internal medicine; Cancer; Chemotherapy; Breast cancer; Endocrine system; Hormone; Receptor; Metastatic breast cancer","score_opus":0.008396602502152975,"score_gpt":0.2926130271226839,"score_spread":0.2842164246205309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309348334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97950524,0.0010050156,0.000020387428,0.0016871507,0.00007338369,0.002063605,0.015523125,0.000086140695,0.00003594738],"genre_scores_gemma":[0.997541,0.00018793726,0.00024245033,0.00064725196,0.00017274747,0.00035261482,0.0005597355,0.00015193617,0.00014432464],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99644166,0.0005627931,0.0006152772,0.0007749618,0.0009469465,0.00065833254],"domain_scores_gemma":[0.99719906,0.00069077575,0.0006595519,0.0006972397,0.00048617192,0.00026722474],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025974947,0.0006858122,0.0013727057,0.00016135542,0.0004232109,0.000023011597,0.00042474776,0.00007051894,0.0017663816],"category_scores_gemma":[0.000030819316,0.00044639755,0.00022219429,0.00068982685,0.00054276775,0.00021945496,0.00019004884,0.0004551315,0.000013178276],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19052821,0.0009852503,0.050598305,0.00009928777,0.0021214793,0.000013614304,0.009181246,0.00015392018,0.44262877,0.0000128795555,0.00012914054,0.30354786],"study_design_scores_gemma":[0.024149943,0.010591491,0.8500681,0.0002390948,0.00014279221,0.000058405083,0.00053146033,0.0000122865695,0.11348709,0.00002261789,0.0001875722,0.0005091586],"about_ca_topic_score_codex":0.0014762514,"about_ca_topic_score_gemma":0.000036140347,"teacher_disagreement_score":0.79946977,"about_ca_system_score_codex":0.00044563357,"about_ca_system_score_gemma":0.0001022025,"threshold_uncertainty_score":0.9997988},"labels":[],"label_agreement":null},{"id":"W4311302338","doi":"10.1016/j.breast.2022.12.003","title":"Final findings from the CONTROL trial: Strategies to reduce the incidence and severity of neratinib-associated diarrhea in patients with HER2-positive early-stage breast cancer","year":2022,"lang":"en","type":"article","venue":"The Breast","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; McGill University Health Centre","funders":"Puma Biotechnology","keywords":"Neratinib; Medicine; Loperamide; Diarrhea; Internal medicine; Incidence (geometry); Discontinuation; Gastroenterology; Tolerability; Oncology; Breast cancer; Adverse effect; Cancer; Trastuzumab","score_opus":0.02128492988764032,"score_gpt":0.31009708585149054,"score_spread":0.28881215596385024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311302338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98020643,0.00008556712,0.000004400746,0.014943253,0.000080120364,0.0019604152,0.002598559,0.000014818778,0.00010643975],"genre_scores_gemma":[0.99857134,0.000011345286,0.000005796434,0.00070751144,0.00008963183,0.00038908247,0.000024659204,0.000023957227,0.00017667726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99753696,0.00073863077,0.00025738435,0.0002858708,0.0008385283,0.00034259984],"domain_scores_gemma":[0.9985495,0.0006562703,0.00013394364,0.00038905395,0.00018404581,0.00008718208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011327713,0.0001686927,0.00033000475,0.00003959382,0.00035311145,0.000073393734,0.0003921915,0.000036785706,0.00030484982],"category_scores_gemma":[0.00010470448,0.00008493403,0.00004266069,0.0004897761,0.0003134097,0.000098875884,0.00020408366,0.0006789518,0.0000020965588],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.055978246,0.00039172982,0.92809933,0.000017499073,0.00023099256,0.00002094886,0.010687289,0.00028399852,0.00029911514,0.000093019014,0.0012936046,0.0026042112],"study_design_scores_gemma":[0.0153114,0.00068006146,0.9814105,0.00016698986,0.0000620683,0.000016672953,0.0019878757,0.00010331842,0.00006970992,0.00003542452,0.000054486984,0.00010146493],"about_ca_topic_score_codex":0.042419642,"about_ca_topic_score_gemma":0.00369088,"teacher_disagreement_score":0.05331118,"about_ca_system_score_codex":0.00030552203,"about_ca_system_score_gemma":0.0006124752,"threshold_uncertainty_score":0.96395695},"labels":[],"label_agreement":null},{"id":"W4318825455","doi":"10.1016/j.breast.2023.01.014","title":"Decision regret in breast cancer patients after adjuvant radiotherapy","year":2023,"lang":"en","type":"article","venue":"The Breast","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Regret; Medicine; Breast cancer; Radiation therapy; Decision aids; Cancer; Family medicine; Internal medicine; Alternative medicine; Pathology","score_opus":0.09029501513942356,"score_gpt":0.41219364437273887,"score_spread":0.3218986292333153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318825455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96536994,0.0016573882,0.00000889243,0.02856519,0.0014583968,0.0015836144,0.0006867691,0.00022937419,0.00044043484],"genre_scores_gemma":[0.9938164,0.0009135428,0.00009329744,0.0029526583,0.00021613836,0.0013185682,0.000063190644,0.00005649377,0.00056973804],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969877,0.0009687113,0.000664915,0.0003097827,0.00042236602,0.0006465182],"domain_scores_gemma":[0.9974365,0.00078429986,0.0002305892,0.0011499927,0.00025874376,0.0001398345],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00043931956,0.0001903669,0.00027016166,0.00020064262,0.00053358485,0.000010702503,0.00065112807,0.00016746903,0.00096966536],"category_scores_gemma":[0.00006305273,0.00012892821,0.000062104846,0.00086915394,0.000085692576,0.0001539033,0.00031953055,0.0007148381,0.0008661456],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006340279,0.000068017085,0.9297973,0.00007179464,0.000011479884,0.0000027220867,0.010172236,0.000026289506,0.000010897219,0.000073491545,0.013948891,0.045182835],"study_design_scores_gemma":[0.0014074639,0.000019625992,0.9890969,0.00076846074,0.000005548362,0.0000037161105,0.0014753969,0.0007171105,8.4812365e-7,0.000498434,0.005861734,0.0001447879],"about_ca_topic_score_codex":0.0029626489,"about_ca_topic_score_gemma":0.0016032261,"teacher_disagreement_score":0.059299555,"about_ca_system_score_codex":0.0005214647,"about_ca_system_score_gemma":0.00027778637,"threshold_uncertainty_score":0.99994355},"labels":[],"label_agreement":null},{"id":"W4319872582","doi":"10.1016/j.breast.2023.02.005","title":"Long-term outcomes and effects of hypofractionated radiotherapy in microinvasive breast cancer: Analysis from a randomized trial","year":2023,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Princess Margaret Cancer Centre; Sunnybrook Health Science Centre; Northeast Cancer Centre; University of Ottawa; Health Sciences Centre; London Health Sciences Centre; McMaster University","funders":"National Cancer Institute; Canada Research Chairs","keywords":"Medicine; Breast cancer; Hazard ratio; Internal medicine; Context (archaeology); Confidence interval; Randomized controlled trial; Breast-conserving surgery; Radiation therapy; Oncology; Cancer; Surgery; Mastectomy","score_opus":0.007469719082759991,"score_gpt":0.273344885973577,"score_spread":0.26587516689081697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319872582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946183,0.0024052453,0.00004228864,0.0018073795,0.00014210795,0.0006104449,0.00034847768,0.000016259606,0.000009487656],"genre_scores_gemma":[0.9965677,0.0026153075,0.000018857423,0.00014118003,0.0001391615,0.00023594806,0.0001693014,0.000017114577,0.00009541935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989587,0.00021695989,0.00024063514,0.00028903157,0.000116486466,0.00017816809],"domain_scores_gemma":[0.99914384,0.00035891798,0.00014994048,0.0002645318,0.00004823311,0.000034508408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001731182,0.00018474403,0.0006415172,0.00012601563,0.00005692193,0.0000127138555,0.00012534647,0.000074899486,0.00002241547],"category_scores_gemma":[0.00003342214,0.00011903606,0.00024486822,0.00041346997,0.00019834252,0.0000053550716,0.000069018504,0.000058099897,0.0000019215192],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4546037,0.00024946863,0.48693323,0.00003971584,0.013124974,0.000018245206,0.0004718278,0.00009534873,0.03374832,0.0000092991995,0.0002541916,0.010451703],"study_design_scores_gemma":[0.2510791,0.000021998785,0.7451988,0.000022180837,0.0007050846,0.000014389534,0.000023946752,0.000024758665,0.0027762365,0.000029650875,0.00000426745,0.00009956048],"about_ca_topic_score_codex":0.0028127187,"about_ca_topic_score_gemma":0.0007649809,"teacher_disagreement_score":0.25826558,"about_ca_system_score_codex":0.00003267881,"about_ca_system_score_gemma":0.000044177767,"threshold_uncertainty_score":0.48541498},"labels":[],"label_agreement":null},{"id":"W4323545813","doi":"10.1016/j.breast.2023.03.004","title":"Regularly scheduled physical examinations and the detection of breast cancer recurrences","year":2023,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Ontario Clinical Oncology Group; Ottawa Hospital","funders":"","keywords":"Medicine; Breast cancer; Survivorship curve; Physical exam; Health care; Cancer; Cancer recurrence; General surgery; Pediatrics; Surgery; Internal medicine","score_opus":0.008723617018628088,"score_gpt":0.25745588878212783,"score_spread":0.24873227176349974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323545813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99358463,0.0008385355,0.000054512104,0.0048784455,0.00010285398,0.0001675491,0.00016436791,0.000018888708,0.0001901848],"genre_scores_gemma":[0.9990591,0.00037849502,0.0000053020717,0.000031090338,0.00024854724,0.000116414674,0.000014161001,0.000008510175,0.0001384224],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99944454,0.00008498691,0.000084280335,0.00015959314,0.0001056906,0.00012090283],"domain_scores_gemma":[0.99957955,0.00004887143,0.000064155596,0.00020849564,0.00007999312,0.000018918006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015475166,0.00009435045,0.0001106959,0.000020463374,0.00018271529,0.000013265803,0.00012014194,0.000030142206,0.0000037191887],"category_scores_gemma":[0.000018525378,0.000049697483,0.000053167925,0.00019594682,0.00045596447,0.0000041976978,0.000103979735,0.000049768165,0.0000044956637],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023238817,0.00034514428,0.02487423,0.00010783656,0.001600364,0.0000023154173,0.0048105977,0.000115520874,0.38817784,0.0052281586,0.0014317386,0.5709824],"study_design_scores_gemma":[0.0014266054,0.00004107625,0.9774489,0.000034763438,0.00015208809,0.00013070005,0.00079559354,0.00033184479,0.018250365,0.00086994015,0.00039499346,0.00012313726],"about_ca_topic_score_codex":0.0003373124,"about_ca_topic_score_gemma":0.00019219177,"teacher_disagreement_score":0.9525747,"about_ca_system_score_codex":0.00000887909,"about_ca_system_score_gemma":0.0000256246,"threshold_uncertainty_score":0.20266046},"labels":[],"label_agreement":null},{"id":"W4324131925","doi":"10.1016/s0960-9776(23)00380-6","title":"P262 How patients prioritize features of different potential treatment pathways in early breast cancer: a best-worst scaling study","year":2023,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Global Affairs Canada","funders":"","keywords":"Medicine; Breast cancer; Oncology; Scaling; Cancer; Internal medicine","score_opus":0.011028462127131424,"score_gpt":0.24217250126201273,"score_spread":0.2311440391348813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324131925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99690163,0.0003654542,0.000002029154,0.0008225456,0.00021785917,0.0006973997,0.00092223164,0.000028541259,0.000042317177],"genre_scores_gemma":[0.99870825,0.0004096939,0.000005473775,0.000019488929,0.0002647567,0.00027894325,0.00011840213,0.000038675247,0.00015630115],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850076,0.00012731733,0.0002279825,0.00044586512,0.00028718446,0.00041085653],"domain_scores_gemma":[0.99923605,0.000021558766,0.00012731088,0.00044171713,0.00010479662,0.00006857424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000083237355,0.0003279825,0.00035280152,0.00008400594,0.00015682432,0.000035448862,0.0002539192,0.00008437957,0.0000047967396],"category_scores_gemma":[0.000007949763,0.00021225534,0.00013981237,0.00024665616,0.00011370188,0.0000066480998,0.0002392798,0.00008701384,0.000006047271],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000981344,0.0023346338,0.91955274,0.000027706705,0.0006424256,0.00002348637,0.0023673282,0.000062978645,0.0073985173,0.000012667296,0.00017340122,0.06642279],"study_design_scores_gemma":[0.0032179253,0.0004518898,0.99203557,0.00006332344,0.00014921596,0.000022219434,0.0013197054,0.0000063597854,0.0024910783,0.000021728136,0.000022148193,0.00019881006],"about_ca_topic_score_codex":0.002265276,"about_ca_topic_score_gemma":0.0013879676,"teacher_disagreement_score":0.07248288,"about_ca_system_score_codex":0.00011764408,"about_ca_system_score_gemma":0.00005688687,"threshold_uncertainty_score":0.8655522},"labels":[],"label_agreement":null},{"id":"W4324132198","doi":"10.1016/s0960-9776(23)00177-7","title":"P058 Outcomes of Rural Men With Breast Cancer: A Multicenter Population Based Retrospective Cohort Study","year":2023,"lang":"en","type":"article","venue":"The Breast","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency; University of Saskatchewan","funders":"","keywords":"Medicine; Retrospective cohort study; Breast cancer; Oncology; Gynecology; Cohort study; Internal medicine; Demography; Cancer","score_opus":0.010276856039041393,"score_gpt":0.27553135792528544,"score_spread":0.26525450188624405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324132198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99507165,0.000011049792,0.000006091809,0.002296721,0.000077451325,0.0012293162,0.0002841649,0.00008844641,0.0009350991],"genre_scores_gemma":[0.99866295,0.000007246417,0.000014653398,0.00026088097,0.00007833065,0.00010090098,0.00010732793,0.000026843341,0.000740889],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888974,0.00006410713,0.000226342,0.00017738494,0.00042854072,0.00021385893],"domain_scores_gemma":[0.9992422,0.00004908902,0.00012106451,0.00038494568,0.00013324295,0.00006947919],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002506389,0.00015677242,0.0004072723,0.00009079974,0.00008667303,0.000010468237,0.00010867284,0.0000315104,0.00044810053],"category_scores_gemma":[0.000009175675,0.00008840168,0.000076606804,0.00031104928,0.000059794205,0.00008539273,0.000033688288,0.00013971872,0.000016327365],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013662509,0.00016215483,0.9948911,0.000026312906,0.00036492848,0.000009047326,0.00076371524,0.000101050515,0.00016445683,0.0000061233736,0.00039394514,0.0017509055],"study_design_scores_gemma":[0.0039795693,0.0001570339,0.99140906,0.000060079125,0.00027690816,0.000034575773,0.0018817439,0.0020580199,0.000028203298,0.000003514578,0.0000093417975,0.00010192069],"about_ca_topic_score_codex":0.00790673,"about_ca_topic_score_gemma":0.00059306086,"teacher_disagreement_score":0.007313669,"about_ca_system_score_codex":0.00027093716,"about_ca_system_score_gemma":0.00010670589,"threshold_uncertainty_score":0.9986997},"labels":[],"label_agreement":null},{"id":"W4324132274","doi":"10.1016/s0960-9776(23)00123-6","title":"P004 Pyrotinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer : a multicenter, open-label, phase 2 trial","year":2023,"lang":"en","type":"article","venue":"The Breast","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Seagen (Canada)","funders":"","keywords":"Medicine; Trastuzumab; Open label; Oncology; Adjuvant; Breast cancer; Internal medicine; Adjuvant therapy; Clinical trial; Cancer","score_opus":0.04864517656838026,"score_gpt":0.3922865478377956,"score_spread":0.34364137126941535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324132274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853463,0.00010620952,0.00000793748,0.006735173,0.00024116822,0.005799182,0.0013974434,0.000094992145,0.00027159136],"genre_scores_gemma":[0.99568516,0.000060363695,0.000036631445,0.0011782607,0.0003096202,0.001983523,0.00016786522,0.0001083805,0.00047018417],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99694616,0.00034293605,0.00038402152,0.0005799853,0.0009464143,0.0008004785],"domain_scores_gemma":[0.99849266,0.00017208159,0.00012028305,0.00066632597,0.00027689818,0.00027175917],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00068752386,0.0003497575,0.00055315567,0.00021398025,0.00012793097,0.00010686888,0.0005463847,0.000100513025,0.0010980058],"category_scores_gemma":[0.000026339441,0.00021011417,0.000069012116,0.0009921237,0.0002745666,0.00016246889,0.00015639185,0.0005458721,0.00014754897],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6766312,0.009649857,0.11446324,0.0000891168,0.00028838505,0.0002625784,0.0018257683,0.000028710128,0.0003325153,0.000004013367,0.0028362197,0.19358839],"study_design_scores_gemma":[0.38496748,0.004540281,0.6071829,0.001045739,0.00006668635,0.000023682274,0.00018483726,0.00083685655,0.0003040338,0.00000592733,0.00054097874,0.000300582],"about_ca_topic_score_codex":0.0020854068,"about_ca_topic_score_gemma":0.00052459416,"teacher_disagreement_score":0.49271968,"about_ca_system_score_codex":0.0004902542,"about_ca_system_score_gemma":0.0007885969,"threshold_uncertainty_score":0.9998151},"labels":[],"label_agreement":null},{"id":"W4366825031","doi":"10.1016/j.breast.2023.04.007","title":"Partial Breast Irradiation","year":2023,"lang":"en","type":"review","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Breast cancer; Radiation therapy; Cancer; Stage (stratigraphy); Intensive care medicine; Oncology; Medical physics; Surgery; Internal medicine","score_opus":0.04154735797831621,"score_gpt":0.32771374149377075,"score_spread":0.28616638351545454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366825031","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000010957062,0.9973314,0.000009875955,0.00029657508,0.00039281056,0.00041868733,0.0010299864,0.000056701527,0.00045300185],"genre_scores_gemma":[0.00018462008,0.99535507,0.000007641273,0.00004769522,0.0020106996,0.00030252404,0.0010755933,0.00009292831,0.00092325057],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986465,0.00014354163,0.0002945736,0.00043527732,0.0001598378,0.0003202791],"domain_scores_gemma":[0.9990202,0.00003677437,0.00020422744,0.00063405547,0.000043727603,0.00006102444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001583479,0.000382641,0.0005894718,0.00004373253,0.00017332523,0.000034214692,0.0003691928,0.00021919,0.000027205091],"category_scores_gemma":[0.0000151708255,0.00023809829,0.00038806614,0.00020135324,0.00011371625,0.0000019936413,0.00024598226,0.00014331844,0.00063883245],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002449413,0.00003936552,0.000020458065,0.00091024,0.0007653015,0.000004940313,0.0000238859,0.000001541678,0.000002339696,0.00008524872,0.0075445403,0.99057764],"study_design_scores_gemma":[0.00018330636,0.000018500528,0.00074151333,0.00095041696,0.0007901252,0.0012318358,0.000015700056,9.393442e-7,0.0000017268277,0.000021513304,0.9957552,0.0002892321],"about_ca_topic_score_codex":0.00008323734,"about_ca_topic_score_gemma":0.000041349478,"teacher_disagreement_score":0.99028844,"about_ca_system_score_codex":0.00005622336,"about_ca_system_score_gemma":0.0001735773,"threshold_uncertainty_score":0.97093666},"labels":[],"label_agreement":null},{"id":"W4367625869","doi":"10.1016/j.breast.2023.04.008","title":"Intrathecal trastuzumab versus alternate routes of delivery for HER2-targeted therapies in patients with HER2+ breast cancer leptomeningeal metastases","year":2023,"lang":"en","type":"review","venue":"The Breast","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Jewish General Hospital; Montreal Neurological Institute and Hospital; Université de Montréal; McGill University; Institute for Research in Immunology and Cancer","funders":"National Cancer Institute","keywords":"Medicine; Trastuzumab; Intrathecal; Breast cancer; Oncology; Cancer; Internal medicine; Surgery","score_opus":0.04405675240668845,"score_gpt":0.3281233339356311,"score_spread":0.28406658152894265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367625869","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026315823,0.9554478,0.000014227581,0.0003164907,0.00038373965,0.003919213,0.0134801995,0.00009229696,0.00003020769],"genre_scores_gemma":[0.03088193,0.9647434,0.00035735924,0.000045358025,0.00036811287,0.0012219902,0.0019442977,0.0002635458,0.00017405141],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99746084,0.0002516375,0.00072941446,0.00052404596,0.0004965704,0.00053747394],"domain_scores_gemma":[0.9981059,0.000538759,0.00050100207,0.0005311945,0.00019465484,0.0001285345],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037643273,0.0006638024,0.00212702,0.00024132583,0.000088839486,0.000031729694,0.00030918134,0.00014072115,0.00012505508],"category_scores_gemma":[0.000016587188,0.00034539145,0.0005523095,0.00051202707,0.00020380571,0.00007852343,0.00007953369,0.0003281148,0.000014647102],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049567986,0.0009797853,0.0012795952,0.0055202344,0.0068238685,0.00004178222,0.0002969731,0.000012815469,3.3776908e-7,0.00008912708,0.00024136362,0.9797573],"study_design_scores_gemma":[0.15675431,0.023933461,0.16122763,0.18149874,0.105345555,0.0025086175,0.003561653,0.00022235009,0.00006142368,0.0003357898,0.3573464,0.0072040744],"about_ca_topic_score_codex":0.0016565715,"about_ca_topic_score_gemma":0.00037352525,"teacher_disagreement_score":0.97255325,"about_ca_system_score_codex":0.00033590526,"about_ca_system_score_gemma":0.00043575445,"threshold_uncertainty_score":0.9998998},"labels":[],"label_agreement":null},{"id":"W4379179922","doi":"10.1016/j.breast.2023.05.008","title":"Risk-adjusted benchmarking of long-term overall survival in patients with HER2-positive early-stage Breast cancer: A Swedish retrospective cohort study","year":2023,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Benchmarking; Medicine; Breast cancer; Proportional hazards model; Stage (stratigraphy); Demography; Retrospective cohort study; Cohort; Population; Cancer; Internal medicine; Environmental health","score_opus":0.005951133295760421,"score_gpt":0.23550581238406515,"score_spread":0.22955467908830474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379179922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966751,0.000044051547,0.000005979965,0.00008293998,0.00014815545,0.0009734583,0.0018611512,0.000025483481,0.00018370408],"genre_scores_gemma":[0.9991886,0.00008840126,0.0000044994235,0.000015414205,0.00015400175,0.00015576291,0.00024910964,0.0000411508,0.000103086684],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825263,0.00019549731,0.00024835858,0.0005281792,0.00039908802,0.0003762216],"domain_scores_gemma":[0.99897563,0.000030735213,0.0002424065,0.00045052465,0.0002452285,0.000055500102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026350465,0.00028608672,0.00037976017,0.000068936024,0.00014626193,0.000020534137,0.0002397139,0.00006392078,0.00002859757],"category_scores_gemma":[0.000011056946,0.00020306921,0.000076481236,0.00037683517,0.00017172114,0.000011128064,0.0002585463,0.00016220196,0.000004308692],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014692964,0.0005536052,0.9952278,0.000012084721,0.00083582645,0.00001590839,0.00064936886,0.0000805055,0.000052732812,0.0000039366637,0.00003721657,0.0010617314],"study_design_scores_gemma":[0.0029836874,0.00042449904,0.9957241,0.000077530814,0.000173448,0.000008483575,0.00025010243,0.000006315404,0.00012508698,0.0000033791193,9.389769e-7,0.00022246],"about_ca_topic_score_codex":0.009153393,"about_ca_topic_score_gemma":0.00709596,"teacher_disagreement_score":0.0025134974,"about_ca_system_score_codex":0.00015451883,"about_ca_system_score_gemma":0.0000630471,"threshold_uncertainty_score":0.99744475},"labels":[],"label_agreement":null},{"id":"W4379229810","doi":"10.1016/j.breast.2023.06.001","title":"Does age affect outcome with breast cancer?","year":2023,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Breast cancer; Radiation therapy; Stage (stratigraphy); Internal medicine; Cancer; Oncology; Pathological; Cohort; Disease; Mastectomy; Retrospective cohort study; Population; Chemotherapy; Hormonal therapy","score_opus":0.011888363476697542,"score_gpt":0.2749742049590731,"score_spread":0.26308584148237557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379229810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860601,0.00019767207,0.00002530808,0.011118382,0.00033235038,0.0002936604,0.00073663826,0.00013345394,0.0011024431],"genre_scores_gemma":[0.9961609,0.00012302121,0.00001903625,0.000312742,0.00050709164,0.000150055,0.00008406172,0.000037038717,0.0026060315],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999048,0.00004576462,0.0001100725,0.0003111008,0.0001526989,0.00033236042],"domain_scores_gemma":[0.9993849,0.000020089587,0.00005454609,0.00043790592,0.000045517387,0.000057044694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000105929765,0.00020685529,0.0001693756,0.0000281166,0.00018916334,0.000026483374,0.00023633998,0.00005256043,0.00004047284],"category_scores_gemma":[0.0000048999873,0.00008778124,0.00007729625,0.00020741434,0.00017939653,0.000003410601,0.00016582807,0.000070938775,0.00007726585],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011680521,0.00014240544,0.9352662,0.000078162106,0.0011079478,0.000115970746,0.0004444782,0.00019272212,0.019296862,0.00020551778,0.012620627,0.029361062],"study_design_scores_gemma":[0.00075645634,0.00004524347,0.9925252,0.000030281122,0.00008825499,0.00030771998,0.00021074619,0.000005397981,0.0019638797,0.00004368474,0.003807402,0.00021573287],"about_ca_topic_score_codex":0.00049279927,"about_ca_topic_score_gemma":0.000926395,"teacher_disagreement_score":0.05725901,"about_ca_system_score_codex":0.00002854328,"about_ca_system_score_gemma":0.00003842938,"threshold_uncertainty_score":0.35796154},"labels":[],"label_agreement":null},{"id":"W4382794593","doi":"10.1016/j.breast.2023.06.010","title":"Individualising radiation therapy decisions in breast cancer patients based on tumour infiltrating lymphocytes and genomic biomarkers","year":2023,"lang":"en","type":"review","venue":"The Breast","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Health Sciences Centre","funders":"AstraZeneca; Breast Cancer Research Foundation","keywords":"Medicine; Breast cancer; Oncology; Radiation therapy; Internal medicine; Cancer","score_opus":0.04843570531051944,"score_gpt":0.3313331753465822,"score_spread":0.28289747003606275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382794593","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02331247,0.97268414,0.0000016095146,0.0005947343,0.00033767484,0.0018020289,0.0010835556,0.00007835154,0.00010540811],"genre_scores_gemma":[0.008537058,0.9900693,0.000016747073,0.00048198397,0.00022484911,0.00019291877,0.0003450043,0.000109135464,0.000022978475],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9977991,0.0002867254,0.0007047775,0.00045319877,0.00039239548,0.00036383167],"domain_scores_gemma":[0.9983079,0.0007293366,0.00043533297,0.0003797448,0.000050957697,0.000096727825],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00070573646,0.00045504954,0.00095627666,0.00051041244,0.00019581297,0.00009334247,0.00022683726,0.00021965822,0.00006303369],"category_scores_gemma":[0.00004391606,0.0002826752,0.00028465892,0.0009019593,0.00012401537,0.00006667554,0.000046349112,0.000297011,0.000018171939],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067480054,0.00009684488,0.004050199,0.0005390651,0.00031271583,0.000006551027,0.00014369939,0.000003831463,0.000020654888,0.000001447008,0.00028784413,0.99386233],"study_design_scores_gemma":[0.015440955,0.0003744724,0.7529523,0.08297899,0.0012164689,0.0006743149,0.00019091064,0.00055400276,0.000013466155,0.000023269016,0.14421856,0.0013622943],"about_ca_topic_score_codex":0.0010715158,"about_ca_topic_score_gemma":0.00006112372,"teacher_disagreement_score":0.99250007,"about_ca_system_score_codex":0.0007445499,"about_ca_system_score_gemma":0.00077837484,"threshold_uncertainty_score":0.99996257},"labels":[],"label_agreement":null},{"id":"W4386047410","doi":"10.1016/j.breast.2023.08.006","title":"Explaining risks and benefits of loco-regional treatments to patients","year":2023,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Sentinel lymph node; Multidisciplinary approach; Modalities; Breast cancer; Intensive care medicine; Sentinel node; Quality of life (healthcare); Radiation therapy; Medical physics; Cancer; Surgery; Internal medicine; Nursing","score_opus":0.03801203491805294,"score_gpt":0.2804020069672601,"score_spread":0.24238997204920715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386047410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99878126,0.00018483207,0.00000439863,0.00048435037,0.00004172781,0.0001398005,0.00016427514,0.000011000509,0.00018832948],"genre_scores_gemma":[0.9993773,0.0001240866,0.00003812495,0.0001122737,0.00007280448,0.000049909282,0.00010988322,0.00001223816,0.00010339466],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994721,0.00001890179,0.000088046785,0.00017481076,0.00009824751,0.00014788625],"domain_scores_gemma":[0.99968475,0.000015309995,0.000038648817,0.0001714519,0.00004668736,0.00004316261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000044880002,0.00010226296,0.00009481188,0.000027809981,0.00008839142,0.0000050592807,0.000083012164,0.000030265417,0.0000040748387],"category_scores_gemma":[0.000009600885,0.00007010599,0.000031865475,0.00010053703,0.000055359862,0.0000017804472,0.00014533222,0.000018678355,0.000020975533],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004900939,0.00018568772,0.9105416,0.000015004919,0.00048209293,0.0000012514679,0.00096729165,0.00027806585,0.0028307615,0.00014746666,0.0038338797,0.080226816],"study_design_scores_gemma":[0.0007114011,0.00009523238,0.99585754,0.00001966662,0.00003300853,0.000011316285,0.000109171626,0.0000028196675,0.002512979,0.000022755197,0.0005522499,0.000071842485],"about_ca_topic_score_codex":0.00015060225,"about_ca_topic_score_gemma":0.00003554414,"teacher_disagreement_score":0.08531597,"about_ca_system_score_codex":0.00000934485,"about_ca_system_score_gemma":0.000010699448,"threshold_uncertainty_score":0.28588393},"labels":[],"label_agreement":null},{"id":"W4388536914","doi":"10.1016/s0960-9776(23)00621-5","title":"PO55 IDENTIFYING THE EDUCATION, INFORMATION AND SUPPORT NEEDS OF CANADIANS DIAGNOSED WITH BREAST CANCER: A CANADIAN BREAST CANCER NETWORK (CBCN) ASSESSMENT PROJECT","year":2023,"lang":"en","type":"article","venue":"The Breast","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Oncology; Family medicine; Internal medicine; Cancer; Gynecology","score_opus":0.01647969720470941,"score_gpt":0.24954873400062685,"score_spread":0.23306903679591745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388536914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88777864,0.0020926667,0.00016651729,0.05443306,0.0022468315,0.002345003,0.019258035,0.00011359472,0.031565633],"genre_scores_gemma":[0.99535215,0.0013225743,0.000017665721,0.0015195737,0.0004561812,0.0003307136,0.00008396638,0.00003150357,0.0008857011],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99856997,0.000021890428,0.0005580817,0.00018927906,0.00006593696,0.00059484283],"domain_scores_gemma":[0.9987142,0.00005159469,0.0004936592,0.0003864705,0.00014472884,0.00020932005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006412535,0.0002154528,0.00035347915,0.00036921774,0.00044601946,0.00021012021,0.00037746772,0.00008406933,0.00035056108],"category_scores_gemma":[0.00001043134,0.00016181957,0.00006377325,0.0009564672,0.00018408636,0.0007653243,0.00005358664,0.00020511688,0.00005288599],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004884804,0.000025938403,0.86323017,0.00008854861,0.00020711921,0.0000020531656,0.006355029,0.0012963788,7.7566136e-7,0.028311772,0.04689592,0.053537432],"study_design_scores_gemma":[0.00036546236,0.000020177977,0.9694945,0.00009517101,0.000033655313,0.0001454806,0.002300537,0.0004834852,3.62621e-7,0.0007614869,0.026058985,0.00024066342],"about_ca_topic_score_codex":0.8830397,"about_ca_topic_score_gemma":0.68148226,"teacher_disagreement_score":0.20155746,"about_ca_system_score_codex":0.0005924731,"about_ca_system_score_gemma":0.0029764178,"threshold_uncertainty_score":0.65988106},"labels":[],"label_agreement":null},{"id":"W4388536916","doi":"10.1016/s0960-9776(23)00609-4","title":"IN37 INEQUITIES IN ACCESS TO NEW CANCER DRUGS: ROLE OF REGULATORS AND CLINICAL TRIALS","year":2023,"lang":"en","type":"article","venue":"The Breast","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Clinical trial; Cancer drugs; Oncology; Cancer; Intensive care medicine; Family medicine; Internal medicine","score_opus":0.29638580323579866,"score_gpt":0.5522378578766761,"score_spread":0.25585205464087746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388536916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9502632,0.0015323446,7.734056e-7,0.04615372,0.00012997622,0.00029105516,0.00001939597,0.00001971393,0.0015898444],"genre_scores_gemma":[0.9955213,0.0021308297,0.000009375214,0.0013032384,0.00041605713,0.000013767615,0.0000012674959,0.000007135299,0.00059701654],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990294,0.00019965364,0.00038396748,0.00010916492,0.00013712581,0.00014070168],"domain_scores_gemma":[0.99844104,0.0012062892,0.00009605591,0.000115223804,0.000025140194,0.00011624103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024267486,0.00006309657,0.00038606933,0.000042593176,0.00002995897,0.000015892481,0.00010021952,0.000033696855,0.00014439152],"category_scores_gemma":[0.00070845295,0.0000355397,0.000049388334,0.00029787075,0.000068194866,0.00007045904,0.00021234572,0.00012853331,0.000012402306],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002216399,0.000070136215,0.20696957,0.00007512512,0.0002393607,0.0000047482895,0.0024586332,0.000013233082,0.00047661606,0.00030731354,0.0187274,0.76844144],"study_design_scores_gemma":[0.0019063823,0.000090882946,0.92417103,0.0002112655,0.00023141327,0.000012140522,0.0022180614,0.00016914794,0.000487774,0.0014232032,0.06899425,0.000084442036],"about_ca_topic_score_codex":0.002451723,"about_ca_topic_score_gemma":0.00027127363,"teacher_disagreement_score":0.76835704,"about_ca_system_score_codex":0.000013671154,"about_ca_system_score_gemma":0.00006329278,"threshold_uncertainty_score":0.3706288},"labels":[],"label_agreement":null},{"id":"W4388536933","doi":"10.1016/s0960-9776(23)00591-x","title":"Poster Session","year":2023,"lang":"en","type":"article","venue":"The Breast","topic":"Cancer survivorship and care","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Session (web analytics); Medical physics; World Wide Web","score_opus":0.01910894706484904,"score_gpt":0.28104695670949525,"score_spread":0.2619380096446462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388536933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95030075,0.00007098143,0.0000046583923,0.018426795,0.00040731512,0.00009376833,0.000013159943,0.00015311476,0.030529454],"genre_scores_gemma":[0.9874901,0.000009180606,7.396604e-7,0.0009668174,0.00024096672,0.000005465988,0.000015013448,0.000008007777,0.011263666],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99969006,0.00001311363,0.00003995222,0.000059816703,0.00010440327,0.00009263687],"domain_scores_gemma":[0.99974984,0.0000169746,0.000008410377,0.00017106012,0.000019502359,0.000034198063],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008213936,0.000036039866,0.000051949177,0.000020418935,0.000038325386,0.000006239793,0.00004127441,0.000018334455,0.00027388742],"category_scores_gemma":[0.0000036132778,0.000019365278,0.000033812354,0.0001639052,0.000018137545,0.000014108014,0.000031240146,0.000057900088,0.00085539185],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013836108,0.00012975938,0.21209563,0.00026815356,0.0001491864,0.00029668046,0.012130449,0.0000044309318,0.022937525,0.0014676702,0.29213294,0.45700398],"study_design_scores_gemma":[0.0005587003,0.000050273706,0.9370325,0.00012712467,0.00004875213,0.0006364605,0.0012076645,0.000047302256,0.0010211339,0.0002713503,0.058911737,0.0000869821],"about_ca_topic_score_codex":0.00014820752,"about_ca_topic_score_gemma":0.000059268714,"teacher_disagreement_score":0.7249369,"about_ca_system_score_codex":0.000010908629,"about_ca_system_score_gemma":0.000017205095,"threshold_uncertainty_score":0.9999226},"labels":[],"label_agreement":null},{"id":"W4388536952","doi":"10.1016/s0960-9776(23)00602-1","title":"IN27 REVISITING OLIGOMETASTATIC DISEASE","year":2023,"lang":"en","type":"article","venue":"The Breast","topic":"RNA regulation and disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Oncology; Internal medicine","score_opus":0.011710682113753337,"score_gpt":0.25900233389492366,"score_spread":0.24729165178117032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388536952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99448836,0.00027574736,0.00017007219,0.0032761206,0.00006236851,0.000117189426,0.000050868253,0.00004751931,0.0015117802],"genre_scores_gemma":[0.99609894,0.000030162222,0.000018928904,0.0004778788,0.0002638242,0.000012627669,0.00015529507,0.0000115634,0.0029307776],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9995228,0.00004586585,0.00008171152,0.00012705271,0.00008869295,0.00013387253],"domain_scores_gemma":[0.999558,0.000009292432,0.000028417062,0.00026962877,0.0000253978,0.00010931881],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013325247,0.000063815736,0.00004520641,0.000022458185,0.00008944346,0.00002296392,0.0001147295,0.000015024163,0.000048636997],"category_scores_gemma":[0.0000597897,0.000044624456,0.000057402223,0.0001456894,0.000041494735,0.0000017491955,0.00007169506,0.00002324095,0.00026069087],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016384046,0.00026727142,0.20614545,0.0004598038,0.00043374617,0.00017884193,0.00044578352,0.0055972296,0.33069918,0.014484298,0.16295545,0.27669454],"study_design_scores_gemma":[0.00066442933,0.000022164524,0.95450526,0.000036399713,0.000066117966,0.000050973664,0.00019170948,0.0017432807,0.0008608316,0.0011620526,0.04042372,0.0002730668],"about_ca_topic_score_codex":0.0000023756788,"about_ca_topic_score_gemma":7.918241e-7,"teacher_disagreement_score":0.7483598,"about_ca_system_score_codex":0.000003066835,"about_ca_system_score_gemma":0.000033765904,"threshold_uncertainty_score":0.33507407},"labels":[],"label_agreement":null},{"id":"W4388537066","doi":"10.1016/s0960-9776(23)00632-x","title":"PO66 ASSESSING SELECT EMOTIONAL AND PSYCHOLOGICAL STATES OF STAGE IV BREAST CANCER PATIENTS: A CANADIAN BREAST CANCER NETWORK (CBCN) ASSESSMENT PROJECT","year":2023,"lang":"en","type":"article","venue":"The Breast","topic":"Bioinformatics and Genomic Networks","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Breast Cancer Network","funders":"","keywords":"Medicine; Breast cancer; Stage (stratigraphy); Oncology; Cancer; Internal medicine; Gynecology","score_opus":0.01530091572164715,"score_gpt":0.3020152930271996,"score_spread":0.28671437730555244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388537066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99298203,0.0002241008,0.0001393864,0.0017695997,0.0002636349,0.00039584065,0.0035016823,0.000021305961,0.0007023953],"genre_scores_gemma":[0.99756604,0.000496239,0.0001306367,0.00047862137,0.0004358025,0.000058206904,0.0005302357,0.000025543763,0.00027868035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99858695,0.000090057445,0.00030366206,0.00029625944,0.00018641095,0.0005366418],"domain_scores_gemma":[0.9992368,0.00002087248,0.0001728204,0.00024978849,0.00017329578,0.00014642367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034424732,0.00021555329,0.00020768668,0.000057082983,0.00025160427,0.00007869723,0.00023015002,0.00014578091,0.00009755421],"category_scores_gemma":[0.0000031024017,0.00015243223,0.00006898623,0.0003081311,0.00015968432,0.000014355894,0.00013195857,0.00018650829,0.0000031274194],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038689404,0.00041503843,0.7468518,0.0002404774,0.00086186937,0.000010030034,0.00058048323,0.011962996,0.0030832326,0.00055860885,0.105018675,0.13002992],"study_design_scores_gemma":[0.0006223867,0.00008735033,0.9911536,0.000093331815,0.000036843285,0.000110110224,0.0001496715,0.005391817,0.0000141271985,0.00011436557,0.001976789,0.00024960988],"about_ca_topic_score_codex":0.016649283,"about_ca_topic_score_gemma":0.015830163,"teacher_disagreement_score":0.24430181,"about_ca_system_score_codex":0.000075515614,"about_ca_system_score_gemma":0.00039751612,"threshold_uncertainty_score":0.9898989},"labels":[],"label_agreement":null},{"id":"W4388541367","doi":"10.1016/s0960-9776(23)00671-9","title":"PO107 TREATMENT PATTERNS AND CLINICAL OUTCOMES AMONG PATIENTS RECEIVING CDK4/6 INHIBITORS FOR HR+/HER2-ADVANCED/METASTATIC BREAST CANCER IN A SINGLE-CENTRE, CANADIAN REAL-WORLD SETTING USING AI-EXTRACTED DATA","year":2023,"lang":"en","type":"article","venue":"The Breast","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Oncology; Metastatic breast cancer; Internal medicine; Real world data; Breast cancer; Cancer; Gynecology; Data science","score_opus":0.06498576353557098,"score_gpt":0.3755091171562621,"score_spread":0.31052335362069117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388541367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98842674,0.00005727628,0.000043735305,0.0048223143,0.00050269463,0.0018407,0.0041271434,0.00013241102,0.000047003065],"genre_scores_gemma":[0.9972876,0.00010074471,0.0006152309,0.0004902464,0.00032398172,0.00009735924,0.00058787863,0.00013557484,0.00036140875],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967474,0.0001926434,0.00087481533,0.00083858037,0.00034719662,0.0009993967],"domain_scores_gemma":[0.99745923,0.00063838065,0.00035839475,0.00090001797,0.00018754089,0.00045645045],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00059750193,0.00047044258,0.00077745644,0.0004219824,0.00028767902,0.000077023,0.00030547584,0.00009529022,0.000061663195],"category_scores_gemma":[0.0001459679,0.00034902504,0.00013605946,0.0007436467,0.00020946149,0.00047611372,0.00017497975,0.00033607037,0.0000060576986],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030549653,0.00022213632,0.77297515,0.000068698675,0.00022915736,0.00003444686,0.00046249418,0.0001323638,0.000039626866,0.0000026009295,0.00005556198,0.22547227],"study_design_scores_gemma":[0.005162057,0.00010576701,0.9880039,0.0011037668,0.00032589093,0.00006114801,0.0007561929,0.0036977595,0.00001427383,0.000042494557,0.0003841686,0.00034256696],"about_ca_topic_score_codex":0.17823991,"about_ca_topic_score_gemma":0.6592951,"teacher_disagreement_score":0.48105517,"about_ca_system_score_codex":0.0013692678,"about_ca_system_score_gemma":0.0004603727,"threshold_uncertainty_score":0.99989617},"labels":[],"label_agreement":null},{"id":"W4391544428","doi":"10.1016/j.breast.2024.103678","title":"“The Uncertainty Principle”– studying immediate lymphatic reconstruction impacts the natural history of breast cancer related lymphedema","year":2024,"lang":"en","type":"article","venue":"The Breast","topic":"Lymphatic System and Diseases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Lymphedema; Sequela; Medicine; Breast cancer; Natural history; Lymphatic system; Axillary Lymph Node Dissection; Surgery; General surgery; Cancer; Sentinel lymph node; Internal medicine; Pathology","score_opus":0.014337550091481174,"score_gpt":0.26900190397925394,"score_spread":0.25466435388777275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391544428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92422634,0.055085644,0.0000032250387,0.012376789,0.0051516434,0.00095069077,0.000066851,0.00019608102,0.0019427212],"genre_scores_gemma":[0.99577194,0.00055073714,0.0000041171525,0.00018803561,0.00049738074,0.000078400706,0.0000075420076,0.000034331686,0.0028675178],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99804854,0.00024277219,0.0005220157,0.0002562766,0.0005852661,0.00034513877],"domain_scores_gemma":[0.9983923,0.0005224304,0.00021960797,0.0005771638,0.00015655952,0.00013197622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009552407,0.00022244528,0.00030185026,0.00006710888,0.00024473484,0.000057645186,0.0003054763,0.00007324826,0.00017858465],"category_scores_gemma":[0.00009616505,0.00009342792,0.00021312764,0.0003157122,0.00039100528,0.00012866997,0.00008267691,0.000048574107,0.000058792415],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049271057,0.0009969681,0.11581757,0.0059381495,0.010232409,0.00033369815,0.04886765,0.00050588575,0.011788726,0.019063117,0.039935026,0.7415937],"study_design_scores_gemma":[0.006139332,0.0001429305,0.8928228,0.0064594164,0.0037974084,0.03159133,0.010849152,0.03829579,0.00014339393,0.0011346854,0.007933368,0.0006903857],"about_ca_topic_score_codex":0.0012372101,"about_ca_topic_score_gemma":0.00007096499,"teacher_disagreement_score":0.77700526,"about_ca_system_score_codex":0.001627751,"about_ca_system_score_gemma":0.0017014269,"threshold_uncertainty_score":0.42565125},"labels":[],"label_agreement":null},{"id":"W4391694263","doi":"10.1016/j.breast.2024.103689","title":"Acceptance of outpatient enhanced recovery after surgery (ERAS©) protocols for implant-based breast reconstruction nudged on by the COVID-19 pandemic","year":2024,"lang":"en","type":"article","venue":"The Breast","topic":"Enhanced Recovery After Surgery","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Medicine; Pandemic; Coronavirus disease 2019 (COVID-19); Implant; Outpatient surgery; 2019-20 coronavirus outbreak; Outpatient visits; Breast reconstruction; Emergency medicine; Outpatient clinic; Breast surgery; Retrospective cohort study; Health care; General surgery; Medical emergency; Surgery; Internal medicine; Breast cancer; Disease; Pathology; Ambulatory","score_opus":0.03261693403500457,"score_gpt":0.3068541239689837,"score_spread":0.27423718993397916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391694263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9584714,0.0003928809,0.011669996,0.0061496357,0.001942927,0.01817774,0.002578921,0.00034009782,0.00027640458],"genre_scores_gemma":[0.97885066,0.000032819968,0.00009232284,0.0029869208,0.00036087213,0.016765667,0.00012252823,0.000072143455,0.00071605964],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99765146,0.00025904496,0.0006973234,0.0005303576,0.00040997958,0.00045184355],"domain_scores_gemma":[0.99597967,0.002674342,0.00027735392,0.0007605257,0.00013721957,0.00017088567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012890713,0.0003357003,0.00056564255,0.00017313696,0.00014531211,0.000064990934,0.00020229825,0.00017628002,0.0002659723],"category_scores_gemma":[0.0002637495,0.00019360478,0.00046962,0.00038426818,0.00023821398,0.00017687202,0.000034746383,0.00040775587,0.000036417357],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05674483,0.0008210248,0.02766634,0.003873719,0.00075225416,0.00005165527,0.0009147872,0.00022182123,0.09156372,0.000050600876,0.073630214,0.743709],"study_design_scores_gemma":[0.024101501,0.008432177,0.21434347,0.03653426,0.0029806902,0.06793334,0.0021527375,0.0046973946,0.46367007,0.005440038,0.16296905,0.0067452616],"about_ca_topic_score_codex":0.00005356452,"about_ca_topic_score_gemma":0.000037847873,"teacher_disagreement_score":0.73696375,"about_ca_system_score_codex":0.00037798448,"about_ca_system_score_gemma":0.00065068516,"threshold_uncertainty_score":0.7894974},"labels":[],"label_agreement":null},{"id":"W4392948130","doi":"10.1016/j.breast.2024.103715","title":"Is Oncotype DX testing informative for breast cancers with low ER expression? A retrospective review from a biomarker testing referral center","year":2024,"lang":"en","type":"review","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Breast cancer; Estrogen receptor; Biomarker; Immunohistochemistry; Oncology; Internal medicine; Single Center; Staining; Cancer; Pathology; Biology","score_opus":0.05407487999830693,"score_gpt":0.3393136598317154,"score_spread":0.2852387798334085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392948130","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000039436287,0.9858256,0.000035855723,0.00029710273,0.00021872831,0.0018158298,0.009983324,0.000060943723,0.0017232057],"genre_scores_gemma":[0.0009208249,0.9934824,0.00097638275,0.0006010975,0.00083596405,0.0015029059,0.0012275991,0.00017883521,0.0002739959],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976161,0.0001242549,0.00059682823,0.00084777264,0.00028539947,0.00052962464],"domain_scores_gemma":[0.9979195,0.00015587978,0.0006066427,0.00078657444,0.00042170985,0.00010967329],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022061772,0.00084467506,0.0013273454,0.0000622728,0.0002748319,0.00007700619,0.00047818053,0.00023353133,0.000035286736],"category_scores_gemma":[0.0001163732,0.00045033722,0.00042569096,0.00051135663,0.00021706488,0.00001660448,0.0004364514,0.00035996188,0.000048579117],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034171753,0.00009521195,0.0006513379,0.022604372,0.0032887973,0.000016073138,0.00031517842,7.243404e-7,0.000040269148,0.0000041877556,0.032287445,0.9403547],"study_design_scores_gemma":[0.0018183427,0.00041088802,0.0031834808,0.39005485,0.008597934,0.0035586252,0.00021533098,0.000023411427,0.000046039713,0.00007119834,0.590088,0.0019318965],"about_ca_topic_score_codex":0.0003547802,"about_ca_topic_score_gemma":0.00009457861,"teacher_disagreement_score":0.9384228,"about_ca_system_score_codex":0.0004474861,"about_ca_system_score_gemma":0.0007111792,"threshold_uncertainty_score":0.99979484},"labels":[],"label_agreement":null},{"id":"W4393970104","doi":"10.1016/j.breast.2024.103727","title":"Global representativeness and impact of funding sources in cost-effectiveness research on systemic therapies for advanced breast cancer: A systematic review","year":2024,"lang":"en","type":"review","venue":"The Breast","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Representativeness heuristic; Breast cancer; Oncology; Cancer; Intensive care medicine; Internal medicine","score_opus":0.17853200373280306,"score_gpt":0.4579822645300993,"score_spread":0.2794502607972963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393970104","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011405649,0.9826931,0.00003060645,0.000093006514,0.00027346768,0.0077775,0.007695736,0.000019711897,0.00027632774],"genre_scores_gemma":[0.052119523,0.9435225,0.0000027976755,0.000014472445,0.00015540536,0.0040239794,0.000021920521,0.000070009824,0.000069384434],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9966149,0.0004496608,0.0015221669,0.0007526021,0.000089628134,0.0005710513],"domain_scores_gemma":[0.9968093,0.0011627751,0.0011372358,0.00067397754,0.00012058087,0.00009613531],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004909597,0.0005035551,0.004378022,0.00040956473,0.00012636473,0.0001265501,0.00063181296,0.00020292305,0.00001884217],"category_scores_gemma":[0.00020664406,0.00033027443,0.00073954393,0.0009357395,0.00022916241,0.00022911697,0.00015010612,0.0003767305,0.000039011375],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014996895,0.000050329567,0.0008228772,0.92616016,0.00085842883,0.0000033918284,0.00021777084,0.00005119007,8.9469054e-8,0.017976347,0.00008734357,0.053622097],"study_design_scores_gemma":[0.00058431184,0.00015114565,0.0019094486,0.98814774,0.00064177415,0.00046032696,0.00021364698,0.00003955558,8.661334e-8,0.0045280126,0.0027988085,0.00052512117],"about_ca_topic_score_codex":0.0017219525,"about_ca_topic_score_gemma":0.000073288524,"teacher_disagreement_score":0.061987597,"about_ca_system_score_codex":0.0017978743,"about_ca_system_score_gemma":0.00032018518,"threshold_uncertainty_score":0.99991494},"labels":[],"label_agreement":null},{"id":"W4393970330","doi":"10.1016/j.breast.2024.103725","title":"Phase II randomized trial comparing metronomic anthracycline-containing chemotherapy versus standard schedule in untreated HER2 negative advanced breast cancer: activity and quality of life results of the GOIM 21003 trial","year":2024,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Polytechnique Montréal","funders":"","keywords":"Medicine; Breast cancer; Oncology; Anthracycline; Chemotherapy; Cancer; Internal medicine; Randomized controlled trial; Clinical trial; Paclitaxel; Intensive care medicine","score_opus":0.027479019557511437,"score_gpt":0.34786666042149866,"score_spread":0.32038764086398724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393970330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944558,0.001072779,0.00003273615,0.0014520749,0.00043548463,0.0013248621,0.0010700742,0.000015200084,0.00014094567],"genre_scores_gemma":[0.99913585,0.00034652738,0.000047832422,0.000017898003,0.00024140517,0.0001404674,0.00002378291,0.000023330573,0.000022896062],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9979682,0.00059134624,0.00061300397,0.000408593,0.00018622173,0.00023263712],"domain_scores_gemma":[0.9985691,0.00048971205,0.0004194137,0.0003813473,0.000091293536,0.00004914438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010591501,0.00026411074,0.00092664047,0.00004844472,0.00013693944,0.000019831545,0.00019940455,0.0000898914,0.000008751756],"category_scores_gemma":[0.00027015788,0.00016114602,0.00024426935,0.0002229758,0.0005428187,0.000017232527,0.00017209332,0.00016392524,1.9229194e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9750399,0.0004493281,0.00023191441,0.00003007423,0.000997218,2.8777475e-7,0.0005642922,0.00012777354,0.009687239,0.00004070005,0.000015547928,0.012815697],"study_design_scores_gemma":[0.96095264,0.0010308395,0.0032525342,0.00013153972,0.00017982286,0.0000028588836,0.00037023166,0.0002974262,0.033564225,0.00003600505,0.00001992455,0.00016195854],"about_ca_topic_score_codex":0.0035499383,"about_ca_topic_score_gemma":0.0018207841,"teacher_disagreement_score":0.023876984,"about_ca_system_score_codex":0.00011913167,"about_ca_system_score_gemma":0.0003246741,"threshold_uncertainty_score":0.65713435},"labels":[],"label_agreement":null},{"id":"W4399068599","doi":"10.1016/j.breast.2024.103756","title":"6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7)","year":2024,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":197,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Comprehensive Cancer Network; European Oncology Nursing Society; American Society of Clinical Oncology","keywords":"Medicine; Guideline; Breast cancer; Consensus conference; Alliance; Expert opinion; Cancer; Family medicine; Intensive care medicine; Medical physics; Internal medicine; Pathology","score_opus":0.035208989634672415,"score_gpt":0.3513847015563822,"score_spread":0.3161757119217098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399068599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41501647,0.16090581,0.0027244594,0.40957415,0.0024046104,0.0018657375,0.006108799,0.00008695804,0.0013130093],"genre_scores_gemma":[0.9852854,0.01036998,0.0017535387,0.0006541824,0.0006311823,0.00020091882,0.000037631675,0.00002539204,0.0010417724],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99936306,0.000010820858,0.00018980246,0.00022621138,0.000093978524,0.000116126655],"domain_scores_gemma":[0.9994374,0.000038321716,0.00004857981,0.00017365861,0.00028064012,0.00002140404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001413335,0.00012898853,0.00010106671,0.000015823729,0.000095605625,0.000024446737,0.00012858868,0.00002701068,0.000009613493],"category_scores_gemma":[0.0000113840215,0.00006907174,0.000046609595,0.000042742853,0.00018511231,0.0000028505183,0.00017400224,0.000026905418,5.559561e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011706707,0.000057315345,0.0035382484,0.0003357054,0.004288575,0.000006810826,0.00024279776,0.0007195064,0.010764309,0.002786601,0.06450809,0.9115814],"study_design_scores_gemma":[0.008776282,0.00028065598,0.3429255,0.0021878327,0.002977079,0.00410442,0.008648726,0.008936401,0.0103759,0.0031029414,0.60634476,0.0013395327],"about_ca_topic_score_codex":0.00014231373,"about_ca_topic_score_gemma":0.00007648109,"teacher_disagreement_score":0.91024184,"about_ca_system_score_codex":0.000011187541,"about_ca_system_score_gemma":0.00002476946,"threshold_uncertainty_score":0.2816664},"labels":[],"label_agreement":null},{"id":"W4399360795","doi":"10.1016/j.breast.2024.103758","title":"Capturing longer term surgical outcome measures as part of routine care of breast cancer patients","year":2024,"lang":"en","type":"article","venue":"The Breast","topic":"Digital Imaging in Medicine","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Department of Health and Social Care; National Institute for Health and Care Research; Institute of Cancer Research; Cancer Research UK; Royal Marsden Cancer Charity; Association of Breast Surgery; Royal Marsden NHS Foundation Trust","keywords":"Oncoplastic Surgery; Medicine; Breast cancer; Population; Family medicine; Patient-reported outcome; General surgery; Cancer; Breast surgery; Quality of life (healthcare); Nursing; Internal medicine","score_opus":0.01998252014009268,"score_gpt":0.30548683153378936,"score_spread":0.2855043113936967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399360795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837463,0.002040806,0.0000025573027,0.0023405855,0.00054428953,0.000291484,0.000321651,0.00007811299,0.010634222],"genre_scores_gemma":[0.99800134,0.000026225696,0.00000831463,0.00011474409,0.00037779263,0.000013595242,0.00004117863,0.000039843882,0.0013769576],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998374,0.000035075514,0.0004570379,0.00023000143,0.00065206224,0.0002518509],"domain_scores_gemma":[0.9990366,0.000077149554,0.00009333102,0.0003714782,0.00030108317,0.00012033734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020747587,0.00018699434,0.00043502665,0.00009305831,0.000025539724,0.00001813318,0.00017326731,0.000050674986,0.00026799718],"category_scores_gemma":[0.00004895189,0.000108099724,0.00014881116,0.00021688805,0.00028122382,0.000091406335,0.00009077429,0.00022697488,0.00003200959],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046449187,0.00026782777,0.9182779,0.0011651217,0.00032420634,0.00016467168,0.003509687,0.0000105343315,0.00046392964,0.00018149053,0.0012961983,0.0738739],"study_design_scores_gemma":[0.002196223,0.00015524223,0.987059,0.0033674566,0.0005729034,0.0016463852,0.00071941095,0.000046170382,0.0014494832,0.00003321542,0.0025486746,0.000205845],"about_ca_topic_score_codex":0.00045024787,"about_ca_topic_score_gemma":0.000012813397,"teacher_disagreement_score":0.073668055,"about_ca_system_score_codex":0.00009074739,"about_ca_system_score_gemma":0.00010608764,"threshold_uncertainty_score":0.44081786},"labels":[],"label_agreement":null},{"id":"W4401371497","doi":"10.1016/j.breast.2024.103784","title":"Efficacy and safety of oncoplastic breast-conserving surgery versus conventional breast-conserving surgery: An updated meta-analysis","year":2024,"lang":"en","type":"review","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Hubei Agricultural Science and Technology Innovation Center; Youth Innovation Team Project for Talent Introduction and Cultivation in Universities of Shandong Province","keywords":"Medicine; Breast-conserving surgery; Oncoplastic Surgery; Breast cancer; Meta-analysis; Mastectomy; Breast surgery; General surgery; Surgery; Cancer; Internal medicine","score_opus":0.0810175731642195,"score_gpt":0.3347189798190219,"score_spread":0.2537014066548024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401371497","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014008782,0.989902,0.000034363235,0.00056876586,0.0004851408,0.00054797705,0.006908096,0.00006114709,0.00009158488],"genre_scores_gemma":[0.04841709,0.9404043,0.0000645694,0.00007882023,0.0006140357,0.00024626308,0.00968333,0.000215103,0.00027647556],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99554205,0.00088758324,0.0013059101,0.0012209881,0.0004486238,0.0005948256],"domain_scores_gemma":[0.9961479,0.0012321953,0.00084490987,0.001288223,0.00026822856,0.00021857258],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011356493,0.0010377314,0.0042415275,0.0004514952,0.00027821818,0.00010755977,0.0005339858,0.000395323,0.00040588807],"category_scores_gemma":[0.000069434165,0.00068248855,0.0037069798,0.0010937914,0.00047079357,0.000018856528,0.0006594334,0.00034348754,0.000037173602],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003133119,0.0006393582,0.0007527239,0.006320203,0.7506281,0.00008746022,0.000086604865,0.00003438842,0.00002282967,0.00013504922,0.0069800243,0.23118013],"study_design_scores_gemma":[0.0011618994,0.00006856722,0.0068535055,0.0016030596,0.88438505,0.006271106,0.000106169755,0.000029775643,0.000010355655,0.000026341157,0.09797285,0.0015113042],"about_ca_topic_score_codex":0.00054902444,"about_ca_topic_score_gemma":0.00045010052,"teacher_disagreement_score":0.22966883,"about_ca_system_score_codex":0.000100165824,"about_ca_system_score_gemma":0.00081011915,"threshold_uncertainty_score":0.9995626},"labels":[],"label_agreement":null},{"id":"W4403679785","doi":"10.1016/j.breast.2024.103826","title":"Adjuvant denosumab for early breast cancer–Evidence and controversy","year":2024,"lang":"en","type":"article","venue":"The Breast","topic":"Bone health and treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Denosumab; Adjuvant; Breast cancer; Oncology; Internal medicine; Cancer","score_opus":0.026056213707314573,"score_gpt":0.3317920827648059,"score_spread":0.3057358690574913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403679785","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89919835,0.03172432,0.00012655708,0.065198496,0.00056926656,0.0016207773,0.00074232975,0.00017542714,0.0006444923],"genre_scores_gemma":[0.9960541,0.00053113356,0.0000448017,0.0007298078,0.000200174,0.00012782062,0.000005611474,0.000020078664,0.0022864637],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9992862,0.000017301281,0.0001237364,0.00019980673,0.00012440862,0.00024858944],"domain_scores_gemma":[0.99940276,0.00019461534,0.000023764174,0.00017263195,0.000050439063,0.00015580576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012717428,0.00011037735,0.00018374836,0.00002979385,0.00010683325,0.000038918173,0.00004688637,0.00003969239,0.000069825786],"category_scores_gemma":[0.00001515683,0.00006332966,0.000054081593,0.00008085252,0.000070213406,0.00008963053,0.000020316775,0.00009987828,0.00004738674],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053965813,0.00024822183,0.17335178,0.0016051376,0.0007738076,0.00022602688,0.0017302155,0.0000012275102,0.00075022725,0.0043772985,0.019899808,0.7916397],"study_design_scores_gemma":[0.0024227367,0.00027922328,0.9856671,0.0012718253,0.0005434388,0.0035239507,0.00006363158,0.0005559022,0.000051148214,0.0004559132,0.005052141,0.00011296404],"about_ca_topic_score_codex":0.0025262563,"about_ca_topic_score_gemma":0.00014420885,"teacher_disagreement_score":0.81231534,"about_ca_system_score_codex":0.000079404046,"about_ca_system_score_gemma":0.00018685973,"threshold_uncertainty_score":0.38189605},"labels":[],"label_agreement":null},{"id":"W4408080074","doi":"10.1016/j.breast.2025.104432","title":"A composite 18F-FDG PET/CT and HER2 tissue-based biomarker to predict response to neoadjuvant pertuzumab and trastuzumab in HER2-positive breast cancer (TBCRC026)","year":2025,"lang":"en","type":"article","venue":"The Breast","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Association of Schools and Colleges of Optometry; Breakthrough Cancer Research; Translational Breast Cancer Research Consortium; Susan G. Komen; AbbVie; Breast Cancer Research Foundation; National Cancer Institute; Conquer Cancer Foundation; Sidney Kimmel Comprehensive Cancer Center; Genentech; Susan G. Komen for the Cure","keywords":"Medicine; Pertuzumab; Trastuzumab; Breast cancer; Oncology; Biomarker; Internal medicine; Neoadjuvant therapy; Cancer","score_opus":0.015187110065405239,"score_gpt":0.34014640719778816,"score_spread":0.3249592971323829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408080074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9124891,0.00095907156,0.00008398993,0.08242516,0.00012530321,0.0020577982,0.0008358004,0.000078815356,0.00094495446],"genre_scores_gemma":[0.99402994,0.000067721565,0.00018579795,0.0032214418,0.00008609787,0.00027085847,0.000018883993,0.00006386232,0.0020553875],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9968743,0.00059024047,0.00039670573,0.0007701778,0.0006133319,0.000755281],"domain_scores_gemma":[0.99803793,0.0004948114,0.00005424606,0.0006621376,0.0001984514,0.0005524384],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011873583,0.00039508205,0.0006182645,0.00053798745,0.00022282345,0.00012125497,0.00031324135,0.000033225322,0.00024095953],"category_scores_gemma":[0.000111035035,0.00029608613,0.000067058565,0.0011058389,0.0003422014,0.00008026034,0.00029739898,0.00046576356,0.000035762558],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14591774,0.0016586111,0.24011047,0.001219426,0.00087865704,0.009097365,0.0051498017,0.0003472329,0.12957904,0.00010404112,0.028368661,0.43756896],"study_design_scores_gemma":[0.0044479305,0.0006934076,0.9738538,0.002665759,0.00012685244,0.007030535,0.0005369514,0.0016320861,0.0022320824,0.000018076824,0.00642102,0.00034145475],"about_ca_topic_score_codex":0.0073739155,"about_ca_topic_score_gemma":0.0013495655,"teacher_disagreement_score":0.73374337,"about_ca_system_score_codex":0.0009491685,"about_ca_system_score_gemma":0.00093943777,"threshold_uncertainty_score":0.9999491},"labels":[],"label_agreement":null},{"id":"W4408165382","doi":"10.1016/j.breast.2025.104429","title":"Systematic literature review and trial-level meta-analysis of aromatase inhibitors vs tamoxifen in patients with HR+/HER2− early breast cancer","year":2025,"lang":"en","type":"review","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"Novartis Pharmaceuticals Corporation; Novartis","keywords":"Medicine; Meta-analysis; Aromatase; Tamoxifen; Oncology; Breast cancer; Internal medicine; Gynecology; Cancer","score_opus":0.022054445923889283,"score_gpt":0.2943155683501745,"score_spread":0.2722611224262852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408165382","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016187933,0.98226136,0.0000011464562,0.00018587137,0.0000494151,0.003072536,0.014241578,0.00000665735,0.000019575751],"genre_scores_gemma":[0.0008133791,0.9957091,0.00001490659,0.00013309543,0.00005804451,0.001628672,0.0013671239,0.000039679493,0.00023599739],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99712795,0.0006302754,0.0010050932,0.00065955037,0.00030610707,0.00027101318],"domain_scores_gemma":[0.99761325,0.00010387759,0.00093187444,0.0010536985,0.00022996664,0.000067322835],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00041474524,0.0006878778,0.0052110776,0.00025053107,0.0000669086,0.000040925883,0.00039840263,0.00023260854,0.0000223078],"category_scores_gemma":[0.0000414355,0.00033794012,0.0012674935,0.0013784285,0.00012993721,0.000009045165,0.00024118654,0.0002005136,0.0000015319126],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018443367,0.0004848318,0.00069464307,0.6206314,0.36235267,0.000008456325,0.000118446624,0.0000019451227,1.8100721e-7,0.000012603821,0.0010550044,0.012795486],"study_design_scores_gemma":[0.0036387038,0.00012947555,0.005111334,0.15439044,0.8341174,0.000053804713,0.000007687797,1.1713159e-7,7.6209517e-7,0.0000019012831,0.0020195185,0.00052886386],"about_ca_topic_score_codex":0.00026386336,"about_ca_topic_score_gemma":0.00024239018,"teacher_disagreement_score":0.4717647,"about_ca_system_score_codex":0.00006599014,"about_ca_system_score_gemma":0.00019078351,"threshold_uncertainty_score":0.99990726},"labels":[],"label_agreement":null},{"id":"W4410774867","doi":"10.1016/j.breast.2025.104509","title":"Intellectual or developmental disabilities and curative female breast cancer treatment: A population-based retrospective cohort study","year":2025,"lang":"en","type":"article","venue":"The Breast","topic":"Down syndrome and intellectual disability research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Kingston General Hospital; Queen's University","funders":"Canadian Institutes of Health Research; Ontario Ministry of Health and Long-Term Care; Institute for Clinical Evaluative Sciences","keywords":"Medicine; Retrospective cohort study; Breast cancer; Cohort; Oncology; Gynecology; Cancer; Internal medicine","score_opus":0.038157220014991264,"score_gpt":0.3508706628714092,"score_spread":0.31271344285641794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410774867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98959756,0.00006239255,0.0000144527785,0.002065118,0.000054696353,0.0020668625,0.0002055265,0.000057578425,0.0058758087],"genre_scores_gemma":[0.9863643,0.000026203228,0.000014668925,0.00014628476,0.00004304657,0.00046740862,0.000038374623,0.000017149932,0.012882562],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984744,0.00017385771,0.00028269313,0.00043748663,0.00033788205,0.00029367144],"domain_scores_gemma":[0.9988182,0.00057423883,0.00002814022,0.00029418763,0.0001859071,0.000099292374],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002507712,0.00024130176,0.0004520952,0.000113456386,0.0003287468,0.00006480783,0.000114963565,0.000053717973,0.006041759],"category_scores_gemma":[0.00054700114,0.00013105094,0.00007715613,0.00055593083,0.00043616875,0.00009126108,0.0000819408,0.00018196032,0.000086592285],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020221327,0.0010241844,0.9822517,0.000032500102,0.00045154995,0.0000015297195,0.008697364,0.000001743391,0.000026265177,0.000050881063,0.0007675149,0.004672624],"study_design_scores_gemma":[0.0014302294,0.00066849537,0.97694224,0.00011504527,0.00015858842,0.00020087544,0.019814566,0.00026769558,0.000086097076,0.00008075807,0.000103704624,0.00013168919],"about_ca_topic_score_codex":0.0053003794,"about_ca_topic_score_gemma":0.0018080092,"teacher_disagreement_score":0.011117202,"about_ca_system_score_codex":0.001165131,"about_ca_system_score_gemma":0.0005099099,"threshold_uncertainty_score":0.99486685},"labels":[],"label_agreement":null},{"id":"W4411989599","doi":"10.1016/j.breast.2025.104528","title":"Does RSClin provide additional information over classic clinico-pathologic scores (PREDICT 2.1, INFLUENCE 2.0, CTS5)?","year":2025,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Ontario Institute for Cancer Research; McMaster University; University of Ottawa","funders":"Daiichi Sankyo Europe; LEO Pharma; Eisai; Puma Biotechnology; Genomic Health; GlaxoSmithKline; Pfizer; Celgene; PharmaMar; Government of Ontario; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Exemestane; Oncology; Internal medicine; Breast cancer; Tamoxifen; Cohort; Population; Gynecology; Cancer","score_opus":0.004593320587251226,"score_gpt":0.24602974150859971,"score_spread":0.24143642092134848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411989599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869121,0.00031414063,0.00030881338,0.0036817568,0.0004982135,0.0005128874,0.0036632796,0.00008146676,0.0040273885],"genre_scores_gemma":[0.99591374,0.000099297744,0.00010725466,0.00204014,0.00022630363,0.00018229817,0.0008956508,0.0000071210898,0.00052816846],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991071,0.00006542888,0.00025915803,0.00021611135,0.00014350803,0.00020864328],"domain_scores_gemma":[0.9992927,0.0000758366,0.00012470601,0.00036087947,0.00011323843,0.0000326722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001383936,0.00017027644,0.000132776,0.00004292529,0.00020042133,0.000031917494,0.0002470956,0.0001043334,0.00014060053],"category_scores_gemma":[0.00011432849,0.00008877573,0.00008822862,0.000119112876,0.0002677922,0.000022692477,0.00020297672,0.00010707455,0.000060228158],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003092002,0.00070584303,0.5163174,0.0002809444,0.0012997636,0.00002092106,0.00058781763,0.0008209318,0.012741435,0.00446153,0.32902676,0.13064465],"study_design_scores_gemma":[0.0008368538,0.00006205526,0.942402,0.00008659496,0.000064185304,0.0000452267,0.00010176654,0.000035820645,0.001296993,0.0012567212,0.053650286,0.0001614834],"about_ca_topic_score_codex":0.000059578168,"about_ca_topic_score_gemma":0.00007234006,"teacher_disagreement_score":0.4260846,"about_ca_system_score_codex":0.00003388233,"about_ca_system_score_gemma":0.00014263573,"threshold_uncertainty_score":0.3620169},"labels":[],"label_agreement":null},{"id":"W4412535807","doi":"10.1016/j.breast.2025.104545","title":"Biomarkers of response and resistance to immune checkpoint inhibitors in breast cancer","year":2025,"lang":"en","type":"review","venue":"The Breast","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Santé Montérégie","funders":"","keywords":"Medicine; Breast cancer; Oncology; Cancer; Immune system; Cancer research; Internal medicine; Immunology","score_opus":0.016240443658560786,"score_gpt":0.31449669898182714,"score_spread":0.29825625532326633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412535807","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012229525,0.9903863,8.383514e-7,0.005657648,0.00023298066,0.0013692881,0.0006000781,0.000021664986,0.00050823216],"genre_scores_gemma":[0.00095165044,0.9962218,0.000038991846,0.00014239004,0.00009093914,0.00020688731,0.000016862516,0.000041273906,0.0022892407],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977486,0.00034433368,0.0009427023,0.0004052295,0.00025360176,0.0003055466],"domain_scores_gemma":[0.9984911,0.00032148833,0.0003290108,0.0006906661,0.00007800966,0.00008971295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013854365,0.00038630338,0.0014860935,0.0004619641,0.000056414716,0.000017253396,0.0002650403,0.00021097584,0.000091811664],"category_scores_gemma":[0.000057459118,0.00024376277,0.0004120828,0.0013095953,0.00025752303,0.00003214579,0.00013735663,0.0003014331,0.0000045265438],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019909235,0.00008925738,0.00013041875,0.016569627,0.00063080434,0.000023941577,0.000241324,5.730858e-8,0.00077841996,0.000010272308,0.0016114757,0.96000516],"study_design_scores_gemma":[0.0020723476,0.00007955575,0.035568964,0.17760327,0.00096314837,0.0007764595,0.00017059306,3.4338973e-7,0.00008524868,0.000013188143,0.78221256,0.00045429743],"about_ca_topic_score_codex":0.0010530697,"about_ca_topic_score_gemma":0.00024572772,"teacher_disagreement_score":0.95955086,"about_ca_system_score_codex":0.00040603807,"about_ca_system_score_gemma":0.0009968688,"threshold_uncertainty_score":0.9940357},"labels":[],"label_agreement":null},{"id":"W4412658536","doi":"10.1016/j.breast.2025.104547","title":"Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial","year":2025,"lang":"en","type":"article","venue":"The Breast","topic":"Reproductive Biology and Fertility","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; ECOG-ACRIN Cancer Research Group; National Institutes of Health; Rising Tide Foundation; American College of Radiology Imaging Network; NRG Oncology; Fonds De La Recherche Scientifique - FNRS; Fondazione Umberto Veronesi; Gateway for Cancer Research; Rising Tide Foundation for Clinical Cancer Research; Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung; Breast Cancer Research Foundation","keywords":"Medicine; Ovarian reserve; Pregnancy; Anti-Müllerian hormone; Hormone; Prolactin; Follicle-stimulating hormone; Breast cancer; Gynecology; Infertility; Fertility; Obstetrics; Cancer; Internal medicine; Population; Luteinizing hormone","score_opus":0.014981135986165763,"score_gpt":0.2908316096341852,"score_spread":0.27585047364801946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412658536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959405,0.0002737673,0.000022658656,0.0010456677,0.0001293073,0.0019679773,0.0003110311,0.000014519061,0.00029454575],"genre_scores_gemma":[0.999649,0.000009901158,0.000007488027,0.00008155972,0.00003638929,0.00011376428,0.000028443666,0.0000084380645,0.000065010834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985843,0.00021191624,0.0003674287,0.00041719366,0.00016748763,0.0002517039],"domain_scores_gemma":[0.9991818,0.00009408161,0.000098862765,0.00035951677,0.00021646325,0.000049294023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023639727,0.00018443949,0.00043615783,0.00012480674,0.000039338593,0.0000035622759,0.00014287059,0.00005969613,0.00003952304],"category_scores_gemma":[0.000073503004,0.000100884914,0.000061248815,0.00037409368,0.00019695896,0.000073599425,0.000078741905,0.00028603818,8.112066e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26459187,0.0007530198,0.7175928,0.000016372356,0.00010307056,0.0000017261311,0.00096443464,0.0000049935843,0.00028353932,0.0000041014155,0.000005320351,0.015678762],"study_design_scores_gemma":[0.019290693,0.000865618,0.97749907,0.00086465833,0.000029757814,0.0000035204512,0.00020468315,0.000009986099,0.0011055819,0.00004563869,0.0000019178547,0.00007888927],"about_ca_topic_score_codex":0.0012270594,"about_ca_topic_score_gemma":0.00020315392,"teacher_disagreement_score":0.25990626,"about_ca_system_score_codex":0.00019482987,"about_ca_system_score_gemma":0.00014566845,"threshold_uncertainty_score":0.41139674},"labels":[],"label_agreement":null},{"id":"W4413201858","doi":"10.1016/j.breast.2025.104558","title":"Brain imaging screening in metastatic breast cancer: patients’ and physicians’ perspectives","year":2025,"lang":"en","type":"article","venue":"The Breast","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"Instituto de Salud Carlos III; Associazione Italiana di Oncologia Medica","keywords":"Medicine; Cancer; Metastatic breast cancer; Oncology; Breast cancer; Internal medicine; Radiology; Medical physics","score_opus":0.008059041160481175,"score_gpt":0.2778434102466243,"score_spread":0.2697843690861431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413201858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92115414,0.0034111103,0.00034131412,0.07295469,0.000067940506,0.00060623663,0.00022828298,0.000043571366,0.001192721],"genre_scores_gemma":[0.9975257,0.000058389418,0.0003241203,0.0016589984,0.000043257092,0.00004122378,0.000015888778,0.000013661338,0.00031877603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99916434,0.00009056494,0.00014850512,0.00023958179,0.00013466009,0.00022236229],"domain_scores_gemma":[0.9995523,0.00011767765,0.000048377024,0.00017964243,0.000060229275,0.000041759184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018358178,0.00014601326,0.00024218441,0.00010450114,0.00010493907,0.000028868522,0.00006338716,0.00001145193,0.00004883262],"category_scores_gemma":[0.000018235103,0.000096256306,0.00006078358,0.00028945605,0.00012721056,0.000075945034,0.00005773277,0.00013346695,0.0000029920718],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039761054,0.00068847707,0.5181076,0.00008497646,0.0003994516,0.000038926126,0.0029503577,0.000020301495,0.00015122676,0.0023882142,0.001655201,0.47311768],"study_design_scores_gemma":[0.0029285972,0.000027975762,0.9901066,0.00036900892,0.00023063837,0.00011890062,0.0048950794,0.00062599237,0.000032378863,0.00030275778,0.00026935656,0.000092718685],"about_ca_topic_score_codex":0.0012684731,"about_ca_topic_score_gemma":0.00009697177,"teacher_disagreement_score":0.47302496,"about_ca_system_score_codex":0.00006969821,"about_ca_system_score_gemma":0.000046514793,"threshold_uncertainty_score":0.39252183},"labels":[],"label_agreement":null},{"id":"W4414446280","doi":"10.1016/j.breast.2025.104570","title":"Corrigendum to “Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial” [The Breast 83 (2025) 104547]","year":2025,"lang":"en","type":"erratum","venue":"The Breast","topic":"Reproductive Biology and Fertility","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Breast cancer; Fertility; Adjuvant; Pregnancy; Endocrine system","score_opus":0.023547799776237523,"score_gpt":0.29089738645089797,"score_spread":0.26734958667466047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414446280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96823704,0.0017333636,0.000033941757,0.004606368,0.006712995,0.009398777,0.007296943,0.00005819076,0.0019223619],"genre_scores_gemma":[0.9872352,0.000087700144,0.00000809049,0.00035777167,0.0005095058,0.0006396306,0.00060670485,0.00005928067,0.010496124],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951993,0.0007757805,0.0011218278,0.0014067369,0.00067370327,0.0008226152],"domain_scores_gemma":[0.9968189,0.00018130399,0.0004913699,0.0014151066,0.0008735735,0.00021977394],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006992865,0.0008184054,0.0016051017,0.00039659988,0.00015968253,0.000021263857,0.00076581794,0.00037986497,0.00021783139],"category_scores_gemma":[0.00021496284,0.00043218478,0.00026179952,0.0010566368,0.00044743303,0.00012282327,0.00039849494,0.0018378759,0.000007506196],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.33073556,0.0016971527,0.62964934,0.00015127844,0.0006767942,0.00001556114,0.0030828586,0.000008562453,0.000053218348,0.000004171231,0.0071775955,0.026747929],"study_design_scores_gemma":[0.011768088,0.0015342515,0.9803019,0.0048536006,0.00017996205,0.000042657277,0.00047496732,0.000011124078,0.00008773583,0.000021907206,0.000367078,0.00035668732],"about_ca_topic_score_codex":0.006089477,"about_ca_topic_score_gemma":0.0015973912,"teacher_disagreement_score":0.35065264,"about_ca_system_score_codex":0.0008374887,"about_ca_system_score_gemma":0.0010127416,"threshold_uncertainty_score":0.999813},"labels":[],"label_agreement":null},{"id":"W4414622121","doi":"10.1016/j.breast.2025.104593","title":"Opportunities to improve the environmental sustainability of breast cancer care: A scoping review","year":2025,"lang":"en","type":"review","venue":"The Breast","topic":"Climate Change and Health Impacts","field":"Environmental Science","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network; Canada Research Chairs","funders":"","keywords":"Breast cancer; Sustainability; Health care; MEDLINE; Healthcare system","score_opus":0.07497958448967627,"score_gpt":0.3815790261966443,"score_spread":0.306599441706968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414622121","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000013721844,0.9854904,0.000001297327,0.006304235,0.00015264191,0.004860915,0.0022642093,0.000016716816,0.0008958724],"genre_scores_gemma":[0.00007486978,0.9962762,0.0000026363073,0.0018989372,0.00012154529,0.0008495139,0.00005227289,0.000027741471,0.00069629075],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99766374,0.0003282865,0.000677308,0.0004146089,0.00038793124,0.0005281047],"domain_scores_gemma":[0.9981248,0.0002563025,0.00040438463,0.0010075615,0.000017662227,0.00018928855],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007346449,0.0003927747,0.0011384333,0.000036607602,0.0002830349,0.000025131527,0.00084287056,0.00010565709,0.002318689],"category_scores_gemma":[0.000045038032,0.0002037078,0.00031442207,0.00024648482,0.0003967851,0.000080341546,0.0009421622,0.00029803618,0.00007522641],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000062793697,0.0000243161,0.00003705982,0.12778312,0.000014654546,0.0000020483828,0.00037825276,9.5298634e-7,2.5348265e-7,0.000005559497,0.0024065739,0.86934096],"study_design_scores_gemma":[0.00013864486,0.0000629555,0.0011141795,0.5171693,0.00133103,0.00024803873,0.0013941996,8.673099e-7,7.6650656e-7,0.000036103076,0.47795564,0.0005482924],"about_ca_topic_score_codex":0.0015883498,"about_ca_topic_score_gemma":0.00037924276,"teacher_disagreement_score":0.86879265,"about_ca_system_score_codex":0.0013509403,"about_ca_system_score_gemma":0.00051869435,"threshold_uncertainty_score":0.99859333},"labels":[],"label_agreement":null},{"id":"W4415532641","doi":"10.1016/j.breast.2025.104621","title":"Evaluation of breast cancer screening programmes: Candidate performance indicators and their association with breast cancer mortality","year":2025,"lang":"en","type":"article","venue":"The Breast","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"Joint Research Centre; European Commission; World Health Organization","keywords":"Breast cancer; Breast cancer screening; Performance indicator; Association (psychology); Cancer","score_opus":0.03912520745066936,"score_gpt":0.34411501128583677,"score_spread":0.3049898038351674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415532641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99288416,0.0011234718,0.00007890044,0.003949391,0.00007634297,0.000670596,0.00039161503,0.000041326875,0.00078417535],"genre_scores_gemma":[0.99892396,0.00024613852,0.000030362327,0.0003423377,0.00013241575,0.00018460292,0.000022853732,0.000014505939,0.000102851904],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804765,0.00013666216,0.00029009432,0.00028712244,0.0009048669,0.00033359125],"domain_scores_gemma":[0.9984696,0.000041141255,0.00032518734,0.00030259782,0.00076698087,0.00009450561],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018984784,0.00020589544,0.00033608347,0.00011903035,0.00020929666,0.000038662653,0.00014632517,0.00009346783,0.000107896696],"category_scores_gemma":[0.000023866207,0.000120674646,0.00005596369,0.00073196425,0.00016001667,0.00021718572,0.000060842885,0.00024569652,8.9500264e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035843134,0.00003124071,0.7380047,0.00007519432,0.00043368028,5.146305e-7,0.00036493738,0.00017512399,0.00015566764,0.000017474847,0.00014805226,0.26023498],"study_design_scores_gemma":[0.0014404525,0.00004496557,0.9898963,0.0011660346,0.0010650777,0.0001584618,0.0007885868,0.004684287,0.0005264287,0.000022824148,0.000079240526,0.00012734786],"about_ca_topic_score_codex":0.010309415,"about_ca_topic_score_gemma":0.002101296,"teacher_disagreement_score":0.26010764,"about_ca_system_score_codex":0.0005229695,"about_ca_system_score_gemma":0.00081356644,"threshold_uncertainty_score":0.996281},"labels":[],"label_agreement":null},{"id":"W4415680787","doi":"10.1016/j.breast.2025.104619","title":"Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancer","year":2025,"lang":"en","type":"article","venue":"The Breast","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Lunenfeld-Tanenbaum Research Institute","funders":"Medical Research and Materiel Command; Division of Graduate Education; NIHR Cambridge Biomedical Research Centre; Servicio Gallego de Salud; Instituto de Salud Carlos III; Cancer Council Tasmania; National Health and Medical Research Council; Medical Research Council; Canadian Institutes of Health Research; Programme Grants for Applied Research; Manchester Biomedical Research Centre; U.S. Army; National Institutes of Health; Cancer Council Victoria; Ministry of Science and Higher Education of the Russian Federation; Xunta de Galicia; Agence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail; Institut National Du Cancer; Deutsche Krebshilfe; Medizinischen Hochschule Hannover; Associazione Italiana per la Ricerca sul Cancro; Fondazione Umberto Veronesi; University of Utah; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Fondation de France; Ministero della Salute; University of Crete; Kuopion Yliopistollinen Sairaala; University of Wisconsin-Madison; Karolinska Institutet; Deutsche Forschungsgemeinschaft; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Deutsche Gesetzliche Unfallversicherung; Chief Scientist Office, Scottish Government Health and Social Care Directorate; Bundesministerium für Bildung und Forschung; Ministerio de Economía y Competitividad; Cancer Australia; Agence Nationale de la Recherche; Robert Bosch Stiftung; Cancerfonden; National Cancer Institute; Cancer Institute NSW; National Breast Cancer Foundation; European Commission; University of Cambridge; Ministerio de Sanidad, Servicios Sociales e Igualdad; Government of Canada; Wellcome Trust; Fondation du cancer du sein du Québec; KWF Kankerbestrijding; Cancer Research UK; Itä-Suomen Yliopisto; Genome Canada; Deutsches Krebsforschungszentrum; Fondazione AIRC per la ricerca sul cancro ETS; National Institute for Health and Care Research; Scottish Government; Division of Cancer Prevention, National Cancer Institute; Department of Health and Social Care; Freistaat Sachsen; Huntsman Cancer Institute; Agency for Science, Technology and Research; University of Pennsylvania; Scottish Funding Council; Kreftforeningen; Cancer Council South Australia; American Cancer Society; Ministerie van Volksgezondheid, Welzijn en Sport; U.S. Department of Health and Human Services; Breast Cancer Research Foundation; Cancer Council NSW; Susan G. Komen for the Cure; Research Promotion Foundation; European Regional Development Fund; King's College London","keywords":"Breast cancer; Germline; Disease; Cancer; Mutation; Genetic testing","score_opus":0.04476582959621345,"score_gpt":0.3426895326240133,"score_spread":0.29792370302779986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415680787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8953978,0.0037593625,0.07889065,0.013114213,0.00037254416,0.0017242549,0.0059355437,0.000022633612,0.0007830146],"genre_scores_gemma":[0.9966525,0.00024119327,0.0002657747,0.00025700475,0.000087250126,0.0006455433,0.0001376708,0.000015182627,0.0016979218],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.99861205,0.00020070036,0.00027709643,0.00052668154,0.00015469719,0.00022877475],"domain_scores_gemma":[0.99891865,0.0002024979,0.00012707422,0.00036050478,0.00033717207,0.00005408232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039468447,0.00021593992,0.00041823083,0.00014610379,0.00023557067,0.00006278462,0.00014918002,0.00014139673,0.00012576059],"category_scores_gemma":[0.00008810288,0.00014836057,0.00023750772,0.0004610317,0.00015426683,0.000011676134,0.00017905088,0.00014566342,8.5246563e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014841465,0.002979262,0.30173814,0.0005788366,0.3975313,0.000008058802,0.015366181,0.011997002,0.14116667,0.010386283,0.063021354,0.04038543],"study_design_scores_gemma":[0.0024655666,0.000050814815,0.9578944,0.000019942738,0.020587046,0.000038121056,0.0012138265,0.0019116281,0.008829744,0.0058979453,0.00077654986,0.0003144514],"about_ca_topic_score_codex":0.00038459458,"about_ca_topic_score_gemma":0.012302147,"teacher_disagreement_score":0.65615624,"about_ca_system_score_codex":0.00007332773,"about_ca_system_score_gemma":0.00014145617,"threshold_uncertainty_score":0.6864887},"labels":[],"label_agreement":null},{"id":"W4415961645","doi":"10.1016/s0960-9776(25)00694-0","title":"#MAKEMECOUNT: ADDRESSING THE NEED FOR COMPLETE AND HARMONIZED CANCER DATA IN CANADA","year":2025,"lang":"en","type":"article","venue":"The Breast","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; MEDLINE; Real world data","score_opus":0.25428833617257046,"score_gpt":0.38777107684933737,"score_spread":0.1334827406767669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415961645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8240568,0.011299333,0.0005186538,0.15705332,0.0005073315,0.0014763057,0.0013680229,0.000028346158,0.003691874],"genre_scores_gemma":[0.9934088,0.000053386393,0.00007651299,0.006087151,0.00008948861,0.000033284454,0.000031834592,0.000005266681,0.00021427876],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9993766,0.000024888306,0.00012963256,0.00015019016,0.0001361433,0.00018253112],"domain_scores_gemma":[0.9993502,0.00013769176,0.00003604675,0.00040080256,0.00004498641,0.000030260184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028894458,0.000072416646,0.00014858849,0.000017445982,0.00014565146,0.000027508993,0.00026084334,0.000015283416,0.000028819464],"category_scores_gemma":[0.000045637957,0.00003956042,0.000012637075,0.00014791831,0.000054279302,0.000050395498,0.00012609108,0.00011422309,4.030157e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038333181,0.000040428826,0.37173924,0.0004609006,0.0004410224,0.000060562605,0.00111827,0.00019301716,0.0028502722,0.0023169739,0.2061461,0.4107999],"study_design_scores_gemma":[0.003999361,0.000021130376,0.87523925,0.0012778952,0.00029769944,0.00018053802,0.0036401055,0.03307928,0.00010112987,0.0004993269,0.08148448,0.00017978674],"about_ca_topic_score_codex":0.90326273,"about_ca_topic_score_gemma":0.9341959,"teacher_disagreement_score":0.50350004,"about_ca_system_score_codex":0.00018309486,"about_ca_system_score_gemma":0.0009861343,"threshold_uncertainty_score":0.174936},"labels":[],"label_agreement":null},{"id":"W4416091508","doi":"10.1016/j.breast.2025.104642","title":"The Breast International Group (BIG) Patient Partnership: Embedding meaningful patient involvement in the design and conduct of breast cancer clinical research","year":2025,"lang":"en","type":"article","venue":"The Breast","topic":"Mental Health and Patient Involvement","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Cancer Society","funders":"Breast Cancer Research Foundation","keywords":"General partnership; Clinical research; Breast cancer; Work (physics); Value (mathematics); Alternative medicine; Research design","score_opus":0.47775741543762434,"score_gpt":0.5456380337938939,"score_spread":0.06788061835626952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416091508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9665255,0.001075254,0.000120966724,0.021289974,0.0024931196,0.0047225095,0.00031218855,0.000029418235,0.0034310764],"genre_scores_gemma":[0.99438834,0.00056280015,0.00006912207,0.00333742,0.00027392636,0.0010647009,0.00005404493,0.00001872418,0.00023094921],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9899934,0.0060945167,0.001470432,0.00043442124,0.0010744127,0.0009328096],"domain_scores_gemma":[0.9937487,0.0045670257,0.00045343698,0.0006272532,0.00042875536,0.00017478215],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.011233417,0.00023259733,0.00031818912,0.00015256027,0.0016587515,0.000044852946,0.00078133796,0.00013966649,0.00011965205],"category_scores_gemma":[0.00009777022,0.00011580818,0.000087165965,0.00049944664,0.0005164392,0.00009330795,0.0005970437,0.0012790947,0.000021508577],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00492362,0.0016705848,0.60042125,0.000880099,0.00030801646,0.000011352958,0.05084041,0.00014075419,0.000102830185,0.02891888,0.034057043,0.27772516],"study_design_scores_gemma":[0.007912039,0.0016620033,0.64417,0.00995352,0.00016423028,0.00010746351,0.25271118,0.0076171015,0.00010026075,0.010670634,0.0641803,0.0007512827],"about_ca_topic_score_codex":0.004020819,"about_ca_topic_score_gemma":0.0024560392,"teacher_disagreement_score":0.27697387,"about_ca_system_score_codex":0.00045429473,"about_ca_system_score_gemma":0.0005956192,"threshold_uncertainty_score":0.99964094},"labels":[],"label_agreement":null},{"id":"W4417535527","doi":"10.1016/j.breast.2025.104676","title":"Beyond survival: Confronting the unmet needs in oncofertility care for young women with breast cancer","year":2025,"lang":"en","type":"article","venue":"The Breast","topic":"Reproductive Biology and Fertility","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; BC Cancer Agency","funders":"","keywords":"Oncofertility; Breast cancer; MEDLINE; Cancer; Young adult","score_opus":0.011125617682673875,"score_gpt":0.2811530932693606,"score_spread":0.2700274755866867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417535527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9813619,0.00093415746,0.00009090593,0.0109775085,0.0003040987,0.0009863521,0.00016498455,0.000036337326,0.0051437207],"genre_scores_gemma":[0.99789804,0.000012660398,0.000016415355,0.0004615816,0.00018563267,0.00029600636,0.000015326375,0.000011574242,0.001102744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99887055,0.00016073963,0.00020610345,0.00030508536,0.00011326936,0.00034423478],"domain_scores_gemma":[0.9989035,0.00014221185,0.00006148943,0.00061009056,0.0002398234,0.000042881737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009400997,0.00015619316,0.00032273526,0.000050165207,0.00021973836,0.000013840144,0.0001986572,0.00008030492,0.00005378033],"category_scores_gemma":[0.00006193517,0.000073750685,0.000049788017,0.0003505309,0.00037716862,0.000047234113,0.0000650297,0.0002679589,0.0000019398262],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021030068,0.00012433005,0.9388079,0.00017977372,0.00023445913,0.000002110685,0.009462758,0.000009343797,0.0010884402,0.00046162473,0.00026823537,0.02833093],"study_design_scores_gemma":[0.0011499623,0.000058827136,0.9835961,0.00008020388,0.00008257665,0.00005468508,0.01321396,0.000027512777,0.0002792448,0.00039495385,0.0009807487,0.000081263286],"about_ca_topic_score_codex":0.0014732319,"about_ca_topic_score_gemma":0.0015458098,"teacher_disagreement_score":0.044788133,"about_ca_system_score_codex":0.0002557648,"about_ca_system_score_gemma":0.0002459036,"threshold_uncertainty_score":0.3007466},"labels":[],"label_agreement":null},{"id":"W7117382419","doi":"10.1016/j.breast.2025.104682","title":"Multidisciplinary meeting for breast cancer care: EUSOMA recommendations for optimization","year":2025,"lang":"en","type":"article","venue":"The Breast","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital","funders":"AstraZeneca","keywords":"Multidisciplinary approach; Breast cancer; Multidisciplinary team; MEDLINE","score_opus":0.011649647930743752,"score_gpt":0.31112864123488176,"score_spread":0.299478993304138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117382419","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.057254348,0.019426432,0.47883222,0.36073306,0.0047343336,0.013340339,0.030493466,0.0005344251,0.03465139],"genre_scores_gemma":[0.9776123,0.00025985664,0.014059668,0.0004609809,0.0006306794,0.002284519,0.00073915254,0.0000702968,0.0038825513],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99940586,0.000021915383,0.00012163465,0.00023878379,0.00003596899,0.00017584421],"domain_scores_gemma":[0.99951345,0.000038739618,0.00006267897,0.0002054346,0.00015822415,0.0000214754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000062796855,0.00012554828,0.00010031305,0.000026957792,0.00036748304,0.000016816624,0.00013149655,0.000053006526,0.000019968684],"category_scores_gemma":[0.000015345131,0.00009543577,0.00008369856,0.00008063786,0.000051828443,0.0000033333479,0.00010244424,0.000023643059,0.0000011155355],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063236095,0.0010266722,0.051910877,0.00089822,0.004189306,0.0000010730112,0.0036149216,0.06868606,0.043649197,0.0050887177,0.17952299,0.6350883],"study_design_scores_gemma":[0.039615404,0.00084144104,0.4962142,0.0023678457,0.0043790224,0.0004675399,0.02478877,0.028430035,0.076644264,0.002400877,0.3198215,0.0040290924],"about_ca_topic_score_codex":0.00009483501,"about_ca_topic_score_gemma":0.0001949507,"teacher_disagreement_score":0.92035794,"about_ca_system_score_codex":0.00004783821,"about_ca_system_score_gemma":0.000069210335,"threshold_uncertainty_score":0.38917574},"labels":[],"label_agreement":null}]}